data_2jxw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jxw _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? . . . . . 0 C--O 1.233 0.232 0 CA-C-O 121.148 0.499 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.408 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 90.9 m95 -115.44 137.54 51.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.842 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 p -114.39 141.01 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.225 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.09 131.64 39.41 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.035 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.16 148.52 19.61 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.014 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.9 mm -91.49 142.62 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 120.676 0.274 . . . . 0.0 111.156 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.454 HG22 ' CD1' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -124.49 161.76 25.4 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.982 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.76 149.83 0.79 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.532 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 80.85 -55.76 0.32 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.217 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.1 55.84 0.03 OUTLIER Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.45 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -120.21 159.7 24.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.66 0.267 . . . . 0.0 110.755 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -115.83 117.04 29.1 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.06 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.454 ' CD1' HG22 ' A' ' 12' ' ' THR . 23.4 p90 -111.12 151.84 27.67 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.96 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -124.19 149.26 46.56 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.82 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -135.24 145.4 47.57 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.929 0.395 . . . . 0.0 111.446 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.408 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 6.9 t70 -109.73 122.58 47.82 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.75 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.07 -24.82 32.55 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.589 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.8 mt -60.7 -59.88 3.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.754 0.311 . . . . 0.0 110.858 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.46 -34.7 20.0 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.083 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.25 56.53 1.91 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.351 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -142.92 141.6 31.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.799 0.333 . . . . 0.0 111.544 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -86.85 131.23 34.17 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.472 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -124.74 168.58 13.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.187 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -127.54 -46.55 1.45 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.25 126.55 29.99 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.64 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -67.59 122.26 82.6 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.984 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo . . . . . 0 C--N 1.351 0.696 0 C-N-CA 122.735 2.29 . . . . 0.0 112.816 -179.801 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.416 ' CH2' ' HB2' ' A' ' 62' ' ' ASN . 83.5 m95 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.628 0.251 . . . . 0.0 110.714 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.5 p -106.6 137.27 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.819 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.9 121.83 33.08 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.857 0.36 . . . . 0.0 111.151 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.408 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -119.42 160.34 14.39 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.862 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 tp -113.0 131.6 55.7 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.93 0.395 . . . . 0.0 110.745 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.46 151.77 42.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.576 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 66.58 -157.24 0.25 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.739 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.19 -26.37 60.53 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.7 46.53 0.02 OUTLIER Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.219 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -95.68 137.97 33.99 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.68 120.06 36.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.95 0.405 . . . . 0.0 111.328 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.408 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 19.6 p90 -113.2 146.24 39.63 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.526 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -119.9 141.96 49.12 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.784 0.326 . . . . 0.0 110.905 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -130.64 149.61 52.21 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.207 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.416 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 10.4 t-20 -113.45 128.36 56.42 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.243 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.4 p -81.32 -20.3 41.04 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.739 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -58.52 -62.87 1.53 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.548 0.213 . . . . 0.0 111.263 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.0 t -99.84 -41.56 7.19 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.183 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.13 61.28 0.71 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.722 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -137.67 126.92 24.59 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.788 0.328 . . . . 0.0 110.975 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.6 p -77.84 150.14 34.25 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.841 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.6 ttt85 -133.02 157.94 43.98 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.042 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 93.4 m95 . . . . . 0 CA--C 1.535 0.385 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.007 179.897 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.416 ' HB2' HD11 ' A' ' 23' ' ' ILE . 11.5 mpt_? . . . . . 0 C--O 1.234 0.288 0 CA-C-O 120.931 0.396 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -113.38 154.63 26.61 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.197 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 2.9 t -124.82 130.45 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.685 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -90.97 130.64 36.87 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.895 0.378 . . . . 0.0 111.025 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.29 148.75 19.59 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.603 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.9 mm -104.18 142.62 17.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.653 0.263 . . . . 0.0 111.092 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.87 161.53 27.22 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.931 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.53 150.77 0.63 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.792 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 82.4 -55.49 0.21 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.145 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.1 50.76 0.05 OUTLIER Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.533 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -113.98 147.6 38.32 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.504 0.192 . . . . 0.0 110.538 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -111.6 116.68 31.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.897 0.38 . . . . 0.0 110.923 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -111.35 151.68 28.14 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.84 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 59.9 m-85 -124.55 149.71 46.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.075 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -129.73 144.61 51.38 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.331 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -109.23 122.72 47.94 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.522 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.75 -28.63 24.47 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.283 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 6' ' ' ARG . 3.8 mt -58.29 -49.8 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.167 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.01 -43.44 5.77 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.41 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.84 34.46 3.77 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.469 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -121.62 127.79 51.24 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.798 0.332 . . . . 0.0 111.068 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.91 152.68 33.14 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.969 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -133.36 167.56 20.18 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.106 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -127.64 7.99 6.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.72 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -136.03 129.56 32.18 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -66.92 133.28 93.9 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.09 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 C--N 1.35 0.621 0 C-N-CA 122.655 2.236 . . . . 0.0 112.254 179.98 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 97.7 m95 . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.815 0.34 . . . . 0.0 111.388 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 2.9 t -112.07 139.08 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.811 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.77 122.51 44.63 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.638 0.256 . . . . 0.0 111.089 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.415 ' HA3' ' CE1' ' A' ' 59' ' ' TYR . . . -118.67 154.06 16.69 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.758 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.4 tp -109.67 126.51 53.75 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.853 0.359 . . . . 0.0 111.284 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.66 152.08 37.69 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.957 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -46.73 153.64 0.38 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.658 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 68.08 8.8 6.76 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.172 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.36 55.96 5.36 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.839 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -116.32 93.07 4.08 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.755 0.312 . . . . 0.0 110.543 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.3 m -72.6 120.58 18.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.989 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.415 ' CE1' ' HA3' ' A' ' 51' ' ' GLY . 32.9 p90 -112.61 145.88 39.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.504 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 24.0 m-85 -120.26 142.07 49.39 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.864 0.364 . . . . 0.0 111.331 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -125.88 156.1 40.18 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.654 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -113.53 126.75 55.65 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.221 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.5 p -93.85 29.51 2.06 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.869 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -120.91 -55.47 1.99 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.877 0.37 . . . . 0.0 110.434 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.6 p -96.3 -33.1 12.09 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.016 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.25 64.45 1.23 Allowed Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.571 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -149.71 128.86 12.76 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.861 0.362 . . . . 0.0 111.022 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.94 149.93 29.19 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.584 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.58 156.6 48.4 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.274 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 93.9 m95 . . . . . 0 CA--C 1.534 0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.09 179.651 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 . . . . . 0 C--O 1.233 0.219 0 CA-C-O 121.11 0.481 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -106.55 141.66 37.47 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.564 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 p -115.76 138.78 45.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.935 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -90.45 132.77 35.46 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.875 0.369 . . . . 0.0 111.022 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.76 146.82 18.6 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.536 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.7 mm -102.56 141.72 18.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.557 0.218 . . . . 0.0 110.982 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.14 162.04 27.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.828 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.9 m -48.42 149.58 1.56 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.634 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 82.43 -55.89 0.21 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.086 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.93 52.21 0.04 OUTLIER Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.451 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -116.47 129.97 56.5 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.512 0.196 . . . . 0.0 110.577 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -95.58 117.14 29.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.768 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -110.69 151.28 27.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.737 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -124.42 149.38 46.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.872 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -136.45 147.71 47.35 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.483 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -111.98 122.23 47.18 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.612 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.81 -33.49 46.14 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.574 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.5 mt -60.88 -55.59 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.707 0.289 . . . . 0.0 110.994 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.9 t -84.22 -36.27 22.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.25 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.01 47.37 5.03 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.217 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -136.07 143.3 44.56 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.838 0.352 . . . . 0.0 111.539 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.01 143.01 27.55 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.572 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -134.39 167.03 21.49 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.188 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -127.38 7.25 6.4 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.671 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -123.54 127.83 48.89 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.41 110.94 3.55 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.757 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 C--N 1.349 0.605 0 C-N-CA 122.393 2.062 . . . . 0.0 112.217 -179.862 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.503 ' CH2' ' HB2' ' A' ' 62' ' ' ASN . 78.9 m95 . . . . . 0 C--O 1.233 0.226 0 CA-C-O 120.793 0.33 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.5 p -115.45 144.73 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.005 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -95.57 122.21 38.07 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.781 0.324 . . . . 0.0 110.97 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.67 158.71 14.69 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.6 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.34 128.54 55.99 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.923 0.392 . . . . 0.0 111.234 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.6 m -107.46 151.96 24.85 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.861 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -44.15 148.9 0.38 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.918 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 t0 82.84 -52.82 0.18 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.173 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.22 54.13 0.03 OUTLIER Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.611 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -122.14 132.1 54.29 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 110.48 -0.193 . . . . 0.0 110.48 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.05 120.69 35.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.805 0.336 . . . . 0.0 111.028 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -112.69 145.95 39.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.788 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -120.41 141.98 49.63 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.796 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -122.86 149.87 43.62 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.217 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.503 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 53.6 t30 -113.0 131.31 55.81 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.154 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.0 p -84.14 -28.68 27.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.56 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -60.07 -62.6 1.75 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.71 0.29 . . . . 0.0 111.018 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.1 p -86.21 -44.3 12.29 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.141 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.93 51.13 1.83 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.43 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -134.68 140.35 45.94 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 111.081 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.99 140.79 34.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.407 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.21 158.04 42.77 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.931 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 79.0 m95 . . . . . 0 CA--C 1.535 0.389 0 CA-C-O 120.79 0.329 . . . . 0.0 111.016 179.869 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.75 0.309 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.544 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 58.8 m95 -123.8 144.77 49.51 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.329 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.2 p -112.71 138.01 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.725 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -90.25 131.02 36.3 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.827 0.346 . . . . 0.0 110.979 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.26 148.51 19.62 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.657 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.6 mm -95.32 144.5 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.712 0.291 . . . . 0.0 111.288 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 p -128.15 162.05 27.83 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.054 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.0 m -45.16 152.69 0.25 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.583 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 78.48 -55.99 0.47 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.132 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.8 51.99 0.04 OUTLIER Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.389 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -115.9 151.27 35.67 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.683 0.278 . . . . 0.0 110.86 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -108.59 117.07 33.23 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.922 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.41 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 21.5 p90 -110.72 151.44 27.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.659 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -124.13 149.42 46.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.581 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -130.99 142.33 50.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.073 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 20.7 t70 -111.2 123.48 50.29 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.508 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.57 -30.34 33.06 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.393 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.1 mt -60.22 -45.27 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 120.685 0.279 . . . . 0.0 111.01 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.87 -35.6 10.05 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.277 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.05 60.89 1.71 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.311 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.6 155.58 37.63 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.989 0.423 . . . . 0.0 111.92 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 t -97.62 143.5 28.23 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.728 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -135.67 168.64 18.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.826 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.41 ' CZ3' ' HB3' ' A' ' 18' ' ' TYR . 95.3 m95 -127.0 -44.64 1.61 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.66 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -80.04 135.22 36.31 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.541 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.11 142.93 92.82 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.021 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo . . . . . 0 C--N 1.351 0.677 0 C-N-CA 122.74 2.293 . . . . 0.0 113.229 -179.615 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.451 ' CH2' ' HB2' ' A' ' 62' ' ' ASN . 80.1 m95 . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.734 0.302 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 4.2 t -100.85 153.83 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.675 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -106.34 122.27 45.91 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 111.128 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.414 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.9 157.91 15.07 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.607 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.2 tp -111.97 123.59 50.59 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.883 0.373 . . . . 0.0 111.149 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.53 152.24 30.49 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.87 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -46.79 154.98 0.28 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.683 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 67.81 9.6 7.22 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.227 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.38 58.72 3.52 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.003 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -123.53 110.52 15.16 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.63 0.253 . . . . 0.0 110.617 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.41 120.42 24.95 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.001 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.414 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 38.0 p90 -112.53 145.78 39.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.47 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 36.9 m-85 -120.11 142.12 49.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.834 0.349 . . . . 0.0 111.225 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -121.85 149.44 43.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.189 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.451 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 46.8 t-20 -117.47 131.77 56.67 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.191 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.2 p -78.82 -26.62 44.25 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.503 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -57.64 -63.34 1.27 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.307 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.4 p -88.12 -46.14 9.55 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.082 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.4 47.17 2.22 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.494 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -136.08 143.72 44.77 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.773 0.321 . . . . 0.0 110.973 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.4 p -74.52 148.78 40.62 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -133.66 155.26 50.01 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.076 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 77.2 m95 . . . . . 0 CA--C 1.531 0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.765 179.657 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.962 0.411 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.472 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 59.9 m95 -122.14 143.83 49.31 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.102 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 1.5 t -109.28 139.66 31.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.665 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -90.76 133.67 35.01 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.819 0.342 . . . . 0.0 111.202 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.89 148.47 19.56 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.695 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.0 mm -95.51 144.74 9.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.7 0.286 . . . . 0.0 111.257 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.89 161.91 28.75 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.793 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -47.88 149.38 1.34 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.404 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 79.79 -56.8 0.38 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.926 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.18 48.72 0.03 OUTLIER Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.553 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -110.08 146.14 35.91 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.571 0.224 . . . . 0.0 110.516 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -108.73 116.98 33.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.811 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -110.64 151.14 28.03 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.514 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.7 m-85 -124.83 149.57 47.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.254 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -125.36 148.67 48.67 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.972 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.472 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 33.4 t70 -116.59 125.75 52.28 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.951 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.59 -31.78 24.13 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.478 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.5 mt -59.99 -57.61 10.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.637 0.256 . . . . 0.0 111.036 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.7 m -86.43 -41.43 14.44 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.978 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.07 48.46 2.86 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.298 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.3 144.92 48.6 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.823 0.344 . . . . 0.0 111.26 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.59 132.38 36.91 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.76 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.41 165.63 14.66 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -127.52 6.28 6.26 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.747 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -132.14 128.15 37.47 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.38 112.34 6.3 Favored Pre-proline 0 C--O 1.233 0.205 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.744 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo . . . . . 0 C--N 1.351 0.669 0 C-N-CA 122.766 2.311 . . . . 0.0 112.63 -179.719 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.47 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 84.5 m95 . . . . . 0 C--O 1.234 0.248 0 CA-C-O 120.776 0.322 . . . . 0.0 111.377 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 21.2 t -99.94 155.4 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.717 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -112.72 122.4 47.57 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.792 0.329 . . . . 0.0 111.116 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.408 ' HA3' ' CE1' ' A' ' 59' ' ' TYR . . . -118.83 156.69 15.57 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.812 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.4 tp -109.69 127.15 54.38 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.917 0.389 . . . . 0.0 111.233 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.426 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 17.0 t -119.97 152.05 38.03 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.702 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -45.39 155.39 0.14 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.564 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.19 6.71 5.81 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.137 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.04 51.42 5.8 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.635 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.426 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 32.6 m-85 -112.72 125.62 54.51 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.579 0.228 . . . . 0.0 110.412 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.5 m -100.43 120.6 40.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.834 0.35 . . . . 0.0 111.111 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.408 ' CE1' ' HA3' ' A' ' 51' ' ' GLY . 35.8 p90 -112.45 145.45 40.16 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.388 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.521 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 17.5 m-85 -120.73 141.92 50.0 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.84 0.352 . . . . 0.0 111.349 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -121.86 145.52 48.0 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.96 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.47 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 54.9 t-20 -113.17 126.15 55.12 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.0 p -78.61 -30.19 46.39 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.359 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -55.6 -54.83 39.28 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.284 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.8 p -93.82 -33.09 13.7 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.334 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.69 58.77 2.33 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.31 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -147.71 141.34 25.54 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.829 0.347 . . . . 0.0 111.204 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 99.1 p -76.35 143.5 40.72 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.627 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.427 ' HD3' ' CH2' ' A' ' 48' ' ' TRP . 14.3 ttt85 -133.72 158.2 43.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.6 m95 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.532 179.771 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 . . . . . 0 C--O 1.233 0.232 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.428 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 80.0 m95 -116.29 149.91 38.47 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.09 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 3.0 t -113.69 150.73 15.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.974 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -102.46 130.18 49.18 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.829 0.347 . . . . 0.0 111.155 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.28 148.08 19.44 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.74 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.4 mm -106.68 146.68 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.693 0.282 . . . . 0.0 111.305 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.6 161.53 31.34 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.895 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 m -46.96 153.26 0.44 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.486 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 81.29 -56.33 0.28 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.03 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.72 51.05 0.05 OUTLIER Glycine 0 C--N 1.337 0.598 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.586 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -114.82 140.96 48.51 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.66 0.267 . . . . 0.0 110.508 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -107.2 116.82 32.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.809 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -111.02 151.31 28.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.806 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 48.5 m-85 -124.56 149.82 46.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.834 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -128.75 148.25 50.84 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.329 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.428 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 10.7 t70 -113.93 127.89 56.16 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.795 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.29 -38.86 21.57 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.286 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mt -61.13 -50.9 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.988 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.7 m -85.32 -40.83 16.1 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.173 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.7 37.27 8.75 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.391 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -127.6 148.02 50.36 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.82 0.343 . . . . 0.0 111.265 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 95.5 p -93.58 141.69 28.19 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.749 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.46 167.97 20.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.923 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -127.61 5.96 6.19 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.727 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -120.78 122.03 39.46 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -64.15 119.51 56.36 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.85 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo . . . . . 0 C--N 1.351 0.672 0 C-N-CA 122.724 2.282 . . . . 0.0 112.518 -179.818 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.44 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 59.0 m95 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.716 0.293 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 9.4 p -99.26 140.29 19.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.472 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.79 122.42 33.51 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.839 0.352 . . . . 0.0 111.032 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.75 158.93 14.61 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.459 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 tp -109.88 137.26 47.92 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 111.103 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.2 152.15 46.42 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.791 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.53 153.61 0.36 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.503 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 67.59 11.37 8.34 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.076 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.63 66.74 1.93 Allowed Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.869 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -131.33 111.7 12.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.723 0.297 . . . . 0.0 110.631 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 m -81.49 120.35 24.91 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.06 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -112.77 145.83 39.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.617 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 89.9 m-85 -120.38 141.87 49.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.771 0.319 . . . . 0.0 111.01 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -127.19 148.8 50.18 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.44 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 52.6 t-20 -115.55 132.31 56.67 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.182 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.1 p -80.71 -29.75 36.4 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.4 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.1 -64.66 0.86 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.179 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.1 t -82.74 -34.8 27.09 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.994 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.28 47.14 5.86 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.602 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -133.39 136.94 45.6 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.784 0.326 . . . . 0.0 110.899 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.6 p -80.81 143.54 32.74 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.966 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.44 157.7 44.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.925 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 73.7 m95 . . . . . 0 CA--C 1.531 0.215 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.865 179.866 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.229 0 CA-C-O 120.834 0.35 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.458 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 87.4 m95 -112.35 134.24 54.0 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.96 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -112.66 141.4 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.183 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.37 131.63 36.72 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.893 0.377 . . . . 0.0 111.292 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.26 148.61 19.41 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.617 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.0 mm -99.9 143.26 13.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 120.612 0.244 . . . . 0.0 111.183 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.24 161.56 27.46 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.862 0.363 . . . . 0.0 111.053 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.6 m -46.45 151.95 0.49 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.668 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 81.67 -54.98 0.26 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.191 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.64 51.52 0.05 OUTLIER Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.426 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -118.54 151.81 37.15 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.633 0.254 . . . . 0.0 110.832 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -111.85 117.21 32.16 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.07 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -110.94 151.39 27.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.617 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -124.13 149.58 46.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.741 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -131.23 147.37 52.58 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.197 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.458 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 34.3 t70 -114.75 122.38 46.21 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.739 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.18 -29.75 48.67 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.19 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.5 mt -60.52 -60.16 3.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-O 120.684 0.278 . . . . 0.0 111.016 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.07 -30.81 25.74 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.484 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.22 45.82 7.31 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.18 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -132.63 151.41 51.96 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.916 0.389 . . . . 0.0 111.666 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.07 145.99 24.09 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.902 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -133.72 168.66 18.31 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.136 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -126.97 -40.97 1.83 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.044 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.88 137.56 33.61 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.59 0.233 . . . . 0.0 110.454 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.87 139.28 97.3 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.198 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo . . . . . 0 C--N 1.35 0.654 0 C-N-CA 122.765 2.31 . . . . 0.0 112.422 179.867 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 62.7 m95 . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.755 0.312 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 14.0 p -104.95 149.34 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.175 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -96.89 122.44 39.87 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.406 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.402 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.96 157.42 15.28 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.712 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.5 tp -106.25 130.42 54.11 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.905 0.383 . . . . 0.0 111.326 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.462 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 12.1 t -119.93 152.09 37.93 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.974 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.96 153.41 0.65 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.655 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 67.25 10.86 8.04 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.195 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.92 65.8 2.12 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.347 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.462 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 31.8 m-85 -131.13 106.61 8.47 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.717 0.294 . . . . 0.0 110.748 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.4 m -73.93 120.22 19.21 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.839 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.402 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 23.4 p90 -112.9 146.14 39.48 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.637 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 49.5 m-85 -120.04 141.97 49.26 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 110.777 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -129.51 147.16 51.29 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.438 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -113.11 128.34 56.46 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.974 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.7 p -79.13 -24.01 43.64 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.408 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -60.06 -64.7 0.86 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.294 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.2 t -90.06 -34.38 15.96 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.22 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.24 53.17 2.55 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.551 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -135.46 142.34 45.52 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.913 0.387 . . . . 0.0 111.308 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.52 144.71 27.77 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.762 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -133.49 157.83 44.64 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 82.7 m95 . . . . . 0 N--CA 1.465 0.294 0 CA-C-O 120.916 0.388 . . . . 0.0 110.913 179.841 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.984 0.421 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.497 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 94.6 m95 -120.46 137.47 54.33 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.101 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.7 p -113.03 130.95 65.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.028 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -90.55 129.64 36.68 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.891 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.24 148.67 19.68 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.678 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.1 mm -97.85 129.05 48.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.529 0.204 . . . . 0.0 111.011 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.6 p -131.66 154.04 49.36 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.714 0.292 . . . . 0.0 111.076 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.2 -150.14 0.42 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.758 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -81.29 3.49 23.88 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.48 68.91 0.01 OUTLIER Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.084 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -138.52 109.87 6.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.692 0.282 . . . . 0.0 110.596 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -78.12 116.72 18.79 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.963 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -111.22 151.91 27.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.743 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -123.85 149.25 45.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.794 0.33 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -136.27 146.11 46.31 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.497 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 24.5 t70 -113.33 124.13 51.76 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.981 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.43 -28.63 34.17 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.712 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.9 mt -60.46 -52.58 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.696 0.284 . . . . 0.0 110.998 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.9 m -93.07 -31.61 14.77 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.335 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.01 48.38 5.18 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.307 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -131.99 147.69 52.47 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.855 0.36 . . . . 0.0 111.735 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.76 131.07 41.0 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.731 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -121.53 168.86 11.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.914 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -127.0 -34.95 2.3 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.089 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -82.54 145.19 29.88 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.66 0.267 . . . . 0.0 110.643 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -70.13 135.2 87.13 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.177 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo . . . . . 0 C--N 1.353 0.801 0 C-N-CA 122.94 2.426 . . . . 0.0 112.769 -179.807 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.437 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 71.0 m95 . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.693 0.282 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 2.1 t -104.12 155.69 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.725 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -112.98 121.91 46.05 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.771 0.32 . . . . 0.0 111.307 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.44 ' HA3' ' CE2' ' A' ' 59' ' ' TYR . . . -119.33 158.27 15.08 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.86 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.82 127.96 55.97 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.756 0.313 . . . . 0.0 110.979 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.17 151.77 44.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.729 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.07 -158.67 0.31 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.809 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -57.31 -26.23 60.58 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.29 48.72 0.02 OUTLIER Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.121 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -98.37 123.87 42.72 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.99 120.52 32.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.32 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.44 ' CE2' ' HA3' ' A' ' 51' ' ' GLY . 25.1 p90 -112.73 145.68 40.09 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.455 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 13.9 m-85 -120.4 141.85 49.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.844 0.354 . . . . 0.0 111.044 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -124.81 146.53 49.2 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.627 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.437 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 35.4 t30 -113.6 122.74 48.13 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.543 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.3 p -74.98 -25.07 58.58 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.484 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -55.14 -61.79 2.09 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.381 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 t -97.27 -32.88 11.68 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.387 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.45 63.26 1.18 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.44 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -145.6 142.7 29.34 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.836 0.35 . . . . 0.0 111.617 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.88 141.24 28.92 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.91 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.27 156.67 48.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.781 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 45.0 m95 . . . . . 0 CA--C 1.532 0.253 0 CA-C-O 120.838 0.351 . . . . 0.0 110.652 179.525 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.887 0.375 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.5 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 82.3 m95 -110.45 147.21 34.52 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.054 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 p -112.97 139.06 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.768 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.29 130.53 36.39 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.93 0.395 . . . . 0.0 110.909 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.3 147.91 19.37 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.779 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.3 mm -93.33 142.62 12.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.625 0.25 . . . . 0.0 111.107 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.39 161.97 24.85 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.673 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -50.0 151.18 2.01 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.383 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 80.73 -54.38 0.33 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.132 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.78 52.24 0.04 OUTLIER Glycine 0 C--N 1.336 0.563 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.357 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -118.67 146.18 44.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.599 0.238 . . . . 0.0 110.67 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -105.69 117.05 33.04 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.953 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -110.94 151.83 27.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.747 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -124.33 149.56 46.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.966 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -135.12 144.26 47.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.785 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.5 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 13.5 t70 -110.08 124.33 51.31 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.896 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.78 -32.08 35.57 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.936 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.5 mt -59.16 -54.73 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.757 0.313 . . . . 0.0 111.059 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.4 p -85.97 -35.7 20.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.167 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.39 54.11 3.07 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.28 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -140.73 147.03 38.53 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.879 0.371 . . . . 0.0 111.522 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.1 p -88.03 132.76 34.15 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.565 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -126.27 166.94 16.17 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.869 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -127.52 -43.99 1.56 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.031 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -70.11 150.93 46.03 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.783 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -99.08 102.54 15.88 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.94 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 C--N 1.349 0.585 0 C-N-CA 122.657 2.238 . . . . 0.0 112.605 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 90.1 m95 . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 120.806 0.336 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 2.2 t -106.3 133.77 49.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.65 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.1 122.26 33.6 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.825 0.345 . . . . 0.0 110.865 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.42 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.83 158.53 14.79 Favored Glycine 0 C--N 1.332 0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.581 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.8 tp -109.76 136.03 49.73 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.867 0.365 . . . . 0.0 111.236 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.408 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 3.9 t -123.88 151.81 43.07 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.641 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.42 155.18 0.78 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.481 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 69.91 7.4 6.21 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.278 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.83 63.04 2.15 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.911 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 28.4 m-85 -127.77 128.38 45.22 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.553 0.216 . . . . 0.0 110.544 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.68 120.44 39.12 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.829 0.347 . . . . 0.0 111.013 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.42 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 30.5 p90 -112.91 146.18 39.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.536 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 55.6 m-85 -119.8 141.88 49.1 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.852 0.358 . . . . 0.0 110.884 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -128.15 147.69 50.56 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.982 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -114.11 130.67 56.57 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.679 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.8 p -78.44 -29.06 46.81 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.862 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -59.98 -66.47 0.51 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.386 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.1 t -82.42 -39.13 23.05 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.475 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.3 40.61 6.04 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.929 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -125.46 133.95 52.25 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.813 0.34 . . . . 0.0 110.872 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.05 148.43 37.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.736 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -133.2 153.61 51.38 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.878 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 94.4 m95 . . . . . 0 N--CA 1.464 0.264 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.908 179.615 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.409 ' HB3' HD23 ' A' ' 22' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.234 0.262 0 CA-C-O 120.993 0.425 . . . . 0.0 110.627 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.486 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 97.0 m95 -116.18 151.49 35.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.142 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 2.8 t -124.7 131.51 72.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.613 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -90.69 130.05 36.73 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.939 0.399 . . . . 0.0 111.099 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.07 148.5 19.59 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.678 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.1 mm -97.86 144.25 11.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.639 0.257 . . . . 0.0 111.086 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.33 162.19 28.54 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.895 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.22 149.65 0.7 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.739 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 79.83 -55.98 0.38 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.295 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.57 52.44 0.04 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.336 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -116.48 134.66 54.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.617 0.246 . . . . 0.0 110.531 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -98.3 116.86 31.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.845 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -110.75 151.34 27.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.789 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 64.0 m-85 -124.2 149.52 46.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.131 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -125.99 147.34 49.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.035 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.486 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 32.9 t70 -118.92 122.09 41.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.704 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.409 HD23 ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -81.44 -26.76 35.06 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.321 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.5 mt -58.69 -48.71 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.766 0.317 . . . . 0.0 110.984 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.2 m -100.83 -35.49 9.41 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.346 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.44 51.31 3.14 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.127 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -137.69 154.83 49.62 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.963 0.411 . . . . 0.0 111.78 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.95 143.57 26.35 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.853 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -134.18 168.63 18.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.037 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -127.24 -47.9 1.46 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.582 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -73.47 125.23 27.43 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.346 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -60.95 138.0 93.91 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.175 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo . . . . . 0 C--N 1.353 0.771 0 C-N-CA 122.82 2.347 . . . . 0.0 112.59 -179.716 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.445 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 33.0 m95 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.655 0.264 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 12.0 p -96.43 145.44 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -94.14 122.15 36.37 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.8 0.334 . . . . 0.0 111.105 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -119.0 153.02 17.08 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.53 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.4 tp -109.78 138.94 45.43 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.998 0.427 . . . . 0.0 111.687 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.03 152.38 38.67 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.685 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 0.4 OUTLIER -45.14 152.24 0.27 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.742 -179.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 25.6 m-20 81.04 -44.29 0.21 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.14 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.22 48.33 0.11 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.425 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -114.27 130.04 56.64 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.6 m -99.36 120.45 39.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.876 0.369 . . . . 0.0 111.213 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -112.56 145.59 40.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.567 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 93.4 m-85 -120.42 142.06 49.56 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.747 0.308 . . . . 0.0 111.068 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -120.93 150.6 40.84 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.061 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.445 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 48.8 t-20 -114.31 130.14 56.66 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.281 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.3 p -82.66 -26.11 32.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.452 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -56.77 -61.8 2.18 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.653 -0.248 . . . . 0.0 111.353 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.0 p -93.8 -46.92 7.0 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.136 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.16 55.27 0.87 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.65 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -134.59 132.06 38.61 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.715 0.293 . . . . 0.0 110.832 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 86.9 p -71.94 148.76 45.7 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.758 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.59 157.71 45.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.211 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.6 m95 . . . . . 0 CA--C 1.532 0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.611 179.517 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.458 ' HD2' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.21 0 CA-C-O 120.942 0.401 . . . . 0.0 110.135 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -121.52 135.93 54.99 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.812 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.6 p -119.24 143.02 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.134 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -96.66 133.48 41.14 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.827 0.346 . . . . 0.0 111.215 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.41 148.51 19.63 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.736 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.9 mm -102.52 123.2 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 120.63 0.252 . . . . 0.0 110.948 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.38 157.72 44.81 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.99 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.4 t 60.83 -148.29 0.43 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.69 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.99 -28.93 40.88 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 111.546 0.202 . . . . 0.0 111.546 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.45 46.72 0.03 OUTLIER Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.335 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -95.46 120.11 35.14 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -73.77 116.68 14.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.895 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -111.24 151.96 27.68 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.747 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -123.75 149.53 45.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.489 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -136.07 148.95 48.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.969 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -115.08 123.02 47.94 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.01 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.53 -21.19 32.81 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.391 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.458 HG13 ' HD2' ' A' ' 6' ' ' ARG . 9.6 mt -51.95 -55.81 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 120.611 0.243 . . . . 0.0 111.038 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.29 -40.75 4.58 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.054 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.14 54.04 0.68 Allowed Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.48 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -127.74 110.27 12.47 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.717 0.294 . . . . 0.0 110.997 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.0 p -69.46 132.63 46.62 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.675 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.27 168.06 16.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.141 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -127.67 6.6 6.19 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.501 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -118.0 129.28 55.49 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -70.49 113.66 20.06 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.914 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 C--N 1.351 0.666 0 C-N-CA 122.672 2.248 . . . . 0.0 112.61 -179.939 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 87.3 m95 . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.9 t -110.7 139.25 35.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.624 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -91.06 122.07 33.4 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.82 0.343 . . . . 0.0 111.018 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.434 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.82 160.13 14.16 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.491 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.0 tp -113.1 135.46 53.78 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.847 0.356 . . . . 0.0 111.163 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.1 152.08 40.24 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.815 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -47.51 155.28 0.37 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.463 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 67.6 11.25 8.28 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.247 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.05 66.46 1.91 Allowed Glycine 0 C--N 1.338 0.667 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.061 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -131.95 120.12 22.05 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.655 0.264 . . . . 0.0 110.617 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.3 m -89.16 120.49 30.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.883 0.373 . . . . 0.0 111.062 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.434 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 33.4 p90 -112.75 146.06 39.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.392 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 80.1 m-85 -120.09 141.54 49.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.748 0.309 . . . . 0.0 111.063 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -127.75 149.08 50.4 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -119.44 129.33 54.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.932 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.8 p -74.94 -35.36 62.16 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.537 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -59.6 -60.19 4.24 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.694 0.283 . . . . 0.0 111.177 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.0 p -78.78 -34.43 45.53 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.204 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.49 44.66 20.77 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.25 -0.5 . . . . 0.0 112.591 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -136.74 134.4 37.08 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.886 0.374 . . . . 0.0 111.057 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.39 145.75 39.18 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.624 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -133.05 157.55 44.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.059 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 72.3 m95 . . . . . 0 C--O 1.234 0.241 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 179.658 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 . . . . . 0 CA--C 1.531 0.216 0 CA-C-O 120.96 0.41 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.4 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 86.8 m95 -114.54 140.48 48.73 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.954 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 11.8 p -110.7 133.25 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.594 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -90.44 130.15 36.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.003 0.43 . . . . 0.0 111.221 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.15 148.57 19.51 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.371 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 mp -101.08 138.18 26.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.665 0.269 . . . . 0.0 110.937 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.455 HG21 ' CD1' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -119.68 161.76 20.15 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.167 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.8 m -41.87 148.64 0.16 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.739 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.433 ' HB3' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 82.16 -57.04 0.22 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.058 -179.528 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.79 58.39 0.03 OUTLIER Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.446 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.433 ' CE2' ' HB3' ' A' ' 14' ' ' GLU . 29.9 m-85 -124.78 138.78 54.26 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.718 0.295 . . . . 0.0 111.018 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -100.27 117.27 34.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.916 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.455 ' CD1' HG21 ' A' ' 12' ' ' THR . 24.9 p90 -110.89 151.53 27.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.557 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 64.9 m-85 -124.39 149.54 46.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.911 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -131.84 145.81 51.77 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.175 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.4 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 2.6 t0 -110.64 123.13 49.41 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.098 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.82 -25.68 27.95 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.224 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.3 -54.73 26.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.098 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.6 m -97.62 -38.55 9.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.099 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.07 53.24 1.52 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.265 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -135.75 129.33 32.42 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.797 0.332 . . . . 0.0 111.251 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.54 145.63 38.93 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.91 168.36 18.57 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.073 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.402 ' CZ3' ' HB3' ' A' ' 18' ' ' TYR . 90.2 m95 -127.46 -47.13 1.44 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.847 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.7 134.09 37.13 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.664 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -68.16 133.91 91.54 Favored Pre-proline 0 N--CA 1.463 0.216 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.191 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo . . . . . 0 C--N 1.35 0.643 0 C-N-CA 122.659 2.239 . . . . 0.0 112.606 179.95 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.448 ' CH2' ' HB2' ' A' ' 62' ' ' ASN . 65.5 m95 . . . . . 0 C--O 1.233 0.231 0 CA-C-O 120.68 0.276 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.8 p -104.02 139.52 24.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.761 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -90.76 122.16 33.26 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.923 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.416 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.72 156.36 15.7 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.611 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.7 tp -108.99 137.85 46.26 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.76 0.314 . . . . 0.0 111.247 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.99 152.08 48.35 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.95 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -47.28 154.19 0.42 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.77 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 67.25 10.96 8.11 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.118 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.18 66.56 1.94 Allowed Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.171 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -130.67 108.05 9.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.742 0.306 . . . . 0.0 110.694 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.6 m -80.63 120.44 24.57 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.864 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.416 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 33.2 p90 -112.66 146.16 39.15 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.014 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -119.99 141.92 49.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.804 0.335 . . . . 0.0 110.877 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -127.06 145.7 50.63 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.08 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.448 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 51.4 t-20 -114.02 126.23 54.89 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.162 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.0 p -75.92 -24.61 55.57 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.445 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -56.23 -62.43 1.72 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.287 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.0 p -91.37 -37.66 13.09 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.066 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.73 49.69 2.88 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.131 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -135.48 138.18 42.88 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.917 0.389 . . . . 0.0 111.231 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.35 140.45 38.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.805 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -133.57 157.85 44.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.774 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 69.1 m95 . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 120.879 0.371 . . . . 0.0 110.753 179.818 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 . . . . . 0 C--O 1.233 0.216 0 CA-C-O 120.925 0.393 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.55 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 80.1 m95 -108.29 132.11 54.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.905 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 1.6 t -103.46 132.14 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.469 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.66 129.65 36.75 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.965 0.412 . . . . 0.0 111.311 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.409 ' HA3' ' CE1' ' A' ' 18' ' ' TYR . . . -135.47 148.72 19.73 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.571 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.0 mm -95.43 125.82 48.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.481 0.182 . . . . 0.0 110.69 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.25 148.03 51.97 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.873 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.51 -150.54 0.39 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.549 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -56.62 -26.33 55.45 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.68 43.27 0.02 OUTLIER Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.635 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -93.24 111.95 23.74 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -73.35 116.69 14.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.409 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 17.9 p90 -110.86 151.72 27.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.203 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 55.3 m-85 -123.97 149.17 46.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.873 0.368 . . . . 0.0 110.975 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -133.99 139.46 46.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.798 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 16.6 t70 -110.14 126.38 54.0 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.551 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.43 -31.19 26.75 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.742 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.3 mt -56.56 -45.53 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.78 0.324 . . . . 0.0 111.031 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.36 -35.2 9.67 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.166 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.92 41.52 6.29 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.171 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -128.88 153.62 47.3 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.895 0.379 . . . . 0.0 111.372 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.5 p -95.37 149.73 21.05 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.89 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.85 167.17 21.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.955 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -127.54 6.38 6.26 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.923 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -136.43 138.12 41.16 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.08 114.34 48.03 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.899 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo . . . . . 0 C--N 1.352 0.712 0 C-N-CA 122.805 2.337 . . . . 0.0 112.483 -179.87 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.452 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 44.9 m95 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.593 0.235 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 p -104.44 145.89 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -96.97 122.55 40.08 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.103 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.62 158.33 14.84 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.621 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.4 tp -106.59 141.7 37.44 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.862 0.363 . . . . 0.0 111.267 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.426 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 34.1 t -133.58 152.22 51.85 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.826 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.79 153.52 0.39 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.55 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.59 11.41 8.1 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.12 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.81 65.85 2.28 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.969 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.426 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 34.3 m-85 -128.19 103.89 7.44 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.756 0.312 . . . . 0.0 110.7 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.4 m -76.19 120.05 20.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.852 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -112.87 145.96 39.77 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.721 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -120.33 141.86 49.66 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.736 0.303 . . . . 0.0 110.79 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -124.57 152.36 43.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.452 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 18.3 t-20 -113.68 136.37 52.91 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.771 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.9 p -87.27 -30.84 20.59 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.814 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -60.58 -62.96 1.48 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.65 0.262 . . . . 0.0 111.045 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 75.1 p -84.02 -44.56 14.0 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.094 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.11 48.63 2.39 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.453 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -134.23 140.74 46.67 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.761 0.315 . . . . 0.0 110.855 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.2 p -80.71 148.99 29.9 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.0 tpt85 -134.02 155.67 49.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.732 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 87.8 m95 . . . . . 0 C--O 1.234 0.244 0 CA-C-O 120.788 0.327 . . . . 0.0 111.286 -179.98 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 120.853 0.358 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.41 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 82.2 m95 -121.26 137.39 54.71 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.052 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.5 p -115.55 133.91 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.961 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -90.61 132.09 35.94 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.866 0.365 . . . . 0.0 111.174 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.73 147.73 18.76 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.549 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.3 mm -95.96 141.65 15.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.634 0.254 . . . . 0.0 110.914 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.09 162.08 25.37 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.805 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 m -46.66 152.7 0.45 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.528 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 77.48 -54.72 0.53 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.424 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.24 50.49 0.04 OUTLIER Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.578 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -115.85 141.2 48.41 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.506 0.193 . . . . 0.0 110.528 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -105.54 117.07 33.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.77 0.319 . . . . 0.0 110.825 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -110.74 151.27 27.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.721 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -124.84 149.23 47.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.751 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -127.48 144.64 51.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.076 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.41 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 29.1 t70 -117.34 123.23 45.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.679 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.35 -25.72 28.96 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.157 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.5 mt -58.71 -46.7 90.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.576 0.227 . . . . 0.0 110.871 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -104.46 -32.24 9.09 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.526 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.56 45.39 5.24 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.265 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -132.77 132.45 42.26 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.815 0.34 . . . . 0.0 111.378 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.2 p -86.26 142.0 28.88 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.709 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.02 167.62 18.75 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.193 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -127.72 7.01 6.19 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.672 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.6 130.12 51.85 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.34 113.93 14.8 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.004 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo . . . . . 0 C--N 1.353 0.79 0 C-N-CA 122.996 2.464 . . . . 0.0 112.828 -179.518 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.519 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 72.0 m95 . . . . . 0 C--O 1.233 0.209 0 CA-C-O 120.711 0.291 . . . . 0.0 111.036 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.3 p -107.22 141.61 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.022 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -90.78 122.33 33.42 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.016 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.91 158.4 14.87 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.469 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.45 131.65 55.46 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.866 0.365 . . . . 0.0 111.424 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.08 151.94 27.5 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.794 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -44.56 148.54 0.48 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.327 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 82.6 -51.67 0.19 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.073 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 140.26 51.18 0.05 OUTLIER Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.451 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -117.51 118.68 32.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.608 0.242 . . . . 0.0 110.498 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.46 120.39 25.41 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.846 0.355 . . . . 0.0 111.117 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -112.75 146.11 39.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.436 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -119.75 141.93 49.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.843 0.354 . . . . 0.0 110.84 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -123.33 154.74 38.5 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.859 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.519 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 39.3 t30 -113.5 122.14 46.39 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.924 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.3 p -74.26 -30.74 62.26 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.716 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -64.58 -66.97 0.47 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.517 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.2 p -78.09 -48.95 14.87 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.517 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.82 42.25 2.7 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.599 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -129.67 133.24 46.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.763 0.316 . . . . 0.0 110.894 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.19 146.72 45.35 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.7 157.64 44.37 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.075 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 87.6 m95 . . . . . 0 CA--C 1.532 0.256 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.84 179.484 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.752 0.311 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.489 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 91.1 m95 -127.14 137.05 52.9 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.047 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.9 p -117.34 147.85 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.265 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.68 131.67 46.46 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.194 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.59 148.58 19.68 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.956 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.6 mm -94.35 144.17 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.72 0.295 . . . . 0.0 111.185 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.16 161.67 27.96 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.969 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 t -45.76 152.22 0.37 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.637 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 80.66 -55.82 0.33 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.187 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.16 51.9 0.05 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.484 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -118.32 151.65 37.3 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.57 0.224 . . . . 0.0 110.585 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -109.94 116.7 32.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.798 0.332 . . . . 0.0 110.871 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.415 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 17.2 p90 -111.15 151.43 28.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.941 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -124.41 149.29 46.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.783 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -125.86 149.53 48.59 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.232 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.489 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 23.5 t70 -119.11 122.02 41.12 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.022 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.82 -26.46 31.69 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.5 mt -56.53 -46.8 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.759 0.314 . . . . 0.0 111.084 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m -103.83 -44.38 5.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.003 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.23 36.9 3.23 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.57 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -119.32 156.88 29.21 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.803 0.335 . . . . 0.0 111.297 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 p -100.09 131.14 46.22 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.033 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -122.2 168.4 12.05 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.832 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.415 ' CZ3' ' HB3' ' A' ' 18' ' ' TYR . 93.3 m95 -127.38 -45.34 1.52 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.078 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -73.41 119.6 17.87 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.578 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.02 125.27 91.25 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.748 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 C--N 1.349 0.582 0 C-N-CA 122.631 2.22 . . . . 0.0 112.236 179.826 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 94.2 m95 . . . . . 0 N--CA 1.464 0.231 0 CA-C-O 120.516 0.198 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.6 t -111.46 131.66 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.419 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.447 ' HG3' ' CD1' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -94.6 122.25 37.0 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.941 0.401 . . . . 0.0 111.521 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.449 ' HA3' ' CE2' ' A' ' 59' ' ' TYR . . . -118.86 158.0 15.02 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.265 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.43 121.59 45.26 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.753 0.277 . . . . 0.0 110.943 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.17 142.13 31.35 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.803 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 55.73 95.06 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.461 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 68.1 -63.29 0.33 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.052 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.37 40.21 0.05 OUTLIER Glycine 0 CA--C 1.518 0.272 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.696 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -85.31 121.28 27.81 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.11 120.03 23.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.998 0.427 . . . . 0.0 111.229 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.449 ' CE2' ' HA3' ' A' ' 51' ' ' GLY . 25.2 p90 -113.05 146.18 39.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.816 179.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.473 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 2.6 m-85 -119.59 141.74 49.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.935 0.398 . . . . 0.0 111.165 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -129.65 155.02 46.52 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.573 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -113.48 129.23 56.59 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.891 0.377 . . . . 0.0 111.265 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.6 p -93.39 22.27 5.41 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.757 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -95.7 -60.04 1.74 Allowed 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 120.666 0.269 . . . . 0.0 110.707 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.8 t -110.39 -36.2 5.85 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.14 73.58 0.71 Allowed Glycine 0 C--N 1.335 0.513 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.707 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -149.9 126.89 11.18 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.819 0.342 . . . . 0.0 111.007 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.49 150.69 25.84 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.697 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.6 ttt-85 -130.73 155.35 46.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.261 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.8 m95 . . . . . 0 CA--C 1.532 0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 179.602 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 121.08 0.467 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.429 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 80.9 m95 -105.75 140.17 39.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.754 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 p -116.17 133.57 62.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.085 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -90.7 131.51 36.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.272 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.25 148.58 19.65 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.66 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.8 mm -98.01 127.08 50.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.585 0.231 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.2 p -133.43 150.06 51.78 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.947 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.02 -149.78 0.41 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.622 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.28 -29.57 47.64 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.13 44.09 0.02 OUTLIER Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.56 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -92.81 112.75 24.82 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -74.54 116.8 15.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.949 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -111.02 151.51 27.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.517 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -124.41 148.81 47.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.949 0.405 . . . . 0.0 110.93 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -136.56 147.88 47.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.132 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.429 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 4.7 t0 -112.09 122.05 46.68 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.653 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.39 -26.94 27.99 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.274 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.3 mt -60.72 -53.39 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.733 0.302 . . . . 0.0 110.871 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.06 -36.51 12.08 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.22 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.04 60.19 1.34 Allowed Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.293 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -142.64 129.24 20.27 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.844 0.354 . . . . 0.0 111.415 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.7 p -85.29 132.19 34.29 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.54 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -131.91 168.3 18.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.22 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -127.81 7.37 6.18 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.705 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -120.44 139.89 52.18 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.662 0.268 . . . . 0.0 110.713 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -77.64 131.67 70.47 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.962 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 C--N 1.35 0.629 0 C-N-CA 122.679 2.253 . . . . 0.0 112.253 179.882 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.458 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 76.5 m95 . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.557 0.218 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.9 p -108.37 137.88 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.957 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -91.08 122.05 33.39 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.001 0.429 . . . . 0.0 110.952 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.75 151.38 17.75 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.349 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.81 133.4 54.83 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.911 0.386 . . . . 0.0 111.419 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.1 t -112.29 151.8 29.25 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.84 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -45.08 154.63 0.14 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.333 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 80.54 -55.58 0.34 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.061 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.16 55.06 0.03 OUTLIER Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.407 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -124.77 124.24 41.7 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.632 0.253 . . . . 0.0 110.538 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.3 m -93.56 120.95 34.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.85 0.357 . . . . 0.0 111.068 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -112.56 146.21 38.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.56 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -119.93 141.86 49.24 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.848 0.356 . . . . 0.0 110.942 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -125.91 147.19 49.55 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.926 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.458 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 53.3 t30 -113.33 122.76 48.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.668 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.1 p -77.75 -23.1 49.4 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.558 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -55.08 -60.94 2.69 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.405 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.7 t -102.27 -38.43 7.66 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.441 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.72 46.8 1.73 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.607 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -123.54 121.12 34.81 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.781 0.324 . . . . 0.0 110.674 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.2 p -71.32 150.14 45.41 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -133.82 157.79 45.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.088 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 94.1 m95 . . . . . 0 CA--C 1.533 0.32 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.049 179.695 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? . . . . . 0 C--O 1.234 0.269 0 CA-C-O 120.999 0.428 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -125.11 148.92 48.33 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.228 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 2.0 t -118.14 132.88 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.503 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -90.89 129.83 36.89 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.942 0.401 . . . . 0.0 111.53 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.52 148.69 19.72 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.653 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.6 mm -105.18 125.47 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.5 0.19 . . . . 0.0 110.809 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.89 153.76 51.53 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.34 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.1 -148.02 0.43 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.748 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -55.03 -29.24 57.0 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.56 44.43 0.02 OUTLIER Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.358 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -92.51 113.95 26.36 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -73.86 116.64 14.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.845 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -111.02 151.46 27.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.218 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 85.3 m-85 -124.05 149.39 46.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.844 0.354 . . . . 0.0 111.092 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -131.87 140.36 49.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.77 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -109.8 125.67 52.97 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.74 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.15 -29.67 28.45 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.714 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.1 mt -54.65 -49.34 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.804 0.335 . . . . 0.0 110.882 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m -101.92 -39.13 7.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.292 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.73 44.84 3.29 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.347 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -127.91 135.54 50.12 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 111.477 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.8 t -85.94 147.57 26.17 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.665 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -133.74 167.79 19.88 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.92 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -127.44 8.94 6.54 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.663 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -132.06 137.98 47.99 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.406 ' HE3' ' OH ' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -62.09 132.66 93.84 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.351 -179.49 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 C--N 1.35 0.641 0 C-N-CA 122.681 2.254 . . . . 0.0 112.268 179.768 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 78.3 m95 . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.592 0.234 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.2 p -106.33 132.29 53.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.462 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -90.59 122.0 33.01 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.915 0.388 . . . . 0.0 110.945 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.408 ' HA3' ' CE1' ' A' ' 59' ' ' TYR . . . -118.86 152.88 17.17 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.351 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.74 129.05 55.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.954 0.407 . . . . 0.0 111.296 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.406 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 40.2 t -109.39 151.94 25.98 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.648 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -45.64 151.98 0.37 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.368 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 82.77 -53.68 0.19 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.9 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.52 55.78 0.04 OUTLIER Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.445 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.406 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 22.0 m-85 -123.7 129.25 50.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.524 0.202 . . . . 0.0 110.749 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.3 m -98.1 120.85 39.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.854 0.359 . . . . 0.0 111.086 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.408 ' CE1' ' HA3' ' A' ' 51' ' ' GLY . 30.0 p90 -112.64 145.94 39.51 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.596 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -120.25 142.26 49.21 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.736 0.303 . . . . 0.0 110.86 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -124.2 152.25 43.12 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.851 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.61 122.51 47.89 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.911 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.3 p -78.74 -24.97 44.51 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.447 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -59.47 -63.41 1.31 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.432 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.0 t -91.24 -40.27 11.62 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.377 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.87 56.43 1.08 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.736 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -136.22 139.2 42.58 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.802 0.334 . . . . 0.0 110.865 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 p -80.58 146.35 31.28 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.789 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.48 149.29 49.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.07 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 63.5 m95 . . . . . 0 CA--C 1.531 0.239 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.013 179.75 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.0 mtt85 . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.752 0.311 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.43 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 58.2 m95 -126.15 141.21 52.03 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.117 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.8 p -114.72 134.48 57.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.826 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -90.64 130.87 36.61 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.913 0.387 . . . . 0.0 111.304 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.11 148.69 19.68 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.74 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.7 mm -98.09 125.74 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 120.452 0.168 . . . . 0.0 111.021 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.3 p -132.99 155.36 49.31 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.024 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.1 t 58.73 -148.09 0.48 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.67 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -62.0 -23.69 66.58 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.89 43.05 0.02 OUTLIER Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.577 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -94.0 112.24 24.05 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -75.0 116.45 15.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.002 0.429 . . . . 0.0 110.72 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -111.03 151.71 27.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.388 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -124.05 149.35 46.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.819 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -134.42 147.98 50.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.679 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.43 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 10.2 t70 -109.93 122.1 46.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.679 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.67 -23.64 29.35 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.4 mt -57.85 -52.53 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.636 0.255 . . . . 0.0 110.953 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.67 -41.12 6.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.16 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.44 53.02 0.95 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.433 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -133.57 127.73 33.73 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.857 0.361 . . . . 0.0 111.281 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.7 t -76.11 145.75 39.78 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.762 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -132.66 168.19 18.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.121 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -127.57 -46.79 1.44 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.802 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.99 129.97 35.03 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.537 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -71.11 133.93 85.54 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.015 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo . . . . . 0 C--N 1.351 0.703 0 C-N-CA 122.61 2.207 . . . . 0.0 112.576 -179.938 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.438 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 85.4 m95 . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.715 0.293 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.5 p -105.64 136.8 38.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.855 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -91.54 122.0 33.73 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.817 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.41 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.75 153.38 16.98 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.431 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.23 141.5 45.86 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.113 0.482 . . . . 0.0 111.544 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.1 t -123.54 152.27 41.97 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.497 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 0.7 OUTLIER -44.7 156.23 0.09 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.849 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 22.2 m-20 76.88 -54.67 0.57 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.889 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.12 54.29 0.03 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.131 -0.556 . . . . 0.0 112.264 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.404 ' CE2' ' HB2' ' A' ' 55' ' ' ASP . 18.3 m-85 -120.01 118.0 29.5 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.656 0.265 . . . . 0.0 110.811 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.47 120.67 29.0 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.01 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.415 ' HB3' ' CZ3' ' A' ' 70' ' ' TRP . 30.8 p90 -112.51 145.97 39.31 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.744 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -120.23 142.03 49.4 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.846 0.355 . . . . 0.0 110.95 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -130.27 150.55 51.46 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.341 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.438 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 56.3 t30 -114.37 133.48 55.67 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.052 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.4 p -82.09 -26.26 33.79 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.617 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -62.58 -66.78 0.49 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.36 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.9 t -84.5 -34.77 23.27 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.307 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.21 49.88 3.83 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.601 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -129.52 137.07 50.59 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.801 0.334 . . . . 0.0 111.138 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.51 146.17 27.05 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.66 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.04 155.59 50.5 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.415 ' CZ3' ' HB3' ' A' ' 59' ' ' TYR . 94.1 m95 . . . . . 0 CA--C 1.532 0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.926 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.235 0 CA-C-O 120.831 0.348 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -127.98 148.42 50.52 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.892 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 2.2 t -119.3 129.06 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.758 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.76 131.98 36.11 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.95 0.405 . . . . 0.0 111.445 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.12 147.18 19.07 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.404 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.2 mm -100.39 123.9 53.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 120.465 0.174 . . . . 0.0 110.875 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.02 156.17 47.84 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.965 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 57.14 -148.32 0.5 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.523 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.43 -21.25 66.19 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.76 44.58 0.02 OUTLIER Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.411 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -92.83 105.46 17.59 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -73.36 116.67 14.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.929 0.395 . . . . 0.0 110.959 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -110.9 151.51 27.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.466 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 56.1 m-85 -124.32 149.47 46.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 111.21 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -131.81 142.26 49.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.964 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -109.54 124.35 50.95 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.528 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.66 -26.45 27.78 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.214 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.8 mt -62.65 -45.44 98.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.7 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 t -99.64 -35.83 9.7 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.301 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.9 62.52 1.3 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.335 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.19 157.19 33.93 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.94 0.4 . . . . 0.0 111.866 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.3 t -101.52 151.98 21.32 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.711 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.91 168.12 19.35 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.043 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -127.57 7.49 6.32 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.706 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.12 131.97 47.3 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.544 0.211 . . . . 0.0 110.474 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -73.62 126.04 90.07 Favored Pre-proline 0 N--CA 1.462 0.17 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.875 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 31' ' ' LYS . 32.0 Cg_exo . . . . . 0 C--N 1.352 0.719 0 C-N-CA 122.941 2.427 . . . . 0.0 112.469 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 80.6 m95 . . . . . 0 C--O 1.233 0.219 0 CA-C-O 120.687 0.28 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.7 p -115.43 135.17 56.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.889 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.2 122.36 35.51 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.945 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.52 158.89 14.58 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.718 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.0 tp -107.71 136.8 46.85 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.954 0.407 . . . . 0.0 111.174 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.448 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 44.2 t -126.29 152.26 46.41 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.953 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -45.85 152.31 0.37 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.651 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 68.25 11.49 8.38 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.119 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.86 64.72 2.48 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.169 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.448 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 34.0 m-85 -128.03 106.55 9.15 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.731 0.3 . . . . 0.0 110.658 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.81 120.27 23.21 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.815 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -112.97 145.86 40.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.822 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -120.41 141.84 49.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.91 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -128.52 153.0 47.64 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.744 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.463 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 20.8 t-20 -113.77 134.43 54.77 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.073 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.9 p -89.15 -29.8 19.06 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.51 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -59.1 -60.49 3.79 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.507 0.194 . . . . 0.0 111.178 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.1 t -91.09 -36.19 14.16 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.236 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.51 50.06 2.84 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.65 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -130.42 135.61 48.19 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.846 0.355 . . . . 0.0 111.198 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.93 145.1 26.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.784 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.23 143.96 46.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.856 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 55.4 m95 . . . . . 0 CA--C 1.535 0.397 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.226 179.901 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.1 mtt-85 . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.992 0.425 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.526 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 91.6 m95 -109.17 141.6 41.17 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.75 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.5 p -114.64 135.4 54.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.978 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -90.41 130.42 36.49 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.881 0.372 . . . . 0.0 110.756 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.87 148.18 19.33 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.783 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.6 mm -97.16 142.12 14.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.723 0.296 . . . . 0.0 111.21 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.92 161.68 26.09 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.974 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -44.25 150.55 0.29 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.599 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.419 ' HB3' ' CE2' ' A' ' 16' ' ' TYR . 0.8 OUTLIER 81.1 -56.83 0.29 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.212 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.53 49.54 0.05 OUTLIER Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.585 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.419 ' CE2' ' HB3' ' A' ' 14' ' ' GLU . 31.3 m-85 -113.44 148.55 35.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.538 0.209 . . . . 0.0 110.487 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -108.67 116.75 32.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.935 0.398 . . . . 0.0 110.824 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -111.35 151.79 28.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.122 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -124.17 149.69 46.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.709 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -135.55 147.74 48.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.224 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.526 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 5.9 t70 -113.66 122.28 46.67 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.858 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.4 -26.56 30.3 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.346 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 mt -59.33 -50.5 79.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-O 120.69 0.281 . . . . 0.0 111.023 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 m -98.74 -50.22 4.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.977 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.74 55.34 0.66 Allowed Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.456 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -137.68 142.5 41.09 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.808 0.337 . . . . 0.0 111.306 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.34 130.79 35.66 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.792 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -124.11 168.75 12.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.8 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -127.27 -45.95 1.51 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.788 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.03 136.46 46.69 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.361 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -65.32 119.36 58.73 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.818 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo . . . . . 0 C--N 1.352 0.72 0 C-N-CA 122.741 2.294 . . . . 0.0 112.614 -179.671 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.449 ' CH2' ' HB2' ' A' ' 62' ' ' ASN . 65.3 m95 . . . . . 0 C--O 1.234 0.255 0 CA-C-O 120.797 0.332 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 2.3 t -101.8 156.12 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.579 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -113.25 121.89 45.81 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.67 0.271 . . . . 0.0 111.267 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.482 ' HA3' ' CE2' ' A' ' 59' ' ' TYR . . . -119.13 154.94 16.25 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.826 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -113.16 121.95 46.04 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 57' ' ' PHE . 0.6 OUTLIER -142.76 142.09 31.85 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.444 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 50.56 98.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.016 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 65.84 -63.54 0.22 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.35 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.14 40.27 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.733 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 53' ' ' SER . 20.9 m-85 -84.7 106.12 16.01 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.01 119.77 16.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.555 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.482 ' CE2' ' HA3' ' A' ' 51' ' ' GLY . 25.5 p90 -113.44 145.94 40.35 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.115 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 43.4 m-85 -120.08 141.77 49.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.787 0.327 . . . . 0.0 111.127 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -125.94 147.55 49.47 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.072 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.449 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 60.9 t30 -113.82 125.83 54.51 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.028 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.8 p -76.47 -26.58 55.52 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.332 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -58.46 -62.81 1.57 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.305 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.8 p -89.09 -44.27 10.46 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.131 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.47 52.78 1.52 Allowed Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.508 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -137.83 133.63 34.19 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.9 0.381 . . . . 0.0 111.025 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.4 p -75.34 145.57 41.62 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.919 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -132.82 158.13 43.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.807 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 65.6 m95 . . . . . 0 CA--C 1.534 0.332 0 CA-C-O 120.869 0.366 . . . . 0.0 111.039 -179.888 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.594 0.235 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.98 126.48 21.59 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.827 2.351 . . . . 0.0 112.701 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 t -170.31 -50.96 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.801 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.84 147.54 0.09 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.443 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.06 42.99 0.09 OUTLIER Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.713 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -94.41 76.56 3.88 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.148 0.499 . . . . 0.0 110.137 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.408 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 90.9 m95 -115.44 137.54 51.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.842 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 p -114.39 141.01 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.225 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.09 131.64 39.41 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.035 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.16 148.52 19.61 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.014 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.9 mm -91.49 142.62 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 120.676 0.274 . . . . 0.0 111.156 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.454 HG22 ' CD1' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -124.49 161.76 25.4 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.982 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.76 149.83 0.79 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.532 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 80.85 -55.76 0.32 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.217 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.1 55.84 0.03 OUTLIER Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.45 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -120.21 159.7 24.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.66 0.267 . . . . 0.0 110.755 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -115.83 117.04 29.1 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.06 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.454 ' CD1' HG22 ' A' ' 12' ' ' THR . 23.4 p90 -111.12 151.84 27.67 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.96 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -124.19 149.26 46.56 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.82 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -135.24 145.4 47.57 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.929 0.395 . . . . 0.0 111.446 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.408 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 6.9 t70 -109.73 122.58 47.82 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.75 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.07 -24.82 32.55 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.589 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.8 mt -60.7 -59.88 3.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.754 0.311 . . . . 0.0 110.858 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.46 -34.7 20.0 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.083 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.25 56.53 1.91 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.351 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -142.92 141.6 31.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.799 0.333 . . . . 0.0 111.544 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -86.85 131.23 34.17 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.472 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -124.74 168.58 13.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.187 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -127.54 -46.55 1.45 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.25 126.55 29.99 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.64 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -67.59 122.26 82.6 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.984 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.34 179.14 5.78 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.735 2.29 . . . . 0.0 112.816 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.19 75.99 10.24 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.724 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 151.26 49.23 0.02 OUTLIER Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.578 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -124.81 170.94 10.55 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.558 0.218 . . . . 0.0 110.672 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.0 34.66 2.43 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.925 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.06 -139.05 31.93 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.605 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -78.87 178.28 8.08 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.671 0.272 . . . . 0.0 110.778 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.1 tt -146.61 96.97 2.85 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.136 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.7 tttm 64.0 171.75 0.18 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.025 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 62.54 100.26 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.084 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.6 m 63.36 24.3 14.14 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.986 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.23 177.3 7.78 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.0 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.66 90.71 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.13 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.74 118.74 11.87 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.824 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.6 p -73.3 176.95 5.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.231 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.9 p -77.88 -29.96 16.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.289 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.416 ' CH2' ' HB2' ' A' ' 62' ' ' ASN . 83.5 m95 -90.58 143.17 27.01 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.714 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.5 p -106.6 137.27 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.819 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.9 121.83 33.08 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.857 0.36 . . . . 0.0 111.151 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.408 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -119.42 160.34 14.39 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.862 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 tp -113.0 131.6 55.7 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.93 0.395 . . . . 0.0 110.745 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.46 151.77 42.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.576 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 66.58 -157.24 0.25 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.739 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.19 -26.37 60.53 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.7 46.53 0.02 OUTLIER Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.219 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -95.68 137.97 33.99 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.68 120.06 36.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.95 0.405 . . . . 0.0 111.328 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.408 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 19.6 p90 -113.2 146.24 39.63 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.526 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -119.9 141.96 49.12 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.784 0.326 . . . . 0.0 110.905 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -130.64 149.61 52.21 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.207 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.416 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 10.4 t-20 -113.45 128.36 56.42 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.243 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.4 p -81.32 -20.3 41.04 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.739 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -58.52 -62.87 1.53 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.548 0.213 . . . . 0.0 111.263 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.0 t -99.84 -41.56 7.19 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.183 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.13 61.28 0.71 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.722 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -137.67 126.92 24.59 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.788 0.328 . . . . 0.0 110.975 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.6 p -77.84 150.14 34.25 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.841 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.6 ttt85 -133.02 157.94 43.98 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.042 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -126.53 28.92 5.84 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.007 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -151.0 148.73 28.72 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.566 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.3 114.72 36.22 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.741 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.59 147.45 70.28 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.568 2.179 . . . . 0.0 112.838 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -98.74 160.81 14.02 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.462 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.1 p30 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.523 -0.751 . . . . 0.0 111.215 179.828 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.8 140.4 57.42 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.526 2.151 . . . . 0.0 112.813 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 t -116.43 175.54 5.51 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.242 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.64 131.16 27.07 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.93 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.23 -70.94 0.31 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.507 -0.854 . . . . 0.0 113.101 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.416 ' HB2' HD11 ' A' ' 23' ' ' ILE . 11.5 mpt_? -71.99 88.94 1.08 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.931 0.396 . . . . 0.0 110.874 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -113.38 154.63 26.61 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.197 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 2.9 t -124.82 130.45 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.685 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -90.97 130.64 36.87 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.895 0.378 . . . . 0.0 111.025 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.29 148.75 19.59 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.603 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.9 mm -104.18 142.62 17.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.653 0.263 . . . . 0.0 111.092 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.87 161.53 27.22 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.931 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.53 150.77 0.63 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.792 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 82.4 -55.49 0.21 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.145 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.1 50.76 0.05 OUTLIER Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.533 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -113.98 147.6 38.32 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.504 0.192 . . . . 0.0 110.538 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -111.6 116.68 31.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.897 0.38 . . . . 0.0 110.923 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -111.35 151.68 28.14 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.84 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 59.9 m-85 -124.55 149.71 46.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.075 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -129.73 144.61 51.38 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.331 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -109.23 122.72 47.94 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.522 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.75 -28.63 24.47 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.283 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 6' ' ' ARG . 3.8 mt -58.29 -49.8 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.167 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.01 -43.44 5.77 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.41 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.84 34.46 3.77 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.469 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -121.62 127.79 51.24 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.798 0.332 . . . . 0.0 111.068 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.91 152.68 33.14 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.969 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -133.36 167.56 20.18 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.106 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -127.64 7.99 6.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.72 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -136.03 129.56 32.18 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -66.92 133.28 93.9 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.09 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.44 178.06 5.4 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.655 2.236 . . . . 0.0 112.254 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -68.35 89.33 0.33 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.018 0.437 . . . . 0.0 110.591 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.22 -95.0 0.59 Allowed Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.649 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 87.3 t80 66.45 -73.9 0.07 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 122.661 0.384 . . . . 0.0 111.255 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.34 30.94 4.93 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.714 0.292 . . . . 0.0 110.854 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.09 153.38 7.37 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.427 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.44 31.19 2.87 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.66 0.267 . . . . 0.0 111.253 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 mt 51.5 56.31 8.09 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.064 0.459 . . . . 0.0 111.057 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.79 136.16 50.52 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.984 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -94.66 100.61 12.52 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.923 0.392 . . . . 0.0 111.281 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.25 150.12 26.6 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.026 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -96.37 103.81 15.73 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.031 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.4 p -104.42 131.31 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.046 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -71.37 -179.8 2.61 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.063 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.2 p -61.84 105.26 0.54 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.181 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.3 t -103.38 23.05 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.652 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -119.11 145.04 46.28 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.815 0.34 . . . . 0.0 111.388 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 2.9 t -112.07 139.08 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.811 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.77 122.51 44.63 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.638 0.256 . . . . 0.0 111.089 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.415 ' HA3' ' CE1' ' A' ' 59' ' ' TYR . . . -118.67 154.06 16.69 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.758 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.4 tp -109.67 126.51 53.75 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.853 0.359 . . . . 0.0 111.284 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.66 152.08 37.69 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.957 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -46.73 153.64 0.38 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.658 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 68.08 8.8 6.76 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.172 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.36 55.96 5.36 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.839 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -116.32 93.07 4.08 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.755 0.312 . . . . 0.0 110.543 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.3 m -72.6 120.58 18.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.989 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.415 ' CE1' ' HA3' ' A' ' 51' ' ' GLY . 32.9 p90 -112.61 145.88 39.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.504 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 24.0 m-85 -120.26 142.07 49.39 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.864 0.364 . . . . 0.0 111.331 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -125.88 156.1 40.18 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.654 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -113.53 126.75 55.65 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.221 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.5 p -93.85 29.51 2.06 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.869 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -120.91 -55.47 1.99 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.877 0.37 . . . . 0.0 110.434 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.6 p -96.3 -33.1 12.09 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.016 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.25 64.45 1.23 Allowed Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.571 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -149.71 128.86 12.76 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.861 0.362 . . . . 0.0 111.022 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.94 149.93 29.19 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.584 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.58 156.6 48.4 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.274 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -126.73 24.57 6.54 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.09 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -145.05 132.14 20.39 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.522 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.1 ttpp -63.56 133.78 95.63 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.017 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.76 99.81 0.89 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.571 2.181 . . . . 0.0 112.182 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 67.9 177.8 0.24 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.227 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.893 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.558 0.218 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.78 74.76 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.875 2.383 . . . . 0.0 112.631 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.89 -49.49 2.98 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.172 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -150.26 49.63 0.9 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.312 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.79 -170.82 26.39 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.921 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -127.67 91.42 3.29 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.11 0.481 . . . . 0.0 110.823 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -106.55 141.66 37.47 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.564 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 p -115.76 138.78 45.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.935 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -90.45 132.77 35.46 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.875 0.369 . . . . 0.0 111.022 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.76 146.82 18.6 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.536 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.7 mm -102.56 141.72 18.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.557 0.218 . . . . 0.0 110.982 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.14 162.04 27.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.828 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.9 m -48.42 149.58 1.56 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.634 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 82.43 -55.89 0.21 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.086 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.93 52.21 0.04 OUTLIER Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.451 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -116.47 129.97 56.5 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.512 0.196 . . . . 0.0 110.577 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -95.58 117.14 29.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.768 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -110.69 151.28 27.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.737 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -124.42 149.38 46.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.872 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -136.45 147.71 47.35 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.483 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -111.98 122.23 47.18 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.612 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.81 -33.49 46.14 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.574 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.5 mt -60.88 -55.59 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.707 0.289 . . . . 0.0 110.994 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.9 t -84.22 -36.27 22.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.25 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.01 47.37 5.03 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.217 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -136.07 143.3 44.56 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.838 0.352 . . . . 0.0 111.539 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.01 143.01 27.55 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.572 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -134.39 167.03 21.49 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.188 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -127.38 7.25 6.4 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.671 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -123.54 127.83 48.89 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.41 110.94 3.55 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.757 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.19 149.94 71.12 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.393 2.062 . . . . 0.0 112.217 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.72 90.46 0.17 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.022 0.439 . . . . 0.0 110.611 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.97 47.72 0.07 OUTLIER Glycine 0 CA--C 1.52 0.396 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.479 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -117.38 -51.08 2.53 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.614 0.245 . . . . 0.0 110.784 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -124.71 176.96 6.23 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.267 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.9 64.78 4.17 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.985 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.26 91.52 1.69 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.827 0.346 . . . . 0.0 110.747 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.75 113.41 4.84 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.358 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -89.68 169.06 11.62 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.069 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.88 98.06 10.56 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.207 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.17 174.28 15.42 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -102.37 22.29 13.64 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.673 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -109.39 119.24 58.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.696 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.8 mttp -110.96 108.1 17.75 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.917 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.28 148.32 52.44 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.293 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.453 HG12 ' CG ' ' A' ' 64' ' ' GLU . 19.2 t -141.18 -53.59 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.628 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.503 ' CH2' ' HB2' ' A' ' 62' ' ' ASN . 78.9 m95 -72.47 142.67 48.59 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.264 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.5 p -115.45 144.73 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.005 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -95.57 122.21 38.07 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.781 0.324 . . . . 0.0 110.97 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.67 158.71 14.69 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.6 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.34 128.54 55.99 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.923 0.392 . . . . 0.0 111.234 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.6 m -107.46 151.96 24.85 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.861 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -44.15 148.9 0.38 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.918 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 t0 82.84 -52.82 0.18 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.173 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.22 54.13 0.03 OUTLIER Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.611 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -122.14 132.1 54.29 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 110.48 -0.193 . . . . 0.0 110.48 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.05 120.69 35.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.805 0.336 . . . . 0.0 111.028 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -112.69 145.95 39.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.788 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -120.41 141.98 49.63 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.796 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -122.86 149.87 43.62 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.217 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.503 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 53.6 t30 -113.0 131.31 55.81 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.154 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.0 p -84.14 -28.68 27.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.56 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.453 ' CG ' HG12 ' A' ' 47' ' ' VAL . 10.1 mt-10 -60.07 -62.6 1.75 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.71 0.29 . . . . 0.0 111.018 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.1 p -86.21 -44.3 12.29 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.141 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.93 51.13 1.83 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.43 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -134.68 140.35 45.94 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 111.081 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.99 140.79 34.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.407 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.21 158.04 42.77 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.931 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -126.34 27.55 6.18 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.79 0.329 . . . . 0.0 111.016 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -143.22 130.84 21.26 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.015 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.5 mttp -55.77 109.19 1.48 Allowed Pre-proline 0 N--CA 1.467 0.377 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.176 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.95 167.19 16.41 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.785 2.324 . . . . 0.0 112.45 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 72.96 175.34 0.28 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.815 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.148 -0.929 . . . . 0.0 111.315 -179.778 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.3 t70 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 120.764 0.316 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.8 134.93 26.84 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.777 2.318 . . . . 0.0 112.607 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.94 88.33 0.96 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.811 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.49 96.41 9.11 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.008 0.432 . . . . 0.0 111.137 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.23 113.42 4.11 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.763 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -101.83 95.44 6.4 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.75 0.309 . . . . 0.0 110.841 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.544 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 58.8 m95 -123.8 144.77 49.51 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.329 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.2 p -112.71 138.01 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.725 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -90.25 131.02 36.3 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.827 0.346 . . . . 0.0 110.979 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.26 148.51 19.62 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.657 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.6 mm -95.32 144.5 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.712 0.291 . . . . 0.0 111.288 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 p -128.15 162.05 27.83 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.054 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.0 m -45.16 152.69 0.25 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.583 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 78.48 -55.99 0.47 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.132 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.8 51.99 0.04 OUTLIER Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.389 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -115.9 151.27 35.67 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.683 0.278 . . . . 0.0 110.86 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -108.59 117.07 33.23 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.922 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.41 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 21.5 p90 -110.72 151.44 27.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.659 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -124.13 149.42 46.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.581 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -130.99 142.33 50.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.073 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 20.7 t70 -111.2 123.48 50.29 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.508 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.57 -30.34 33.06 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.393 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.1 mt -60.22 -45.27 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 120.685 0.279 . . . . 0.0 111.01 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.87 -35.6 10.05 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.277 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.05 60.89 1.71 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.311 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.6 155.58 37.63 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.989 0.423 . . . . 0.0 111.92 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 t -97.62 143.5 28.23 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.728 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -135.67 168.64 18.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.826 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.41 ' CZ3' ' HB3' ' A' ' 18' ' ' TYR . 95.3 m95 -127.0 -44.64 1.61 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.66 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -80.04 135.22 36.31 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.541 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.11 142.93 92.82 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.021 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -85.95 31.66 0.47 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.74 2.293 . . . . 0.0 113.229 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 52.12 28.71 5.67 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.685 0.279 . . . . 0.0 111.706 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.07 39.82 0.31 Allowed Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.769 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -120.74 -47.67 2.3 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.634 0.254 . . . . 0.0 110.933 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -105.6 128.04 53.39 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.84 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -158.41 146.31 13.03 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.683 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.25 113.28 25.66 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.734 0.302 . . . . 0.0 111.061 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.4 mt -94.58 175.7 6.57 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.107 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -99.25 34.84 2.06 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.82 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -137.88 153.47 49.55 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.891 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.42 127.69 33.52 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.93 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.81 141.39 29.33 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.239 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.9 p -89.31 145.27 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.339 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -98.14 36.06 1.64 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 m 59.77 85.76 0.1 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.009 0.433 . . . . 0.0 111.401 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.2 t -98.09 40.34 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.921 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.451 ' CH2' ' HB2' ' A' ' 62' ' ' ASN . 80.1 m95 -126.14 144.2 50.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.93 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 4.2 t -100.85 153.83 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.675 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -106.34 122.27 45.91 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 111.128 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.414 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.9 157.91 15.07 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.607 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.2 tp -111.97 123.59 50.59 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.883 0.373 . . . . 0.0 111.149 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.53 152.24 30.49 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.87 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -46.79 154.98 0.28 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.683 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 67.81 9.6 7.22 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.227 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.38 58.72 3.52 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.003 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -123.53 110.52 15.16 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.63 0.253 . . . . 0.0 110.617 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.41 120.42 24.95 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.001 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.414 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 38.0 p90 -112.53 145.78 39.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.47 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 36.9 m-85 -120.11 142.12 49.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.834 0.349 . . . . 0.0 111.225 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -121.85 149.44 43.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.189 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.451 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 46.8 t-20 -117.47 131.77 56.67 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.191 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.2 p -78.82 -26.62 44.25 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.503 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -57.64 -63.34 1.27 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.307 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.4 p -88.12 -46.14 9.55 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.082 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.4 47.17 2.22 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.494 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -136.08 143.72 44.77 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.773 0.321 . . . . 0.0 110.973 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.4 p -74.52 148.78 40.62 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -133.66 155.26 50.01 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.076 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -126.41 32.23 5.23 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.765 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -139.86 120.04 13.77 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.596 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -72.66 116.34 48.84 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.833 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.92 105.66 1.19 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.681 2.254 . . . . 0.0 112.107 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -98.3 145.56 26.55 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.482 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.658 -0.687 . . . . 0.0 111.127 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.707 0.289 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.99 78.95 1.73 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.699 2.266 . . . . 0.0 112.429 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.87 146.71 30.27 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.019 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? 61.72 92.55 0.05 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.192 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.64 82.5 0.05 OUTLIER Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.706 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -99.53 78.81 2.21 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.962 0.411 . . . . 0.0 110.503 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.472 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 59.9 m95 -122.14 143.83 49.31 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.102 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 1.5 t -109.28 139.66 31.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.665 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -90.76 133.67 35.01 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.819 0.342 . . . . 0.0 111.202 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.89 148.47 19.56 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.695 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.0 mm -95.51 144.74 9.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.7 0.286 . . . . 0.0 111.257 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.89 161.91 28.75 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.793 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -47.88 149.38 1.34 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.404 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 79.79 -56.8 0.38 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.926 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.18 48.72 0.03 OUTLIER Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.553 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -110.08 146.14 35.91 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.571 0.224 . . . . 0.0 110.516 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -108.73 116.98 33.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.811 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -110.64 151.14 28.03 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.514 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.7 m-85 -124.83 149.57 47.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.254 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -125.36 148.67 48.67 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.972 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.472 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 33.4 t70 -116.59 125.75 52.28 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.951 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.59 -31.78 24.13 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.478 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.5 mt -59.99 -57.61 10.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.637 0.256 . . . . 0.0 111.036 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.7 m -86.43 -41.43 14.44 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.978 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.07 48.46 2.86 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.298 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.3 144.92 48.6 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.823 0.344 . . . . 0.0 111.26 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.59 132.38 36.91 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.76 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.41 165.63 14.66 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -127.52 6.28 6.26 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.747 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -132.14 128.15 37.47 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.38 112.34 6.3 Favored Pre-proline 0 C--O 1.233 0.205 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.744 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.53 169.56 3.08 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.766 2.311 . . . . 0.0 112.63 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.64 86.75 0.32 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.668 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.54 -68.71 0.54 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.661 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.0 t80 67.79 -70.84 0.11 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.696 0.398 . . . . 0.0 111.43 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -82.61 95.32 7.75 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.705 0.288 . . . . 0.0 110.638 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -122.16 38.7 2.51 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.774 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.69 -179.56 5.2 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.63 0.215 . . . . 0.0 111.066 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 68.47 101.8 0.05 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.725 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.0 tttt 71.5 119.03 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.896 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.14 131.22 55.27 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.499 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.8 m -128.27 -48.66 1.31 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.863 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.27 99.54 11.19 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.242 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.07 129.38 72.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.055 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.8 87.99 0.09 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.298 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.23 154.61 32.86 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.359 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.7 t -100.39 -29.0 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.456 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.47 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 84.5 m95 -78.53 144.32 35.76 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.776 0.322 . . . . 0.0 111.377 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 21.2 t -99.94 155.4 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.717 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -112.72 122.4 47.57 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.792 0.329 . . . . 0.0 111.116 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.408 ' HA3' ' CE1' ' A' ' 59' ' ' TYR . . . -118.83 156.69 15.57 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.812 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.4 tp -109.69 127.15 54.38 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.917 0.389 . . . . 0.0 111.233 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.426 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 17.0 t -119.97 152.05 38.03 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.702 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -45.39 155.39 0.14 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.564 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.19 6.71 5.81 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.137 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.04 51.42 5.8 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.635 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.426 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 32.6 m-85 -112.72 125.62 54.51 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.579 0.228 . . . . 0.0 110.412 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.5 m -100.43 120.6 40.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.834 0.35 . . . . 0.0 111.111 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.408 ' CE1' ' HA3' ' A' ' 51' ' ' GLY . 35.8 p90 -112.45 145.45 40.16 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.388 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.521 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 17.5 m-85 -120.73 141.92 50.0 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.84 0.352 . . . . 0.0 111.349 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -121.86 145.52 48.0 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.96 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.47 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 54.9 t-20 -113.17 126.15 55.12 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.0 p -78.61 -30.19 46.39 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.359 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -55.6 -54.83 39.28 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.284 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.8 p -93.82 -33.09 13.7 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.334 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.69 58.77 2.33 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.31 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -147.71 141.34 25.54 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.829 0.347 . . . . 0.0 111.204 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 99.1 p -76.35 143.5 40.72 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.627 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.427 ' HD3' ' CH2' ' A' ' 48' ' ' TRP . 14.3 ttt85 -133.72 158.2 43.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -125.77 -47.33 1.68 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.532 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.82 134.18 48.24 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.412 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -72.24 134.56 82.65 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.901 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.71 161.09 44.82 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.598 2.199 . . . . 0.0 112.368 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.53 120.97 29.45 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.465 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.55 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.67 0.271 . . . . 0.0 111.411 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.84 112.43 2.68 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.754 2.303 . . . . 0.0 112.29 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.8 t -113.33 108.66 17.55 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -156.39 145.39 20.36 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.148 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.08 -174.87 21.71 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.987 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -114.46 99.74 7.78 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.428 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 80.0 m95 -116.29 149.91 38.47 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.09 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 3.0 t -113.69 150.73 15.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.974 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -102.46 130.18 49.18 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.829 0.347 . . . . 0.0 111.155 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.28 148.08 19.44 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.74 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.4 mm -106.68 146.68 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.693 0.282 . . . . 0.0 111.305 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.6 161.53 31.34 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.895 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 m -46.96 153.26 0.44 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.486 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 81.29 -56.33 0.28 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.03 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.72 51.05 0.05 OUTLIER Glycine 0 C--N 1.337 0.598 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.586 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -114.82 140.96 48.51 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.66 0.267 . . . . 0.0 110.508 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -107.2 116.82 32.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.809 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -111.02 151.31 28.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.806 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 48.5 m-85 -124.56 149.82 46.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.834 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -128.75 148.25 50.84 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.329 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.428 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 10.7 t70 -113.93 127.89 56.16 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.795 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.29 -38.86 21.57 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.286 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mt -61.13 -50.9 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.988 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.7 m -85.32 -40.83 16.1 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.173 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.7 37.27 8.75 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.391 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -127.6 148.02 50.36 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.82 0.343 . . . . 0.0 111.265 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 95.5 p -93.58 141.69 28.19 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.749 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.46 167.97 20.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.923 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -127.61 5.96 6.19 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.727 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -120.78 122.03 39.46 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -64.15 119.51 56.36 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.85 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.89 177.53 0.99 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.724 2.282 . . . . 0.0 112.518 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.69 -35.33 78.62 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.028 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.53 91.46 0.65 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 121.165 -0.541 . . . . 0.0 112.399 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -139.8 162.76 34.37 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.524 0.202 . . . . 0.0 110.598 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 68.05 -154.93 0.19 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.398 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -132.39 -142.5 4.91 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.741 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 9.0 p-10 -165.25 173.56 11.14 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 122.014 0.125 . . . . 0.0 110.736 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 38' ' ' ASP . 3.5 mm? 68.8 168.27 0.28 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.927 0.394 . . . . 0.0 111.142 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.62 171.92 7.29 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.709 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 73.08 128.9 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.75 122.02 9.6 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.252 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -146.5 95.42 2.6 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.321 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.86 135.77 38.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.936 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.6 tttt -75.92 104.73 6.59 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.792 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.4 p -105.79 177.84 4.74 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.41 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.3 p -98.98 24.06 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.532 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.44 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 59.0 m95 -114.79 140.09 49.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.858 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 9.4 p -99.26 140.29 19.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.472 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.79 122.42 33.51 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.839 0.352 . . . . 0.0 111.032 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.75 158.93 14.61 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.459 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 tp -109.88 137.26 47.92 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 111.103 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.2 152.15 46.42 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.791 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.53 153.61 0.36 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.503 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 67.59 11.37 8.34 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.076 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.63 66.74 1.93 Allowed Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.869 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -131.33 111.7 12.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.723 0.297 . . . . 0.0 110.631 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 m -81.49 120.35 24.91 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.06 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -112.77 145.83 39.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.617 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 89.9 m-85 -120.38 141.87 49.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.771 0.319 . . . . 0.0 111.01 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -127.19 148.8 50.18 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.44 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 52.6 t-20 -115.55 132.31 56.67 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.182 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.1 p -80.71 -29.75 36.4 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.4 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.1 -64.66 0.86 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.179 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.1 t -82.74 -34.8 27.09 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.994 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.28 47.14 5.86 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.602 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -133.39 136.94 45.6 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.784 0.326 . . . . 0.0 110.899 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.6 p -80.81 143.54 32.74 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.966 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.44 157.7 44.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.925 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -126.45 39.84 3.85 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.865 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -146.95 138.12 24.02 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.786 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -73.17 116.52 51.59 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.524 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.84 100.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.866 2.378 . . . . 0.0 112.621 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.21 166.55 23.07 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.21 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.23 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.33 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.14 155.49 25.79 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.029 1.819 . . . . 0.0 112.325 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.4 t 59.39 46.13 12.89 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.253 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -172.26 76.6 0.05 OUTLIER 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.337 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -118.41 93.29 0.56 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.968 -0.635 . . . . 0.0 112.641 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.11 78.2 6.77 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.834 0.35 . . . . 0.0 110.915 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.458 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 87.4 m95 -112.35 134.24 54.0 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.96 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -112.66 141.4 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.183 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.37 131.63 36.72 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.893 0.377 . . . . 0.0 111.292 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.26 148.61 19.41 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.617 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.0 mm -99.9 143.26 13.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 120.612 0.244 . . . . 0.0 111.183 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.24 161.56 27.46 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.862 0.363 . . . . 0.0 111.053 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.6 m -46.45 151.95 0.49 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.668 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 81.67 -54.98 0.26 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.191 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.64 51.52 0.05 OUTLIER Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.426 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -118.54 151.81 37.15 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.633 0.254 . . . . 0.0 110.832 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -111.85 117.21 32.16 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.07 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -110.94 151.39 27.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.617 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -124.13 149.58 46.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.741 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -131.23 147.37 52.58 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.197 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.458 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 34.3 t70 -114.75 122.38 46.21 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.739 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.18 -29.75 48.67 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.19 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.5 mt -60.52 -60.16 3.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-O 120.684 0.278 . . . . 0.0 111.016 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.07 -30.81 25.74 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.484 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.22 45.82 7.31 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.18 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -132.63 151.41 51.96 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.916 0.389 . . . . 0.0 111.666 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.07 145.99 24.09 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.902 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -133.72 168.66 18.31 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.136 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -126.97 -40.97 1.83 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.044 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.88 137.56 33.61 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.59 0.233 . . . . 0.0 110.454 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.87 139.28 97.3 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.198 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.441 ' HG2' ' HB2' ' A' ' 35' ' ' PHE . 42.1 Cg_endo -67.02 -177.3 0.97 Allowed 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.765 2.31 . . . . 0.0 112.422 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.6 87.25 2.13 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.872 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.79 -81.16 0.29 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.112 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.441 ' HB2' ' HG2' ' A' ' 32' ' ' PRO . 32.2 t80 69.42 148.03 0.07 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.533 0.333 . . . . 0.0 111.065 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 65.41 94.8 0.06 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.269 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.63 -82.96 0.05 OUTLIER Glycine 0 C--N 1.337 0.59 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.292 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -160.03 145.64 15.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.772 0.32 . . . . 0.0 111.121 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mt -131.87 115.7 16.25 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.217 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.1 ttpp -90.32 74.63 6.96 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.808 0.337 . . . . 0.0 111.236 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.78 150.68 5.88 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.143 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.28 161.41 39.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.951 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.56 107.92 9.83 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.201 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.8 p -79.46 68.91 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 121.449 0.642 . . . . 0.0 110.66 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -129.81 163.07 27.06 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.063 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -116.6 38.0 3.58 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.068 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.481 HG13 ' OD1' ' A' ' 62' ' ' ASN . 10.4 p -104.82 26.59 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.065 0.46 . . . . 0.0 111.054 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -110.08 142.49 41.46 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.99 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 14.0 p -104.95 149.34 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.175 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -96.89 122.44 39.87 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.406 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.402 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.96 157.42 15.28 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.712 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.5 tp -106.25 130.42 54.11 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.905 0.383 . . . . 0.0 111.326 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.462 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 12.1 t -119.93 152.09 37.93 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.974 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.96 153.41 0.65 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.655 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 67.25 10.86 8.04 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.195 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.92 65.8 2.12 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.347 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.462 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 31.8 m-85 -131.13 106.61 8.47 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.717 0.294 . . . . 0.0 110.748 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.4 m -73.93 120.22 19.21 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.839 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.402 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 23.4 p90 -112.9 146.14 39.48 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.637 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 49.5 m-85 -120.04 141.97 49.26 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 110.777 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -129.51 147.16 51.29 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.438 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.481 ' OD1' HG13 ' A' ' 47' ' ' VAL . 52.3 t-20 -113.11 128.34 56.46 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.974 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.7 p -79.13 -24.01 43.64 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.408 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -60.06 -64.7 0.86 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.294 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.2 t -90.06 -34.38 15.96 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.22 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.24 53.17 2.55 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.551 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -135.46 142.34 45.52 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.913 0.387 . . . . 0.0 111.308 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.52 144.71 27.77 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.762 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -133.49 157.83 44.64 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -126.24 37.04 4.4 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.916 0.388 . . . . 0.0 110.913 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -153.03 133.4 13.59 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.334 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 112.94 6.97 Favored Pre-proline 0 N--CA 1.466 0.337 0 CA-C-O 120.661 0.267 . . . . 0.0 110.799 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.36 93.39 0.83 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.544 2.163 . . . . 0.0 112.548 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -161.57 90.35 0.79 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.736 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.941 -179.793 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 120.806 0.336 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.37 143.13 42.54 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.697 2.265 . . . . 0.0 112.534 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.6 150.74 47.67 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.137 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -129.55 158.03 40.41 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.791 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.13 46.76 4.34 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.323 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -75.64 81.62 2.63 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.984 0.421 . . . . 0.0 110.303 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.497 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 94.6 m95 -120.46 137.47 54.33 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.101 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.7 p -113.03 130.95 65.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.028 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -90.55 129.64 36.68 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.891 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.24 148.67 19.68 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.678 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.1 mm -97.85 129.05 48.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.529 0.204 . . . . 0.0 111.011 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.6 p -131.66 154.04 49.36 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.714 0.292 . . . . 0.0 111.076 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.2 -150.14 0.42 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.758 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -81.29 3.49 23.88 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.48 68.91 0.01 OUTLIER Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.084 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -138.52 109.87 6.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.692 0.282 . . . . 0.0 110.596 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -78.12 116.72 18.79 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.963 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -111.22 151.91 27.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.743 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -123.85 149.25 45.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.794 0.33 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -136.27 146.11 46.31 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.497 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 24.5 t70 -113.33 124.13 51.76 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.981 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.43 -28.63 34.17 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.712 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.9 mt -60.46 -52.58 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.696 0.284 . . . . 0.0 110.998 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.9 m -93.07 -31.61 14.77 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.335 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.01 48.38 5.18 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.307 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -131.99 147.69 52.47 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.855 0.36 . . . . 0.0 111.735 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.76 131.07 41.0 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.731 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -121.53 168.86 11.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.914 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -127.0 -34.95 2.3 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.089 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -82.54 145.19 29.88 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.66 0.267 . . . . 0.0 110.643 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -70.13 135.2 87.13 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.177 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 35' ' ' PHE . 36.1 Cg_exo -60.17 179.3 0.32 Allowed 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.94 2.426 . . . . 0.0 112.769 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -62.77 -36.44 83.09 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.5 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.19 81.82 0.2 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.977 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.454 ' HB2' ' HD2' ' A' ' 32' ' ' PRO . 85.5 t80 -99.85 -60.24 1.57 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.561 0.219 . . . . 0.0 110.801 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -117.44 -42.35 2.89 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.299 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.92 145.1 17.64 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.721 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -124.0 108.19 12.12 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.751 0.31 . . . . 0.0 111.118 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.78 81.83 1.5 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.728 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -96.38 117.64 31.28 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.874 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -144.31 161.48 38.85 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.453 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -81.63 -36.65 28.63 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.072 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.73 155.85 17.67 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.39 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.9 t -121.97 96.78 4.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.393 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.45 89.52 0.69 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.199 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.86 87.11 2.09 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.643 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.6 p -83.86 -24.71 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.215 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.437 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 71.0 m95 -78.35 142.6 37.57 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.011 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 2.1 t -104.12 155.69 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.725 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -112.98 121.91 46.05 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.771 0.32 . . . . 0.0 111.307 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.44 ' HA3' ' CE2' ' A' ' 59' ' ' TYR . . . -119.33 158.27 15.08 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.86 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.82 127.96 55.97 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.756 0.313 . . . . 0.0 110.979 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.17 151.77 44.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.729 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.07 -158.67 0.31 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.809 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -57.31 -26.23 60.58 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.29 48.72 0.02 OUTLIER Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.121 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -98.37 123.87 42.72 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.99 120.52 32.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.32 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.44 ' CE2' ' HA3' ' A' ' 51' ' ' GLY . 25.1 p90 -112.73 145.68 40.09 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.455 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 13.9 m-85 -120.4 141.85 49.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.844 0.354 . . . . 0.0 111.044 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -124.81 146.53 49.2 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.627 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.437 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 35.4 t30 -113.6 122.74 48.13 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.543 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.3 p -74.98 -25.07 58.58 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.484 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -55.14 -61.79 2.09 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.381 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 t -97.27 -32.88 11.68 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.387 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.45 63.26 1.18 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.44 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -145.6 142.7 29.34 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.836 0.35 . . . . 0.0 111.617 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.88 141.24 28.92 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.91 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.27 156.67 48.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.781 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 45.0 m95 -126.42 31.78 5.31 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.838 0.351 . . . . 0.0 110.652 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -144.56 135.93 25.43 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.537 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -69.87 135.48 87.68 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.889 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 72' ' ' LYS . 40.5 Cg_exo -57.11 116.62 3.34 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.856 2.371 . . . . 0.0 112.857 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -136.56 118.13 14.87 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.029 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.021 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 15.4 t70 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.456 0.169 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.51 95.95 0.89 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.519 2.146 . . . . 0.0 112.261 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.09 -64.22 0.37 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.355 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -78.63 114.42 17.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.824 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.3 144.97 16.0 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.893 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -124.77 90.0 3.17 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.887 0.375 . . . . 0.0 110.411 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.5 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 82.3 m95 -110.45 147.21 34.52 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.054 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 p -112.97 139.06 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.768 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.29 130.53 36.39 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.93 0.395 . . . . 0.0 110.909 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.3 147.91 19.37 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.779 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.3 mm -93.33 142.62 12.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.625 0.25 . . . . 0.0 111.107 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.39 161.97 24.85 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.673 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -50.0 151.18 2.01 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.383 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 80.73 -54.38 0.33 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.132 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.78 52.24 0.04 OUTLIER Glycine 0 C--N 1.336 0.563 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.357 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -118.67 146.18 44.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.599 0.238 . . . . 0.0 110.67 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -105.69 117.05 33.04 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.953 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -110.94 151.83 27.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.747 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -124.33 149.56 46.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.966 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -135.12 144.26 47.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.785 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.5 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 13.5 t70 -110.08 124.33 51.31 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.896 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.78 -32.08 35.57 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.936 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.5 mt -59.16 -54.73 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.757 0.313 . . . . 0.0 111.059 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.4 p -85.97 -35.7 20.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.167 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.39 54.11 3.07 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.28 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -140.73 147.03 38.53 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.879 0.371 . . . . 0.0 111.522 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.1 p -88.03 132.76 34.15 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.565 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -126.27 166.94 16.17 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.869 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -127.52 -43.99 1.56 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.031 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -70.11 150.93 46.03 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.783 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -99.08 102.54 15.88 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.94 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.85 -176.15 1.68 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.657 2.238 . . . . 0.0 112.605 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -83.7 131.47 34.93 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.023 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.56 20.51 10.07 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.21 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -108.67 -51.75 2.85 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 117.03 0.415 . . . . 0.0 110.866 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.27 113.19 13.51 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.701 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.28 141.65 3.8 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.997 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -139.0 48.22 1.89 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.804 0.335 . . . . 0.0 111.785 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.1 tt -162.51 77.61 0.48 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.578 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 tttt 64.03 168.02 0.16 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.43 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.73 178.72 6.15 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 26.7 m -87.44 -60.88 1.85 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.2 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 61.38 102.25 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.82 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.6 t -112.06 135.8 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.516 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -100.45 35.31 2.15 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.807 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.1 p 42.31 84.27 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.101 -0.499 . . . . 0.0 112.274 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.4 t -121.95 38.82 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.397 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -123.51 143.83 49.93 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.806 0.336 . . . . 0.0 111.078 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 2.2 t -106.3 133.77 49.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.65 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.1 122.26 33.6 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.825 0.345 . . . . 0.0 110.865 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.42 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.83 158.53 14.79 Favored Glycine 0 C--N 1.332 0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.581 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.8 tp -109.76 136.03 49.73 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.867 0.365 . . . . 0.0 111.236 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.408 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 3.9 t -123.88 151.81 43.07 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.641 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.42 155.18 0.78 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.481 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 69.91 7.4 6.21 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.278 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.83 63.04 2.15 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.911 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 28.4 m-85 -127.77 128.38 45.22 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.553 0.216 . . . . 0.0 110.544 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.68 120.44 39.12 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.829 0.347 . . . . 0.0 111.013 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.42 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 30.5 p90 -112.91 146.18 39.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.536 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 55.6 m-85 -119.8 141.88 49.1 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.852 0.358 . . . . 0.0 110.884 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -128.15 147.69 50.56 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.982 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -114.11 130.67 56.57 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.679 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.8 p -78.44 -29.06 46.81 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.862 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -59.98 -66.47 0.51 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.386 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.1 t -82.42 -39.13 23.05 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.475 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.3 40.61 6.04 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.929 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -125.46 133.95 52.25 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.813 0.34 . . . . 0.0 110.872 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.05 148.43 37.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.736 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -133.2 153.61 51.38 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.878 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -126.26 29.82 5.73 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.908 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -141.91 135.76 29.78 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.127 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.61 111.39 4.68 Favored Pre-proline 0 C--O 1.234 0.28 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.642 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -70.03 169.36 19.44 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.406 2.071 . . . . 0.0 112.638 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -89.77 101.11 13.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.624 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.163 -179.995 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 120.503 0.192 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.54 101.84 0.92 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.729 2.286 . . . . 0.0 112.667 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 p -98.11 -57.7 2.15 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.257 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -143.89 -171.64 3.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.849 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 138.77 -31.0 2.43 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.825 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.409 ' HB3' HD23 ' A' ' 22' ' ' LEU . 0.6 OUTLIER -78.42 72.91 4.98 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.993 0.425 . . . . 0.0 110.627 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.486 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 97.0 m95 -116.18 151.49 35.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.142 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 2.8 t -124.7 131.51 72.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.613 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -90.69 130.05 36.73 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.939 0.399 . . . . 0.0 111.099 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.07 148.5 19.59 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.678 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.1 mm -97.86 144.25 11.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.639 0.257 . . . . 0.0 111.086 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.33 162.19 28.54 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.895 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.22 149.65 0.7 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.739 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 79.83 -55.98 0.38 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.295 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.57 52.44 0.04 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.336 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -116.48 134.66 54.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.617 0.246 . . . . 0.0 110.531 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -98.3 116.86 31.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.845 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -110.75 151.34 27.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.789 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 64.0 m-85 -124.2 149.52 46.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.131 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -125.99 147.34 49.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.035 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.486 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 32.9 t70 -118.92 122.09 41.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.704 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.409 HD23 ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -81.44 -26.76 35.06 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.321 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.5 mt -58.69 -48.71 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.766 0.317 . . . . 0.0 110.984 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.2 m -100.83 -35.49 9.41 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.346 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.44 51.31 3.14 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.127 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -137.69 154.83 49.62 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.963 0.411 . . . . 0.0 111.78 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.95 143.57 26.35 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.853 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -134.18 168.63 18.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.037 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -127.24 -47.9 1.46 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.582 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -73.47 125.23 27.43 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.346 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -60.95 138.0 93.91 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.175 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.15 -178.79 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.82 2.347 . . . . 0.0 112.59 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -93.69 41.07 1.08 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.093 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.38 -42.83 0.23 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.032 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 72.99 -68.45 0.23 Allowed 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.176 0.19 . . . . 0.0 111.063 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -124.86 127.12 46.64 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.623 0.249 . . . . 0.0 110.687 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -174.81 75.11 0.08 OUTLIER Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.682 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -98.19 122.88 41.89 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.796 0.331 . . . . 0.0 110.784 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 35.9 mt -76.53 88.3 3.26 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.882 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -98.24 34.03 2.06 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.04 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.63 31.89 5.42 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.235 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.8 m -84.44 -38.89 19.63 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.178 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.78 126.05 10.75 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.302 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -87.41 64.3 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 120.982 0.42 . . . . 0.0 110.501 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.36 159.45 17.14 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.919 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.9 m -87.97 87.3 7.3 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.096 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.7 p -97.62 23.73 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.274 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.445 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 33.0 m95 -115.87 140.07 49.59 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.799 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 12.0 p -96.43 145.44 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -94.14 122.15 36.37 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.8 0.334 . . . . 0.0 111.105 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -119.0 153.02 17.08 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.53 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.4 tp -109.78 138.94 45.43 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.998 0.427 . . . . 0.0 111.687 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.03 152.38 38.67 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.685 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 0.4 OUTLIER -45.14 152.24 0.27 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.742 -179.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 25.6 m-20 81.04 -44.29 0.21 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.14 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.22 48.33 0.11 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.425 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -114.27 130.04 56.64 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.6 m -99.36 120.45 39.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.876 0.369 . . . . 0.0 111.213 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -112.56 145.59 40.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.567 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 93.4 m-85 -120.42 142.06 49.56 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.747 0.308 . . . . 0.0 111.068 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -120.93 150.6 40.84 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.061 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.445 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 48.8 t-20 -114.31 130.14 56.66 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.281 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.3 p -82.66 -26.11 32.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.452 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -56.77 -61.8 2.18 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.653 -0.248 . . . . 0.0 111.353 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.0 p -93.8 -46.92 7.0 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.136 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.16 55.27 0.87 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.65 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -134.59 132.06 38.61 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.715 0.293 . . . . 0.0 110.832 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 86.9 p -71.94 148.76 45.7 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.758 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.59 157.71 45.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.211 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -126.25 29.61 5.78 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.611 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.405 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 4.3 mt-10 -146.14 162.42 38.01 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.239 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -99.02 99.25 7.59 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-O 120.578 0.228 . . . . 0.0 110.975 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 72.4 Cg_endo -76.02 125.59 8.74 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.686 2.257 . . . . 0.0 112.841 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -171.61 118.25 0.43 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.931 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.4 t70 . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.373 -0.822 . . . . 0.0 111.125 -179.715 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 120.605 0.241 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.17 132.64 48.94 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.735 2.29 . . . . 0.0 112.471 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.05 -170.32 0.72 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.969 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.3 tttm 65.02 45.26 3.15 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.128 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.79 35.87 0.85 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.85 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.458 ' HD2' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -137.36 70.96 1.4 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.942 0.401 . . . . 0.0 110.135 179.618 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -121.52 135.93 54.99 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.812 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.6 p -119.24 143.02 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.134 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -96.66 133.48 41.14 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.827 0.346 . . . . 0.0 111.215 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.41 148.51 19.63 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.736 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.9 mm -102.52 123.2 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 120.63 0.252 . . . . 0.0 110.948 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.38 157.72 44.81 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.99 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.4 t 60.83 -148.29 0.43 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.69 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.99 -28.93 40.88 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 111.546 0.202 . . . . 0.0 111.546 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.45 46.72 0.03 OUTLIER Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.335 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -95.46 120.11 35.14 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -73.77 116.68 14.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.895 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -111.24 151.96 27.68 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.747 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -123.75 149.53 45.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.489 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -136.07 148.95 48.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.969 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -115.08 123.02 47.94 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.01 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.53 -21.19 32.81 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.391 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.458 HG13 ' HD2' ' A' ' 6' ' ' ARG . 9.6 mt -51.95 -55.81 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 120.611 0.243 . . . . 0.0 111.038 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.29 -40.75 4.58 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.054 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.14 54.04 0.68 Allowed Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.48 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -127.74 110.27 12.47 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.717 0.294 . . . . 0.0 110.997 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.0 p -69.46 132.63 46.62 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.675 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.27 168.06 16.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.141 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -127.67 6.6 6.19 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.501 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -118.0 129.28 55.49 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -70.49 113.66 20.06 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.914 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.57 -173.04 0.74 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.672 2.248 . . . . 0.0 112.61 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.2 pm0 -89.28 30.24 1.0 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.806 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.17 32.3 1.78 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.777 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -111.46 -59.48 1.97 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.703 0.251 . . . . 0.0 110.664 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -136.97 87.06 2.25 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.876 0.369 . . . . 0.0 110.604 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.09 130.54 16.63 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.716 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.52 114.16 26.46 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.815 0.34 . . . . 0.0 111.176 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.13 62.98 0.68 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.481 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.4 tttp 57.78 36.95 26.98 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.02 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.55 169.63 15.22 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.032 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.17 -30.61 65.16 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.362 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.78 144.07 55.31 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.73 0.3 . . . . 0.0 111.247 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.5 t -129.97 140.2 49.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.099 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -108.62 67.6 0.67 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.346 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.0 t -168.83 106.67 0.44 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.947 0.403 . . . . 0.0 111.313 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.7 t -109.24 -24.46 4.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.566 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -70.87 143.66 50.94 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 111.141 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.9 t -110.7 139.25 35.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.624 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -91.06 122.07 33.4 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.82 0.343 . . . . 0.0 111.018 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.434 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.82 160.13 14.16 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.491 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.0 tp -113.1 135.46 53.78 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.847 0.356 . . . . 0.0 111.163 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.1 152.08 40.24 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.815 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -47.51 155.28 0.37 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.463 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 67.6 11.25 8.28 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.247 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.05 66.46 1.91 Allowed Glycine 0 C--N 1.338 0.667 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.061 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -131.95 120.12 22.05 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.655 0.264 . . . . 0.0 110.617 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.3 m -89.16 120.49 30.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.883 0.373 . . . . 0.0 111.062 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.434 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 33.4 p90 -112.75 146.06 39.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.392 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 80.1 m-85 -120.09 141.54 49.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.748 0.309 . . . . 0.0 111.063 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -127.75 149.08 50.4 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -119.44 129.33 54.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.932 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.8 p -74.94 -35.36 62.16 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.537 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -59.6 -60.19 4.24 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.694 0.283 . . . . 0.0 111.177 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.0 p -78.78 -34.43 45.53 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.204 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.49 44.66 20.77 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.25 -0.5 . . . . 0.0 112.591 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -136.74 134.4 37.08 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.886 0.374 . . . . 0.0 111.057 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.39 145.75 39.18 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.624 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -133.05 157.55 44.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.059 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -126.64 31.51 5.32 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.31 135.21 15.57 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.797 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.1 pttm -60.01 146.19 83.02 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.718 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.86 94.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.934 2.422 . . . . 0.0 112.753 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.05 95.13 0.19 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.794 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.6 t0 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.064 -0.97 . . . . 0.0 111.297 -179.508 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 120.725 0.298 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.37 133.71 26.98 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.717 2.278 . . . . 0.0 112.529 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.91 97.96 11.23 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.999 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.19 177.58 5.81 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.085 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.74 147.58 19.09 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.278 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -71.51 80.86 0.8 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.96 0.41 . . . . 0.0 110.246 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.4 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 86.8 m95 -114.54 140.48 48.73 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.954 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 11.8 p -110.7 133.25 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.594 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -90.44 130.15 36.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.003 0.43 . . . . 0.0 111.221 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.15 148.57 19.51 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.371 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 mp -101.08 138.18 26.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.665 0.269 . . . . 0.0 110.937 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.455 HG21 ' CD1' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -119.68 161.76 20.15 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.167 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.8 m -41.87 148.64 0.16 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.739 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.433 ' HB3' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 82.16 -57.04 0.22 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.058 -179.528 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.79 58.39 0.03 OUTLIER Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.446 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.433 ' CE2' ' HB3' ' A' ' 14' ' ' GLU . 29.9 m-85 -124.78 138.78 54.26 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.718 0.295 . . . . 0.0 111.018 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -100.27 117.27 34.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.916 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.455 ' CD1' HG21 ' A' ' 12' ' ' THR . 24.9 p90 -110.89 151.53 27.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.557 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 64.9 m-85 -124.39 149.54 46.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.911 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -131.84 145.81 51.77 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.175 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.4 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 2.6 t0 -110.64 123.13 49.41 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.098 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.82 -25.68 27.95 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.224 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.3 -54.73 26.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.098 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.6 m -97.62 -38.55 9.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.099 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.07 53.24 1.52 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.265 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -135.75 129.33 32.42 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.797 0.332 . . . . 0.0 111.251 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.54 145.63 38.93 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.91 168.36 18.57 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.073 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.402 ' CZ3' ' HB3' ' A' ' 18' ' ' TYR . 90.2 m95 -127.46 -47.13 1.44 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.847 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.7 134.09 37.13 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.664 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -68.16 133.91 91.54 Favored Pre-proline 0 N--CA 1.463 0.216 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.191 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.87 -176.36 2.04 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.659 2.239 . . . . 0.0 112.606 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -97.83 41.24 1.13 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.19 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.27 41.98 0.12 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.854 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -114.24 -59.43 2.02 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.588 0.232 . . . . 0.0 110.708 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.73 93.23 3.87 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.609 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -114.87 140.79 16.61 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.615 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -143.43 98.24 3.22 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.974 0.416 . . . . 0.0 111.212 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.11 78.35 1.67 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.787 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.05 156.01 1.24 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.985 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 59.68 -163.11 0.24 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.127 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 81.1 p -57.28 139.76 51.89 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.84 0.353 . . . . 0.0 110.967 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.76 161.28 10.39 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.874 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.62 146.12 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.755 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.23 150.55 38.58 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.713 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.3 t 50.1 -175.65 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.063 0.545 . . . . 0.0 112.155 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.2 t -144.76 31.64 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.12 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.448 ' CH2' ' HB2' ' A' ' 62' ' ' ASN . 65.5 m95 -118.65 143.59 46.72 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.983 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.8 p -104.02 139.52 24.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.761 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -90.76 122.16 33.26 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.923 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.416 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.72 156.36 15.7 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.611 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.7 tp -108.99 137.85 46.26 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.76 0.314 . . . . 0.0 111.247 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.99 152.08 48.35 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.95 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -47.28 154.19 0.42 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.77 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 67.25 10.96 8.11 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.118 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.18 66.56 1.94 Allowed Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.171 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -130.67 108.05 9.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.742 0.306 . . . . 0.0 110.694 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.6 m -80.63 120.44 24.57 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.864 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.416 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 33.2 p90 -112.66 146.16 39.15 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.014 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -119.99 141.92 49.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.804 0.335 . . . . 0.0 110.877 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -127.06 145.7 50.63 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.08 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.448 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 51.4 t-20 -114.02 126.23 54.89 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.162 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.0 p -75.92 -24.61 55.57 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.445 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -56.23 -62.43 1.72 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.287 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.0 p -91.37 -37.66 13.09 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.066 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.73 49.69 2.88 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.131 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -135.48 138.18 42.88 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.917 0.389 . . . . 0.0 111.231 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.35 140.45 38.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.805 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -133.57 157.85 44.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.774 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -126.2 33.67 4.99 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.879 0.371 . . . . 0.0 110.753 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -145.74 123.95 12.22 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.442 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.98 113.78 8.15 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.975 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.87 -177.48 0.25 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.787 2.325 . . . . 0.0 112.796 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.87 163.96 21.79 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.731 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 t0 . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.549 -0.738 . . . . 0.0 110.84 179.701 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 120.681 0.277 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.66 128.06 15.57 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.867 2.378 . . . . 0.0 112.491 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 m -74.68 -36.49 62.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.15 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -109.53 164.78 12.2 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.789 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.74 130.47 3.53 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.664 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -92.55 85.76 5.4 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.925 0.393 . . . . 0.0 110.542 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.55 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 80.1 m95 -108.29 132.11 54.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.905 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 1.6 t -103.46 132.14 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.469 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.66 129.65 36.75 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.965 0.412 . . . . 0.0 111.311 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.409 ' HA3' ' CE1' ' A' ' 18' ' ' TYR . . . -135.47 148.72 19.73 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.571 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.0 mm -95.43 125.82 48.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.481 0.182 . . . . 0.0 110.69 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.25 148.03 51.97 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.873 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.51 -150.54 0.39 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.549 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -56.62 -26.33 55.45 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.68 43.27 0.02 OUTLIER Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.635 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -93.24 111.95 23.74 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -73.35 116.69 14.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.409 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 17.9 p90 -110.86 151.72 27.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.203 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 55.3 m-85 -123.97 149.17 46.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.873 0.368 . . . . 0.0 110.975 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -133.99 139.46 46.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.798 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 16.6 t70 -110.14 126.38 54.0 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.551 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.43 -31.19 26.75 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.742 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.3 mt -56.56 -45.53 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.78 0.324 . . . . 0.0 111.031 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.36 -35.2 9.67 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.166 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.92 41.52 6.29 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.171 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -128.88 153.62 47.3 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.895 0.379 . . . . 0.0 111.372 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.5 p -95.37 149.73 21.05 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.89 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.85 167.17 21.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.955 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -127.54 6.38 6.26 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.923 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -136.43 138.12 41.16 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.08 114.34 48.03 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.899 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.16 -179.98 0.98 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.805 2.337 . . . . 0.0 112.483 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -73.2 106.85 5.21 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.929 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.03 -59.13 0.45 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.744 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 25.1 t80 66.97 -75.23 0.06 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.545 0.338 . . . . 0.0 111.1 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -93.04 -33.18 14.21 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.569 0.223 . . . . 0.0 110.892 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.95 -110.75 3.58 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.286 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.4 54.13 2.24 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.98 0.419 . . . . 0.0 110.787 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.4 mt -143.89 108.72 4.93 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.727 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 61.97 93.49 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.537 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.6 mttt -107.94 94.05 4.87 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.048 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.3 p -84.12 168.03 16.22 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.018 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.32 172.92 15.14 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.881 0.372 . . . . 0.0 111.717 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.2 p -93.91 42.99 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.216 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.28 28.17 5.52 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.99 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -161.28 130.17 4.55 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.882 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.5 t -97.77 37.82 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.01 0.434 . . . . 0.0 110.911 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.452 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 44.9 m95 -136.96 140.87 42.53 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 p -104.44 145.89 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -96.97 122.55 40.08 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.103 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.62 158.33 14.84 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.621 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.4 tp -106.59 141.7 37.44 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.862 0.363 . . . . 0.0 111.267 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.426 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 34.1 t -133.58 152.22 51.85 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.826 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.79 153.52 0.39 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.55 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.59 11.41 8.1 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.12 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.81 65.85 2.28 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.969 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.426 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 34.3 m-85 -128.19 103.89 7.44 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.756 0.312 . . . . 0.0 110.7 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.4 m -76.19 120.05 20.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.852 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -112.87 145.96 39.77 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.721 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -120.33 141.86 49.66 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.736 0.303 . . . . 0.0 110.79 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -124.57 152.36 43.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.452 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 18.3 t-20 -113.68 136.37 52.91 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.771 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.9 p -87.27 -30.84 20.59 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.814 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -60.58 -62.96 1.48 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.65 0.262 . . . . 0.0 111.045 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 75.1 p -84.02 -44.56 14.0 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.094 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.11 48.63 2.39 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.453 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -134.23 140.74 46.67 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.761 0.315 . . . . 0.0 110.855 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.2 p -80.71 148.99 29.9 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.0 tpt85 -134.02 155.67 49.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.732 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -126.5 25.12 6.57 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.788 0.327 . . . . 0.0 111.286 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -146.4 133.5 20.4 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.135 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -59.86 111.85 4.5 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.642 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -56.96 101.9 0.1 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.843 2.362 . . . . 0.0 112.576 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -90.0 126.85 35.9 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.874 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.0 t70 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.617 -179.925 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.71 0.29 . . . . 0.0 111.523 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.35 155.82 59.66 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.841 2.361 . . . . 0.0 112.458 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 t -145.98 104.74 3.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.87 0.367 . . . . 0.0 111.076 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -134.09 33.14 3.4 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.758 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.75 81.84 1.6 Allowed Glycine 0 C--N 1.337 0.591 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.616 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.33 75.66 5.9 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.853 0.358 . . . . 0.0 111.109 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.41 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 82.2 m95 -121.26 137.39 54.71 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.052 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.5 p -115.55 133.91 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.961 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 35' ' ' PHE . 44.0 tt0 -90.61 132.09 35.94 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.866 0.365 . . . . 0.0 111.174 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.73 147.73 18.76 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.549 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.3 mm -95.96 141.65 15.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.634 0.254 . . . . 0.0 110.914 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.09 162.08 25.37 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.805 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 m -46.66 152.7 0.45 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.528 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 77.48 -54.72 0.53 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.424 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.24 50.49 0.04 OUTLIER Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.578 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -115.85 141.2 48.41 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.506 0.193 . . . . 0.0 110.528 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -105.54 117.07 33.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.77 0.319 . . . . 0.0 110.825 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -110.74 151.27 27.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.721 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -124.84 149.23 47.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.751 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -127.48 144.64 51.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.076 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.41 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 29.1 t70 -117.34 123.23 45.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.679 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.35 -25.72 28.96 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.157 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.5 mt -58.71 -46.7 90.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.576 0.227 . . . . 0.0 110.871 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -104.46 -32.24 9.09 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.526 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.56 45.39 5.24 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.265 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -132.77 132.45 42.26 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.815 0.34 . . . . 0.0 111.378 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.2 p -86.26 142.0 28.88 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.709 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.02 167.62 18.75 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.193 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -127.72 7.01 6.19 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.672 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.6 130.12 51.85 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 0.4 OUTLIER -66.34 113.93 14.8 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.004 -179.291 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.46 -175.12 0.4 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.996 2.464 . . . . 0.0 112.828 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.51 29.35 1.74 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.612 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -132.9 -46.43 0.11 Allowed Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.82 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.483 ' CZ ' ' HB2' ' A' ' 9' ' ' GLU . 52.8 t80 -54.01 -64.12 0.93 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.645 0.222 . . . . 0.0 111.105 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.45 ' HB2' ' HE2' ' A' ' 31' ' ' LYS . 20.6 mt-30 -153.36 81.67 1.18 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.732 0.301 . . . . 0.0 110.723 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.33 172.82 23.34 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.882 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -72.21 174.95 6.51 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.811 0.338 . . . . 0.0 111.246 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.34 157.83 18.86 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.436 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -78.15 157.78 29.3 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.246 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.15 169.18 21.3 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.369 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.97 -37.09 62.01 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.169 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.93 99.22 12.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.01 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.4 t -128.84 130.18 68.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.291 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.48 161.1 29.48 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.96 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.7 p 47.08 52.89 11.34 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.665 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.7 p -102.1 9.58 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.917 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.519 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 72.0 m95 -117.31 141.98 47.64 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.711 0.291 . . . . 0.0 111.036 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.3 p -107.22 141.61 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.022 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -90.78 122.33 33.42 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.016 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.91 158.4 14.87 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.469 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.45 131.65 55.46 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.866 0.365 . . . . 0.0 111.424 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.08 151.94 27.5 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.794 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -44.56 148.54 0.48 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.327 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 82.6 -51.67 0.19 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.073 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 140.26 51.18 0.05 OUTLIER Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.451 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -117.51 118.68 32.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.608 0.242 . . . . 0.0 110.498 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.46 120.39 25.41 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.846 0.355 . . . . 0.0 111.117 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -112.75 146.11 39.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.436 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -119.75 141.93 49.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.843 0.354 . . . . 0.0 110.84 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -123.33 154.74 38.5 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.859 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.519 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 39.3 t30 -113.5 122.14 46.39 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.924 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.3 p -74.26 -30.74 62.26 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.716 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -64.58 -66.97 0.47 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.517 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.2 p -78.09 -48.95 14.87 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.517 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.82 42.25 2.7 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.599 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -129.67 133.24 46.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.763 0.316 . . . . 0.0 110.894 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.19 146.72 45.35 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.7 157.64 44.37 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.075 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -126.47 30.79 5.49 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.84 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -148.48 122.47 9.43 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.609 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.42 123.75 85.23 Favored Pre-proline 0 CA--C 1.529 0.173 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.665 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.62 85.25 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.617 2.212 . . . . 0.0 111.841 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.98 119.59 39.12 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.877 -179.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.32 -0.848 . . . . 0.0 111.076 179.682 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.743 0.306 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.54 151.53 64.69 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.869 2.38 . . . . 0.0 112.963 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.4 t -102.68 -35.25 8.75 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.447 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.59 178.99 9.24 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.718 0.294 . . . . 0.0 111.298 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -123.07 139.76 12.57 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.543 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -78.99 92.83 5.0 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.752 0.311 . . . . 0.0 110.722 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.489 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 91.1 m95 -127.14 137.05 52.9 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.047 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.9 p -117.34 147.85 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.265 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.68 131.67 46.46 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.194 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.59 148.58 19.68 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.956 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.6 mm -94.35 144.17 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.72 0.295 . . . . 0.0 111.185 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.16 161.67 27.96 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.969 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 t -45.76 152.22 0.37 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.637 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 80.66 -55.82 0.33 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.187 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.16 51.9 0.05 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.484 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -118.32 151.65 37.3 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.57 0.224 . . . . 0.0 110.585 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -109.94 116.7 32.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.798 0.332 . . . . 0.0 110.871 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.415 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 17.2 p90 -111.15 151.43 28.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.941 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -124.41 149.29 46.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.783 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -125.86 149.53 48.59 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.232 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.489 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 23.5 t70 -119.11 122.02 41.12 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.022 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.82 -26.46 31.69 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.5 mt -56.53 -46.8 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.759 0.314 . . . . 0.0 111.084 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m -103.83 -44.38 5.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.003 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.23 36.9 3.23 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.57 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -119.32 156.88 29.21 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.803 0.335 . . . . 0.0 111.297 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 p -100.09 131.14 46.22 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.033 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -122.2 168.4 12.05 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.832 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.415 ' CZ3' ' HB3' ' A' ' 18' ' ' TYR . 93.3 m95 -127.38 -45.34 1.52 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.078 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -73.41 119.6 17.87 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.578 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.02 125.27 91.25 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.748 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.39 167.05 28.01 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.631 2.22 . . . . 0.0 112.236 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -66.76 120.06 12.87 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.519 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.58 -97.1 0.87 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.444 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 25.7 t80 66.97 160.12 0.15 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.521 0.2 . . . . 0.0 110.975 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -60.78 101.15 0.13 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.828 0.347 . . . . 0.0 110.671 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.68 -123.34 6.09 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.109 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.7 t70 61.43 100.27 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.996 0.427 . . . . 0.0 111.569 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 mp -105.94 38.06 2.1 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.143 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.0 mtpp -140.89 136.42 32.28 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.566 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -81.78 56.68 3.13 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.672 0.272 . . . . 0.0 111.305 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.1 m 65.12 166.78 0.18 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.16 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.06 143.83 47.31 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.557 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.0 t -137.6 37.65 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.362 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -144.22 80.89 1.66 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.692 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.06 105.46 8.4 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.259 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.9 p -104.04 -18.12 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.775 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -113.7 145.15 41.78 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.516 0.198 . . . . 0.0 110.913 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.6 t -111.46 131.66 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.419 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.447 ' HG3' ' CD1' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -94.6 122.25 37.0 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.941 0.401 . . . . 0.0 111.521 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.449 ' HA3' ' CE2' ' A' ' 59' ' ' TYR . . . -118.86 158.0 15.02 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.265 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.43 121.59 45.26 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.753 0.277 . . . . 0.0 110.943 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.17 142.13 31.35 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.803 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 55.73 95.06 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.461 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 68.1 -63.29 0.33 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.052 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.37 40.21 0.05 OUTLIER Glycine 0 CA--C 1.518 0.272 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.696 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -85.31 121.28 27.81 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.11 120.03 23.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.998 0.427 . . . . 0.0 111.229 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.449 ' CE2' ' HA3' ' A' ' 51' ' ' GLY . 25.2 p90 -113.05 146.18 39.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.816 179.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.473 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 2.6 m-85 -119.59 141.74 49.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.935 0.398 . . . . 0.0 111.165 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -129.65 155.02 46.52 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.573 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -113.48 129.23 56.59 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.891 0.377 . . . . 0.0 111.265 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.6 p -93.39 22.27 5.41 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.757 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -95.7 -60.04 1.74 Allowed 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 120.666 0.269 . . . . 0.0 110.707 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.8 t -110.39 -36.2 5.85 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.14 73.58 0.71 Allowed Glycine 0 C--N 1.335 0.513 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.707 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -149.9 126.89 11.18 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.819 0.342 . . . . 0.0 111.007 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.49 150.69 25.84 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.697 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.6 ttt-85 -130.73 155.35 46.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.261 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -126.59 27.1 6.17 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.11 162.27 40.3 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.724 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -86.3 107.68 14.38 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.993 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.95 143.39 49.77 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.71 2.273 . . . . 0.0 112.694 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -168.06 111.12 0.61 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.947 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.6 t70 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.438 -0.791 . . . . 0.0 111.386 -179.84 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.689 0.28 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.04 143.72 36.68 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.847 2.364 . . . . 0.0 112.391 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 t -124.42 141.11 52.33 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.044 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.2 124.02 35.72 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.75 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.17 79.49 0.04 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.75 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -87.16 68.53 9.95 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.08 0.467 . . . . 0.0 110.516 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.429 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 80.9 m95 -105.75 140.17 39.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.754 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 p -116.17 133.57 62.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.085 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -90.7 131.51 36.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.272 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.25 148.58 19.65 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.66 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.8 mm -98.01 127.08 50.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.585 0.231 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.2 p -133.43 150.06 51.78 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.947 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.02 -149.78 0.41 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.622 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.28 -29.57 47.64 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.13 44.09 0.02 OUTLIER Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.56 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -92.81 112.75 24.82 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -74.54 116.8 15.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.949 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -111.02 151.51 27.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.517 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -124.41 148.81 47.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.949 0.405 . . . . 0.0 110.93 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -136.56 147.88 47.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.132 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.429 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 4.7 t0 -112.09 122.05 46.68 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.653 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.39 -26.94 27.99 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.274 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.3 mt -60.72 -53.39 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.733 0.302 . . . . 0.0 110.871 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.06 -36.51 12.08 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.22 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.04 60.19 1.34 Allowed Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.293 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -142.64 129.24 20.27 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.844 0.354 . . . . 0.0 111.415 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.7 p -85.29 132.19 34.29 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.54 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -131.91 168.3 18.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.22 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -127.81 7.37 6.18 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.705 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -120.44 139.89 52.18 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.662 0.268 . . . . 0.0 110.713 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -77.64 131.67 70.47 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.962 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.56 -171.08 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.679 2.253 . . . . 0.0 112.253 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.62 89.9 0.11 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.907 0.384 . . . . 0.0 110.732 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.97 -90.95 0.68 Allowed Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.652 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 67.7 t80 66.16 -77.45 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 122.431 0.293 . . . . 0.0 110.883 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -142.87 31.78 1.42 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.87 0.367 . . . . 0.0 110.791 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -124.26 114.42 2.27 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.151 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -63.43 123.77 19.61 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.669 0.271 . . . . 0.0 111.154 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 tp -103.63 108.19 19.36 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 1.9 mmtp -65.9 135.63 55.04 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.554 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 52.15 -171.23 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.35 0.406 . . . . 0.0 111.386 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.3 m 57.16 26.11 11.75 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.798 0.332 . . . . 0.0 111.073 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -165.11 -177.11 4.43 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.19 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.5 p -59.34 140.8 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 120.891 0.377 . . . . 0.0 111.446 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -108.56 127.28 53.8 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.104 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.9 t -95.53 -177.51 4.1 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.097 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.5 t -78.81 -31.27 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.404 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.458 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 76.5 m95 -93.87 143.38 26.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.82 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.9 p -108.37 137.88 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.957 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -91.08 122.05 33.39 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.001 0.429 . . . . 0.0 110.952 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.75 151.38 17.75 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.349 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.81 133.4 54.83 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.911 0.386 . . . . 0.0 111.419 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.1 t -112.29 151.8 29.25 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.84 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -45.08 154.63 0.14 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.333 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 80.54 -55.58 0.34 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.061 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.16 55.06 0.03 OUTLIER Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.407 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -124.77 124.24 41.7 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.632 0.253 . . . . 0.0 110.538 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.3 m -93.56 120.95 34.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.85 0.357 . . . . 0.0 111.068 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -112.56 146.21 38.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.56 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -119.93 141.86 49.24 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.848 0.356 . . . . 0.0 110.942 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -125.91 147.19 49.55 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.926 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.458 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 53.3 t30 -113.33 122.76 48.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.668 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.1 p -77.75 -23.1 49.4 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.558 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -55.08 -60.94 2.69 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.405 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.7 t -102.27 -38.43 7.66 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.441 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.72 46.8 1.73 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.607 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -123.54 121.12 34.81 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.781 0.324 . . . . 0.0 110.674 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.2 p -71.32 150.14 45.41 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -133.82 157.79 45.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.088 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -126.5 28.4 5.95 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.049 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -151.68 134.61 15.72 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.296 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.91 109.65 1.86 Allowed Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.827 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.4 105.17 1.94 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.604 2.202 . . . . 0.0 112.658 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.1 t70 68.01 158.62 0.15 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.357 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.7 t70 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.104 -0.951 . . . . 0.0 111.347 -179.65 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 120.334 0.111 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.79 94.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.759 2.306 . . . . 0.0 112.558 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.8 46.37 2.34 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.771 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -157.32 109.03 2.36 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.293 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.05 147.67 19.35 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.586 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -75.68 85.05 2.7 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.999 0.428 . . . . 0.0 110.464 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -125.11 148.92 48.33 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.228 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 2.0 t -118.14 132.88 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.503 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -90.89 129.83 36.89 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.942 0.401 . . . . 0.0 111.53 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.52 148.69 19.72 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.653 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.6 mm -105.18 125.47 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.5 0.19 . . . . 0.0 110.809 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.89 153.76 51.53 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.34 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.1 -148.02 0.43 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.748 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -55.03 -29.24 57.0 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.56 44.43 0.02 OUTLIER Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.358 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -92.51 113.95 26.36 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -73.86 116.64 14.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.845 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -111.02 151.46 27.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.218 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 85.3 m-85 -124.05 149.39 46.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.844 0.354 . . . . 0.0 111.092 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -131.87 140.36 49.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.77 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -109.8 125.67 52.97 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.74 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.15 -29.67 28.45 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.714 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.1 mt -54.65 -49.34 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.804 0.335 . . . . 0.0 110.882 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m -101.92 -39.13 7.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.292 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.73 44.84 3.29 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.347 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -127.91 135.54 50.12 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 111.477 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.8 t -85.94 147.57 26.17 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.665 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -133.74 167.79 19.88 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.92 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -127.44 8.94 6.54 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.663 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -132.06 137.98 47.99 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.406 ' HE3' ' OH ' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -62.09 132.66 93.84 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.351 -179.49 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.38 -177.21 2.88 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.681 2.254 . . . . 0.0 112.268 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.96 107.72 7.21 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.341 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.25 -84.21 1.0 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.908 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 24.2 t80 69.87 161.43 0.22 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.605 0.203 . . . . 0.0 110.738 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -66.66 88.14 0.14 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.912 0.387 . . . . 0.0 110.932 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.1 122.09 0.73 Allowed Glycine 0 CA--C 1.517 0.21 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.084 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -78.33 95.85 5.15 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.909 0.385 . . . . 0.0 111.26 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.3 mt -72.2 174.14 7.61 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.63 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -107.22 172.67 6.7 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.24 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 69.25 92.92 0.08 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.037 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.9 m -62.21 -34.32 76.25 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.323 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.47 127.29 35.83 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.97 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 p -100.55 144.08 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.302 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -83.95 151.53 25.0 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.307 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.9 t -162.78 97.22 0.95 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.393 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.5 t -119.82 31.96 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.935 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -133.87 143.99 48.63 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.69 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.2 p -106.33 132.29 53.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.462 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -90.59 122.0 33.01 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.915 0.388 . . . . 0.0 110.945 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.408 ' HA3' ' CE1' ' A' ' 59' ' ' TYR . . . -118.86 152.88 17.17 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.351 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.74 129.05 55.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.954 0.407 . . . . 0.0 111.296 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.406 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 40.2 t -109.39 151.94 25.98 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.648 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -45.64 151.98 0.37 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.368 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 82.77 -53.68 0.19 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.9 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.52 55.78 0.04 OUTLIER Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.445 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.406 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 22.0 m-85 -123.7 129.25 50.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.524 0.202 . . . . 0.0 110.749 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.3 m -98.1 120.85 39.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.854 0.359 . . . . 0.0 111.086 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.408 ' CE1' ' HA3' ' A' ' 51' ' ' GLY . 30.0 p90 -112.64 145.94 39.51 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.596 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -120.25 142.26 49.21 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.736 0.303 . . . . 0.0 110.86 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -124.2 152.25 43.12 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.851 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.61 122.51 47.89 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.911 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.3 p -78.74 -24.97 44.51 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.447 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -59.47 -63.41 1.31 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.432 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.0 t -91.24 -40.27 11.62 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.377 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.87 56.43 1.08 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.736 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -136.22 139.2 42.58 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.802 0.334 . . . . 0.0 110.865 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 p -80.58 146.35 31.28 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.789 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.48 149.29 49.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.07 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -126.97 29.0 5.7 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.013 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -145.06 123.86 12.63 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.534 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -63.9 121.77 73.15 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.729 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.07 106.61 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.716 2.278 . . . . 0.0 112.591 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.17 110.54 11.66 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.627 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 t70 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.887 -179.64 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -76.26 -177.63 3.83 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.428 2.085 . . . . 0.0 112.71 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.4 t -138.88 113.87 9.34 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.156 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.5 tttp -145.79 94.84 2.55 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.782 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -175.79 169.38 42.07 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.689 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.0 mtt85 -135.71 99.94 4.33 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.752 0.311 . . . . 0.0 110.489 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.43 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 58.2 m95 -126.15 141.21 52.03 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.117 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.8 p -114.72 134.48 57.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.826 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -90.64 130.87 36.61 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.913 0.387 . . . . 0.0 111.304 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.11 148.69 19.68 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.74 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.7 mm -98.09 125.74 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 120.452 0.168 . . . . 0.0 111.021 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.3 p -132.99 155.36 49.31 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.024 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.1 t 58.73 -148.09 0.48 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.67 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -62.0 -23.69 66.58 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.89 43.05 0.02 OUTLIER Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.577 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -94.0 112.24 24.05 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -75.0 116.45 15.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.002 0.429 . . . . 0.0 110.72 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -111.03 151.71 27.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.388 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -124.05 149.35 46.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.819 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -134.42 147.98 50.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.679 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.43 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 10.2 t70 -109.93 122.1 46.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.679 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.67 -23.64 29.35 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.4 mt -57.85 -52.53 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.636 0.255 . . . . 0.0 110.953 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.67 -41.12 6.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.16 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.44 53.02 0.95 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.433 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -133.57 127.73 33.73 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.857 0.361 . . . . 0.0 111.281 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.7 t -76.11 145.75 39.78 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.762 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -132.66 168.19 18.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.121 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -127.57 -46.79 1.44 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.802 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.99 129.97 35.03 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.537 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -71.11 133.93 85.54 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.015 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -73.06 -176.81 2.58 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.61 2.207 . . . . 0.0 112.576 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.84 31.57 1.59 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.496 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.18 33.45 0.38 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.009 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -111.33 -47.98 3.14 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.7 0.286 . . . . 0.0 110.629 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.84 -179.87 6.08 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.926 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.41 154.3 6.7 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.084 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -164.15 134.06 4.05 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.629 0.252 . . . . 0.0 111.355 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 pp -124.58 161.49 26.1 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.085 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.28 143.26 46.72 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.055 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -84.28 80.09 9.32 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.189 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.5 m 66.45 -76.9 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.289 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.21 122.29 30.0 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.632 0.253 . . . . 0.0 110.901 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 p -77.58 126.46 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.379 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -104.82 113.32 26.83 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.9 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.5 p -88.94 121.92 31.79 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.191 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.2 p -113.93 21.72 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.615 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.438 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 85.4 m95 -119.02 143.68 46.95 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.715 0.293 . . . . 0.0 110.962 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.5 p -105.64 136.8 38.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.855 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -91.54 122.0 33.73 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.817 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.41 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.75 153.38 16.98 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.431 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.23 141.5 45.86 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.113 0.482 . . . . 0.0 111.544 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.1 t -123.54 152.27 41.97 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.497 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 0.7 OUTLIER -44.7 156.23 0.09 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.849 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 22.2 m-20 76.88 -54.67 0.57 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.889 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.12 54.29 0.03 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.131 -0.556 . . . . 0.0 112.264 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.404 ' CE2' ' HB2' ' A' ' 55' ' ' ASP . 18.3 m-85 -120.01 118.0 29.5 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.656 0.265 . . . . 0.0 110.811 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.47 120.67 29.0 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.01 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.415 ' HB3' ' CZ3' ' A' ' 70' ' ' TRP . 30.8 p90 -112.51 145.97 39.31 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.744 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -120.23 142.03 49.4 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.846 0.355 . . . . 0.0 110.95 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -130.27 150.55 51.46 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.341 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.438 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 56.3 t30 -114.37 133.48 55.67 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.052 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.4 p -82.09 -26.26 33.79 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.617 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -62.58 -66.78 0.49 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.36 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.9 t -84.5 -34.77 23.27 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.307 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.21 49.88 3.83 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.601 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -129.52 137.07 50.59 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.801 0.334 . . . . 0.0 111.138 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.51 146.17 27.05 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.66 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.04 155.59 50.5 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.415 ' CZ3' ' HB3' ' A' ' 59' ' ' TYR . 94.1 m95 -126.32 29.95 5.69 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.926 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -148.12 127.93 13.46 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.558 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 125.82 90.33 Favored Pre-proline 0 N--CA 1.465 0.31 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.103 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.37 -178.45 2.58 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.685 2.257 . . . . 0.0 112.269 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.7 t70 75.9 158.8 0.21 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.712 0.292 . . . . 0.0 110.997 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.231 -179.617 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.656 0.265 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.29 125.7 19.27 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.911 2.408 . . . . 0.0 112.737 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.2 t -103.89 175.84 5.35 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.386 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -144.18 76.1 1.49 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.311 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.67 -88.54 0.07 OUTLIER Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.994 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.78 92.19 0.34 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.831 0.348 . . . . 0.0 111.409 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -127.98 148.42 50.52 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.892 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 2.2 t -119.3 129.06 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.758 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -90.76 131.98 36.11 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.95 0.405 . . . . 0.0 111.445 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.12 147.18 19.07 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.404 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.2 mm -100.39 123.9 53.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 120.465 0.174 . . . . 0.0 110.875 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.02 156.17 47.84 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.965 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 57.14 -148.32 0.5 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.523 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.43 -21.25 66.19 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.76 44.58 0.02 OUTLIER Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.411 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -92.83 105.46 17.59 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -73.36 116.67 14.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.929 0.395 . . . . 0.0 110.959 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -110.9 151.51 27.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.466 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 56.1 m-85 -124.32 149.47 46.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 111.21 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -131.81 142.26 49.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.964 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -109.54 124.35 50.95 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.528 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.66 -26.45 27.78 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.214 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.8 mt -62.65 -45.44 98.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.7 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 t -99.64 -35.83 9.7 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.301 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.9 62.52 1.3 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.335 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.19 157.19 33.93 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.94 0.4 . . . . 0.0 111.866 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.3 t -101.52 151.98 21.32 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.711 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.91 168.12 19.35 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.043 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -127.57 7.49 6.32 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.706 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.12 131.97 47.3 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.544 0.211 . . . . 0.0 110.474 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -73.62 126.04 90.07 Favored Pre-proline 0 N--CA 1.462 0.17 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.875 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 31' ' ' LYS . 32.0 Cg_exo -61.64 -174.83 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.941 2.427 . . . . 0.0 112.469 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.89 35.98 0.75 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.624 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 160.22 71.95 0.02 OUTLIER Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.835 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 9' ' ' GLU . 23.0 t80 -88.85 -72.09 0.56 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.612 0.206 . . . . 0.0 110.684 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -149.15 39.15 0.82 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.826 0.346 . . . . 0.0 110.922 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.87 92.36 1.68 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.248 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -83.32 83.84 7.72 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.862 0.363 . . . . 0.0 110.983 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.9 mt -153.28 64.07 0.76 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.948 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.7 89.59 0.06 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.439 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.64 97.23 3.16 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.363 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.5 m -103.85 23.66 12.48 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.953 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.75 139.84 30.36 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.067 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.5 p -96.5 146.1 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.383 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.85 36.66 1.38 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.395 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 64.4 p -137.7 85.44 2.11 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.966 0.412 . . . . 0.0 110.812 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.5 p -80.15 -31.41 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.431 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 80.6 m95 -82.01 139.17 34.67 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.83 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.7 p -115.43 135.17 56.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.889 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.2 122.36 35.51 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.945 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.52 158.89 14.58 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.718 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.0 tp -107.71 136.8 46.85 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.954 0.407 . . . . 0.0 111.174 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.448 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 44.2 t -126.29 152.26 46.41 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.953 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -45.85 152.31 0.37 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.651 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 68.25 11.49 8.38 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.119 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.86 64.72 2.48 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.169 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.448 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 34.0 m-85 -128.03 106.55 9.15 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.731 0.3 . . . . 0.0 110.658 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.81 120.27 23.21 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.815 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -112.97 145.86 40.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.822 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -120.41 141.84 49.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.91 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -128.52 153.0 47.64 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.744 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.463 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 20.8 t-20 -113.77 134.43 54.77 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.073 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.9 p -89.15 -29.8 19.06 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.51 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -59.1 -60.49 3.79 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.507 0.194 . . . . 0.0 111.178 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.1 t -91.09 -36.19 14.16 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.236 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.51 50.06 2.84 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.65 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -130.42 135.61 48.19 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.846 0.355 . . . . 0.0 111.198 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.93 145.1 26.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.784 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.23 143.96 46.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.856 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -126.23 19.84 7.53 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.226 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -137.87 16.38 2.86 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp 71.14 137.07 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.13 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.14 151.06 66.76 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.591 2.194 . . . . 0.0 112.704 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -127.07 167.31 16.13 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.349 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.1 t70 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.421 -0.799 . . . . 0.0 110.961 179.824 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.1 t0 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 120.633 0.254 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.55 118.71 5.18 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.89 2.393 . . . . 0.0 112.58 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 t -82.55 81.22 8.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.633 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 ptpm? -117.33 114.01 22.96 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.795 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.11 165.93 54.69 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.885 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.1 mtt-85 -104.16 78.35 1.5 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.992 0.425 . . . . 0.0 110.624 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.526 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 91.6 m95 -109.17 141.6 41.17 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.75 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.5 p -114.64 135.4 54.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.978 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -90.41 130.42 36.49 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.881 0.372 . . . . 0.0 110.756 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.87 148.18 19.33 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.783 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.6 mm -97.16 142.12 14.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.723 0.296 . . . . 0.0 111.21 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.92 161.68 26.09 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.974 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -44.25 150.55 0.29 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.599 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.419 ' HB3' ' CE2' ' A' ' 16' ' ' TYR . 0.8 OUTLIER 81.1 -56.83 0.29 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.212 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.53 49.54 0.05 OUTLIER Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.585 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.419 ' CE2' ' HB3' ' A' ' 14' ' ' GLU . 31.3 m-85 -113.44 148.55 35.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.538 0.209 . . . . 0.0 110.487 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -108.67 116.75 32.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.935 0.398 . . . . 0.0 110.824 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -111.35 151.79 28.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.122 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -124.17 149.69 46.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.709 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -135.55 147.74 48.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.224 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.526 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 5.9 t70 -113.66 122.28 46.67 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.858 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.4 -26.56 30.3 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.346 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 mt -59.33 -50.5 79.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-O 120.69 0.281 . . . . 0.0 111.023 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 m -98.74 -50.22 4.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.977 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.74 55.34 0.66 Allowed Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.456 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -137.68 142.5 41.09 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.808 0.337 . . . . 0.0 111.306 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.34 130.79 35.66 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.792 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -124.11 168.75 12.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.8 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -127.27 -45.95 1.51 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.788 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.03 136.46 46.69 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.361 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -65.32 119.36 58.73 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.818 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.97 171.34 0.8 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.741 2.294 . . . . 0.0 112.614 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -68.12 84.42 0.24 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.609 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.89 -78.77 0.34 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.772 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.1 t80 67.33 -75.32 0.06 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.34 0.256 . . . . 0.0 110.986 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -154.48 100.61 2.28 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.64 0.257 . . . . 0.0 110.748 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -139.46 -159.53 8.02 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.847 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.79 171.33 8.15 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.776 0.322 . . . . 0.0 111.122 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tp -96.77 32.91 1.96 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.992 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -92.02 144.09 25.8 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.075 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.38 34.55 3.73 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.17 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.3 m -111.82 134.3 53.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.687 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 62.71 -174.57 0.15 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.597 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.8 t -112.09 155.79 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.098 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.79 110.93 0.72 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.424 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.43 -178.27 6.86 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.117 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.2 t -95.8 37.08 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.23 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.449 ' CH2' ' HB2' ' A' ' 62' ' ' ASN . 65.3 m95 -130.12 144.28 51.26 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.204 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 2.3 t -101.8 156.12 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.579 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -113.25 121.89 45.81 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.67 0.271 . . . . 0.0 111.267 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.482 ' HA3' ' CE2' ' A' ' 59' ' ' TYR . . . -119.13 154.94 16.25 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.826 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -113.16 121.95 46.04 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 57' ' ' PHE . 0.6 OUTLIER -142.76 142.09 31.85 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.444 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 50.56 98.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.016 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 65.84 -63.54 0.22 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.35 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.14 40.27 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.733 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 53' ' ' SER . 20.9 m-85 -84.7 106.12 16.01 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.01 119.77 16.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.555 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.482 ' CE2' ' HA3' ' A' ' 51' ' ' GLY . 25.5 p90 -113.44 145.94 40.35 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.115 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 43.4 m-85 -120.08 141.77 49.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.787 0.327 . . . . 0.0 111.127 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -125.94 147.55 49.47 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.072 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.449 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 60.9 t30 -113.82 125.83 54.51 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.028 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.8 p -76.47 -26.58 55.52 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.332 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -58.46 -62.81 1.57 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.305 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.8 p -89.09 -44.27 10.46 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.131 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.47 52.78 1.52 Allowed Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.508 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -137.83 133.63 34.19 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.9 0.381 . . . . 0.0 111.025 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.4 p -75.34 145.57 41.62 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.919 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -132.82 158.13 43.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.807 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -125.97 28.17 6.18 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.869 0.366 . . . . 0.0 111.039 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -152.18 127.91 10.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.45 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -63.86 122.04 74.61 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.881 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -73.43 150.95 47.24 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.614 2.209 . . . . 0.0 112.689 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.11 -165.96 0.23 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.295 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.834 -179.917 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? . . . . . 0 C--O 1.233 0.232 0 CA-C-O 121.148 0.499 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.419 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 90.9 m95 -115.44 137.54 51.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.842 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 p -114.39 141.01 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.225 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.09 131.64 39.41 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.035 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.16 148.52 19.61 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.014 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.9 mm -91.49 142.62 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 120.676 0.274 . . . . 0.0 111.156 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.49 161.76 25.4 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.982 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.76 149.83 0.79 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.532 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 80.85 -55.76 0.32 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.217 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.1 55.84 0.03 OUTLIER Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.45 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -120.21 159.7 24.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.66 0.267 . . . . 0.0 110.755 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -115.83 117.04 29.1 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.06 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -111.12 151.84 27.67 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.96 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -124.19 149.26 46.56 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.82 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -135.24 145.4 47.57 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.929 0.395 . . . . 0.0 111.446 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.419 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 6.9 t70 -109.73 122.58 47.82 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.75 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.07 -24.82 32.55 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.589 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.8 mt -60.7 -59.88 3.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.754 0.311 . . . . 0.0 110.858 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.46 -34.7 20.0 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.083 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.25 56.53 1.91 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.351 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -142.92 141.6 31.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.799 0.333 . . . . 0.0 111.544 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -86.85 131.23 34.17 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.472 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -124.74 168.58 13.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.187 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -127.54 -46.55 1.45 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.25 126.55 29.99 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.64 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -67.59 122.26 82.6 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.984 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo . . . . . 0 C--N 1.351 0.696 0 C-N-CA 122.735 2.29 . . . . 0.0 112.816 -179.801 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.424 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 83.5 m95 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.628 0.251 . . . . 0.0 110.714 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.5 p -106.6 137.27 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.819 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.9 121.83 33.08 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.857 0.36 . . . . 0.0 111.151 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.416 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -119.42 160.34 14.39 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.862 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.422 HD11 ' HA2' ' A' ' 56' ' ' GLY . 3.3 tp -113.0 131.6 55.7 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.93 0.395 . . . . 0.0 110.745 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.46 151.77 42.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.576 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 66.58 -157.24 0.25 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.739 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.19 -26.37 60.53 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.422 ' HA2' HD11 ' A' ' 52' ' ' LEU . . . 163.7 46.53 0.02 OUTLIER Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.219 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -95.68 137.97 33.99 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.68 120.06 36.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.95 0.405 . . . . 0.0 111.328 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.416 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 19.6 p90 -113.2 146.24 39.63 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.526 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -119.9 141.96 49.12 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.784 0.326 . . . . 0.0 110.905 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -130.64 149.61 52.21 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.207 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.424 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 10.4 t-20 -113.45 128.36 56.42 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.243 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.4 p -81.32 -20.3 41.04 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.739 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -58.52 -62.87 1.53 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.548 0.213 . . . . 0.0 111.263 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.0 t -99.84 -41.56 7.19 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.183 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.13 61.28 0.71 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.722 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -137.67 126.92 24.59 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.788 0.328 . . . . 0.0 110.975 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.6 p -77.84 150.14 34.25 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.841 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.6 ttt85 -133.02 157.94 43.98 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.042 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 93.4 m95 . . . . . 0 CA--C 1.535 0.385 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.007 179.897 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.514 ' HB2' HD11 ' A' ' 23' ' ' ILE . 11.5 mpt_? . . . . . 0 C--O 1.234 0.288 0 CA-C-O 120.931 0.396 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -113.38 154.63 26.61 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.197 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 2.9 t -124.82 130.45 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.685 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -90.97 130.64 36.87 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.895 0.378 . . . . 0.0 111.025 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.29 148.75 19.59 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.603 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.9 mm -104.18 142.62 17.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.653 0.263 . . . . 0.0 111.092 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.87 161.53 27.22 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.931 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.53 150.77 0.63 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.792 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 82.4 -55.49 0.21 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.145 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.1 50.76 0.05 OUTLIER Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.533 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -113.98 147.6 38.32 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.504 0.192 . . . . 0.0 110.538 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -111.6 116.68 31.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.897 0.38 . . . . 0.0 110.923 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -111.35 151.68 28.14 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.84 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 59.9 m-85 -124.55 149.71 46.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.075 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -129.73 144.61 51.38 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.331 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.624 ' OD1' HD12 ' A' ' 23' ' ' ILE . 4.6 t0 -109.23 122.72 47.94 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.522 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.424 HD21 ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -85.75 -28.63 24.47 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.283 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.624 HD12 ' OD1' ' A' ' 21' ' ' ASP . 3.8 mt -58.29 -49.8 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.167 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.01 -43.44 5.77 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.41 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.84 34.46 3.77 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.469 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -121.62 127.79 51.24 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.798 0.332 . . . . 0.0 111.068 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.91 152.68 33.14 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.969 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -133.36 167.56 20.18 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.106 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -127.64 7.99 6.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.72 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -136.03 129.56 32.18 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -66.92 133.28 93.9 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.09 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 C--N 1.35 0.621 0 C-N-CA 122.655 2.236 . . . . 0.0 112.254 179.98 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 97.7 m95 . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.815 0.34 . . . . 0.0 111.388 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 2.9 t -112.07 139.08 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.811 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.77 122.51 44.63 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.638 0.256 . . . . 0.0 111.089 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.419 ' HA3' ' CE1' ' A' ' 59' ' ' TYR . . . -118.67 154.06 16.69 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.758 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.4 tp -109.67 126.51 53.75 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.853 0.359 . . . . 0.0 111.284 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.66 152.08 37.69 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.957 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -46.73 153.64 0.38 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.658 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 68.08 8.8 6.76 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.172 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.36 55.96 5.36 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.839 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -116.32 93.07 4.08 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.755 0.312 . . . . 0.0 110.543 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.3 m -72.6 120.58 18.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.989 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.419 ' CE1' ' HA3' ' A' ' 51' ' ' GLY . 32.9 p90 -112.61 145.88 39.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.504 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 24.0 m-85 -120.26 142.07 49.39 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.864 0.364 . . . . 0.0 111.331 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -125.88 156.1 40.18 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.654 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -113.53 126.75 55.65 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.221 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.5 p -93.85 29.51 2.06 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.869 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -120.91 -55.47 1.99 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.877 0.37 . . . . 0.0 110.434 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.6 p -96.3 -33.1 12.09 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.016 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.25 64.45 1.23 Allowed Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.571 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -149.71 128.86 12.76 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.861 0.362 . . . . 0.0 111.022 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.94 149.93 29.19 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.584 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.58 156.6 48.4 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.274 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 93.9 m95 . . . . . 0 CA--C 1.534 0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.09 179.651 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 . . . . . 0 C--O 1.233 0.219 0 CA-C-O 121.11 0.481 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -106.55 141.66 37.47 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.564 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 p -115.76 138.78 45.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.935 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -90.45 132.77 35.46 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.875 0.369 . . . . 0.0 111.022 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.76 146.82 18.6 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.536 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.7 mm -102.56 141.72 18.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.557 0.218 . . . . 0.0 110.982 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.14 162.04 27.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.828 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.9 m -48.42 149.58 1.56 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.634 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 82.43 -55.89 0.21 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.086 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.93 52.21 0.04 OUTLIER Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.451 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -116.47 129.97 56.5 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.512 0.196 . . . . 0.0 110.577 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -95.58 117.14 29.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.768 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -110.69 151.28 27.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.737 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -124.42 149.38 46.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.872 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -136.45 147.71 47.35 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.483 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -111.98 122.23 47.18 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.612 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.81 -33.49 46.14 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.574 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.5 mt -60.88 -55.59 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.707 0.289 . . . . 0.0 110.994 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.9 t -84.22 -36.27 22.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.25 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.01 47.37 5.03 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.217 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -136.07 143.3 44.56 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.838 0.352 . . . . 0.0 111.539 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.01 143.01 27.55 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.572 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -134.39 167.03 21.49 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.188 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -127.38 7.25 6.4 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.671 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -123.54 127.83 48.89 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.41 110.94 3.55 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.757 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 C--N 1.349 0.605 0 C-N-CA 122.393 2.062 . . . . 0.0 112.217 -179.862 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.51 ' CH2' ' HB2' ' A' ' 62' ' ' ASN . 78.9 m95 . . . . . 0 C--O 1.233 0.226 0 CA-C-O 120.793 0.33 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.5 p -115.45 144.73 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.005 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -95.57 122.21 38.07 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.781 0.324 . . . . 0.0 110.97 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.67 158.71 14.69 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.6 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.34 128.54 55.99 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.923 0.392 . . . . 0.0 111.234 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.6 m -107.46 151.96 24.85 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.861 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -44.15 148.9 0.38 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.918 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.404 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 7.7 t0 82.84 -52.82 0.18 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.173 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.22 54.13 0.03 OUTLIER Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.611 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.404 ' CE2' ' HB3' ' A' ' 55' ' ' ASP . 35.3 m-85 -122.14 132.1 54.29 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 110.48 -0.193 . . . . 0.0 110.48 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.05 120.69 35.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.805 0.336 . . . . 0.0 111.028 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -112.69 145.95 39.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.788 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -120.41 141.98 49.63 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.796 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -122.86 149.87 43.62 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.217 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.51 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 53.6 t30 -113.0 131.31 55.81 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.154 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.0 p -84.14 -28.68 27.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.56 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -60.07 -62.6 1.75 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.71 0.29 . . . . 0.0 111.018 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.1 p -86.21 -44.3 12.29 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.141 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.93 51.13 1.83 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.43 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -134.68 140.35 45.94 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 111.081 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.99 140.79 34.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.407 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.21 158.04 42.77 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.931 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 79.0 m95 . . . . . 0 CA--C 1.535 0.389 0 CA-C-O 120.79 0.329 . . . . 0.0 111.016 179.869 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.75 0.309 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.559 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 58.8 m95 -123.8 144.77 49.51 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.329 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.2 p -112.71 138.01 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.725 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -90.25 131.02 36.3 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.827 0.346 . . . . 0.0 110.979 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.26 148.51 19.62 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.657 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.6 mm -95.32 144.5 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.712 0.291 . . . . 0.0 111.288 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.651 HG23 ' CD1' ' A' ' 18' ' ' TYR . 1.4 p -128.15 162.05 27.83 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.054 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.0 m -45.16 152.69 0.25 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.583 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 78.48 -55.99 0.47 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.132 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.8 51.99 0.04 OUTLIER Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.389 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -115.9 151.27 35.67 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.683 0.278 . . . . 0.0 110.86 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -108.59 117.07 33.23 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.922 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.651 ' CD1' HG23 ' A' ' 12' ' ' THR . 21.5 p90 -110.72 151.44 27.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.659 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -124.13 149.42 46.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.581 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -130.99 142.33 50.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.073 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.559 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 20.7 t70 -111.2 123.48 50.29 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.508 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.57 -30.34 33.06 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.393 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.1 mt -60.22 -45.27 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 120.685 0.279 . . . . 0.0 111.01 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.87 -35.6 10.05 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.277 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.05 60.89 1.71 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.311 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.6 155.58 37.63 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.989 0.423 . . . . 0.0 111.92 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 t -97.62 143.5 28.23 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.728 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -135.67 168.64 18.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.826 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.429 ' CZ3' ' HB3' ' A' ' 18' ' ' TYR . 95.3 m95 -127.0 -44.64 1.61 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.66 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -80.04 135.22 36.31 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.541 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.11 142.93 92.82 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.021 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo . . . . . 0 C--N 1.351 0.677 0 C-N-CA 122.74 2.293 . . . . 0.0 113.229 -179.615 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.471 ' CH2' ' HB2' ' A' ' 62' ' ' ASN . 80.1 m95 . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.734 0.302 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 4.2 t -100.85 153.83 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.675 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -106.34 122.27 45.91 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 111.128 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.9 157.91 15.07 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.607 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.2 tp -111.97 123.59 50.59 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.883 0.373 . . . . 0.0 111.149 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.53 152.24 30.49 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.87 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -46.79 154.98 0.28 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.683 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 67.81 9.6 7.22 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.227 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.38 58.72 3.52 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.003 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -123.53 110.52 15.16 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.63 0.253 . . . . 0.0 110.617 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.41 120.42 24.95 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.001 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.427 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 38.0 p90 -112.53 145.78 39.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.47 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 36.9 m-85 -120.11 142.12 49.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.834 0.349 . . . . 0.0 111.225 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -121.85 149.44 43.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.189 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.471 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 46.8 t-20 -117.47 131.77 56.67 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.191 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.2 p -78.82 -26.62 44.25 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.503 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -57.64 -63.34 1.27 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.307 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.4 p -88.12 -46.14 9.55 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.082 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.4 47.17 2.22 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.494 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -136.08 143.72 44.77 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.773 0.321 . . . . 0.0 110.973 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.4 p -74.52 148.78 40.62 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -133.66 155.26 50.01 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.076 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 77.2 m95 . . . . . 0 CA--C 1.531 0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.765 179.657 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.496 ' HB2' HD11 ' A' ' 23' ' ' ILE . 3.3 mmp_? . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.962 0.411 . . . . 0.0 110.503 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.489 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 59.9 m95 -122.14 143.83 49.31 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.102 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 1.5 t -109.28 139.66 31.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.665 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -90.76 133.67 35.01 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.819 0.342 . . . . 0.0 111.202 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.89 148.47 19.56 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.695 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.0 mm -95.51 144.74 9.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.7 0.286 . . . . 0.0 111.257 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.539 HG21 ' HH2' ' A' ' 29' ' ' TRP . 0.2 OUTLIER -128.89 161.91 28.75 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.793 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -47.88 149.38 1.34 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.404 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 79.79 -56.8 0.38 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.926 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.18 48.72 0.03 OUTLIER Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.553 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -110.08 146.14 35.91 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.571 0.224 . . . . 0.0 110.516 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -108.73 116.98 33.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.811 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -110.64 151.14 28.03 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.514 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.7 m-85 -124.83 149.57 47.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.254 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -125.36 148.67 48.67 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.972 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.489 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 33.4 t70 -116.59 125.75 52.28 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.951 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.59 -31.78 24.13 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.478 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.496 HD11 ' HB2' ' A' ' 6' ' ' ARG . 3.5 mt -59.99 -57.61 10.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.637 0.256 . . . . 0.0 111.036 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.7 m -86.43 -41.43 14.44 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.978 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.07 48.46 2.86 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.298 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.3 144.92 48.6 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.823 0.344 . . . . 0.0 111.26 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.59 132.38 36.91 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.76 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.41 165.63 14.66 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.539 ' HH2' HG21 ' A' ' 12' ' ' THR . 89.8 m95 -127.52 6.28 6.26 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.747 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -132.14 128.15 37.47 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.38 112.34 6.3 Favored Pre-proline 0 C--O 1.233 0.205 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.744 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo . . . . . 0 C--N 1.351 0.669 0 C-N-CA 122.766 2.311 . . . . 0.0 112.63 -179.719 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.489 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 84.5 m95 . . . . . 0 C--O 1.234 0.248 0 CA-C-O 120.776 0.322 . . . . 0.0 111.377 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 21.2 t -99.94 155.4 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.717 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -112.72 122.4 47.57 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.792 0.329 . . . . 0.0 111.116 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.414 ' HA3' ' CE1' ' A' ' 59' ' ' TYR . . . -118.83 156.69 15.57 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.812 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.4 tp -109.69 127.15 54.38 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.917 0.389 . . . . 0.0 111.233 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.442 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 17.0 t -119.97 152.05 38.03 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.702 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -45.39 155.39 0.14 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.564 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.19 6.71 5.81 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.137 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.04 51.42 5.8 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.635 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.442 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 32.6 m-85 -112.72 125.62 54.51 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.579 0.228 . . . . 0.0 110.412 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.5 m -100.43 120.6 40.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.834 0.35 . . . . 0.0 111.111 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.414 ' CE1' ' HA3' ' A' ' 51' ' ' GLY . 35.8 p90 -112.45 145.45 40.16 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.388 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.531 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 17.5 m-85 -120.73 141.92 50.0 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.84 0.352 . . . . 0.0 111.349 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -121.86 145.52 48.0 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.96 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.489 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 54.9 t-20 -113.17 126.15 55.12 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.0 p -78.61 -30.19 46.39 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.359 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -55.6 -54.83 39.28 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.284 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.8 p -93.82 -33.09 13.7 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.334 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.69 58.77 2.33 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.31 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -147.71 141.34 25.54 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.829 0.347 . . . . 0.0 111.204 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 99.1 p -76.35 143.5 40.72 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.627 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.449 ' HD3' ' CH2' ' A' ' 48' ' ' TRP . 14.3 ttt85 -133.72 158.2 43.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.411 ' CZ3' ' HB3' ' A' ' 59' ' ' TYR . 95.6 m95 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.532 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.46 ' HG3' HD11 ' A' ' 23' ' ' ILE . 16.8 mtt180 . . . . . 0 C--O 1.233 0.232 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.437 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 80.0 m95 -116.29 149.91 38.47 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.09 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 3.0 t -113.69 150.73 15.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.974 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -102.46 130.18 49.18 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.829 0.347 . . . . 0.0 111.155 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.28 148.08 19.44 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.74 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.4 mm -106.68 146.68 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.693 0.282 . . . . 0.0 111.305 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.4 ' OG1' ' HB2' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -130.6 161.53 31.34 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.895 179.603 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 m -46.96 153.26 0.44 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.486 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 81.29 -56.33 0.28 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.03 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.72 51.05 0.05 OUTLIER Glycine 0 C--N 1.337 0.598 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.586 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.4 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 19.4 m-85 -114.82 140.96 48.51 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.66 0.267 . . . . 0.0 110.508 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -107.2 116.82 32.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.809 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -111.02 151.31 28.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.806 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 48.5 m-85 -124.56 149.82 46.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.834 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -128.75 148.25 50.84 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.329 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.437 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 10.7 t70 -113.93 127.89 56.16 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.795 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.29 -38.86 21.57 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.286 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.46 HD11 ' HG3' ' A' ' 6' ' ' ARG . 4.2 mt -61.13 -50.9 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.988 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.7 m -85.32 -40.83 16.1 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.173 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.7 37.27 8.75 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.391 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -127.6 148.02 50.36 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.82 0.343 . . . . 0.0 111.265 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 95.5 p -93.58 141.69 28.19 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.749 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.46 167.97 20.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.923 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -127.61 5.96 6.19 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.727 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -120.78 122.03 39.46 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 6.2 ttmt -64.15 119.51 56.36 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.85 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 31' ' ' LYS . 26.7 Cg_exo . . . . . 0 C--N 1.351 0.672 0 C-N-CA 122.724 2.282 . . . . 0.0 112.518 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 59.0 m95 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.716 0.293 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 9.4 p -99.26 140.29 19.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.472 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.79 122.42 33.51 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.839 0.352 . . . . 0.0 111.032 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.406 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.75 158.93 14.61 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.459 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 tp -109.88 137.26 47.92 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 111.103 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.2 152.15 46.42 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.791 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.53 153.61 0.36 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.503 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 67.59 11.37 8.34 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.076 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.63 66.74 1.93 Allowed Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.869 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -131.33 111.7 12.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.723 0.297 . . . . 0.0 110.631 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 m -81.49 120.35 24.91 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.06 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.406 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 32.9 p90 -112.77 145.83 39.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.617 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 89.9 m-85 -120.38 141.87 49.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.771 0.319 . . . . 0.0 111.01 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -127.19 148.8 50.18 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.463 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 52.6 t-20 -115.55 132.31 56.67 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.182 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.1 p -80.71 -29.75 36.4 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.4 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.1 -64.66 0.86 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.179 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.1 t -82.74 -34.8 27.09 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.994 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.28 47.14 5.86 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.602 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -133.39 136.94 45.6 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.784 0.326 . . . . 0.0 110.899 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.6 p -80.81 143.54 32.74 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.966 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.44 157.7 44.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.925 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 73.7 m95 . . . . . 0 CA--C 1.531 0.215 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.865 179.866 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.649 ' HB3' HD21 ' A' ' 22' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.229 0 CA-C-O 120.834 0.35 . . . . 0.0 110.915 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.471 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 87.4 m95 -112.35 134.24 54.0 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.96 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -112.66 141.4 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.183 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.37 131.63 36.72 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.893 0.377 . . . . 0.0 111.292 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.26 148.61 19.41 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.617 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.0 mm -99.9 143.26 13.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 120.612 0.244 . . . . 0.0 111.183 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.574 HG23 ' CD1' ' A' ' 18' ' ' TYR . 1.0 OUTLIER -126.24 161.56 27.46 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.862 0.363 . . . . 0.0 111.053 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.6 m -46.45 151.95 0.49 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.668 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 81.67 -54.98 0.26 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.191 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.64 51.52 0.05 OUTLIER Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.426 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -118.54 151.81 37.15 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.633 0.254 . . . . 0.0 110.832 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -111.85 117.21 32.16 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.07 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.574 ' CD1' HG23 ' A' ' 12' ' ' THR . 20.1 p90 -110.94 151.39 27.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.617 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -124.13 149.58 46.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.741 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -131.23 147.37 52.58 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.197 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.471 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 34.3 t70 -114.75 122.38 46.21 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.739 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.649 HD21 ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -78.18 -29.75 48.67 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.19 179.731 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.587 HD11 ' HD3' ' A' ' 6' ' ' ARG . 4.5 mt -60.52 -60.16 3.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-O 120.684 0.278 . . . . 0.0 111.016 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.07 -30.81 25.74 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.484 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.22 45.82 7.31 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.18 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -132.63 151.41 51.96 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.916 0.389 . . . . 0.0 111.666 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.07 145.99 24.09 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.902 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -133.72 168.66 18.31 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.136 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -126.97 -40.97 1.83 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.044 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.88 137.56 33.61 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.59 0.233 . . . . 0.0 110.454 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.87 139.28 97.3 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.198 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo . . . . . 0 C--N 1.35 0.654 0 C-N-CA 122.765 2.31 . . . . 0.0 112.422 179.867 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 62.7 m95 . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.755 0.312 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 14.0 p -104.95 149.34 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.175 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -96.89 122.44 39.87 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.406 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.412 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.96 157.42 15.28 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.712 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.5 tp -106.25 130.42 54.11 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.905 0.383 . . . . 0.0 111.326 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.484 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 12.1 t -119.93 152.09 37.93 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.974 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.96 153.41 0.65 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.655 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 67.25 10.86 8.04 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.195 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.92 65.8 2.12 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.347 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 31.8 m-85 -131.13 106.61 8.47 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.717 0.294 . . . . 0.0 110.748 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.4 m -73.93 120.22 19.21 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.839 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.412 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 23.4 p90 -112.9 146.14 39.48 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.637 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 49.5 m-85 -120.04 141.97 49.26 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 110.777 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -129.51 147.16 51.29 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.438 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -113.11 128.34 56.46 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.974 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.7 p -79.13 -24.01 43.64 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.408 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -60.06 -64.7 0.86 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.294 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.2 t -90.06 -34.38 15.96 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.22 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.24 53.17 2.55 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.551 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -135.46 142.34 45.52 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.913 0.387 . . . . 0.0 111.308 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.52 144.71 27.77 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.762 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -133.49 157.83 44.64 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 82.7 m95 . . . . . 0 N--CA 1.465 0.294 0 CA-C-O 120.916 0.388 . . . . 0.0 110.913 179.841 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.656 ' HB3' HD21 ' A' ' 22' ' ' LEU . 6.6 mmt85 . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.984 0.421 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.513 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 94.6 m95 -120.46 137.47 54.33 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.101 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.7 p -113.03 130.95 65.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.028 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -90.55 129.64 36.68 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.891 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.24 148.67 19.68 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.678 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.1 mm -97.85 129.05 48.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.529 0.204 . . . . 0.0 111.011 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.546 HG23 ' CE1' ' A' ' 18' ' ' TYR . 7.6 p -131.66 154.04 49.36 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.714 0.292 . . . . 0.0 111.076 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.2 -150.14 0.42 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.758 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -81.29 3.49 23.88 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.48 68.91 0.01 OUTLIER Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.084 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -138.52 109.87 6.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.692 0.282 . . . . 0.0 110.596 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -78.12 116.72 18.79 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.963 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.546 ' CE1' HG23 ' A' ' 12' ' ' THR . 19.9 p90 -111.22 151.91 27.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.743 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -123.85 149.25 45.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.794 0.33 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -136.27 146.11 46.31 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.513 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 24.5 t70 -113.33 124.13 51.76 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.981 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.656 HD21 ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -81.43 -28.63 34.17 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.712 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.9 mt -60.46 -52.58 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.696 0.284 . . . . 0.0 110.998 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.9 m -93.07 -31.61 14.77 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.335 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.01 48.38 5.18 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.307 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -131.99 147.69 52.47 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.855 0.36 . . . . 0.0 111.735 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.76 131.07 41.0 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.731 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -121.53 168.86 11.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.914 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -127.0 -34.95 2.3 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.089 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -82.54 145.19 29.88 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.66 0.267 . . . . 0.0 110.643 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 7.3 ttmt -70.13 135.2 87.13 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.177 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 31' ' ' LYS . 36.1 Cg_exo . . . . . 0 C--N 1.353 0.801 0 C-N-CA 122.94 2.426 . . . . 0.0 112.769 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.442 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 71.0 m95 . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.693 0.282 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 2.1 t -104.12 155.69 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.725 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.414 ' HG2' HG22 ' A' ' 58' ' ' THR . 2.7 tm-20 -112.98 121.91 46.05 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.771 0.32 . . . . 0.0 111.307 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.445 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -119.33 158.27 15.08 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.86 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.82 127.96 55.97 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.756 0.313 . . . . 0.0 110.979 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.17 151.77 44.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.729 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.07 -158.67 0.31 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.809 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -57.31 -26.23 60.58 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.29 48.72 0.02 OUTLIER Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.121 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -98.37 123.87 42.72 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.414 HG22 ' HG2' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -90.99 120.52 32.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.32 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.445 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 25.1 p90 -112.73 145.68 40.09 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.455 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 13.9 m-85 -120.4 141.85 49.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.844 0.354 . . . . 0.0 111.044 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -124.81 146.53 49.2 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.627 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.442 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 35.4 t30 -113.6 122.74 48.13 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.543 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.3 p -74.98 -25.07 58.58 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.484 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -55.14 -61.79 2.09 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.381 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 t -97.27 -32.88 11.68 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.387 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.45 63.26 1.18 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.44 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -145.6 142.7 29.34 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.836 0.35 . . . . 0.0 111.617 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.88 141.24 28.92 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.91 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.27 156.67 48.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.781 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 45.0 m95 . . . . . 0 CA--C 1.532 0.253 0 CA-C-O 120.838 0.351 . . . . 0.0 110.652 179.525 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.424 ' HB2' HD11 ' A' ' 23' ' ' ILE . 14.6 mtp180 . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.887 0.375 . . . . 0.0 110.411 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.521 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 82.3 m95 -110.45 147.21 34.52 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.054 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 p -112.97 139.06 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.768 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.29 130.53 36.39 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.93 0.395 . . . . 0.0 110.909 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.3 147.91 19.37 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.779 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.3 mm -93.33 142.62 12.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.625 0.25 . . . . 0.0 111.107 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.39 161.97 24.85 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.673 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -50.0 151.18 2.01 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.383 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 80.73 -54.38 0.33 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.132 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.78 52.24 0.04 OUTLIER Glycine 0 C--N 1.336 0.563 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.357 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -118.67 146.18 44.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.599 0.238 . . . . 0.0 110.67 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -105.69 117.05 33.04 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.953 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -110.94 151.83 27.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.747 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -124.33 149.56 46.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.966 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -135.12 144.26 47.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.785 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.521 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 13.5 t70 -110.08 124.33 51.31 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.896 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.78 -32.08 35.57 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.936 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' A' ' 6' ' ' ARG . 3.5 mt -59.16 -54.73 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.757 0.313 . . . . 0.0 111.059 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.4 p -85.97 -35.7 20.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.167 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.39 54.11 3.07 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.28 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -140.73 147.03 38.53 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.879 0.371 . . . . 0.0 111.522 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.1 p -88.03 132.76 34.15 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.565 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -126.27 166.94 16.17 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.869 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -127.52 -43.99 1.56 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.031 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -70.11 150.93 46.03 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.783 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -99.08 102.54 15.88 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.94 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 C--N 1.349 0.585 0 C-N-CA 122.657 2.238 . . . . 0.0 112.605 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 90.1 m95 . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 120.806 0.336 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 2.2 t -106.3 133.77 49.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.65 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.1 122.26 33.6 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.825 0.345 . . . . 0.0 110.865 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.431 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.83 158.53 14.79 Favored Glycine 0 C--N 1.332 0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.581 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.8 tp -109.76 136.03 49.73 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.867 0.365 . . . . 0.0 111.236 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 3.9 t -123.88 151.81 43.07 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.641 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.42 155.18 0.78 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.481 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 69.91 7.4 6.21 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.278 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.83 63.04 2.15 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.911 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.419 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 28.4 m-85 -127.77 128.38 45.22 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.553 0.216 . . . . 0.0 110.544 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.68 120.44 39.12 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.829 0.347 . . . . 0.0 111.013 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.431 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 30.5 p90 -112.91 146.18 39.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.536 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.434 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 55.6 m-85 -119.8 141.88 49.1 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.852 0.358 . . . . 0.0 110.884 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -128.15 147.69 50.56 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.982 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -114.11 130.67 56.57 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.679 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.8 p -78.44 -29.06 46.81 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.862 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -59.98 -66.47 0.51 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.386 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.1 t -82.42 -39.13 23.05 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.475 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.3 40.61 6.04 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.929 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -125.46 133.95 52.25 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.813 0.34 . . . . 0.0 110.872 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.05 148.43 37.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.736 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -133.2 153.61 51.38 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.878 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 94.4 m95 . . . . . 0 N--CA 1.464 0.264 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.908 179.615 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.594 ' HB2' HD11 ' A' ' 23' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--O 1.234 0.262 0 CA-C-O 120.993 0.425 . . . . 0.0 110.627 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.495 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 97.0 m95 -116.18 151.49 35.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.142 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 2.8 t -124.7 131.51 72.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.613 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -90.69 130.05 36.73 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.939 0.399 . . . . 0.0 111.099 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.07 148.5 19.59 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.678 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.1 mm -97.86 144.25 11.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.639 0.257 . . . . 0.0 111.086 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.33 162.19 28.54 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.895 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.22 149.65 0.7 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.739 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 79.83 -55.98 0.38 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.295 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.57 52.44 0.04 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.336 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -116.48 134.66 54.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.617 0.246 . . . . 0.0 110.531 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -98.3 116.86 31.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.845 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.418 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 19.8 p90 -110.75 151.34 27.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.789 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 64.0 m-85 -124.2 149.52 46.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.131 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -125.99 147.34 49.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.035 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.495 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 32.9 t70 -118.92 122.09 41.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.704 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.44 -26.76 35.06 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.321 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.594 HD11 ' HB2' ' A' ' 6' ' ' ARG . 7.5 mt -58.69 -48.71 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.766 0.317 . . . . 0.0 110.984 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.2 m -100.83 -35.49 9.41 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.346 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.44 51.31 3.14 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.127 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -137.69 154.83 49.62 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.963 0.411 . . . . 0.0 111.78 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.95 143.57 26.35 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.853 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -134.18 168.63 18.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.037 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.418 ' CZ3' ' HB3' ' A' ' 18' ' ' TYR . 96.5 m95 -127.24 -47.9 1.46 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.582 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -73.47 125.23 27.43 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.346 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 9.8 ttmt -60.95 138.0 93.91 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.175 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 31' ' ' LYS . 36.0 Cg_exo . . . . . 0 C--N 1.353 0.771 0 C-N-CA 122.82 2.347 . . . . 0.0 112.59 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 33.0 m95 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.655 0.264 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 12.0 p -96.43 145.44 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -94.14 122.15 36.37 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.8 0.334 . . . . 0.0 111.105 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -119.0 153.02 17.08 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.53 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.4 tp -109.78 138.94 45.43 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.998 0.427 . . . . 0.0 111.687 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.03 152.38 38.67 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.685 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 0.4 OUTLIER -45.14 152.24 0.27 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.742 -179.714 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 25.6 m-20 81.04 -44.29 0.21 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.14 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.22 48.33 0.11 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.425 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -114.27 130.04 56.64 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.6 m -99.36 120.45 39.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.876 0.369 . . . . 0.0 111.213 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -112.56 145.59 40.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.567 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 93.4 m-85 -120.42 142.06 49.56 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.747 0.308 . . . . 0.0 111.068 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -120.93 150.6 40.84 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.061 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.463 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 48.8 t-20 -114.31 130.14 56.66 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.281 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.3 p -82.66 -26.11 32.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.452 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -56.77 -61.8 2.18 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.653 -0.248 . . . . 0.0 111.353 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.0 p -93.8 -46.92 7.0 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.136 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.16 55.27 0.87 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.65 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -134.59 132.06 38.61 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.715 0.293 . . . . 0.0 110.832 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 86.9 p -71.94 148.76 45.7 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.758 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.59 157.71 45.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.211 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.6 m95 . . . . . 0 CA--C 1.532 0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.611 179.517 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.486 ' HD2' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.21 0 CA-C-O 120.942 0.401 . . . . 0.0 110.135 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -121.52 135.93 54.99 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.812 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.6 p -119.24 143.02 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.134 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -96.66 133.48 41.14 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.827 0.346 . . . . 0.0 111.215 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.41 148.51 19.63 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.736 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.9 mm -102.52 123.2 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 120.63 0.252 . . . . 0.0 110.948 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.38 157.72 44.81 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.99 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.4 t 60.83 -148.29 0.43 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.69 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.99 -28.93 40.88 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 111.546 0.202 . . . . 0.0 111.546 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.45 46.72 0.03 OUTLIER Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.335 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -95.46 120.11 35.14 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -73.77 116.68 14.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.895 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -111.24 151.96 27.68 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.747 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -123.75 149.53 45.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.489 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -136.07 148.95 48.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.969 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -115.08 123.02 47.94 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.01 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.4 ' CG ' ' HB3' ' A' ' 6' ' ' ARG . 0.1 OUTLIER -83.53 -21.19 32.81 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.391 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.486 HG13 ' HD2' ' A' ' 6' ' ' ARG . 9.6 mt -51.95 -55.81 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 120.611 0.243 . . . . 0.0 111.038 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.29 -40.75 4.58 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.054 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.14 54.04 0.68 Allowed Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.48 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -127.74 110.27 12.47 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.717 0.294 . . . . 0.0 110.997 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.0 p -69.46 132.63 46.62 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.675 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.27 168.06 16.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.141 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -127.67 6.6 6.19 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.501 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -118.0 129.28 55.49 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -70.49 113.66 20.06 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.914 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 C--N 1.351 0.666 0 C-N-CA 122.672 2.248 . . . . 0.0 112.61 -179.939 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 87.3 m95 . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.9 t -110.7 139.25 35.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.624 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -91.06 122.07 33.4 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.82 0.343 . . . . 0.0 111.018 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.445 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.82 160.13 14.16 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.491 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.0 tp -113.1 135.46 53.78 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.847 0.356 . . . . 0.0 111.163 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.1 152.08 40.24 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.815 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -47.51 155.28 0.37 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.463 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 67.6 11.25 8.28 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.247 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.05 66.46 1.91 Allowed Glycine 0 C--N 1.338 0.667 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.061 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -131.95 120.12 22.05 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.655 0.264 . . . . 0.0 110.617 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.3 m -89.16 120.49 30.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.883 0.373 . . . . 0.0 111.062 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.445 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 33.4 p90 -112.75 146.06 39.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.392 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 80.1 m-85 -120.09 141.54 49.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.748 0.309 . . . . 0.0 111.063 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -127.75 149.08 50.4 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -119.44 129.33 54.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.932 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.8 p -74.94 -35.36 62.16 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.537 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -59.6 -60.19 4.24 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.694 0.283 . . . . 0.0 111.177 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.0 p -78.78 -34.43 45.53 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.204 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.49 44.66 20.77 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.25 -0.5 . . . . 0.0 112.591 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -136.74 134.4 37.08 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.886 0.374 . . . . 0.0 111.057 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.39 145.75 39.18 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.624 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -133.05 157.55 44.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.059 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 72.3 m95 . . . . . 0 C--O 1.234 0.241 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 179.658 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.461 ' HB2' HD11 ' A' ' 23' ' ' ILE . 22.4 mtt180 . . . . . 0 CA--C 1.531 0.216 0 CA-C-O 120.96 0.41 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.412 ' CZ3' ' HB2' ' A' ' 28' ' ' GLN . 86.8 m95 -114.54 140.48 48.73 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.954 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 11.8 p -110.7 133.25 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.594 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -90.44 130.15 36.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.003 0.43 . . . . 0.0 111.221 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.15 148.57 19.51 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.371 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 11' ' ' ILE . 1.5 mp -101.08 138.18 26.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.665 0.269 . . . . 0.0 110.937 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.68 161.76 20.15 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.167 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.8 m -41.87 148.64 0.16 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.739 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.452 ' HB3' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 82.16 -57.04 0.22 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.058 -179.528 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.79 58.39 0.03 OUTLIER Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.446 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.452 ' CE2' ' HB3' ' A' ' 14' ' ' GLU . 29.9 m-85 -124.78 138.78 54.26 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.718 0.295 . . . . 0.0 111.018 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -100.27 117.27 34.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.916 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.421 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 24.9 p90 -110.89 151.53 27.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.557 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 64.9 m-85 -124.39 149.54 46.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.911 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -131.84 145.81 51.77 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.175 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.406 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 2.6 t0 -110.64 123.13 49.41 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.098 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.82 -25.68 27.95 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.224 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.461 HD11 ' HB2' ' A' ' 6' ' ' ARG . 2.0 mp -57.3 -54.73 26.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.098 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.6 m -97.62 -38.55 9.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.099 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.07 53.24 1.52 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.265 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -135.75 129.33 32.42 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.797 0.332 . . . . 0.0 111.251 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.54 145.63 38.93 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.412 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -132.91 168.36 18.57 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.073 -179.672 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.421 ' CZ3' ' HB3' ' A' ' 18' ' ' TYR . 90.2 m95 -127.46 -47.13 1.44 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.847 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.7 134.09 37.13 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.664 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -68.16 133.91 91.54 Favored Pre-proline 0 N--CA 1.463 0.216 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.191 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo . . . . . 0 C--N 1.35 0.643 0 C-N-CA 122.659 2.239 . . . . 0.0 112.606 179.95 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.471 ' CH2' ' HB2' ' A' ' 62' ' ' ASN . 65.5 m95 . . . . . 0 C--O 1.233 0.231 0 CA-C-O 120.68 0.276 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 12.8 p -104.02 139.52 24.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.761 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -90.76 122.16 33.26 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.923 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.72 156.36 15.7 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.611 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.7 tp -108.99 137.85 46.26 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.76 0.314 . . . . 0.0 111.247 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.99 152.08 48.35 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.95 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -47.28 154.19 0.42 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.77 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 67.25 10.96 8.11 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.118 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.18 66.56 1.94 Allowed Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.171 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -130.67 108.05 9.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.742 0.306 . . . . 0.0 110.694 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.6 m -80.63 120.44 24.57 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.864 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.427 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 33.2 p90 -112.66 146.16 39.15 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.014 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 70.3 m-85 -119.99 141.92 49.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.804 0.335 . . . . 0.0 110.877 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -127.06 145.7 50.63 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.08 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.471 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 51.4 t-20 -114.02 126.23 54.89 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.162 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.0 p -75.92 -24.61 55.57 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.445 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -56.23 -62.43 1.72 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.287 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.0 p -91.37 -37.66 13.09 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.066 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.73 49.69 2.88 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.131 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -135.48 138.18 42.88 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.917 0.389 . . . . 0.0 111.231 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.35 140.45 38.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.805 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -133.57 157.85 44.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.774 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 69.1 m95 . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 120.879 0.371 . . . . 0.0 110.753 179.818 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.492 ' HB3' HD21 ' A' ' 22' ' ' LEU . 1.5 mmt180 . . . . . 0 C--O 1.233 0.216 0 CA-C-O 120.925 0.393 . . . . 0.0 110.542 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.57 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 80.1 m95 -108.29 132.11 54.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.905 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 1.6 t -103.46 132.14 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.469 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.66 129.65 36.75 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.965 0.412 . . . . 0.0 111.311 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.408 ' HA3' ' CE1' ' A' ' 18' ' ' TYR . . . -135.47 148.72 19.73 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.571 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.0 mm -95.43 125.82 48.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.481 0.182 . . . . 0.0 110.69 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.25 148.03 51.97 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.873 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.51 -150.54 0.39 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.549 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -56.62 -26.33 55.45 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.68 43.27 0.02 OUTLIER Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.635 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -93.24 111.95 23.74 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -73.35 116.69 14.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.408 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 17.9 p90 -110.86 151.72 27.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.203 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 55.3 m-85 -123.97 149.17 46.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.873 0.368 . . . . 0.0 110.975 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -133.99 139.46 46.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.798 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.57 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 16.6 t70 -110.14 126.38 54.0 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.551 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.492 HD21 ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -83.43 -31.19 26.75 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.742 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.3 mt -56.56 -45.53 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.78 0.324 . . . . 0.0 111.031 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.36 -35.2 9.67 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.166 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.92 41.52 6.29 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.171 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -128.88 153.62 47.3 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.895 0.379 . . . . 0.0 111.372 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.5 p -95.37 149.73 21.05 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.89 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.85 167.17 21.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.955 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -127.54 6.38 6.26 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.923 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -136.43 138.12 41.16 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.08 114.34 48.03 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.899 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo . . . . . 0 C--N 1.352 0.712 0 C-N-CA 122.805 2.337 . . . . 0.0 112.483 -179.87 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.471 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 44.9 m95 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.593 0.235 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 p -104.44 145.89 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.403 ' HG3' ' CG2' ' A' ' 58' ' ' THR . 41.1 tt0 -96.97 122.55 40.08 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.103 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.62 158.33 14.84 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.621 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.4 tp -106.59 141.7 37.44 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.862 0.363 . . . . 0.0 111.267 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.443 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 34.1 t -133.58 152.22 51.85 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.826 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.79 153.52 0.39 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.55 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.59 11.41 8.1 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.12 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.81 65.85 2.28 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.969 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.443 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 34.3 m-85 -128.19 103.89 7.44 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.756 0.312 . . . . 0.0 110.7 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.504 HG22 ' CE1' ' A' ' 60' ' ' TYR . 29.4 m -76.19 120.05 20.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.852 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -112.87 145.96 39.77 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.721 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.504 ' CE1' HG22 ' A' ' 58' ' ' THR . 11.0 m-85 -120.33 141.86 49.66 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.736 0.303 . . . . 0.0 110.79 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -124.57 152.36 43.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.471 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 18.3 t-20 -113.68 136.37 52.91 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.771 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.9 p -87.27 -30.84 20.59 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.814 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -60.58 -62.96 1.48 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.65 0.262 . . . . 0.0 111.045 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 75.1 p -84.02 -44.56 14.0 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.094 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.11 48.63 2.39 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.453 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -134.23 140.74 46.67 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.761 0.315 . . . . 0.0 110.855 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.2 p -80.71 148.99 29.9 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.0 tpt85 -134.02 155.67 49.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.732 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 87.8 m95 . . . . . 0 C--O 1.234 0.244 0 CA-C-O 120.788 0.327 . . . . 0.0 111.286 -179.98 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.501 ' HB2' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 120.853 0.358 . . . . 0.0 111.109 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.423 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 82.2 m95 -121.26 137.39 54.71 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.052 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.5 p -115.55 133.91 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.961 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -90.61 132.09 35.94 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.866 0.365 . . . . 0.0 111.174 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.73 147.73 18.76 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.549 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.3 mm -95.96 141.65 15.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.634 0.254 . . . . 0.0 110.914 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.09 162.08 25.37 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.805 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 m -46.66 152.7 0.45 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.528 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 77.48 -54.72 0.53 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.424 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.24 50.49 0.04 OUTLIER Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.578 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -115.85 141.2 48.41 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.506 0.193 . . . . 0.0 110.528 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -105.54 117.07 33.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.77 0.319 . . . . 0.0 110.825 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -110.74 151.27 27.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.721 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -124.84 149.23 47.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.751 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -127.48 144.64 51.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.076 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.423 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 29.1 t70 -117.34 123.23 45.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.679 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.409 HD11 ' HG2' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -84.35 -25.72 28.96 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.157 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 6' ' ' ARG . 6.5 mt -58.71 -46.7 90.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.576 0.227 . . . . 0.0 110.871 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -104.46 -32.24 9.09 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.526 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.56 45.39 5.24 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.265 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -132.77 132.45 42.26 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.815 0.34 . . . . 0.0 111.378 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.2 p -86.26 142.0 28.88 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.709 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.02 167.62 18.75 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.193 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -127.72 7.01 6.19 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.672 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.6 130.12 51.85 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.34 113.93 14.8 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.004 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo . . . . . 0 C--N 1.353 0.79 0 C-N-CA 122.996 2.464 . . . . 0.0 112.828 -179.518 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.523 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 72.0 m95 . . . . . 0 C--O 1.233 0.209 0 CA-C-O 120.711 0.291 . . . . 0.0 111.036 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.3 p -107.22 141.61 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.022 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -90.78 122.33 33.42 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.016 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.91 158.4 14.87 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.469 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.45 131.65 55.46 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.866 0.365 . . . . 0.0 111.424 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.08 151.94 27.5 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.794 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -44.56 148.54 0.48 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.327 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 82.6 -51.67 0.19 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.073 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 140.26 51.18 0.05 OUTLIER Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.451 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -117.51 118.68 32.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.608 0.242 . . . . 0.0 110.498 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.46 120.39 25.41 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.846 0.355 . . . . 0.0 111.117 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -112.75 146.11 39.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.436 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -119.75 141.93 49.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.843 0.354 . . . . 0.0 110.84 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -123.33 154.74 38.5 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.859 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.523 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 39.3 t30 -113.5 122.14 46.39 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.924 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.3 p -74.26 -30.74 62.26 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.716 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -64.58 -66.97 0.47 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.517 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.2 p -78.09 -48.95 14.87 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.517 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.82 42.25 2.7 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.599 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -129.67 133.24 46.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.763 0.316 . . . . 0.0 110.894 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.19 146.72 45.35 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.7 157.64 44.37 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.075 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 87.6 m95 . . . . . 0 CA--C 1.532 0.256 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.84 179.484 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.632 ' HB3' HD21 ' A' ' 22' ' ' LEU . 5.8 mmm180 . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.752 0.311 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.502 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 91.1 m95 -127.14 137.05 52.9 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.047 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 14.9 p -117.34 147.85 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.265 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.68 131.67 46.46 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.194 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.59 148.58 19.68 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.956 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.6 mm -94.35 144.17 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.72 0.295 . . . . 0.0 111.185 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.603 HG23 ' CD1' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -127.16 161.67 27.96 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.969 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 t -45.76 152.22 0.37 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.637 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 80.66 -55.82 0.33 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.187 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.16 51.9 0.05 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.484 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -118.32 151.65 37.3 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.57 0.224 . . . . 0.0 110.585 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -109.94 116.7 32.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.798 0.332 . . . . 0.0 110.871 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.603 ' CD1' HG23 ' A' ' 12' ' ' THR . 17.2 p90 -111.15 151.43 28.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.941 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 57.0 m-85 -124.41 149.29 46.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.783 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -125.86 149.53 48.59 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.232 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.672 ' OD1' HD12 ' A' ' 23' ' ' ILE . 23.5 t70 -119.11 122.02 41.12 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.022 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.632 HD21 ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -82.82 -26.46 31.69 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.672 HD12 ' OD1' ' A' ' 21' ' ' ASP . 3.5 mt -56.53 -46.8 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.759 0.314 . . . . 0.0 111.084 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m -103.83 -44.38 5.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.003 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.23 36.9 3.23 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.57 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -119.32 156.88 29.21 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.803 0.335 . . . . 0.0 111.297 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 p -100.09 131.14 46.22 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.033 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -122.2 168.4 12.05 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.832 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.433 ' CZ3' ' HB3' ' A' ' 18' ' ' TYR . 93.3 m95 -127.38 -45.34 1.52 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.078 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -73.41 119.6 17.87 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.578 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.02 125.27 91.25 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.748 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 C--N 1.349 0.582 0 C-N-CA 122.631 2.22 . . . . 0.0 112.236 179.826 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 94.2 m95 . . . . . 0 N--CA 1.464 0.231 0 CA-C-O 120.516 0.198 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.6 t -111.46 131.66 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.419 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.468 ' HG3' ' CD1' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -94.6 122.25 37.0 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.941 0.401 . . . . 0.0 111.521 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.446 ' HA3' ' CE2' ' A' ' 59' ' ' TYR . . . -118.86 158.0 15.02 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.265 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.43 121.59 45.26 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.753 0.277 . . . . 0.0 110.943 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.17 142.13 31.35 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.803 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 55.73 95.06 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.461 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 68.1 -63.29 0.33 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.052 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.37 40.21 0.05 OUTLIER Glycine 0 CA--C 1.518 0.272 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.696 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -85.31 121.28 27.81 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.11 120.03 23.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.998 0.427 . . . . 0.0 111.229 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.446 ' CE2' ' HA3' ' A' ' 51' ' ' GLY . 25.2 p90 -113.05 146.18 39.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.816 179.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.485 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 2.6 m-85 -119.59 141.74 49.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.935 0.398 . . . . 0.0 111.165 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -129.65 155.02 46.52 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.573 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -113.48 129.23 56.59 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.891 0.377 . . . . 0.0 111.265 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.6 p -93.39 22.27 5.41 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.757 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -95.7 -60.04 1.74 Allowed 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 120.666 0.269 . . . . 0.0 110.707 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.8 t -110.39 -36.2 5.85 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.14 73.58 0.71 Allowed Glycine 0 C--N 1.335 0.513 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.707 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -149.9 126.89 11.18 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.819 0.342 . . . . 0.0 111.007 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.49 150.69 25.84 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.697 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.6 ttt-85 -130.73 155.35 46.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.261 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.8 m95 . . . . . 0 CA--C 1.532 0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 179.602 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.419 ' CG ' HD11 ' A' ' 23' ' ' ILE . 31.3 mmt180 . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 121.08 0.467 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.433 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 80.9 m95 -105.75 140.17 39.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.754 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 p -116.17 133.57 62.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.085 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -90.7 131.51 36.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.272 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.25 148.58 19.65 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.66 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.8 mm -98.01 127.08 50.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.585 0.231 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.574 HG23 ' CE1' ' A' ' 18' ' ' TYR . 11.2 p -133.43 150.06 51.78 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.947 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.02 -149.78 0.41 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.622 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.28 -29.57 47.64 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.13 44.09 0.02 OUTLIER Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.56 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -92.81 112.75 24.82 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -74.54 116.8 15.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.949 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.574 ' CE1' HG23 ' A' ' 12' ' ' THR . 20.7 p90 -111.02 151.51 27.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.517 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -124.41 148.81 47.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.949 0.405 . . . . 0.0 110.93 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -136.56 147.88 47.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.132 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.433 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 4.7 t0 -112.09 122.05 46.68 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.653 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.39 -26.94 27.99 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.274 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.419 HD11 ' CG ' ' A' ' 6' ' ' ARG . 6.3 mt -60.72 -53.39 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.733 0.302 . . . . 0.0 110.871 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.06 -36.51 12.08 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.22 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.04 60.19 1.34 Allowed Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.293 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -142.64 129.24 20.27 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.844 0.354 . . . . 0.0 111.415 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.7 p -85.29 132.19 34.29 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.54 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -131.91 168.3 18.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.22 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.404 ' HH2' ' HG1' ' A' ' 12' ' ' THR . 73.3 m95 -127.81 7.37 6.18 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.705 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -120.44 139.89 52.18 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.662 0.268 . . . . 0.0 110.713 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -77.64 131.67 70.47 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.962 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 C--N 1.35 0.629 0 C-N-CA 122.679 2.253 . . . . 0.0 112.253 179.882 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.468 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 76.5 m95 . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.557 0.218 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.9 p -108.37 137.88 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.957 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -91.08 122.05 33.39 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.001 0.429 . . . . 0.0 110.952 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.75 151.38 17.75 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.349 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.81 133.4 54.83 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.911 0.386 . . . . 0.0 111.419 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.1 t -112.29 151.8 29.25 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.84 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -45.08 154.63 0.14 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.333 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 80.54 -55.58 0.34 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.061 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.16 55.06 0.03 OUTLIER Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.407 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -124.77 124.24 41.7 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.632 0.253 . . . . 0.0 110.538 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.3 m -93.56 120.95 34.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.85 0.357 . . . . 0.0 111.068 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -112.56 146.21 38.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.56 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -119.93 141.86 49.24 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.848 0.356 . . . . 0.0 110.942 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -125.91 147.19 49.55 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.926 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.468 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 53.3 t30 -113.33 122.76 48.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.668 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.1 p -77.75 -23.1 49.4 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.558 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -55.08 -60.94 2.69 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.405 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.7 t -102.27 -38.43 7.66 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.441 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.72 46.8 1.73 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.607 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -123.54 121.12 34.81 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.781 0.324 . . . . 0.0 110.674 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.2 p -71.32 150.14 45.41 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -133.82 157.79 45.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.088 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 94.1 m95 . . . . . 0 CA--C 1.533 0.32 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.049 179.695 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.445 ' CD ' HD11 ' A' ' 23' ' ' ILE . 1.5 mpt_? . . . . . 0 C--O 1.234 0.269 0 CA-C-O 120.999 0.428 . . . . 0.0 110.464 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.409 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 89.6 m95 -125.11 148.92 48.33 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.228 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 2.0 t -118.14 132.88 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.503 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -90.89 129.83 36.89 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.942 0.401 . . . . 0.0 111.53 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.52 148.69 19.72 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.653 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.6 mm -105.18 125.47 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.5 0.19 . . . . 0.0 110.809 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.89 153.76 51.53 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.34 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.1 -148.02 0.43 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.748 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -55.03 -29.24 57.0 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.56 44.43 0.02 OUTLIER Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.358 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -92.51 113.95 26.36 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -73.86 116.64 14.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.845 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -111.02 151.46 27.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.218 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 85.3 m-85 -124.05 149.39 46.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.844 0.354 . . . . 0.0 111.092 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -131.87 140.36 49.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.77 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.409 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 9.5 t70 -109.8 125.67 52.97 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.74 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.15 -29.67 28.45 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.714 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.445 HD11 ' CD ' ' A' ' 6' ' ' ARG . 4.1 mt -54.65 -49.34 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.804 0.335 . . . . 0.0 110.882 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m -101.92 -39.13 7.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.292 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.73 44.84 3.29 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.347 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -127.91 135.54 50.12 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 111.477 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.8 t -85.94 147.57 26.17 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.665 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -133.74 167.79 19.88 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.92 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -127.44 8.94 6.54 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.663 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -132.06 137.98 47.99 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.424 ' HE3' ' OH ' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -62.09 132.66 93.84 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.351 -179.49 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 C--N 1.35 0.641 0 C-N-CA 122.681 2.254 . . . . 0.0 112.268 179.768 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 78.3 m95 . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.592 0.234 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.2 p -106.33 132.29 53.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.462 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -90.59 122.0 33.01 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.915 0.388 . . . . 0.0 110.945 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.409 ' HA3' ' CE1' ' A' ' 59' ' ' TYR . . . -118.86 152.88 17.17 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.351 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.74 129.05 55.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.954 0.407 . . . . 0.0 111.296 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.422 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 40.2 t -109.39 151.94 25.98 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.648 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -45.64 151.98 0.37 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.368 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.405 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 0.3 OUTLIER 82.77 -53.68 0.19 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.9 -179.334 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.52 55.78 0.04 OUTLIER Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.445 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 22.0 m-85 -123.7 129.25 50.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.524 0.202 . . . . 0.0 110.749 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.3 m -98.1 120.85 39.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.854 0.359 . . . . 0.0 111.086 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.409 ' CE1' ' HA3' ' A' ' 51' ' ' GLY . 30.0 p90 -112.64 145.94 39.51 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.596 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -120.25 142.26 49.21 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.736 0.303 . . . . 0.0 110.86 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -124.2 152.25 43.12 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.851 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.61 122.51 47.89 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.911 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.3 p -78.74 -24.97 44.51 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.447 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -59.47 -63.41 1.31 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.432 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.0 t -91.24 -40.27 11.62 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.377 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.87 56.43 1.08 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.736 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -136.22 139.2 42.58 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.802 0.334 . . . . 0.0 110.865 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 p -80.58 146.35 31.28 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.789 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.48 149.29 49.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.07 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 63.5 m95 . . . . . 0 CA--C 1.531 0.239 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.013 179.75 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.0 mtt85 . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.752 0.311 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.44 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 58.2 m95 -126.15 141.21 52.03 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.117 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.8 p -114.72 134.48 57.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.826 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -90.64 130.87 36.61 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.913 0.387 . . . . 0.0 111.304 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.11 148.69 19.68 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.74 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.7 mm -98.09 125.74 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 120.452 0.168 . . . . 0.0 111.021 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.518 HG23 ' CE1' ' A' ' 18' ' ' TYR . 9.3 p -132.99 155.36 49.31 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.024 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.1 t 58.73 -148.09 0.48 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.67 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -62.0 -23.69 66.58 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.89 43.05 0.02 OUTLIER Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.577 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -94.0 112.24 24.05 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -75.0 116.45 15.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.002 0.429 . . . . 0.0 110.72 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.518 ' CE1' HG23 ' A' ' 12' ' ' THR . 14.2 p90 -111.03 151.71 27.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.388 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -124.05 149.35 46.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.819 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -134.42 147.98 50.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.679 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.44 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 10.2 t70 -109.93 122.1 46.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.679 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.67 -23.64 29.35 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.4 mt -57.85 -52.53 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.636 0.255 . . . . 0.0 110.953 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.67 -41.12 6.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.16 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.44 53.02 0.95 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.433 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -133.57 127.73 33.73 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.857 0.361 . . . . 0.0 111.281 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.7 t -76.11 145.75 39.78 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.762 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -132.66 168.19 18.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.121 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -127.57 -46.79 1.44 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.802 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.99 129.97 35.03 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.537 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -71.11 133.93 85.54 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.015 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo . . . . . 0 C--N 1.351 0.703 0 C-N-CA 122.61 2.207 . . . . 0.0 112.576 -179.938 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.453 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 85.4 m95 . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.715 0.293 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.5 p -105.64 136.8 38.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.855 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -91.54 122.0 33.73 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.817 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.422 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.75 153.38 16.98 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.431 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.23 141.5 45.86 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.113 0.482 . . . . 0.0 111.544 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.409 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 30.1 t -123.54 152.27 41.97 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.497 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 0.7 OUTLIER -44.7 156.23 0.09 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.849 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 22.2 m-20 76.88 -54.67 0.57 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.889 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.12 54.29 0.03 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.131 -0.556 . . . . 0.0 112.264 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 55' ' ' ASP . 18.3 m-85 -120.01 118.0 29.5 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.656 0.265 . . . . 0.0 110.811 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.47 120.67 29.0 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.01 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.432 ' HB3' ' CZ3' ' A' ' 70' ' ' TRP . 30.8 p90 -112.51 145.97 39.31 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.744 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -120.23 142.03 49.4 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.846 0.355 . . . . 0.0 110.95 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -130.27 150.55 51.46 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.341 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.453 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 1.4 t-20 -114.37 133.48 55.67 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.052 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.4 p -82.09 -26.26 33.79 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.617 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -62.58 -66.78 0.49 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.36 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.9 t -84.5 -34.77 23.27 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.307 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.21 49.88 3.83 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.601 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -129.52 137.07 50.59 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.801 0.334 . . . . 0.0 111.138 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.51 146.17 27.05 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.66 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.04 155.59 50.5 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.432 ' CZ3' ' HB3' ' A' ' 59' ' ' TYR . 94.1 m95 . . . . . 0 CA--C 1.532 0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.926 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.572 ' HB2' HD11 ' A' ' 23' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.235 0 CA-C-O 120.831 0.348 . . . . 0.0 111.409 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -127.98 148.42 50.52 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.892 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 2.2 t -119.3 129.06 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.758 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.76 131.98 36.11 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.95 0.405 . . . . 0.0 111.445 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.12 147.18 19.07 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.404 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.2 mm -100.39 123.9 53.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 120.465 0.174 . . . . 0.0 110.875 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.02 156.17 47.84 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.965 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 57.14 -148.32 0.5 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.523 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.43 -21.25 66.19 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.76 44.58 0.02 OUTLIER Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.411 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -92.83 105.46 17.59 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -73.36 116.67 14.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.929 0.395 . . . . 0.0 110.959 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.419 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 30.1 p90 -110.9 151.51 27.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.466 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 56.1 m-85 -124.32 149.47 46.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 111.21 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -131.81 142.26 49.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.964 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -109.54 124.35 50.95 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.528 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.66 -26.45 27.78 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.214 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.572 HD11 ' HB2' ' A' ' 6' ' ' ARG . 7.8 mt -62.65 -45.44 98.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.7 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 t -99.64 -35.83 9.7 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.301 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.9 62.52 1.3 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.335 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.19 157.19 33.93 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.94 0.4 . . . . 0.0 111.866 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.3 t -101.52 151.98 21.32 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.711 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.91 168.12 19.35 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.043 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.419 ' CZ3' ' HB3' ' A' ' 18' ' ' TYR . 98.3 m95 -127.57 7.49 6.32 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.706 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.12 131.97 47.3 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.544 0.211 . . . . 0.0 110.474 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -73.62 126.04 90.07 Favored Pre-proline 0 N--CA 1.462 0.17 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.875 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 31' ' ' LYS . 32.0 Cg_exo . . . . . 0 C--N 1.352 0.719 0 C-N-CA 122.941 2.427 . . . . 0.0 112.469 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.475 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 80.6 m95 . . . . . 0 C--O 1.233 0.219 0 CA-C-O 120.687 0.28 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.7 p -115.43 135.17 56.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.889 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.2 122.36 35.51 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.945 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.401 ' HA3' ' CE1' ' A' ' 59' ' ' TYR . . . -118.52 158.89 14.58 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.718 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.0 tp -107.71 136.8 46.85 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.954 0.407 . . . . 0.0 111.174 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.469 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 44.2 t -126.29 152.26 46.41 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.953 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -45.85 152.31 0.37 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.651 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 68.25 11.49 8.38 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.119 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.86 64.72 2.48 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.169 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.469 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 34.0 m-85 -128.03 106.55 9.15 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.731 0.3 . . . . 0.0 110.658 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.81 120.27 23.21 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.815 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.401 ' CE1' ' HA3' ' A' ' 51' ' ' GLY . 31.1 p90 -112.97 145.86 40.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.822 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -120.41 141.84 49.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.91 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -128.52 153.0 47.64 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.744 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.565 ' OD1' HG22 ' A' ' 65' ' ' THR . 20.8 t-20 -113.77 134.43 54.77 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.073 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.9 p -89.15 -29.8 19.06 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.51 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -59.1 -60.49 3.79 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.507 0.194 . . . . 0.0 111.178 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.565 HG22 ' OD1' ' A' ' 62' ' ' ASN . 4.1 t -91.09 -36.19 14.16 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.236 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.51 50.06 2.84 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.65 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -130.42 135.61 48.19 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.846 0.355 . . . . 0.0 111.198 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.93 145.1 26.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.784 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.23 143.96 46.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.856 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 55.4 m95 . . . . . 0 CA--C 1.535 0.397 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.226 179.901 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.487 ' HB2' HD11 ' A' ' 23' ' ' ILE . 5.1 mtt-85 . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.992 0.425 . . . . 0.0 110.624 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.533 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 91.6 m95 -109.17 141.6 41.17 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.75 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.5 p -114.64 135.4 54.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.978 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -90.41 130.42 36.49 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.881 0.372 . . . . 0.0 110.756 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.87 148.18 19.33 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.783 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.6 mm -97.16 142.12 14.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.723 0.296 . . . . 0.0 111.21 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.92 161.68 26.09 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.974 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -44.25 150.55 0.29 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.599 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.432 ' HB3' ' CE2' ' A' ' 16' ' ' TYR . 0.8 OUTLIER 81.1 -56.83 0.29 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.212 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.53 49.54 0.05 OUTLIER Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.585 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 14' ' ' GLU . 31.3 m-85 -113.44 148.55 35.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.538 0.209 . . . . 0.0 110.487 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -108.67 116.75 32.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.935 0.398 . . . . 0.0 110.824 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -111.35 151.79 28.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.122 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -124.17 149.69 46.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.709 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -135.55 147.74 48.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.224 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.533 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 5.9 t70 -113.66 122.28 46.67 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.858 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.4 -26.56 30.3 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.346 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.487 HD11 ' HB2' ' A' ' 6' ' ' ARG . 2.1 mt -59.33 -50.5 79.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-O 120.69 0.281 . . . . 0.0 111.023 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 m -98.74 -50.22 4.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.977 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.74 55.34 0.66 Allowed Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.456 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -137.68 142.5 41.09 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.808 0.337 . . . . 0.0 111.306 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.34 130.79 35.66 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.792 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -124.11 168.75 12.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.8 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -127.27 -45.95 1.51 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.788 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.03 136.46 46.69 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.361 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -65.32 119.36 58.73 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.818 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo . . . . . 0 C--N 1.352 0.72 0 C-N-CA 122.741 2.294 . . . . 0.0 112.614 -179.671 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.463 ' CH2' ' HB2' ' A' ' 62' ' ' ASN . 65.3 m95 . . . . . 0 C--O 1.234 0.255 0 CA-C-O 120.797 0.332 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 2.3 t -101.8 156.12 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.579 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -113.25 121.89 45.81 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.67 0.271 . . . . 0.0 111.267 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.484 ' HA3' ' CE2' ' A' ' 59' ' ' TYR . . . -119.13 154.94 16.25 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.826 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -113.16 121.95 46.04 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 57' ' ' PHE . 0.6 OUTLIER -142.76 142.09 31.85 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.444 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 56' ' ' GLY . 10.9 tt0 50.56 98.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.016 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 65.84 -63.54 0.22 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.35 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 176.14 40.27 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.733 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 53' ' ' SER . 20.9 m-85 -84.7 106.12 16.01 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.01 119.77 16.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.555 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.484 ' CE2' ' HA3' ' A' ' 51' ' ' GLY . 25.5 p90 -113.44 145.94 40.35 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.115 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 43.4 m-85 -120.08 141.77 49.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.787 0.327 . . . . 0.0 111.127 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -125.94 147.55 49.47 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.072 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.463 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 60.9 t30 -113.82 125.83 54.51 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.028 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.8 p -76.47 -26.58 55.52 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.332 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -58.46 -62.81 1.57 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.305 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.8 p -89.09 -44.27 10.46 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.131 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.47 52.78 1.52 Allowed Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.508 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -137.83 133.63 34.19 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.9 0.381 . . . . 0.0 111.025 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.4 p -75.34 145.57 41.62 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.919 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -132.82 158.13 43.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.807 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 65.6 m95 . . . . . 0 CA--C 1.534 0.332 0 CA-C-O 120.869 0.366 . . . . 0.0 111.039 -179.888 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.594 0.235 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.98 126.48 21.59 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.827 2.351 . . . . 0.0 112.701 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 t -170.31 -50.96 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.801 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.84 147.54 0.09 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.443 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.06 42.99 0.09 OUTLIER Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.713 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -94.41 76.56 3.88 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.148 0.499 . . . . 0.0 110.137 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.419 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 90.9 m95 -115.44 137.54 51.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.842 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 p -114.39 141.01 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.225 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.09 131.64 39.41 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.035 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.16 148.52 19.61 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.014 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.9 mm -91.49 142.62 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 120.676 0.274 . . . . 0.0 111.156 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.49 161.76 25.4 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.982 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.76 149.83 0.79 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.532 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 80.85 -55.76 0.32 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.217 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.1 55.84 0.03 OUTLIER Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.45 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -120.21 159.7 24.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.66 0.267 . . . . 0.0 110.755 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -115.83 117.04 29.1 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.06 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -111.12 151.84 27.67 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.96 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -124.19 149.26 46.56 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.82 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -135.24 145.4 47.57 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.929 0.395 . . . . 0.0 111.446 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.419 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 6.9 t70 -109.73 122.58 47.82 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.75 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.07 -24.82 32.55 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.589 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.8 mt -60.7 -59.88 3.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.754 0.311 . . . . 0.0 110.858 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.46 -34.7 20.0 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.083 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.25 56.53 1.91 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.351 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -142.92 141.6 31.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.799 0.333 . . . . 0.0 111.544 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -86.85 131.23 34.17 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.472 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -124.74 168.58 13.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.187 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -127.54 -46.55 1.45 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.25 126.55 29.99 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.64 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -67.59 122.26 82.6 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.984 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.34 179.14 5.78 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.735 2.29 . . . . 0.0 112.816 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.19 75.99 10.24 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.724 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 151.26 49.23 0.02 OUTLIER Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.578 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -124.81 170.94 10.55 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.558 0.218 . . . . 0.0 110.672 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.0 34.66 2.43 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.925 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.06 -139.05 31.93 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.605 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -78.87 178.28 8.08 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.671 0.272 . . . . 0.0 110.778 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.1 tt -146.61 96.97 2.85 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.136 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.7 tttm 64.0 171.75 0.18 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.025 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 62.54 100.26 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.084 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.6 m 63.36 24.3 14.14 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.986 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.23 177.3 7.78 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.0 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.66 90.71 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.13 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.74 118.74 11.87 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.824 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.6 p -73.3 176.95 5.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.231 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.566 HG13 ' CD1' ' A' ' 48' ' ' TRP . 14.9 p -77.88 -29.96 16.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.289 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.566 ' CD1' HG13 ' A' ' 47' ' ' VAL . 83.5 m95 -90.58 143.17 27.01 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.714 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.5 p -106.6 137.27 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.819 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.9 121.83 33.08 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.857 0.36 . . . . 0.0 111.151 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.416 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -119.42 160.34 14.39 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.862 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.422 HD11 ' HA2' ' A' ' 56' ' ' GLY . 3.3 tp -113.0 131.6 55.7 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.93 0.395 . . . . 0.0 110.745 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.46 151.77 42.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.576 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 66.58 -157.24 0.25 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.739 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.19 -26.37 60.53 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.422 ' HA2' HD11 ' A' ' 52' ' ' LEU . . . 163.7 46.53 0.02 OUTLIER Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.219 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -95.68 137.97 33.99 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.68 120.06 36.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.95 0.405 . . . . 0.0 111.328 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.416 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 19.6 p90 -113.2 146.24 39.63 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.526 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -119.9 141.96 49.12 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.784 0.326 . . . . 0.0 110.905 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -130.64 149.61 52.21 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.207 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.424 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 10.4 t-20 -113.45 128.36 56.42 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.243 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.4 p -81.32 -20.3 41.04 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.739 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -58.52 -62.87 1.53 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.548 0.213 . . . . 0.0 111.263 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.0 t -99.84 -41.56 7.19 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.183 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.13 61.28 0.71 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.722 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -137.67 126.92 24.59 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.788 0.328 . . . . 0.0 110.975 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.6 p -77.84 150.14 34.25 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.841 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.6 ttt85 -133.02 157.94 43.98 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.042 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -126.53 28.92 5.84 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.007 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -151.0 148.73 28.72 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.566 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.3 114.72 36.22 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.741 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.59 147.45 70.28 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.568 2.179 . . . . 0.0 112.838 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -98.74 160.81 14.02 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.462 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.1 p30 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.523 -0.751 . . . . 0.0 111.215 179.828 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.8 140.4 57.42 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.526 2.151 . . . . 0.0 112.813 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.663 ' CB ' HG21 ' A' ' 23' ' ' ILE . 1.9 t -116.43 175.54 5.51 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.242 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.64 131.16 27.07 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.93 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.23 -70.94 0.31 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.507 -0.854 . . . . 0.0 113.101 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.579 ' H ' HD11 ' A' ' 23' ' ' ILE . 11.5 mpt_? -71.99 88.94 1.08 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.931 0.396 . . . . 0.0 110.874 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -113.38 154.63 26.61 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.197 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 2.9 t -124.82 130.45 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.685 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -90.97 130.64 36.87 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.895 0.378 . . . . 0.0 111.025 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.29 148.75 19.59 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.603 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.9 mm -104.18 142.62 17.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.653 0.263 . . . . 0.0 111.092 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.87 161.53 27.22 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.931 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.53 150.77 0.63 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.792 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 82.4 -55.49 0.21 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.145 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.1 50.76 0.05 OUTLIER Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.533 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -113.98 147.6 38.32 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.504 0.192 . . . . 0.0 110.538 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -111.6 116.68 31.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.897 0.38 . . . . 0.0 110.923 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -111.35 151.68 28.14 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.84 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 59.9 m-85 -124.55 149.71 46.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.075 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -129.73 144.61 51.38 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.331 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.624 ' OD1' HD12 ' A' ' 23' ' ' ILE . 4.6 t0 -109.23 122.72 47.94 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.522 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.424 HD21 ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -85.75 -28.63 24.47 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.283 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.663 HG21 ' CB ' ' A' ' 3' ' ' SER . 3.8 mt -58.29 -49.8 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.167 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.01 -43.44 5.77 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.41 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.84 34.46 3.77 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.469 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -121.62 127.79 51.24 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.798 0.332 . . . . 0.0 111.068 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.91 152.68 33.14 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.969 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -133.36 167.56 20.18 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.106 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -127.64 7.99 6.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.72 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -136.03 129.56 32.18 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -66.92 133.28 93.9 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.09 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.44 178.06 5.4 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.655 2.236 . . . . 0.0 112.254 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -68.35 89.33 0.33 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.018 0.437 . . . . 0.0 110.591 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.22 -95.0 0.59 Allowed Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.649 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 87.3 t80 66.45 -73.9 0.07 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 122.661 0.384 . . . . 0.0 111.255 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.34 30.94 4.93 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.714 0.292 . . . . 0.0 110.854 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.09 153.38 7.37 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.427 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.44 31.19 2.87 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.66 0.267 . . . . 0.0 111.253 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 mt 51.5 56.31 8.09 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.064 0.459 . . . . 0.0 111.057 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.79 136.16 50.52 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.984 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -94.66 100.61 12.52 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.923 0.392 . . . . 0.0 111.281 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.25 150.12 26.6 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.026 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -96.37 103.81 15.73 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.031 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.4 p -104.42 131.31 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.046 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.542 ' O ' HG23 ' A' ' 47' ' ' VAL . 9.7 mttt -71.37 -179.8 2.61 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.063 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.2 p -61.84 105.26 0.54 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.181 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.552 ' O ' HG12 ' A' ' 47' ' ' VAL . 12.3 t -103.38 23.05 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.652 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -119.11 145.04 46.28 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.815 0.34 . . . . 0.0 111.388 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 2.9 t -112.07 139.08 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.811 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.77 122.51 44.63 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.638 0.256 . . . . 0.0 111.089 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.419 ' HA3' ' CE1' ' A' ' 59' ' ' TYR . . . -118.67 154.06 16.69 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.758 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.4 tp -109.67 126.51 53.75 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.853 0.359 . . . . 0.0 111.284 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.66 152.08 37.69 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.957 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -46.73 153.64 0.38 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.658 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 68.08 8.8 6.76 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.172 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.36 55.96 5.36 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.839 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -116.32 93.07 4.08 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.755 0.312 . . . . 0.0 110.543 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.3 m -72.6 120.58 18.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.989 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.419 ' CE1' ' HA3' ' A' ' 51' ' ' GLY . 32.9 p90 -112.61 145.88 39.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.504 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 24.0 m-85 -120.26 142.07 49.39 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.864 0.364 . . . . 0.0 111.331 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -125.88 156.1 40.18 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.654 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -113.53 126.75 55.65 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.221 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.5 p -93.85 29.51 2.06 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.869 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.522 ' HB2' HG11 ' A' ' 47' ' ' VAL . 10.1 tt0 -120.91 -55.47 1.99 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.877 0.37 . . . . 0.0 110.434 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.6 p -96.3 -33.1 12.09 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.016 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.25 64.45 1.23 Allowed Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.571 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -149.71 128.86 12.76 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.861 0.362 . . . . 0.0 111.022 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.94 149.93 29.19 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.584 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.58 156.6 48.4 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.274 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -126.73 24.57 6.54 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.09 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -145.05 132.14 20.39 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.522 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.1 ttpp -63.56 133.78 95.63 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.017 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.76 99.81 0.89 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.571 2.181 . . . . 0.0 112.182 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 67.9 177.8 0.24 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.227 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.893 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.558 0.218 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.78 74.76 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.875 2.383 . . . . 0.0 112.631 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.89 -49.49 2.98 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.172 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -150.26 49.63 0.9 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.312 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.79 -170.82 26.39 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.921 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -127.67 91.42 3.29 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.11 0.481 . . . . 0.0 110.823 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -106.55 141.66 37.47 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.564 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 p -115.76 138.78 45.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.935 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -90.45 132.77 35.46 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.875 0.369 . . . . 0.0 111.022 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.76 146.82 18.6 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.536 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.7 mm -102.56 141.72 18.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.557 0.218 . . . . 0.0 110.982 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.14 162.04 27.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.828 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.9 m -48.42 149.58 1.56 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.634 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 82.43 -55.89 0.21 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.086 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.93 52.21 0.04 OUTLIER Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.451 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -116.47 129.97 56.5 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.512 0.196 . . . . 0.0 110.577 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -95.58 117.14 29.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.768 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -110.69 151.28 27.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.737 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -124.42 149.38 46.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.872 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -136.45 147.71 47.35 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.483 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -111.98 122.23 47.18 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.612 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.81 -33.49 46.14 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.574 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.5 mt -60.88 -55.59 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.707 0.289 . . . . 0.0 110.994 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.9 t -84.22 -36.27 22.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.25 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.01 47.37 5.03 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.217 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -136.07 143.3 44.56 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.838 0.352 . . . . 0.0 111.539 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.01 143.01 27.55 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.572 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -134.39 167.03 21.49 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.188 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -127.38 7.25 6.4 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.671 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -123.54 127.83 48.89 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.41 110.94 3.55 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.757 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.19 149.94 71.12 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.393 2.062 . . . . 0.0 112.217 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.72 90.46 0.17 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.022 0.439 . . . . 0.0 110.611 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.97 47.72 0.07 OUTLIER Glycine 0 CA--C 1.52 0.396 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.479 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -117.38 -51.08 2.53 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.614 0.245 . . . . 0.0 110.784 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -124.71 176.96 6.23 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.267 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.9 64.78 4.17 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.985 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.26 91.52 1.69 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.827 0.346 . . . . 0.0 110.747 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.75 113.41 4.84 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.358 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -89.68 169.06 11.62 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.069 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.88 98.06 10.56 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.207 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.17 174.28 15.42 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -102.37 22.29 13.64 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.673 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -109.39 119.24 58.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.696 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.8 mttp -110.96 108.1 17.75 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.917 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.28 148.32 52.44 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.293 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.57 HG11 ' HG3' ' A' ' 64' ' ' GLU . 19.2 t -141.18 -53.59 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.628 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.51 ' CH2' ' HB2' ' A' ' 62' ' ' ASN . 78.9 m95 -72.47 142.67 48.59 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.264 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.5 p -115.45 144.73 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.005 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -95.57 122.21 38.07 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.781 0.324 . . . . 0.0 110.97 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.67 158.71 14.69 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.6 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.34 128.54 55.99 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.923 0.392 . . . . 0.0 111.234 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.6 m -107.46 151.96 24.85 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.861 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -44.15 148.9 0.38 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.918 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.404 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 7.7 t0 82.84 -52.82 0.18 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.173 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.22 54.13 0.03 OUTLIER Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.611 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.404 ' CE2' ' HB3' ' A' ' 55' ' ' ASP . 35.3 m-85 -122.14 132.1 54.29 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 110.48 -0.193 . . . . 0.0 110.48 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.05 120.69 35.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.805 0.336 . . . . 0.0 111.028 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -112.69 145.95 39.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.788 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -120.41 141.98 49.63 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.796 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -122.86 149.87 43.62 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.217 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.51 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 53.6 t30 -113.0 131.31 55.81 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.154 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.0 p -84.14 -28.68 27.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.56 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.57 ' HG3' HG11 ' A' ' 47' ' ' VAL . 10.1 mt-10 -60.07 -62.6 1.75 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.71 0.29 . . . . 0.0 111.018 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.1 p -86.21 -44.3 12.29 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.141 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.93 51.13 1.83 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.43 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -134.68 140.35 45.94 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 111.081 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.99 140.79 34.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.407 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.21 158.04 42.77 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.931 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -126.34 27.55 6.18 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.79 0.329 . . . . 0.0 111.016 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -143.22 130.84 21.26 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.015 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.5 mttp -55.77 109.19 1.48 Allowed Pre-proline 0 N--CA 1.467 0.377 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.176 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.95 167.19 16.41 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.785 2.324 . . . . 0.0 112.45 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 72.96 175.34 0.28 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.815 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.148 -0.929 . . . . 0.0 111.315 -179.778 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.3 t70 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 120.764 0.316 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.8 134.93 26.84 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.777 2.318 . . . . 0.0 112.607 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.94 88.33 0.96 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.811 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.49 96.41 9.11 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.008 0.432 . . . . 0.0 111.137 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.23 113.42 4.11 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.763 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -101.83 95.44 6.4 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.75 0.309 . . . . 0.0 110.841 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.559 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 58.8 m95 -123.8 144.77 49.51 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.329 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.2 p -112.71 138.01 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.725 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -90.25 131.02 36.3 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.827 0.346 . . . . 0.0 110.979 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.26 148.51 19.62 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.657 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.6 mm -95.32 144.5 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.712 0.291 . . . . 0.0 111.288 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.651 HG23 ' CD1' ' A' ' 18' ' ' TYR . 1.4 p -128.15 162.05 27.83 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.054 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.0 m -45.16 152.69 0.25 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.583 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 78.48 -55.99 0.47 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.132 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.8 51.99 0.04 OUTLIER Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.389 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -115.9 151.27 35.67 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.683 0.278 . . . . 0.0 110.86 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -108.59 117.07 33.23 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.922 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.651 ' CD1' HG23 ' A' ' 12' ' ' THR . 21.5 p90 -110.72 151.44 27.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.659 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -124.13 149.42 46.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.581 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -130.99 142.33 50.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.073 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.559 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 20.7 t70 -111.2 123.48 50.29 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.508 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.57 -30.34 33.06 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.393 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.1 mt -60.22 -45.27 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 120.685 0.279 . . . . 0.0 111.01 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.87 -35.6 10.05 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.277 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.05 60.89 1.71 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.311 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.6 155.58 37.63 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.989 0.423 . . . . 0.0 111.92 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 t -97.62 143.5 28.23 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.728 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -135.67 168.64 18.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.826 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.429 ' CZ3' ' HB3' ' A' ' 18' ' ' TYR . 95.3 m95 -127.0 -44.64 1.61 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.66 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -80.04 135.22 36.31 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.541 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.11 142.93 92.82 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.021 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -85.95 31.66 0.47 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.74 2.293 . . . . 0.0 113.229 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 52.12 28.71 5.67 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.685 0.279 . . . . 0.0 111.706 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.07 39.82 0.31 Allowed Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.769 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -120.74 -47.67 2.3 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.634 0.254 . . . . 0.0 110.933 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -105.6 128.04 53.39 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.84 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -158.41 146.31 13.03 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.683 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.25 113.28 25.66 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.734 0.302 . . . . 0.0 111.061 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.4 mt -94.58 175.7 6.57 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.107 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -99.25 34.84 2.06 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.82 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -137.88 153.47 49.55 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.891 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.42 127.69 33.52 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.93 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.81 141.39 29.33 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.239 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.9 p -89.31 145.27 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.339 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -98.14 36.06 1.64 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 m 59.77 85.76 0.1 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.009 0.433 . . . . 0.0 111.401 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 47' ' ' VAL . 9.2 t -98.09 40.34 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.921 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.471 ' CH2' ' HB2' ' A' ' 62' ' ' ASN . 80.1 m95 -126.14 144.2 50.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.93 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 4.2 t -100.85 153.83 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.675 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -106.34 122.27 45.91 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 111.128 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.9 157.91 15.07 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.607 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.2 tp -111.97 123.59 50.59 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.883 0.373 . . . . 0.0 111.149 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.53 152.24 30.49 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.87 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -46.79 154.98 0.28 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.683 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 67.81 9.6 7.22 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.227 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.38 58.72 3.52 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.003 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -123.53 110.52 15.16 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.63 0.253 . . . . 0.0 110.617 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.41 120.42 24.95 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.001 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.427 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 38.0 p90 -112.53 145.78 39.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.47 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 36.9 m-85 -120.11 142.12 49.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.834 0.349 . . . . 0.0 111.225 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -121.85 149.44 43.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.189 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.471 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 46.8 t-20 -117.47 131.77 56.67 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.191 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.2 p -78.82 -26.62 44.25 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.503 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -57.64 -63.34 1.27 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.307 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.4 p -88.12 -46.14 9.55 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.082 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.4 47.17 2.22 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.494 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -136.08 143.72 44.77 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.773 0.321 . . . . 0.0 110.973 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.4 p -74.52 148.78 40.62 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -133.66 155.26 50.01 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.076 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -126.41 32.23 5.23 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.765 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -139.86 120.04 13.77 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.596 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -72.66 116.34 48.84 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.833 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.92 105.66 1.19 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.681 2.254 . . . . 0.0 112.107 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -98.3 145.56 26.55 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.482 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.658 -0.687 . . . . 0.0 111.127 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.707 0.289 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.99 78.95 1.73 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.699 2.266 . . . . 0.0 112.429 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.87 146.71 30.27 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.019 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? 61.72 92.55 0.05 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.192 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.64 82.5 0.05 OUTLIER Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.706 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.496 ' HB2' HD11 ' A' ' 23' ' ' ILE . 3.3 mmp_? -99.53 78.81 2.21 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.962 0.411 . . . . 0.0 110.503 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.489 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 59.9 m95 -122.14 143.83 49.31 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.102 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 1.5 t -109.28 139.66 31.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.665 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -90.76 133.67 35.01 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.819 0.342 . . . . 0.0 111.202 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.89 148.47 19.56 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.695 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.0 mm -95.51 144.74 9.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.7 0.286 . . . . 0.0 111.257 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.539 HG21 ' HH2' ' A' ' 29' ' ' TRP . 0.2 OUTLIER -128.89 161.91 28.75 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.793 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -47.88 149.38 1.34 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.404 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 79.79 -56.8 0.38 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.926 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.18 48.72 0.03 OUTLIER Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.553 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -110.08 146.14 35.91 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.571 0.224 . . . . 0.0 110.516 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -108.73 116.98 33.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.811 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -110.64 151.14 28.03 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.514 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.7 m-85 -124.83 149.57 47.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.254 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -125.36 148.67 48.67 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.972 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.489 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 33.4 t70 -116.59 125.75 52.28 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.951 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.59 -31.78 24.13 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.478 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.496 HD11 ' HB2' ' A' ' 6' ' ' ARG . 3.5 mt -59.99 -57.61 10.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.637 0.256 . . . . 0.0 111.036 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.7 m -86.43 -41.43 14.44 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.978 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.07 48.46 2.86 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.298 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.3 144.92 48.6 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.823 0.344 . . . . 0.0 111.26 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.59 132.38 36.91 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.76 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.41 165.63 14.66 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.539 ' HH2' HG21 ' A' ' 12' ' ' THR . 89.8 m95 -127.52 6.28 6.26 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.747 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -132.14 128.15 37.47 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.38 112.34 6.3 Favored Pre-proline 0 C--O 1.233 0.205 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.744 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.53 169.56 3.08 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.766 2.311 . . . . 0.0 112.63 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.64 86.75 0.32 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.668 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.54 -68.71 0.54 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.661 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.0 t80 67.79 -70.84 0.11 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.696 0.398 . . . . 0.0 111.43 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -82.61 95.32 7.75 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.705 0.288 . . . . 0.0 110.638 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -122.16 38.7 2.51 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.774 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.69 -179.56 5.2 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.63 0.215 . . . . 0.0 111.066 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 68.47 101.8 0.05 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.725 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.0 tttt 71.5 119.03 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.896 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.14 131.22 55.27 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.499 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.8 m -128.27 -48.66 1.31 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.863 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.27 99.54 11.19 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.242 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.07 129.38 72.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.055 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.8 87.99 0.09 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.298 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.23 154.61 32.86 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.359 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.7 t -100.39 -29.0 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.456 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.489 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 84.5 m95 -78.53 144.32 35.76 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.776 0.322 . . . . 0.0 111.377 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 21.2 t -99.94 155.4 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.717 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -112.72 122.4 47.57 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.792 0.329 . . . . 0.0 111.116 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.414 ' HA3' ' CE1' ' A' ' 59' ' ' TYR . . . -118.83 156.69 15.57 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.812 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.4 tp -109.69 127.15 54.38 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.917 0.389 . . . . 0.0 111.233 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.442 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 17.0 t -119.97 152.05 38.03 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.702 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -45.39 155.39 0.14 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.564 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.19 6.71 5.81 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.137 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.04 51.42 5.8 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.635 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.442 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 32.6 m-85 -112.72 125.62 54.51 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.579 0.228 . . . . 0.0 110.412 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.5 m -100.43 120.6 40.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.834 0.35 . . . . 0.0 111.111 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.414 ' CE1' ' HA3' ' A' ' 51' ' ' GLY . 35.8 p90 -112.45 145.45 40.16 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.388 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.531 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 17.5 m-85 -120.73 141.92 50.0 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.84 0.352 . . . . 0.0 111.349 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -121.86 145.52 48.0 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.96 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.489 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 54.9 t-20 -113.17 126.15 55.12 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.0 p -78.61 -30.19 46.39 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.359 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -55.6 -54.83 39.28 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.284 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.8 p -93.82 -33.09 13.7 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.334 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.69 58.77 2.33 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.31 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -147.71 141.34 25.54 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.829 0.347 . . . . 0.0 111.204 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 99.1 p -76.35 143.5 40.72 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.627 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.449 ' HD3' ' CH2' ' A' ' 48' ' ' TRP . 14.3 ttt85 -133.72 158.2 43.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.411 ' CZ3' ' HB3' ' A' ' 59' ' ' TYR . 95.6 m95 -125.77 -47.33 1.68 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.532 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.82 134.18 48.24 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.412 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -72.24 134.56 82.65 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.901 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.71 161.09 44.82 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.598 2.199 . . . . 0.0 112.368 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.53 120.97 29.45 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.465 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.55 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.67 0.271 . . . . 0.0 111.411 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.84 112.43 2.68 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.754 2.303 . . . . 0.0 112.29 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.8 t -113.33 108.66 17.55 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -156.39 145.39 20.36 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.148 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.08 -174.87 21.71 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.987 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.46 ' HG3' HD11 ' A' ' 23' ' ' ILE . 16.8 mtt180 -114.46 99.74 7.78 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.437 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 80.0 m95 -116.29 149.91 38.47 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.09 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 3.0 t -113.69 150.73 15.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.974 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -102.46 130.18 49.18 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.829 0.347 . . . . 0.0 111.155 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.28 148.08 19.44 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.74 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.4 mm -106.68 146.68 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.693 0.282 . . . . 0.0 111.305 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.4 ' OG1' ' HB2' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -130.6 161.53 31.34 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.895 179.603 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 m -46.96 153.26 0.44 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.486 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 81.29 -56.33 0.28 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.03 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.72 51.05 0.05 OUTLIER Glycine 0 C--N 1.337 0.598 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.586 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.4 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 19.4 m-85 -114.82 140.96 48.51 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.66 0.267 . . . . 0.0 110.508 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -107.2 116.82 32.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.809 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -111.02 151.31 28.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.806 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 48.5 m-85 -124.56 149.82 46.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.834 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -128.75 148.25 50.84 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.329 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.437 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 10.7 t70 -113.93 127.89 56.16 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.795 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.29 -38.86 21.57 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.286 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.46 HD11 ' HG3' ' A' ' 6' ' ' ARG . 4.2 mt -61.13 -50.9 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.988 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.7 m -85.32 -40.83 16.1 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.173 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.7 37.27 8.75 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.391 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -127.6 148.02 50.36 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.82 0.343 . . . . 0.0 111.265 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 95.5 p -93.58 141.69 28.19 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.749 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.46 167.97 20.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.923 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -127.61 5.96 6.19 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.727 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -120.78 122.03 39.46 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 6.2 ttmt -64.15 119.51 56.36 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.85 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 31' ' ' LYS . 26.7 Cg_exo -61.89 177.53 0.99 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.724 2.282 . . . . 0.0 112.518 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.69 -35.33 78.62 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.028 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.53 91.46 0.65 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 121.165 -0.541 . . . . 0.0 112.399 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -139.8 162.76 34.37 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.524 0.202 . . . . 0.0 110.598 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 68.05 -154.93 0.19 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.398 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -132.39 -142.5 4.91 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.741 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.47 ' OD2' HD23 ' A' ' 39' ' ' LEU . 9.0 p-10 -165.25 173.56 11.14 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 122.014 0.125 . . . . 0.0 110.736 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.47 HD23 ' OD2' ' A' ' 38' ' ' ASP . 3.5 mm? 68.8 168.27 0.28 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.927 0.394 . . . . 0.0 111.142 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.62 171.92 7.29 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.709 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 73.08 128.9 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.75 122.02 9.6 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.252 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -146.5 95.42 2.6 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.321 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.86 135.77 38.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.936 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.6 tttt -75.92 104.73 6.59 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.792 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.4 p -105.79 177.84 4.74 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.41 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 47' ' ' VAL . 9.3 p -98.98 24.06 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.532 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 59.0 m95 -114.79 140.09 49.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.858 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 9.4 p -99.26 140.29 19.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.472 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.79 122.42 33.51 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.839 0.352 . . . . 0.0 111.032 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.406 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.75 158.93 14.61 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.459 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 tp -109.88 137.26 47.92 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 111.103 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.2 152.15 46.42 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.791 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.53 153.61 0.36 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.503 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 67.59 11.37 8.34 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.076 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.63 66.74 1.93 Allowed Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.869 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -131.33 111.7 12.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.723 0.297 . . . . 0.0 110.631 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 m -81.49 120.35 24.91 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.06 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.406 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 32.9 p90 -112.77 145.83 39.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.617 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 89.9 m-85 -120.38 141.87 49.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.771 0.319 . . . . 0.0 111.01 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -127.19 148.8 50.18 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.463 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 52.6 t-20 -115.55 132.31 56.67 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.182 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.1 p -80.71 -29.75 36.4 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.4 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.1 -64.66 0.86 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.179 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.1 t -82.74 -34.8 27.09 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.994 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.28 47.14 5.86 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.602 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -133.39 136.94 45.6 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.784 0.326 . . . . 0.0 110.899 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.6 p -80.81 143.54 32.74 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.966 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.44 157.7 44.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.925 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -126.45 39.84 3.85 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.865 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -146.95 138.12 24.02 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.786 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -73.17 116.52 51.59 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.524 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.84 100.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.866 2.378 . . . . 0.0 112.621 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.21 166.55 23.07 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.21 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.23 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.33 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.14 155.49 25.79 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.029 1.819 . . . . 0.0 112.325 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.4 t 59.39 46.13 12.89 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.253 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -172.26 76.6 0.05 OUTLIER 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.337 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -118.41 93.29 0.56 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.968 -0.635 . . . . 0.0 112.641 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.649 ' HB3' HD21 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -80.11 78.2 6.77 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.834 0.35 . . . . 0.0 110.915 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.471 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 87.4 m95 -112.35 134.24 54.0 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.96 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -112.66 141.4 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.183 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.37 131.63 36.72 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.893 0.377 . . . . 0.0 111.292 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.26 148.61 19.41 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.617 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.0 mm -99.9 143.26 13.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 120.612 0.244 . . . . 0.0 111.183 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.574 HG23 ' CD1' ' A' ' 18' ' ' TYR . 1.0 OUTLIER -126.24 161.56 27.46 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.862 0.363 . . . . 0.0 111.053 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.6 m -46.45 151.95 0.49 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.668 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 81.67 -54.98 0.26 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.191 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.64 51.52 0.05 OUTLIER Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.426 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -118.54 151.81 37.15 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.633 0.254 . . . . 0.0 110.832 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -111.85 117.21 32.16 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.07 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.574 ' CD1' HG23 ' A' ' 12' ' ' THR . 20.1 p90 -110.94 151.39 27.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.617 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -124.13 149.58 46.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.741 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -131.23 147.37 52.58 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.197 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.471 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 34.3 t70 -114.75 122.38 46.21 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.739 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.649 HD21 ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -78.18 -29.75 48.67 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.19 179.731 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.587 HD11 ' HD3' ' A' ' 6' ' ' ARG . 4.5 mt -60.52 -60.16 3.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-O 120.684 0.278 . . . . 0.0 111.016 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.07 -30.81 25.74 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.484 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.22 45.82 7.31 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.18 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -132.63 151.41 51.96 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.916 0.389 . . . . 0.0 111.666 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.07 145.99 24.09 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.902 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -133.72 168.66 18.31 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.136 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -126.97 -40.97 1.83 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.044 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.88 137.56 33.61 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.59 0.233 . . . . 0.0 110.454 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.87 139.28 97.3 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.198 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.448 ' HG2' ' HB2' ' A' ' 35' ' ' PHE . 42.1 Cg_endo -67.02 -177.3 0.97 Allowed 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.765 2.31 . . . . 0.0 112.422 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.6 87.25 2.13 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.872 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.79 -81.16 0.29 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.112 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.448 ' HB2' ' HG2' ' A' ' 32' ' ' PRO . 32.2 t80 69.42 148.03 0.07 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.533 0.333 . . . . 0.0 111.065 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 65.41 94.8 0.06 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.269 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.63 -82.96 0.05 OUTLIER Glycine 0 C--N 1.337 0.59 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.292 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -160.03 145.64 15.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.772 0.32 . . . . 0.0 111.121 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mt -131.87 115.7 16.25 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.217 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.1 ttpp -90.32 74.63 6.96 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.808 0.337 . . . . 0.0 111.236 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.78 150.68 5.88 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.143 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.28 161.41 39.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.951 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.56 107.92 9.83 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.201 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.549 ' O ' HG13 ' A' ' 44' ' ' VAL . 12.8 p -79.46 68.91 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 121.449 0.642 . . . . 0.0 110.66 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -129.81 163.07 27.06 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.063 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -116.6 38.0 3.58 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.068 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 47' ' ' VAL . 10.4 p -104.82 26.59 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.065 0.46 . . . . 0.0 111.054 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -110.08 142.49 41.46 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.99 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 14.0 p -104.95 149.34 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.175 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -96.89 122.44 39.87 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.406 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.412 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.96 157.42 15.28 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.712 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.5 tp -106.25 130.42 54.11 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.905 0.383 . . . . 0.0 111.326 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.484 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 12.1 t -119.93 152.09 37.93 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.974 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.96 153.41 0.65 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.655 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 67.25 10.86 8.04 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.195 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.92 65.8 2.12 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.347 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 31.8 m-85 -131.13 106.61 8.47 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.717 0.294 . . . . 0.0 110.748 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.4 m -73.93 120.22 19.21 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.839 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.412 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 23.4 p90 -112.9 146.14 39.48 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.637 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 49.5 m-85 -120.04 141.97 49.26 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 110.777 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -129.51 147.16 51.29 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.438 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -113.11 128.34 56.46 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.974 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.7 p -79.13 -24.01 43.64 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.408 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -60.06 -64.7 0.86 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.294 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.2 t -90.06 -34.38 15.96 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.22 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.24 53.17 2.55 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.551 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -135.46 142.34 45.52 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.913 0.387 . . . . 0.0 111.308 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.52 144.71 27.77 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.762 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -133.49 157.83 44.64 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -126.24 37.04 4.4 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.916 0.388 . . . . 0.0 110.913 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -153.03 133.4 13.59 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.334 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 112.94 6.97 Favored Pre-proline 0 N--CA 1.466 0.337 0 CA-C-O 120.661 0.267 . . . . 0.0 110.799 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.36 93.39 0.83 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.544 2.163 . . . . 0.0 112.548 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -161.57 90.35 0.79 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.736 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.941 -179.793 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 120.806 0.336 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.37 143.13 42.54 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.697 2.265 . . . . 0.0 112.534 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.6 150.74 47.67 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.137 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -129.55 158.03 40.41 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.791 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.13 46.76 4.34 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.323 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.656 ' HB3' HD21 ' A' ' 22' ' ' LEU . 6.6 mmt85 -75.64 81.62 2.63 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.984 0.421 . . . . 0.0 110.303 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.513 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 94.6 m95 -120.46 137.47 54.33 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.101 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.7 p -113.03 130.95 65.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.028 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -90.55 129.64 36.68 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.891 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.24 148.67 19.68 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.678 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.1 mm -97.85 129.05 48.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.529 0.204 . . . . 0.0 111.011 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.546 HG23 ' CE1' ' A' ' 18' ' ' TYR . 7.6 p -131.66 154.04 49.36 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.714 0.292 . . . . 0.0 111.076 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.2 -150.14 0.42 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.758 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -81.29 3.49 23.88 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.48 68.91 0.01 OUTLIER Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.084 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -138.52 109.87 6.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.692 0.282 . . . . 0.0 110.596 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -78.12 116.72 18.79 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.963 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.546 ' CE1' HG23 ' A' ' 12' ' ' THR . 19.9 p90 -111.22 151.91 27.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.743 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -123.85 149.25 45.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.794 0.33 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -136.27 146.11 46.31 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.513 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 24.5 t70 -113.33 124.13 51.76 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.981 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.656 HD21 ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -81.43 -28.63 34.17 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.712 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.9 mt -60.46 -52.58 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.696 0.284 . . . . 0.0 110.998 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.9 m -93.07 -31.61 14.77 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.335 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.01 48.38 5.18 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.307 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -131.99 147.69 52.47 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.855 0.36 . . . . 0.0 111.735 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.76 131.07 41.0 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.731 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -121.53 168.86 11.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.914 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -127.0 -34.95 2.3 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.089 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -82.54 145.19 29.88 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.66 0.267 . . . . 0.0 110.643 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 7.3 ttmt -70.13 135.2 87.13 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.177 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 35' ' ' PHE . 36.1 Cg_exo -60.17 179.3 0.32 Allowed 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.94 2.426 . . . . 0.0 112.769 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -62.77 -36.44 83.09 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.5 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.19 81.82 0.2 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.977 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.457 ' HB2' ' HD2' ' A' ' 32' ' ' PRO . 85.5 t80 -99.85 -60.24 1.57 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.561 0.219 . . . . 0.0 110.801 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -117.44 -42.35 2.89 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.299 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.92 145.1 17.64 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.721 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -124.0 108.19 12.12 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.751 0.31 . . . . 0.0 111.118 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.78 81.83 1.5 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.728 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -96.38 117.64 31.28 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.874 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -144.31 161.48 38.85 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.453 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -81.63 -36.65 28.63 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.072 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.73 155.85 17.67 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.39 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.9 t -121.97 96.78 4.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.393 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.45 89.52 0.69 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.199 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.86 87.11 2.09 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.643 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.6 p -83.86 -24.71 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.215 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.442 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 71.0 m95 -78.35 142.6 37.57 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.011 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 2.1 t -104.12 155.69 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.725 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.414 ' HG2' HG22 ' A' ' 58' ' ' THR . 2.7 tm-20 -112.98 121.91 46.05 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.771 0.32 . . . . 0.0 111.307 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.445 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -119.33 158.27 15.08 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.86 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.82 127.96 55.97 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.756 0.313 . . . . 0.0 110.979 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.17 151.77 44.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.729 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.07 -158.67 0.31 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.809 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -57.31 -26.23 60.58 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.29 48.72 0.02 OUTLIER Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.121 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -98.37 123.87 42.72 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.414 HG22 ' HG2' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -90.99 120.52 32.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.32 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.445 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 25.1 p90 -112.73 145.68 40.09 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.455 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 13.9 m-85 -120.4 141.85 49.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.844 0.354 . . . . 0.0 111.044 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -124.81 146.53 49.2 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.627 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.442 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 35.4 t30 -113.6 122.74 48.13 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.543 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.3 p -74.98 -25.07 58.58 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.484 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -55.14 -61.79 2.09 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.381 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 t -97.27 -32.88 11.68 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.387 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.45 63.26 1.18 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.44 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -145.6 142.7 29.34 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.836 0.35 . . . . 0.0 111.617 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.88 141.24 28.92 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.91 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.27 156.67 48.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.781 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 45.0 m95 -126.42 31.78 5.31 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.838 0.351 . . . . 0.0 110.652 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -144.56 135.93 25.43 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.537 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -69.87 135.48 87.68 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.889 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 72' ' ' LYS . 40.5 Cg_exo -57.11 116.62 3.34 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.856 2.371 . . . . 0.0 112.857 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -136.56 118.13 14.87 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.029 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.021 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 15.4 t70 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.456 0.169 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.51 95.95 0.89 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.519 2.146 . . . . 0.0 112.261 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.09 -64.22 0.37 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.355 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -78.63 114.42 17.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.824 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.3 144.97 16.0 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.893 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.424 ' HB2' HD11 ' A' ' 23' ' ' ILE . 14.6 mtp180 -124.77 90.0 3.17 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.887 0.375 . . . . 0.0 110.411 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.521 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 82.3 m95 -110.45 147.21 34.52 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.054 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 p -112.97 139.06 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.768 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.29 130.53 36.39 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.93 0.395 . . . . 0.0 110.909 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.3 147.91 19.37 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.779 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.3 mm -93.33 142.62 12.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.625 0.25 . . . . 0.0 111.107 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.39 161.97 24.85 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.673 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -50.0 151.18 2.01 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.383 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 80.73 -54.38 0.33 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.132 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.78 52.24 0.04 OUTLIER Glycine 0 C--N 1.336 0.563 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.357 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -118.67 146.18 44.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.599 0.238 . . . . 0.0 110.67 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -105.69 117.05 33.04 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.953 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -110.94 151.83 27.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.747 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -124.33 149.56 46.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.966 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -135.12 144.26 47.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.785 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.521 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 13.5 t70 -110.08 124.33 51.31 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.896 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.78 -32.08 35.57 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.936 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' A' ' 6' ' ' ARG . 3.5 mt -59.16 -54.73 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.757 0.313 . . . . 0.0 111.059 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.4 p -85.97 -35.7 20.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.167 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.39 54.11 3.07 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.28 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -140.73 147.03 38.53 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.879 0.371 . . . . 0.0 111.522 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.1 p -88.03 132.76 34.15 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.565 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -126.27 166.94 16.17 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.869 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -127.52 -43.99 1.56 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.031 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -70.11 150.93 46.03 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.783 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -99.08 102.54 15.88 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.94 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.85 -176.15 1.68 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.657 2.238 . . . . 0.0 112.605 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -83.7 131.47 34.93 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.023 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.56 20.51 10.07 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.21 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -108.67 -51.75 2.85 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 117.03 0.415 . . . . 0.0 110.866 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.27 113.19 13.51 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.701 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.28 141.65 3.8 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.997 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -139.0 48.22 1.89 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.804 0.335 . . . . 0.0 111.785 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.408 ' O ' HD23 ' A' ' 39' ' ' LEU . 5.1 tt -162.51 77.61 0.48 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.578 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 tttt 64.03 168.02 0.16 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.43 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.73 178.72 6.15 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 26.7 m -87.44 -60.88 1.85 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.2 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 61.38 102.25 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.82 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.493 HG21 ' O ' ' A' ' 74' ' ' ASP . 14.6 t -112.06 135.8 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.516 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -100.45 35.31 2.15 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.807 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.1 p 42.31 84.27 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.101 -0.499 . . . . 0.0 112.274 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.495 ' O ' HG12 ' A' ' 47' ' ' VAL . 11.4 t -121.95 38.82 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.397 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -123.51 143.83 49.93 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.806 0.336 . . . . 0.0 111.078 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 2.2 t -106.3 133.77 49.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.65 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.1 122.26 33.6 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.825 0.345 . . . . 0.0 110.865 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.431 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.83 158.53 14.79 Favored Glycine 0 C--N 1.332 0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.581 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.8 tp -109.76 136.03 49.73 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.867 0.365 . . . . 0.0 111.236 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 3.9 t -123.88 151.81 43.07 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.641 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.42 155.18 0.78 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.481 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 69.91 7.4 6.21 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.278 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.83 63.04 2.15 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.911 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.419 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 28.4 m-85 -127.77 128.38 45.22 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.553 0.216 . . . . 0.0 110.544 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.68 120.44 39.12 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.829 0.347 . . . . 0.0 111.013 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.431 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 30.5 p90 -112.91 146.18 39.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.536 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.434 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 55.6 m-85 -119.8 141.88 49.1 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.852 0.358 . . . . 0.0 110.884 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -128.15 147.69 50.56 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.982 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -114.11 130.67 56.57 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.679 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.8 p -78.44 -29.06 46.81 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.862 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -59.98 -66.47 0.51 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.386 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.1 t -82.42 -39.13 23.05 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.475 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.3 40.61 6.04 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.929 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -125.46 133.95 52.25 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.813 0.34 . . . . 0.0 110.872 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.05 148.43 37.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.736 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -133.2 153.61 51.38 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.878 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -126.26 29.82 5.73 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.908 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -141.91 135.76 29.78 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.127 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.61 111.39 4.68 Favored Pre-proline 0 C--O 1.234 0.28 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.642 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -70.03 169.36 19.44 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.406 2.071 . . . . 0.0 112.638 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.493 ' O ' HG21 ' A' ' 44' ' ' VAL . 1.9 m-20 -89.77 101.11 13.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.624 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.163 -179.995 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 120.503 0.192 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.54 101.84 0.92 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.729 2.286 . . . . 0.0 112.667 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 p -98.11 -57.7 2.15 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.257 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -143.89 -171.64 3.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.849 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 138.77 -31.0 2.43 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.825 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.594 ' HB2' HD11 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -78.42 72.91 4.98 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.993 0.425 . . . . 0.0 110.627 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.495 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 97.0 m95 -116.18 151.49 35.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.142 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 2.8 t -124.7 131.51 72.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.613 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -90.69 130.05 36.73 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.939 0.399 . . . . 0.0 111.099 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.07 148.5 19.59 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.678 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.1 mm -97.86 144.25 11.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.639 0.257 . . . . 0.0 111.086 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.33 162.19 28.54 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.895 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.22 149.65 0.7 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.739 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 79.83 -55.98 0.38 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.295 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.57 52.44 0.04 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.336 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -116.48 134.66 54.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.617 0.246 . . . . 0.0 110.531 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -98.3 116.86 31.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.845 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.418 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 19.8 p90 -110.75 151.34 27.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.789 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 64.0 m-85 -124.2 149.52 46.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.131 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -125.99 147.34 49.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.035 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.495 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 32.9 t70 -118.92 122.09 41.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.704 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.44 -26.76 35.06 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.321 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.594 HD11 ' HB2' ' A' ' 6' ' ' ARG . 7.5 mt -58.69 -48.71 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.766 0.317 . . . . 0.0 110.984 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.2 m -100.83 -35.49 9.41 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.346 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.44 51.31 3.14 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.127 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -137.69 154.83 49.62 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.963 0.411 . . . . 0.0 111.78 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.95 143.57 26.35 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.853 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -134.18 168.63 18.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.037 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.418 ' CZ3' ' HB3' ' A' ' 18' ' ' TYR . 96.5 m95 -127.24 -47.9 1.46 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.582 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -73.47 125.23 27.43 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.346 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 9.8 ttmt -60.95 138.0 93.91 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.175 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 31' ' ' LYS . 36.0 Cg_exo -60.15 -178.79 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.82 2.347 . . . . 0.0 112.59 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -93.69 41.07 1.08 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.093 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.38 -42.83 0.23 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.032 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 72.99 -68.45 0.23 Allowed 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.176 0.19 . . . . 0.0 111.063 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -124.86 127.12 46.64 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.623 0.249 . . . . 0.0 110.687 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -174.81 75.11 0.08 OUTLIER Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.682 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -98.19 122.88 41.89 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.796 0.331 . . . . 0.0 110.784 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 35.9 mt -76.53 88.3 3.26 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.882 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -98.24 34.03 2.06 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.04 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.63 31.89 5.42 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.235 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.8 m -84.44 -38.89 19.63 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.178 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.78 126.05 10.75 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.302 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -87.41 64.3 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 120.982 0.42 . . . . 0.0 110.501 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.36 159.45 17.14 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.919 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.9 m -87.97 87.3 7.3 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.096 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 47' ' ' VAL . 10.7 p -97.62 23.73 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.274 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 33.0 m95 -115.87 140.07 49.59 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.799 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 12.0 p -96.43 145.44 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -94.14 122.15 36.37 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.8 0.334 . . . . 0.0 111.105 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -119.0 153.02 17.08 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.53 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.4 tp -109.78 138.94 45.43 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.998 0.427 . . . . 0.0 111.687 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.03 152.38 38.67 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.685 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 0.4 OUTLIER -45.14 152.24 0.27 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.742 -179.714 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 25.6 m-20 81.04 -44.29 0.21 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.14 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.22 48.33 0.11 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.425 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -114.27 130.04 56.64 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.6 m -99.36 120.45 39.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.876 0.369 . . . . 0.0 111.213 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -112.56 145.59 40.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.567 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 93.4 m-85 -120.42 142.06 49.56 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.747 0.308 . . . . 0.0 111.068 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -120.93 150.6 40.84 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.061 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.463 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 48.8 t-20 -114.31 130.14 56.66 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.281 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.3 p -82.66 -26.11 32.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.452 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -56.77 -61.8 2.18 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.653 -0.248 . . . . 0.0 111.353 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.0 p -93.8 -46.92 7.0 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.136 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.16 55.27 0.87 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.65 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -134.59 132.06 38.61 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.715 0.293 . . . . 0.0 110.832 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 86.9 p -71.94 148.76 45.7 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.758 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.59 157.71 45.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.211 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -126.25 29.61 5.78 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.611 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.433 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 4.3 mt-10 -146.14 162.42 38.01 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.239 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -99.02 99.25 7.59 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-O 120.578 0.228 . . . . 0.0 110.975 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 72.4 Cg_endo -76.02 125.59 8.74 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.686 2.257 . . . . 0.0 112.841 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -171.61 118.25 0.43 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.931 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.4 t70 . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.373 -0.822 . . . . 0.0 111.125 -179.715 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 120.605 0.241 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.17 132.64 48.94 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.735 2.29 . . . . 0.0 112.471 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.05 -170.32 0.72 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.969 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.3 tttm 65.02 45.26 3.15 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.128 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.79 35.87 0.85 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.85 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.486 ' HD2' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -137.36 70.96 1.4 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.942 0.401 . . . . 0.0 110.135 179.618 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -121.52 135.93 54.99 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.812 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.6 p -119.24 143.02 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.134 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -96.66 133.48 41.14 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.827 0.346 . . . . 0.0 111.215 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.41 148.51 19.63 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.736 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.9 mm -102.52 123.2 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 120.63 0.252 . . . . 0.0 110.948 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.38 157.72 44.81 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.99 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.4 t 60.83 -148.29 0.43 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.69 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.99 -28.93 40.88 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 111.546 0.202 . . . . 0.0 111.546 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.45 46.72 0.03 OUTLIER Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.335 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -95.46 120.11 35.14 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -73.77 116.68 14.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.895 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -111.24 151.96 27.68 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.747 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -123.75 149.53 45.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.489 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -136.07 148.95 48.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.969 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -115.08 123.02 47.94 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.01 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.4 ' CG ' ' HB3' ' A' ' 6' ' ' ARG . 0.1 OUTLIER -83.53 -21.19 32.81 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.391 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.486 HG13 ' HD2' ' A' ' 6' ' ' ARG . 9.6 mt -51.95 -55.81 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 120.611 0.243 . . . . 0.0 111.038 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.29 -40.75 4.58 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.054 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.14 54.04 0.68 Allowed Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.48 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -127.74 110.27 12.47 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.717 0.294 . . . . 0.0 110.997 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.0 p -69.46 132.63 46.62 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.675 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.27 168.06 16.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.141 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -127.67 6.6 6.19 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.501 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -118.0 129.28 55.49 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -70.49 113.66 20.06 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.914 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.57 -173.04 0.74 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.672 2.248 . . . . 0.0 112.61 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.2 pm0 -89.28 30.24 1.0 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.806 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.17 32.3 1.78 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.777 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -111.46 -59.48 1.97 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.703 0.251 . . . . 0.0 110.664 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -136.97 87.06 2.25 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.876 0.369 . . . . 0.0 110.604 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.09 130.54 16.63 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.716 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.52 114.16 26.46 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.815 0.34 . . . . 0.0 111.176 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.13 62.98 0.68 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.481 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.4 tttp 57.78 36.95 26.98 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.02 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.55 169.63 15.22 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.032 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.17 -30.61 65.16 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.362 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.78 144.07 55.31 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.73 0.3 . . . . 0.0 111.247 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.763 HG12 HG22 ' A' ' 46' ' ' THR . 20.5 t -129.97 140.2 49.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.099 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -108.62 67.6 0.67 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.346 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.763 HG22 HG12 ' A' ' 44' ' ' VAL . 9.0 t -168.83 106.67 0.44 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.947 0.403 . . . . 0.0 111.313 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.65 HG11 ' HG3' ' A' ' 64' ' ' GLU . 19.7 t -109.24 -24.46 4.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.566 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -70.87 143.66 50.94 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 111.141 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.9 t -110.7 139.25 35.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.624 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -91.06 122.07 33.4 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.82 0.343 . . . . 0.0 111.018 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.445 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.82 160.13 14.16 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.491 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.0 tp -113.1 135.46 53.78 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.847 0.356 . . . . 0.0 111.163 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.1 152.08 40.24 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.815 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -47.51 155.28 0.37 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.463 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 67.6 11.25 8.28 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.247 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.05 66.46 1.91 Allowed Glycine 0 C--N 1.338 0.667 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.061 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -131.95 120.12 22.05 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.655 0.264 . . . . 0.0 110.617 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.3 m -89.16 120.49 30.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.883 0.373 . . . . 0.0 111.062 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.445 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 33.4 p90 -112.75 146.06 39.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.392 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 80.1 m-85 -120.09 141.54 49.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.748 0.309 . . . . 0.0 111.063 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -127.75 149.08 50.4 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -119.44 129.33 54.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.932 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.8 p -74.94 -35.36 62.16 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.537 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.65 ' HG3' HG11 ' A' ' 47' ' ' VAL . 13.5 mt-10 -59.6 -60.19 4.24 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.694 0.283 . . . . 0.0 111.177 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.0 p -78.78 -34.43 45.53 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.204 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.49 44.66 20.77 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.25 -0.5 . . . . 0.0 112.591 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -136.74 134.4 37.08 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.886 0.374 . . . . 0.0 111.057 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.39 145.75 39.18 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.624 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -133.05 157.55 44.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.059 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -126.64 31.51 5.32 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.31 135.21 15.57 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.797 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.1 pttm -60.01 146.19 83.02 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.718 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.86 94.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.934 2.422 . . . . 0.0 112.753 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.05 95.13 0.19 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.794 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.6 t0 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.064 -0.97 . . . . 0.0 111.297 -179.508 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 120.725 0.298 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.37 133.71 26.98 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.717 2.278 . . . . 0.0 112.529 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.91 97.96 11.23 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.999 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.19 177.58 5.81 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.085 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.74 147.58 19.09 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.278 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.461 ' HB2' HD11 ' A' ' 23' ' ' ILE . 22.4 mtt180 -71.51 80.86 0.8 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.96 0.41 . . . . 0.0 110.246 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.412 ' CZ3' ' HB2' ' A' ' 28' ' ' GLN . 86.8 m95 -114.54 140.48 48.73 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.954 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 11.8 p -110.7 133.25 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.594 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -90.44 130.15 36.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.003 0.43 . . . . 0.0 111.221 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.15 148.57 19.51 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.371 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 11' ' ' ILE . 1.5 mp -101.08 138.18 26.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.665 0.269 . . . . 0.0 110.937 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.68 161.76 20.15 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.167 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.8 m -41.87 148.64 0.16 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.739 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.452 ' HB3' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 82.16 -57.04 0.22 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.058 -179.528 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.79 58.39 0.03 OUTLIER Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.446 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.452 ' CE2' ' HB3' ' A' ' 14' ' ' GLU . 29.9 m-85 -124.78 138.78 54.26 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.718 0.295 . . . . 0.0 111.018 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -100.27 117.27 34.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.916 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.421 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 24.9 p90 -110.89 151.53 27.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.557 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 64.9 m-85 -124.39 149.54 46.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.911 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -131.84 145.81 51.77 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.175 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.406 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 2.6 t0 -110.64 123.13 49.41 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.098 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.82 -25.68 27.95 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.224 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.461 HD11 ' HB2' ' A' ' 6' ' ' ARG . 2.0 mp -57.3 -54.73 26.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.098 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.6 m -97.62 -38.55 9.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.099 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.07 53.24 1.52 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.265 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -135.75 129.33 32.42 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.797 0.332 . . . . 0.0 111.251 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.54 145.63 38.93 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.412 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -132.91 168.36 18.57 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.073 -179.672 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.421 ' CZ3' ' HB3' ' A' ' 18' ' ' TYR . 90.2 m95 -127.46 -47.13 1.44 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.847 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.7 134.09 37.13 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.664 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -68.16 133.91 91.54 Favored Pre-proline 0 N--CA 1.463 0.216 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.191 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.87 -176.36 2.04 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.659 2.239 . . . . 0.0 112.606 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -97.83 41.24 1.13 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.19 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.27 41.98 0.12 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.854 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -114.24 -59.43 2.02 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.588 0.232 . . . . 0.0 110.708 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.73 93.23 3.87 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.609 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -114.87 140.79 16.61 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.615 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -143.43 98.24 3.22 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.974 0.416 . . . . 0.0 111.212 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.11 78.35 1.67 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.787 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.05 156.01 1.24 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.985 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 59.68 -163.11 0.24 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.127 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 81.1 p -57.28 139.76 51.89 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.84 0.353 . . . . 0.0 110.967 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.76 161.28 10.39 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.874 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.62 146.12 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.755 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.572 ' O ' HG22 ' A' ' 46' ' ' THR . 0.0 OUTLIER -117.23 150.55 38.58 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.713 179.638 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 45' ' ' LYS . 10.3 t 50.1 -175.65 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.063 0.545 . . . . 0.0 112.155 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.486 ' O ' HG12 ' A' ' 47' ' ' VAL . 8.2 t -144.76 31.64 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.12 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.471 ' CH2' ' HB2' ' A' ' 62' ' ' ASN . 65.5 m95 -118.65 143.59 46.72 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.983 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 12.8 p -104.02 139.52 24.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.761 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -90.76 122.16 33.26 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.923 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.72 156.36 15.7 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.611 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.7 tp -108.99 137.85 46.26 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.76 0.314 . . . . 0.0 111.247 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.99 152.08 48.35 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.95 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -47.28 154.19 0.42 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.77 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 67.25 10.96 8.11 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.118 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.18 66.56 1.94 Allowed Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.171 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -130.67 108.05 9.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.742 0.306 . . . . 0.0 110.694 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.6 m -80.63 120.44 24.57 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.864 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.427 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 33.2 p90 -112.66 146.16 39.15 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.014 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 70.3 m-85 -119.99 141.92 49.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.804 0.335 . . . . 0.0 110.877 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -127.06 145.7 50.63 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.08 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.471 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 51.4 t-20 -114.02 126.23 54.89 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.162 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.0 p -75.92 -24.61 55.57 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.445 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -56.23 -62.43 1.72 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.287 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.0 p -91.37 -37.66 13.09 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.066 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.73 49.69 2.88 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.131 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -135.48 138.18 42.88 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.917 0.389 . . . . 0.0 111.231 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.35 140.45 38.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.805 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -133.57 157.85 44.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.774 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -126.2 33.67 4.99 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.879 0.371 . . . . 0.0 110.753 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -145.74 123.95 12.22 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.442 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.98 113.78 8.15 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.975 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.87 -177.48 0.25 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.787 2.325 . . . . 0.0 112.796 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.87 163.96 21.79 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.731 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 t0 . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.549 -0.738 . . . . 0.0 110.84 179.701 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 120.681 0.277 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.66 128.06 15.57 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.867 2.378 . . . . 0.0 112.491 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 m -74.68 -36.49 62.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.15 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -109.53 164.78 12.2 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.789 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.74 130.47 3.53 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.664 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.492 ' HB3' HD21 ' A' ' 22' ' ' LEU . 1.5 mmt180 -92.55 85.76 5.4 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.925 0.393 . . . . 0.0 110.542 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.57 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 80.1 m95 -108.29 132.11 54.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.905 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 1.6 t -103.46 132.14 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.469 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.66 129.65 36.75 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.965 0.412 . . . . 0.0 111.311 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.408 ' HA3' ' CE1' ' A' ' 18' ' ' TYR . . . -135.47 148.72 19.73 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.571 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.0 mm -95.43 125.82 48.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.481 0.182 . . . . 0.0 110.69 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.25 148.03 51.97 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.873 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.51 -150.54 0.39 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.549 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -56.62 -26.33 55.45 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.68 43.27 0.02 OUTLIER Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.635 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -93.24 111.95 23.74 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -73.35 116.69 14.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.408 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 17.9 p90 -110.86 151.72 27.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.203 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 55.3 m-85 -123.97 149.17 46.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.873 0.368 . . . . 0.0 110.975 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -133.99 139.46 46.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.798 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.57 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 16.6 t70 -110.14 126.38 54.0 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.551 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.492 HD21 ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -83.43 -31.19 26.75 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.742 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.3 mt -56.56 -45.53 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.78 0.324 . . . . 0.0 111.031 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.36 -35.2 9.67 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.166 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.92 41.52 6.29 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.171 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -128.88 153.62 47.3 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.895 0.379 . . . . 0.0 111.372 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.5 p -95.37 149.73 21.05 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.89 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.85 167.17 21.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.955 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -127.54 6.38 6.26 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.923 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -136.43 138.12 41.16 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.08 114.34 48.03 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.899 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.16 -179.98 0.98 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.805 2.337 . . . . 0.0 112.483 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -73.2 106.85 5.21 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.929 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.03 -59.13 0.45 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.744 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 25.1 t80 66.97 -75.23 0.06 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.545 0.338 . . . . 0.0 111.1 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -93.04 -33.18 14.21 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.569 0.223 . . . . 0.0 110.892 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.95 -110.75 3.58 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.286 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.4 54.13 2.24 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.98 0.419 . . . . 0.0 110.787 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.4 mt -143.89 108.72 4.93 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.727 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 61.97 93.49 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.537 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.6 mttt -107.94 94.05 4.87 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.048 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.3 p -84.12 168.03 16.22 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.018 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.32 172.92 15.14 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.881 0.372 . . . . 0.0 111.717 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 44' ' ' VAL . 12.2 p -93.91 42.99 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.216 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.429 ' O ' HG23 ' A' ' 46' ' ' THR . 0.4 OUTLIER -128.28 28.17 5.52 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.99 179.649 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -161.28 130.17 4.55 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.882 179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.634 HG11 ' CG ' ' A' ' 64' ' ' GLU . 12.5 t -97.77 37.82 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.01 0.434 . . . . 0.0 110.911 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.471 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 44.9 m95 -136.96 140.87 42.53 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 p -104.44 145.89 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.403 ' HG3' ' CG2' ' A' ' 58' ' ' THR . 41.1 tt0 -96.97 122.55 40.08 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.103 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.62 158.33 14.84 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.621 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.4 tp -106.59 141.7 37.44 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.862 0.363 . . . . 0.0 111.267 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.443 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 34.1 t -133.58 152.22 51.85 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.826 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.79 153.52 0.39 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.55 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.59 11.41 8.1 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.12 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.81 65.85 2.28 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.969 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.443 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 34.3 m-85 -128.19 103.89 7.44 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.756 0.312 . . . . 0.0 110.7 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.504 HG22 ' CE1' ' A' ' 60' ' ' TYR . 29.4 m -76.19 120.05 20.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.852 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -112.87 145.96 39.77 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.721 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.504 ' CE1' HG22 ' A' ' 58' ' ' THR . 11.0 m-85 -120.33 141.86 49.66 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.736 0.303 . . . . 0.0 110.79 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -124.57 152.36 43.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.471 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 18.3 t-20 -113.68 136.37 52.91 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.771 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.9 p -87.27 -30.84 20.59 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.814 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.634 ' CG ' HG11 ' A' ' 47' ' ' VAL . 11.3 mt-10 -60.58 -62.96 1.48 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.65 0.262 . . . . 0.0 111.045 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 75.1 p -84.02 -44.56 14.0 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.094 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.11 48.63 2.39 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.453 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -134.23 140.74 46.67 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.761 0.315 . . . . 0.0 110.855 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.2 p -80.71 148.99 29.9 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.0 tpt85 -134.02 155.67 49.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.732 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -126.5 25.12 6.57 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.788 0.327 . . . . 0.0 111.286 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -146.4 133.5 20.4 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.135 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -59.86 111.85 4.5 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.642 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -56.96 101.9 0.1 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.843 2.362 . . . . 0.0 112.576 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -90.0 126.85 35.9 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.874 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.0 t70 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.617 -179.925 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.71 0.29 . . . . 0.0 111.523 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.35 155.82 59.66 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.841 2.361 . . . . 0.0 112.458 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 t -145.98 104.74 3.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.87 0.367 . . . . 0.0 111.076 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -134.09 33.14 3.4 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.758 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.75 81.84 1.6 Allowed Glycine 0 C--N 1.337 0.591 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.616 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.501 ' HB2' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -79.33 75.66 5.9 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.853 0.358 . . . . 0.0 111.109 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.423 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 82.2 m95 -121.26 137.39 54.71 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.052 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.5 p -115.55 133.91 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.961 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 35' ' ' PHE . 44.0 tt0 -90.61 132.09 35.94 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.866 0.365 . . . . 0.0 111.174 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.73 147.73 18.76 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.549 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.3 mm -95.96 141.65 15.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.634 0.254 . . . . 0.0 110.914 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.09 162.08 25.37 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.805 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 m -46.66 152.7 0.45 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.528 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 77.48 -54.72 0.53 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.424 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.24 50.49 0.04 OUTLIER Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.578 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -115.85 141.2 48.41 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.506 0.193 . . . . 0.0 110.528 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -105.54 117.07 33.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.77 0.319 . . . . 0.0 110.825 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -110.74 151.27 27.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.721 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -124.84 149.23 47.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.751 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -127.48 144.64 51.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.076 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.423 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 29.1 t70 -117.34 123.23 45.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.679 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.409 HD11 ' HG2' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -84.35 -25.72 28.96 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.157 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 6' ' ' ARG . 6.5 mt -58.71 -46.7 90.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.576 0.227 . . . . 0.0 110.871 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -104.46 -32.24 9.09 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.526 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.56 45.39 5.24 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.265 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -132.77 132.45 42.26 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.815 0.34 . . . . 0.0 111.378 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.2 p -86.26 142.0 28.88 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.709 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.02 167.62 18.75 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.193 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -127.72 7.01 6.19 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.672 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.6 130.12 51.85 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.474 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 0.4 OUTLIER -66.34 113.93 14.8 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.004 -179.291 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.46 -175.12 0.4 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.996 2.464 . . . . 0.0 112.828 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.51 29.35 1.74 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.612 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -132.9 -46.43 0.11 Allowed Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.82 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 9' ' ' GLU . 52.8 t80 -54.01 -64.12 0.93 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.645 0.222 . . . . 0.0 111.105 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.474 ' HB2' ' HE2' ' A' ' 31' ' ' LYS . 20.6 mt-30 -153.36 81.67 1.18 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.732 0.301 . . . . 0.0 110.723 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.33 172.82 23.34 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.882 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -72.21 174.95 6.51 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.811 0.338 . . . . 0.0 111.246 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.34 157.83 18.86 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.436 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -78.15 157.78 29.3 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.246 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.15 169.18 21.3 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.369 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.97 -37.09 62.01 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.169 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.93 99.22 12.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.01 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.4 t -128.84 130.18 68.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.291 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.48 161.1 29.48 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.96 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.7 p 47.08 52.89 11.34 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.665 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 47' ' ' VAL . 11.7 p -102.1 9.58 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.917 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.523 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 72.0 m95 -117.31 141.98 47.64 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.711 0.291 . . . . 0.0 111.036 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.3 p -107.22 141.61 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.022 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -90.78 122.33 33.42 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.016 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.91 158.4 14.87 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.469 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.45 131.65 55.46 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.866 0.365 . . . . 0.0 111.424 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.08 151.94 27.5 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.794 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -44.56 148.54 0.48 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.327 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 82.6 -51.67 0.19 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.073 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 140.26 51.18 0.05 OUTLIER Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.451 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -117.51 118.68 32.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.608 0.242 . . . . 0.0 110.498 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.46 120.39 25.41 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.846 0.355 . . . . 0.0 111.117 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -112.75 146.11 39.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.436 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -119.75 141.93 49.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.843 0.354 . . . . 0.0 110.84 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -123.33 154.74 38.5 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.859 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.523 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 39.3 t30 -113.5 122.14 46.39 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.924 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.3 p -74.26 -30.74 62.26 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.716 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -64.58 -66.97 0.47 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.517 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.2 p -78.09 -48.95 14.87 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.517 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.82 42.25 2.7 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.599 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -129.67 133.24 46.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.763 0.316 . . . . 0.0 110.894 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.19 146.72 45.35 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.7 157.64 44.37 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.075 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -126.47 30.79 5.49 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.84 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -148.48 122.47 9.43 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.609 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -65.42 123.75 85.23 Favored Pre-proline 0 CA--C 1.529 0.173 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.665 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 72' ' ' LYS . 33.4 Cg_exo -61.62 85.25 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.617 2.212 . . . . 0.0 111.841 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.98 119.59 39.12 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.877 -179.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.32 -0.848 . . . . 0.0 111.076 179.682 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.743 0.306 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.54 151.53 64.69 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.869 2.38 . . . . 0.0 112.963 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.4 t -102.68 -35.25 8.75 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.447 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.59 178.99 9.24 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.718 0.294 . . . . 0.0 111.298 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -123.07 139.76 12.57 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.543 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.73 ' H ' HD11 ' A' ' 23' ' ' ILE . 5.8 mmm180 -78.99 92.83 5.0 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.752 0.311 . . . . 0.0 110.722 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.502 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 91.1 m95 -127.14 137.05 52.9 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.047 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 14.9 p -117.34 147.85 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.265 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.68 131.67 46.46 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.194 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.59 148.58 19.68 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.956 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.6 mm -94.35 144.17 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.72 0.295 . . . . 0.0 111.185 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.603 HG23 ' CD1' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -127.16 161.67 27.96 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.969 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 t -45.76 152.22 0.37 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.637 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 80.66 -55.82 0.33 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.187 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.16 51.9 0.05 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.484 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -118.32 151.65 37.3 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.57 0.224 . . . . 0.0 110.585 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -109.94 116.7 32.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.798 0.332 . . . . 0.0 110.871 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.603 ' CD1' HG23 ' A' ' 12' ' ' THR . 17.2 p90 -111.15 151.43 28.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.941 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 57.0 m-85 -124.41 149.29 46.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.783 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -125.86 149.53 48.59 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.232 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.672 ' OD1' HD12 ' A' ' 23' ' ' ILE . 23.5 t70 -119.11 122.02 41.12 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.022 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.632 HD21 ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -82.82 -26.46 31.69 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.73 HD11 ' H ' ' A' ' 6' ' ' ARG . 3.5 mt -56.53 -46.8 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.759 0.314 . . . . 0.0 111.084 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m -103.83 -44.38 5.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.003 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.23 36.9 3.23 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.57 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -119.32 156.88 29.21 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.803 0.335 . . . . 0.0 111.297 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 p -100.09 131.14 46.22 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.033 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -122.2 168.4 12.05 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.832 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.433 ' CZ3' ' HB3' ' A' ' 18' ' ' TYR . 93.3 m95 -127.38 -45.34 1.52 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.078 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -73.41 119.6 17.87 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.578 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.02 125.27 91.25 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.748 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.39 167.05 28.01 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.631 2.22 . . . . 0.0 112.236 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -66.76 120.06 12.87 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.519 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.58 -97.1 0.87 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.444 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 25.7 t80 66.97 160.12 0.15 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.521 0.2 . . . . 0.0 110.975 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -60.78 101.15 0.13 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.828 0.347 . . . . 0.0 110.671 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.68 -123.34 6.09 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.109 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.7 t70 61.43 100.27 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.996 0.427 . . . . 0.0 111.569 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 mp -105.94 38.06 2.1 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.143 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.0 mtpp -140.89 136.42 32.28 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.566 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -81.78 56.68 3.13 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.672 0.272 . . . . 0.0 111.305 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.1 m 65.12 166.78 0.18 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.16 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.06 143.83 47.31 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.557 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.492 ' O ' HG12 ' A' ' 44' ' ' VAL . 11.0 t -137.6 37.65 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.362 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -144.22 80.89 1.66 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.692 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.06 105.46 8.4 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.259 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.726 HG13 ' CD1' ' A' ' 48' ' ' TRP . 11.9 p -104.04 -18.12 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.775 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.726 ' CD1' HG13 ' A' ' 47' ' ' VAL . 94.2 m95 -113.7 145.15 41.78 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.516 0.198 . . . . 0.0 110.913 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.6 t -111.46 131.66 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.419 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.468 ' HG3' ' CD1' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -94.6 122.25 37.0 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.941 0.401 . . . . 0.0 111.521 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.446 ' HA3' ' CE2' ' A' ' 59' ' ' TYR . . . -118.86 158.0 15.02 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.265 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.43 121.59 45.26 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.753 0.277 . . . . 0.0 110.943 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.17 142.13 31.35 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.803 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 55.73 95.06 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.461 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 68.1 -63.29 0.33 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.052 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.37 40.21 0.05 OUTLIER Glycine 0 CA--C 1.518 0.272 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.696 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -85.31 121.28 27.81 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.11 120.03 23.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.998 0.427 . . . . 0.0 111.229 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.446 ' CE2' ' HA3' ' A' ' 51' ' ' GLY . 25.2 p90 -113.05 146.18 39.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.816 179.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.485 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 2.6 m-85 -119.59 141.74 49.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.935 0.398 . . . . 0.0 111.165 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -129.65 155.02 46.52 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.573 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -113.48 129.23 56.59 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.891 0.377 . . . . 0.0 111.265 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.6 p -93.39 22.27 5.41 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.757 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -95.7 -60.04 1.74 Allowed 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 120.666 0.269 . . . . 0.0 110.707 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.8 t -110.39 -36.2 5.85 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.14 73.58 0.71 Allowed Glycine 0 C--N 1.335 0.513 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.707 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -149.9 126.89 11.18 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.819 0.342 . . . . 0.0 111.007 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.49 150.69 25.84 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.697 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.6 ttt-85 -130.73 155.35 46.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.261 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -126.59 27.1 6.17 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.11 162.27 40.3 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.724 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -86.3 107.68 14.38 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.993 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.95 143.39 49.77 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.71 2.273 . . . . 0.0 112.694 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -168.06 111.12 0.61 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.947 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.6 t70 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.438 -0.791 . . . . 0.0 111.386 -179.84 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.689 0.28 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.04 143.72 36.68 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.847 2.364 . . . . 0.0 112.391 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 t -124.42 141.11 52.33 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.044 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.2 124.02 35.72 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.75 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.17 79.49 0.04 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.75 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.419 ' CG ' HD11 ' A' ' 23' ' ' ILE . 31.3 mmt180 -87.16 68.53 9.95 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.08 0.467 . . . . 0.0 110.516 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.433 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 80.9 m95 -105.75 140.17 39.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.754 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 p -116.17 133.57 62.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.085 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -90.7 131.51 36.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.272 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.25 148.58 19.65 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.66 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.8 mm -98.01 127.08 50.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.585 0.231 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.574 HG23 ' CE1' ' A' ' 18' ' ' TYR . 11.2 p -133.43 150.06 51.78 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.947 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.02 -149.78 0.41 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.622 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.28 -29.57 47.64 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.13 44.09 0.02 OUTLIER Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.56 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -92.81 112.75 24.82 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -74.54 116.8 15.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.949 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.574 ' CE1' HG23 ' A' ' 12' ' ' THR . 20.7 p90 -111.02 151.51 27.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.517 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -124.41 148.81 47.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.949 0.405 . . . . 0.0 110.93 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -136.56 147.88 47.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.132 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.433 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 4.7 t0 -112.09 122.05 46.68 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.653 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.39 -26.94 27.99 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.274 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.419 HD11 ' CG ' ' A' ' 6' ' ' ARG . 6.3 mt -60.72 -53.39 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.733 0.302 . . . . 0.0 110.871 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.06 -36.51 12.08 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.22 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.04 60.19 1.34 Allowed Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.293 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -142.64 129.24 20.27 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.844 0.354 . . . . 0.0 111.415 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.7 p -85.29 132.19 34.29 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.54 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -131.91 168.3 18.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.22 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.404 ' HH2' ' HG1' ' A' ' 12' ' ' THR . 73.3 m95 -127.81 7.37 6.18 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.705 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -120.44 139.89 52.18 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.662 0.268 . . . . 0.0 110.713 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -77.64 131.67 70.47 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.962 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.56 -171.08 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.679 2.253 . . . . 0.0 112.253 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.62 89.9 0.11 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.907 0.384 . . . . 0.0 110.732 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.97 -90.95 0.68 Allowed Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.652 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 67.7 t80 66.16 -77.45 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 122.431 0.293 . . . . 0.0 110.883 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -142.87 31.78 1.42 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.87 0.367 . . . . 0.0 110.791 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -124.26 114.42 2.27 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.151 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -63.43 123.77 19.61 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.669 0.271 . . . . 0.0 111.154 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 tp -103.63 108.19 19.36 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 1.9 mmtp -65.9 135.63 55.04 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.554 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 52.15 -171.23 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.35 0.406 . . . . 0.0 111.386 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.3 m 57.16 26.11 11.75 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.798 0.332 . . . . 0.0 111.073 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -165.11 -177.11 4.43 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.19 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.5 p -59.34 140.8 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 120.891 0.377 . . . . 0.0 111.446 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -108.56 127.28 53.8 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.104 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 48' ' ' TRP . 11.9 t -95.53 -177.51 4.1 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.097 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.421 HG12 ' OD1' ' A' ' 62' ' ' ASN . 19.5 t -78.81 -31.27 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.404 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.468 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 76.5 m95 -93.87 143.38 26.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.82 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.9 p -108.37 137.88 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.957 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -91.08 122.05 33.39 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.001 0.429 . . . . 0.0 110.952 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.75 151.38 17.75 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.349 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.81 133.4 54.83 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.911 0.386 . . . . 0.0 111.419 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.1 t -112.29 151.8 29.25 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.84 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -45.08 154.63 0.14 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.333 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 80.54 -55.58 0.34 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.061 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.16 55.06 0.03 OUTLIER Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.407 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -124.77 124.24 41.7 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.632 0.253 . . . . 0.0 110.538 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.3 m -93.56 120.95 34.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.85 0.357 . . . . 0.0 111.068 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -112.56 146.21 38.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.56 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.403 ' CE2' ' HG3' ' A' ' 72' ' ' LYS . 85.7 m-85 -119.93 141.86 49.24 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.848 0.356 . . . . 0.0 110.942 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -125.91 147.19 49.55 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.926 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.468 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 53.3 t30 -113.33 122.76 48.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.668 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.1 p -77.75 -23.1 49.4 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.558 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -55.08 -60.94 2.69 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.405 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.7 t -102.27 -38.43 7.66 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.441 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.72 46.8 1.73 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.607 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -123.54 121.12 34.81 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.781 0.324 . . . . 0.0 110.674 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.2 p -71.32 150.14 45.41 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -133.82 157.79 45.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.088 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -126.5 28.4 5.95 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.049 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -151.68 134.61 15.72 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.296 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.403 ' HG3' ' CE2' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -56.91 109.65 1.86 Allowed Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.827 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.4 105.17 1.94 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.604 2.202 . . . . 0.0 112.658 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.1 t70 68.01 158.62 0.15 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.357 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.7 t70 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.104 -0.951 . . . . 0.0 111.347 -179.65 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 120.334 0.111 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.79 94.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.759 2.306 . . . . 0.0 112.558 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.8 46.37 2.34 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.771 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -157.32 109.03 2.36 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.293 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.05 147.67 19.35 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.586 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.445 ' CD ' HD11 ' A' ' 23' ' ' ILE . 1.5 mpt_? -75.68 85.05 2.7 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.999 0.428 . . . . 0.0 110.464 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.409 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 89.6 m95 -125.11 148.92 48.33 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.228 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 2.0 t -118.14 132.88 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.503 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -90.89 129.83 36.89 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.942 0.401 . . . . 0.0 111.53 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.52 148.69 19.72 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.653 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.6 mm -105.18 125.47 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.5 0.19 . . . . 0.0 110.809 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.89 153.76 51.53 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.34 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.1 -148.02 0.43 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.748 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -55.03 -29.24 57.0 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.56 44.43 0.02 OUTLIER Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.358 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -92.51 113.95 26.36 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -73.86 116.64 14.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.845 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -111.02 151.46 27.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.218 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 85.3 m-85 -124.05 149.39 46.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.844 0.354 . . . . 0.0 111.092 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -131.87 140.36 49.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.77 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.409 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 9.5 t70 -109.8 125.67 52.97 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.74 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.15 -29.67 28.45 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.714 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.445 HD11 ' CD ' ' A' ' 6' ' ' ARG . 4.1 mt -54.65 -49.34 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.804 0.335 . . . . 0.0 110.882 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m -101.92 -39.13 7.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.292 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.73 44.84 3.29 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.347 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -127.91 135.54 50.12 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 111.477 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.8 t -85.94 147.57 26.17 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.665 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -133.74 167.79 19.88 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.92 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -127.44 8.94 6.54 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.663 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -132.06 137.98 47.99 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.424 ' HE3' ' OH ' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -62.09 132.66 93.84 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.351 -179.49 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.38 -177.21 2.88 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.681 2.254 . . . . 0.0 112.268 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.96 107.72 7.21 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.341 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 35' ' ' PHE . . . 94.25 -84.21 1.0 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.908 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 34' ' ' GLY . 24.2 t80 69.87 161.43 0.22 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.605 0.203 . . . . 0.0 110.738 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -66.66 88.14 0.14 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.912 0.387 . . . . 0.0 110.932 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.1 122.09 0.73 Allowed Glycine 0 CA--C 1.517 0.21 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.084 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -78.33 95.85 5.15 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.909 0.385 . . . . 0.0 111.26 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.3 mt -72.2 174.14 7.61 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.63 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -107.22 172.67 6.7 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.24 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 69.25 92.92 0.08 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.037 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.9 m -62.21 -34.32 76.25 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.323 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.47 127.29 35.83 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.97 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 p -100.55 144.08 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.302 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -83.95 151.53 25.0 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.307 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.9 t -162.78 97.22 0.95 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.393 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 47' ' ' VAL . 3.5 t -119.82 31.96 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.935 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -133.87 143.99 48.63 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.69 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.2 p -106.33 132.29 53.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.462 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -90.59 122.0 33.01 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.915 0.388 . . . . 0.0 110.945 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.409 ' HA3' ' CE1' ' A' ' 59' ' ' TYR . . . -118.86 152.88 17.17 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.351 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.74 129.05 55.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.954 0.407 . . . . 0.0 111.296 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.422 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 40.2 t -109.39 151.94 25.98 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.648 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -45.64 151.98 0.37 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.368 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.405 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 0.3 OUTLIER 82.77 -53.68 0.19 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.9 -179.334 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.52 55.78 0.04 OUTLIER Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.445 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 22.0 m-85 -123.7 129.25 50.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.524 0.202 . . . . 0.0 110.749 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.3 m -98.1 120.85 39.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.854 0.359 . . . . 0.0 111.086 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.409 ' CE1' ' HA3' ' A' ' 51' ' ' GLY . 30.0 p90 -112.64 145.94 39.51 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.596 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -120.25 142.26 49.21 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.736 0.303 . . . . 0.0 110.86 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -124.2 152.25 43.12 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.851 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.61 122.51 47.89 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.911 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.3 p -78.74 -24.97 44.51 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.447 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -59.47 -63.41 1.31 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.432 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.0 t -91.24 -40.27 11.62 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.377 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.87 56.43 1.08 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.736 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -136.22 139.2 42.58 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.802 0.334 . . . . 0.0 110.865 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 p -80.58 146.35 31.28 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.789 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.48 149.29 49.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.07 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -126.97 29.0 5.7 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.013 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -145.06 123.86 12.63 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.534 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -63.9 121.77 73.15 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.729 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.07 106.61 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.716 2.278 . . . . 0.0 112.591 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.17 110.54 11.66 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.627 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 t70 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.887 -179.64 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -76.26 -177.63 3.83 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.428 2.085 . . . . 0.0 112.71 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.4 t -138.88 113.87 9.34 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.156 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.5 tttp -145.79 94.84 2.55 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.782 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -175.79 169.38 42.07 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.689 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.0 mtt85 -135.71 99.94 4.33 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.752 0.311 . . . . 0.0 110.489 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.44 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 58.2 m95 -126.15 141.21 52.03 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.117 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.8 p -114.72 134.48 57.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.826 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -90.64 130.87 36.61 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.913 0.387 . . . . 0.0 111.304 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.11 148.69 19.68 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.74 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.7 mm -98.09 125.74 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 120.452 0.168 . . . . 0.0 111.021 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.518 HG23 ' CE1' ' A' ' 18' ' ' TYR . 9.3 p -132.99 155.36 49.31 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.024 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.1 t 58.73 -148.09 0.48 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.67 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -62.0 -23.69 66.58 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.89 43.05 0.02 OUTLIER Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.577 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -94.0 112.24 24.05 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -75.0 116.45 15.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.002 0.429 . . . . 0.0 110.72 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.518 ' CE1' HG23 ' A' ' 12' ' ' THR . 14.2 p90 -111.03 151.71 27.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.388 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -124.05 149.35 46.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.819 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -134.42 147.98 50.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.679 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.44 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 10.2 t70 -109.93 122.1 46.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.679 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.67 -23.64 29.35 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.4 mt -57.85 -52.53 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.636 0.255 . . . . 0.0 110.953 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.67 -41.12 6.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.16 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.44 53.02 0.95 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.433 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -133.57 127.73 33.73 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.857 0.361 . . . . 0.0 111.281 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.7 t -76.11 145.75 39.78 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.762 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -132.66 168.19 18.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.121 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -127.57 -46.79 1.44 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.802 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.99 129.97 35.03 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.537 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -71.11 133.93 85.54 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.015 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -73.06 -176.81 2.58 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.61 2.207 . . . . 0.0 112.576 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.84 31.57 1.59 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.496 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.18 33.45 0.38 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.009 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -111.33 -47.98 3.14 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.7 0.286 . . . . 0.0 110.629 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.84 -179.87 6.08 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.926 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.41 154.3 6.7 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.084 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -164.15 134.06 4.05 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.629 0.252 . . . . 0.0 111.355 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 pp -124.58 161.49 26.1 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.085 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.689 ' HG2' HG23 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -118.28 143.26 46.72 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.055 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -84.28 80.09 9.32 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.189 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.5 m 66.45 -76.9 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.289 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.21 122.29 30.0 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.632 0.253 . . . . 0.0 110.901 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.689 HG23 ' HG2' ' A' ' 40' ' ' LYS . 13.0 p -77.58 126.46 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.379 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -104.82 113.32 26.83 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.9 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.5 p -88.94 121.92 31.79 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.191 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 47' ' ' VAL . 8.2 p -113.93 21.72 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.615 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.453 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 85.4 m95 -119.02 143.68 46.95 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.715 0.293 . . . . 0.0 110.962 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.5 p -105.64 136.8 38.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.855 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -91.54 122.0 33.73 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.817 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.422 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.75 153.38 16.98 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.431 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.23 141.5 45.86 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.113 0.482 . . . . 0.0 111.544 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.409 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 30.1 t -123.54 152.27 41.97 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.497 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 0.7 OUTLIER -44.7 156.23 0.09 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.849 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 22.2 m-20 76.88 -54.67 0.57 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.889 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.12 54.29 0.03 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.131 -0.556 . . . . 0.0 112.264 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 55' ' ' ASP . 18.3 m-85 -120.01 118.0 29.5 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.656 0.265 . . . . 0.0 110.811 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.47 120.67 29.0 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.01 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.432 ' HB3' ' CZ3' ' A' ' 70' ' ' TRP . 30.8 p90 -112.51 145.97 39.31 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.744 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -120.23 142.03 49.4 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.846 0.355 . . . . 0.0 110.95 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -130.27 150.55 51.46 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.341 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.461 HD22 HG22 ' A' ' 65' ' ' THR . 56.3 t30 -114.37 133.48 55.67 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.052 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.4 p -82.09 -26.26 33.79 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.617 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -62.58 -66.78 0.49 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.36 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.461 HG22 HD22 ' A' ' 62' ' ' ASN . 6.9 t -84.5 -34.77 23.27 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.307 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.21 49.88 3.83 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.601 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -129.52 137.07 50.59 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.801 0.334 . . . . 0.0 111.138 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.51 146.17 27.05 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.66 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.04 155.59 50.5 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.432 ' CZ3' ' HB3' ' A' ' 59' ' ' TYR . 94.1 m95 -126.32 29.95 5.69 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.926 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -148.12 127.93 13.46 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.558 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 125.82 90.33 Favored Pre-proline 0 N--CA 1.465 0.31 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.103 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.37 -178.45 2.58 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.685 2.257 . . . . 0.0 112.269 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.7 t70 75.9 158.8 0.21 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.712 0.292 . . . . 0.0 110.997 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.231 -179.617 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.656 0.265 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.29 125.7 19.27 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.911 2.408 . . . . 0.0 112.737 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.2 t -103.89 175.84 5.35 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.386 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -144.18 76.1 1.49 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.311 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.67 -88.54 0.07 OUTLIER Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.994 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.572 ' HB2' HD11 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -67.78 92.19 0.34 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.831 0.348 . . . . 0.0 111.409 -179.536 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -127.98 148.42 50.52 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.892 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 2.2 t -119.3 129.06 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.758 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -90.76 131.98 36.11 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.95 0.405 . . . . 0.0 111.445 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.12 147.18 19.07 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.404 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.2 mm -100.39 123.9 53.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 120.465 0.174 . . . . 0.0 110.875 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.02 156.17 47.84 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.965 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 57.14 -148.32 0.5 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.523 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.43 -21.25 66.19 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.76 44.58 0.02 OUTLIER Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.411 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -92.83 105.46 17.59 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -73.36 116.67 14.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.929 0.395 . . . . 0.0 110.959 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.419 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 30.1 p90 -110.9 151.51 27.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.466 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 56.1 m-85 -124.32 149.47 46.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 111.21 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -131.81 142.26 49.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.964 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -109.54 124.35 50.95 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.528 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.66 -26.45 27.78 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.214 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.572 HD11 ' HB2' ' A' ' 6' ' ' ARG . 7.8 mt -62.65 -45.44 98.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.7 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 t -99.64 -35.83 9.7 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.301 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.9 62.52 1.3 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.335 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.19 157.19 33.93 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.94 0.4 . . . . 0.0 111.866 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.3 t -101.52 151.98 21.32 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.711 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.91 168.12 19.35 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.043 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.419 ' CZ3' ' HB3' ' A' ' 18' ' ' TYR . 98.3 m95 -127.57 7.49 6.32 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.706 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.12 131.97 47.3 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.544 0.211 . . . . 0.0 110.474 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -73.62 126.04 90.07 Favored Pre-proline 0 N--CA 1.462 0.17 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.875 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 31' ' ' LYS . 32.0 Cg_exo -61.64 -174.83 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.941 2.427 . . . . 0.0 112.469 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.89 35.98 0.75 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.624 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 160.22 71.95 0.02 OUTLIER Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.835 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 9' ' ' GLU . 23.0 t80 -88.85 -72.09 0.56 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.612 0.206 . . . . 0.0 110.684 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -149.15 39.15 0.82 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.826 0.346 . . . . 0.0 110.922 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.87 92.36 1.68 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.248 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -83.32 83.84 7.72 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.862 0.363 . . . . 0.0 110.983 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.9 mt -153.28 64.07 0.76 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.948 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.7 89.59 0.06 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.439 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.64 97.23 3.16 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.363 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.5 m -103.85 23.66 12.48 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.953 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.75 139.84 30.36 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.067 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.5 p -96.5 146.1 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.383 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.85 36.66 1.38 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.395 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 64.4 p -137.7 85.44 2.11 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.966 0.412 . . . . 0.0 110.812 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.5 p -80.15 -31.41 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.431 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.475 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 80.6 m95 -82.01 139.17 34.67 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.83 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.7 p -115.43 135.17 56.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.889 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.2 122.36 35.51 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.945 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.401 ' HA3' ' CE1' ' A' ' 59' ' ' TYR . . . -118.52 158.89 14.58 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.718 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.0 tp -107.71 136.8 46.85 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.954 0.407 . . . . 0.0 111.174 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.469 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 44.2 t -126.29 152.26 46.41 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.953 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -45.85 152.31 0.37 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.651 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 68.25 11.49 8.38 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.119 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.86 64.72 2.48 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.169 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.469 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 34.0 m-85 -128.03 106.55 9.15 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.731 0.3 . . . . 0.0 110.658 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.81 120.27 23.21 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.815 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.401 ' CE1' ' HA3' ' A' ' 51' ' ' GLY . 31.1 p90 -112.97 145.86 40.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.822 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -120.41 141.84 49.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.91 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -128.52 153.0 47.64 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.744 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.565 ' OD1' HG22 ' A' ' 65' ' ' THR . 20.8 t-20 -113.77 134.43 54.77 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.073 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.9 p -89.15 -29.8 19.06 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.51 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -59.1 -60.49 3.79 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.507 0.194 . . . . 0.0 111.178 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.565 HG22 ' OD1' ' A' ' 62' ' ' ASN . 4.1 t -91.09 -36.19 14.16 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.236 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.51 50.06 2.84 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.65 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -130.42 135.61 48.19 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.846 0.355 . . . . 0.0 111.198 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.93 145.1 26.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.784 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.23 143.96 46.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.856 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -126.23 19.84 7.53 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.226 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -137.87 16.38 2.86 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp 71.14 137.07 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.13 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.14 151.06 66.76 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.591 2.194 . . . . 0.0 112.704 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -127.07 167.31 16.13 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.349 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.1 t70 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.421 -0.799 . . . . 0.0 110.961 179.824 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.1 t0 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 120.633 0.254 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.55 118.71 5.18 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.89 2.393 . . . . 0.0 112.58 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 t -82.55 81.22 8.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.633 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 ptpm? -117.33 114.01 22.96 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.795 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.11 165.93 54.69 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.885 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.487 ' HB2' HD11 ' A' ' 23' ' ' ILE . 5.1 mtt-85 -104.16 78.35 1.5 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.992 0.425 . . . . 0.0 110.624 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.533 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 91.6 m95 -109.17 141.6 41.17 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.75 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.5 p -114.64 135.4 54.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.978 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -90.41 130.42 36.49 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.881 0.372 . . . . 0.0 110.756 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.87 148.18 19.33 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.783 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.6 mm -97.16 142.12 14.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.723 0.296 . . . . 0.0 111.21 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.92 161.68 26.09 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.974 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -44.25 150.55 0.29 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.599 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.432 ' HB3' ' CE2' ' A' ' 16' ' ' TYR . 0.8 OUTLIER 81.1 -56.83 0.29 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.212 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.53 49.54 0.05 OUTLIER Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.585 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 14' ' ' GLU . 31.3 m-85 -113.44 148.55 35.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.538 0.209 . . . . 0.0 110.487 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -108.67 116.75 32.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.935 0.398 . . . . 0.0 110.824 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -111.35 151.79 28.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.122 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -124.17 149.69 46.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.709 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -135.55 147.74 48.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.224 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.533 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 5.9 t70 -113.66 122.28 46.67 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.858 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.4 -26.56 30.3 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.346 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.487 HD11 ' HB2' ' A' ' 6' ' ' ARG . 2.1 mt -59.33 -50.5 79.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-O 120.69 0.281 . . . . 0.0 111.023 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 m -98.74 -50.22 4.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.977 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.74 55.34 0.66 Allowed Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.456 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -137.68 142.5 41.09 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.808 0.337 . . . . 0.0 111.306 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.34 130.79 35.66 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.792 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -124.11 168.75 12.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.8 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -127.27 -45.95 1.51 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.788 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.03 136.46 46.69 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.361 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -65.32 119.36 58.73 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.818 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.97 171.34 0.8 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.741 2.294 . . . . 0.0 112.614 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -68.12 84.42 0.24 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.609 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.89 -78.77 0.34 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.772 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.1 t80 67.33 -75.32 0.06 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.34 0.256 . . . . 0.0 110.986 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -154.48 100.61 2.28 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.64 0.257 . . . . 0.0 110.748 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -139.46 -159.53 8.02 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.847 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.79 171.33 8.15 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.776 0.322 . . . . 0.0 111.122 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tp -96.77 32.91 1.96 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.992 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -92.02 144.09 25.8 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.075 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.38 34.55 3.73 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.17 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.3 m -111.82 134.3 53.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.687 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 62.71 -174.57 0.15 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.597 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.8 t -112.09 155.79 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.098 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.79 110.93 0.72 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.424 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.43 -178.27 6.86 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.117 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.515 ' O ' HG12 ' A' ' 47' ' ' VAL . 13.2 t -95.8 37.08 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.23 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.463 ' CH2' ' HB2' ' A' ' 62' ' ' ASN . 65.3 m95 -130.12 144.28 51.26 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.204 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 2.3 t -101.8 156.12 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.579 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -113.25 121.89 45.81 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.67 0.271 . . . . 0.0 111.267 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.484 ' HA3' ' CE2' ' A' ' 59' ' ' TYR . . . -119.13 154.94 16.25 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.826 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -113.16 121.95 46.04 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 57' ' ' PHE . 0.6 OUTLIER -142.76 142.09 31.85 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.444 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 56' ' ' GLY . 10.9 tt0 50.56 98.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.016 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 65.84 -63.54 0.22 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.35 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 176.14 40.27 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.733 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 53' ' ' SER . 20.9 m-85 -84.7 106.12 16.01 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.01 119.77 16.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.555 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.484 ' CE2' ' HA3' ' A' ' 51' ' ' GLY . 25.5 p90 -113.44 145.94 40.35 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.115 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 43.4 m-85 -120.08 141.77 49.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.787 0.327 . . . . 0.0 111.127 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -125.94 147.55 49.47 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.072 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.463 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 60.9 t30 -113.82 125.83 54.51 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.028 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.8 p -76.47 -26.58 55.52 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.332 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -58.46 -62.81 1.57 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.305 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.8 p -89.09 -44.27 10.46 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.131 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.47 52.78 1.52 Allowed Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.508 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -137.83 133.63 34.19 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.9 0.381 . . . . 0.0 111.025 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.4 p -75.34 145.57 41.62 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.919 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -132.82 158.13 43.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.807 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -125.97 28.17 6.18 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.869 0.366 . . . . 0.0 111.039 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -152.18 127.91 10.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.45 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -63.86 122.04 74.61 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.881 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -73.43 150.95 47.24 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.614 2.209 . . . . 0.0 112.689 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.11 -165.96 0.23 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.295 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.834 -179.917 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? . . . . . 0 C--O 1.233 0.232 0 CA-C-O 121.148 0.499 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.419 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 90.9 m95 -115.44 137.54 51.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.842 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 p -114.39 141.01 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.225 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.09 131.64 39.41 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.035 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.16 148.52 19.61 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.014 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.9 mm -91.49 142.62 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 120.676 0.274 . . . . 0.0 111.156 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.49 161.76 25.4 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.982 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.76 149.83 0.79 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.532 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 80.85 -55.76 0.32 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.217 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.1 55.84 0.03 OUTLIER Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.45 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -120.21 159.7 24.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.66 0.267 . . . . 0.0 110.755 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -115.83 117.04 29.1 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.06 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -111.12 151.84 27.67 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.96 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -124.19 149.26 46.56 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.82 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -135.24 145.4 47.57 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.929 0.395 . . . . 0.0 111.446 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.419 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 6.9 t70 -109.73 122.58 47.82 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.75 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.07 -24.82 32.55 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.589 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.8 mt -60.7 -59.88 3.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.754 0.311 . . . . 0.0 110.858 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.46 -34.7 20.0 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.083 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.25 56.53 1.91 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.351 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -142.92 141.6 31.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.799 0.333 . . . . 0.0 111.544 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -86.85 131.23 34.17 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.472 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -124.74 168.58 13.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.187 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -127.54 -46.55 1.45 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.25 126.55 29.99 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.64 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -67.59 122.26 82.6 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.984 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo . . . . . 0 C--N 1.351 0.696 0 C-N-CA 122.735 2.29 . . . . 0.0 112.816 -179.801 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.424 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 83.5 m95 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.628 0.251 . . . . 0.0 110.714 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.5 p -106.6 137.27 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.819 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.9 121.83 33.08 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.857 0.36 . . . . 0.0 111.151 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.416 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -119.42 160.34 14.39 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.862 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.422 HD11 ' HA2' ' A' ' 56' ' ' GLY . 3.3 tp -113.0 131.6 55.7 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.93 0.395 . . . . 0.0 110.745 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.46 151.77 42.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.576 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 66.58 -157.24 0.25 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.739 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.19 -26.37 60.53 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.422 ' HA2' HD11 ' A' ' 52' ' ' LEU . . . 163.7 46.53 0.02 OUTLIER Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.219 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -95.68 137.97 33.99 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.68 120.06 36.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.95 0.405 . . . . 0.0 111.328 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.416 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 19.6 p90 -113.2 146.24 39.63 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.526 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -119.9 141.96 49.12 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.784 0.326 . . . . 0.0 110.905 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -130.64 149.61 52.21 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.207 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.424 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 10.4 t-20 -113.45 128.36 56.42 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.243 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.4 p -81.32 -20.3 41.04 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.739 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -58.52 -62.87 1.53 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.548 0.213 . . . . 0.0 111.263 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.0 t -99.84 -41.56 7.19 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.183 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.13 61.28 0.71 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.722 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -137.67 126.92 24.59 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.788 0.328 . . . . 0.0 110.975 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.6 p -77.84 150.14 34.25 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.841 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.6 ttt85 -133.02 157.94 43.98 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.042 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 93.4 m95 . . . . . 0 CA--C 1.535 0.385 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.007 179.897 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.514 ' HB2' HD11 ' A' ' 23' ' ' ILE . 11.5 mpt_? . . . . . 0 C--O 1.234 0.288 0 CA-C-O 120.931 0.396 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -113.38 154.63 26.61 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.197 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 2.9 t -124.82 130.45 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.685 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -90.97 130.64 36.87 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.895 0.378 . . . . 0.0 111.025 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.29 148.75 19.59 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.603 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.9 mm -104.18 142.62 17.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.653 0.263 . . . . 0.0 111.092 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.87 161.53 27.22 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.931 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.53 150.77 0.63 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.792 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 82.4 -55.49 0.21 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.145 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.1 50.76 0.05 OUTLIER Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.533 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -113.98 147.6 38.32 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.504 0.192 . . . . 0.0 110.538 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -111.6 116.68 31.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.897 0.38 . . . . 0.0 110.923 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -111.35 151.68 28.14 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.84 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 59.9 m-85 -124.55 149.71 46.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.075 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -129.73 144.61 51.38 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.331 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.624 ' OD1' HD12 ' A' ' 23' ' ' ILE . 4.6 t0 -109.23 122.72 47.94 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.522 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.424 HD21 ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -85.75 -28.63 24.47 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.283 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.624 HD12 ' OD1' ' A' ' 21' ' ' ASP . 3.8 mt -58.29 -49.8 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.167 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.01 -43.44 5.77 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.41 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.84 34.46 3.77 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.469 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -121.62 127.79 51.24 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.798 0.332 . . . . 0.0 111.068 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.91 152.68 33.14 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.969 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -133.36 167.56 20.18 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.106 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -127.64 7.99 6.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.72 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -136.03 129.56 32.18 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -66.92 133.28 93.9 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.09 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 C--N 1.35 0.621 0 C-N-CA 122.655 2.236 . . . . 0.0 112.254 179.98 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 97.7 m95 . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.815 0.34 . . . . 0.0 111.388 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 2.9 t -112.07 139.08 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.811 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.77 122.51 44.63 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.638 0.256 . . . . 0.0 111.089 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.419 ' HA3' ' CE1' ' A' ' 59' ' ' TYR . . . -118.67 154.06 16.69 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.758 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.4 tp -109.67 126.51 53.75 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.853 0.359 . . . . 0.0 111.284 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.66 152.08 37.69 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.957 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -46.73 153.64 0.38 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.658 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 68.08 8.8 6.76 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.172 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.36 55.96 5.36 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.839 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -116.32 93.07 4.08 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.755 0.312 . . . . 0.0 110.543 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.3 m -72.6 120.58 18.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.989 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.419 ' CE1' ' HA3' ' A' ' 51' ' ' GLY . 32.9 p90 -112.61 145.88 39.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.504 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 24.0 m-85 -120.26 142.07 49.39 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.864 0.364 . . . . 0.0 111.331 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -125.88 156.1 40.18 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.654 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -113.53 126.75 55.65 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.221 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.5 p -93.85 29.51 2.06 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.869 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -120.91 -55.47 1.99 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.877 0.37 . . . . 0.0 110.434 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.6 p -96.3 -33.1 12.09 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.016 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.25 64.45 1.23 Allowed Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.571 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -149.71 128.86 12.76 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.861 0.362 . . . . 0.0 111.022 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.94 149.93 29.19 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.584 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.58 156.6 48.4 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.274 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 93.9 m95 . . . . . 0 CA--C 1.534 0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.09 179.651 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 . . . . . 0 C--O 1.233 0.219 0 CA-C-O 121.11 0.481 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -106.55 141.66 37.47 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.564 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 p -115.76 138.78 45.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.935 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -90.45 132.77 35.46 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.875 0.369 . . . . 0.0 111.022 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.76 146.82 18.6 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.536 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.7 mm -102.56 141.72 18.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.557 0.218 . . . . 0.0 110.982 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.14 162.04 27.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.828 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.9 m -48.42 149.58 1.56 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.634 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 82.43 -55.89 0.21 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.086 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.93 52.21 0.04 OUTLIER Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.451 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -116.47 129.97 56.5 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.512 0.196 . . . . 0.0 110.577 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -95.58 117.14 29.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.768 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -110.69 151.28 27.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.737 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -124.42 149.38 46.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.872 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -136.45 147.71 47.35 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.483 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -111.98 122.23 47.18 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.612 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.81 -33.49 46.14 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.574 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.5 mt -60.88 -55.59 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.707 0.289 . . . . 0.0 110.994 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.9 t -84.22 -36.27 22.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.25 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.01 47.37 5.03 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.217 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -136.07 143.3 44.56 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.838 0.352 . . . . 0.0 111.539 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.01 143.01 27.55 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.572 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -134.39 167.03 21.49 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.188 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -127.38 7.25 6.4 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.671 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -123.54 127.83 48.89 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.41 110.94 3.55 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.757 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 C--N 1.349 0.605 0 C-N-CA 122.393 2.062 . . . . 0.0 112.217 -179.862 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.51 ' CH2' ' HB2' ' A' ' 62' ' ' ASN . 78.9 m95 . . . . . 0 C--O 1.233 0.226 0 CA-C-O 120.793 0.33 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.5 p -115.45 144.73 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.005 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -95.57 122.21 38.07 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.781 0.324 . . . . 0.0 110.97 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.67 158.71 14.69 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.6 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.34 128.54 55.99 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.923 0.392 . . . . 0.0 111.234 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.6 m -107.46 151.96 24.85 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.861 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -44.15 148.9 0.38 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.918 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.404 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 7.7 t0 82.84 -52.82 0.18 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.173 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.22 54.13 0.03 OUTLIER Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.611 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.404 ' CE2' ' HB3' ' A' ' 55' ' ' ASP . 35.3 m-85 -122.14 132.1 54.29 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 110.48 -0.193 . . . . 0.0 110.48 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.05 120.69 35.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.805 0.336 . . . . 0.0 111.028 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -112.69 145.95 39.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.788 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -120.41 141.98 49.63 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.796 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -122.86 149.87 43.62 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.217 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.51 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 53.6 t30 -113.0 131.31 55.81 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.154 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.0 p -84.14 -28.68 27.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.56 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -60.07 -62.6 1.75 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.71 0.29 . . . . 0.0 111.018 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.1 p -86.21 -44.3 12.29 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.141 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.93 51.13 1.83 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.43 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -134.68 140.35 45.94 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 111.081 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.99 140.79 34.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.407 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.21 158.04 42.77 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.931 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 79.0 m95 . . . . . 0 CA--C 1.535 0.389 0 CA-C-O 120.79 0.329 . . . . 0.0 111.016 179.869 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.75 0.309 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.559 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 58.8 m95 -123.8 144.77 49.51 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.329 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.2 p -112.71 138.01 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.725 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -90.25 131.02 36.3 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.827 0.346 . . . . 0.0 110.979 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.26 148.51 19.62 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.657 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.6 mm -95.32 144.5 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.712 0.291 . . . . 0.0 111.288 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.651 HG23 ' CD1' ' A' ' 18' ' ' TYR . 1.4 p -128.15 162.05 27.83 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.054 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.0 m -45.16 152.69 0.25 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.583 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 78.48 -55.99 0.47 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.132 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.8 51.99 0.04 OUTLIER Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.389 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -115.9 151.27 35.67 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.683 0.278 . . . . 0.0 110.86 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -108.59 117.07 33.23 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.922 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.651 ' CD1' HG23 ' A' ' 12' ' ' THR . 21.5 p90 -110.72 151.44 27.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.659 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -124.13 149.42 46.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.581 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -130.99 142.33 50.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.073 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.559 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 20.7 t70 -111.2 123.48 50.29 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.508 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.57 -30.34 33.06 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.393 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.1 mt -60.22 -45.27 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 120.685 0.279 . . . . 0.0 111.01 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.87 -35.6 10.05 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.277 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.05 60.89 1.71 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.311 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.6 155.58 37.63 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.989 0.423 . . . . 0.0 111.92 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 t -97.62 143.5 28.23 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.728 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -135.67 168.64 18.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.826 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.429 ' CZ3' ' HB3' ' A' ' 18' ' ' TYR . 95.3 m95 -127.0 -44.64 1.61 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.66 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -80.04 135.22 36.31 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.541 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.11 142.93 92.82 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.021 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo . . . . . 0 C--N 1.351 0.677 0 C-N-CA 122.74 2.293 . . . . 0.0 113.229 -179.615 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.471 ' CH2' ' HB2' ' A' ' 62' ' ' ASN . 80.1 m95 . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.734 0.302 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 4.2 t -100.85 153.83 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.675 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -106.34 122.27 45.91 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 111.128 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.9 157.91 15.07 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.607 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.2 tp -111.97 123.59 50.59 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.883 0.373 . . . . 0.0 111.149 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.53 152.24 30.49 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.87 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -46.79 154.98 0.28 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.683 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 67.81 9.6 7.22 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.227 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.38 58.72 3.52 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.003 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -123.53 110.52 15.16 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.63 0.253 . . . . 0.0 110.617 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.41 120.42 24.95 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.001 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.427 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 38.0 p90 -112.53 145.78 39.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.47 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 36.9 m-85 -120.11 142.12 49.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.834 0.349 . . . . 0.0 111.225 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -121.85 149.44 43.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.189 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.471 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 46.8 t-20 -117.47 131.77 56.67 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.191 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.2 p -78.82 -26.62 44.25 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.503 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -57.64 -63.34 1.27 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.307 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.4 p -88.12 -46.14 9.55 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.082 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.4 47.17 2.22 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.494 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -136.08 143.72 44.77 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.773 0.321 . . . . 0.0 110.973 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.4 p -74.52 148.78 40.62 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -133.66 155.26 50.01 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.076 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 77.2 m95 . . . . . 0 CA--C 1.531 0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.765 179.657 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.496 ' HB2' HD11 ' A' ' 23' ' ' ILE . 3.3 mmp_? . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.962 0.411 . . . . 0.0 110.503 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.489 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 59.9 m95 -122.14 143.83 49.31 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.102 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 1.5 t -109.28 139.66 31.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.665 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -90.76 133.67 35.01 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.819 0.342 . . . . 0.0 111.202 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.89 148.47 19.56 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.695 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.0 mm -95.51 144.74 9.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.7 0.286 . . . . 0.0 111.257 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.539 HG21 ' HH2' ' A' ' 29' ' ' TRP . 0.2 OUTLIER -128.89 161.91 28.75 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.793 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -47.88 149.38 1.34 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.404 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 79.79 -56.8 0.38 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.926 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.18 48.72 0.03 OUTLIER Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.553 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -110.08 146.14 35.91 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.571 0.224 . . . . 0.0 110.516 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -108.73 116.98 33.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.811 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -110.64 151.14 28.03 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.514 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.7 m-85 -124.83 149.57 47.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.254 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -125.36 148.67 48.67 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.972 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.489 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 33.4 t70 -116.59 125.75 52.28 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.951 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.59 -31.78 24.13 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.478 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.496 HD11 ' HB2' ' A' ' 6' ' ' ARG . 3.5 mt -59.99 -57.61 10.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.637 0.256 . . . . 0.0 111.036 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.7 m -86.43 -41.43 14.44 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.978 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.07 48.46 2.86 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.298 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.3 144.92 48.6 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.823 0.344 . . . . 0.0 111.26 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.59 132.38 36.91 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.76 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.41 165.63 14.66 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.539 ' HH2' HG21 ' A' ' 12' ' ' THR . 89.8 m95 -127.52 6.28 6.26 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.747 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -132.14 128.15 37.47 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.38 112.34 6.3 Favored Pre-proline 0 C--O 1.233 0.205 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.744 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo . . . . . 0 C--N 1.351 0.669 0 C-N-CA 122.766 2.311 . . . . 0.0 112.63 -179.719 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.489 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 84.5 m95 . . . . . 0 C--O 1.234 0.248 0 CA-C-O 120.776 0.322 . . . . 0.0 111.377 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 21.2 t -99.94 155.4 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.717 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -112.72 122.4 47.57 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.792 0.329 . . . . 0.0 111.116 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.414 ' HA3' ' CE1' ' A' ' 59' ' ' TYR . . . -118.83 156.69 15.57 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.812 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.4 tp -109.69 127.15 54.38 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.917 0.389 . . . . 0.0 111.233 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.442 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 17.0 t -119.97 152.05 38.03 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.702 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -45.39 155.39 0.14 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.564 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.19 6.71 5.81 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.137 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.04 51.42 5.8 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.635 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.442 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 32.6 m-85 -112.72 125.62 54.51 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.579 0.228 . . . . 0.0 110.412 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.5 m -100.43 120.6 40.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.834 0.35 . . . . 0.0 111.111 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.414 ' CE1' ' HA3' ' A' ' 51' ' ' GLY . 35.8 p90 -112.45 145.45 40.16 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.388 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.531 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 17.5 m-85 -120.73 141.92 50.0 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.84 0.352 . . . . 0.0 111.349 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -121.86 145.52 48.0 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.96 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.489 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 54.9 t-20 -113.17 126.15 55.12 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.0 p -78.61 -30.19 46.39 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.359 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -55.6 -54.83 39.28 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.284 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.8 p -93.82 -33.09 13.7 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.334 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.69 58.77 2.33 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.31 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -147.71 141.34 25.54 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.829 0.347 . . . . 0.0 111.204 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 99.1 p -76.35 143.5 40.72 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.627 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.449 ' HD3' ' CH2' ' A' ' 48' ' ' TRP . 14.3 ttt85 -133.72 158.2 43.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.411 ' CZ3' ' HB3' ' A' ' 59' ' ' TYR . 95.6 m95 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.532 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.46 ' HG3' HD11 ' A' ' 23' ' ' ILE . 16.8 mtt180 . . . . . 0 C--O 1.233 0.232 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.437 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 80.0 m95 -116.29 149.91 38.47 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.09 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 3.0 t -113.69 150.73 15.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.974 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -102.46 130.18 49.18 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.829 0.347 . . . . 0.0 111.155 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.28 148.08 19.44 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.74 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.4 mm -106.68 146.68 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.693 0.282 . . . . 0.0 111.305 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.4 ' OG1' ' HB2' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -130.6 161.53 31.34 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.895 179.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 m -46.96 153.26 0.44 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.486 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 81.29 -56.33 0.28 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.03 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.72 51.05 0.05 OUTLIER Glycine 0 C--N 1.337 0.598 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.586 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.4 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 19.4 m-85 -114.82 140.96 48.51 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.66 0.267 . . . . 0.0 110.508 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -107.2 116.82 32.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.809 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -111.02 151.31 28.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.806 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 48.5 m-85 -124.56 149.82 46.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.834 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -128.75 148.25 50.84 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.329 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.437 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 10.7 t70 -113.93 127.89 56.16 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.795 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.29 -38.86 21.57 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.286 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.46 HD11 ' HG3' ' A' ' 6' ' ' ARG . 4.2 mt -61.13 -50.9 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.988 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.7 m -85.32 -40.83 16.1 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.173 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.7 37.27 8.75 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.391 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -127.6 148.02 50.36 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.82 0.343 . . . . 0.0 111.265 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 95.5 p -93.58 141.69 28.19 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.749 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.46 167.97 20.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.923 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -127.61 5.96 6.19 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.727 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -120.78 122.03 39.46 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 6.2 ttmt -64.15 119.51 56.36 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.85 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 31' ' ' LYS . 26.7 Cg_exo . . . . . 0 C--N 1.351 0.672 0 C-N-CA 122.724 2.282 . . . . 0.0 112.518 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 59.0 m95 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.716 0.293 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 9.4 p -99.26 140.29 19.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.472 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.79 122.42 33.51 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.839 0.352 . . . . 0.0 111.032 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.406 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.75 158.93 14.61 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.459 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 tp -109.88 137.26 47.92 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 111.103 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.2 152.15 46.42 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.791 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.53 153.61 0.36 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.503 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 67.59 11.37 8.34 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.076 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.63 66.74 1.93 Allowed Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.869 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -131.33 111.7 12.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.723 0.297 . . . . 0.0 110.631 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 m -81.49 120.35 24.91 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.06 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.406 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 32.9 p90 -112.77 145.83 39.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.617 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 89.9 m-85 -120.38 141.87 49.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.771 0.319 . . . . 0.0 111.01 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -127.19 148.8 50.18 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.463 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 52.6 t-20 -115.55 132.31 56.67 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.182 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.1 p -80.71 -29.75 36.4 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.4 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.1 -64.66 0.86 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.179 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.1 t -82.74 -34.8 27.09 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.994 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.28 47.14 5.86 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.602 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -133.39 136.94 45.6 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.784 0.326 . . . . 0.0 110.899 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.6 p -80.81 143.54 32.74 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.966 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.44 157.7 44.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.925 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 73.7 m95 . . . . . 0 CA--C 1.531 0.215 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.865 179.866 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.649 ' HB3' HD21 ' A' ' 22' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.229 0 CA-C-O 120.834 0.35 . . . . 0.0 110.915 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.471 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 87.4 m95 -112.35 134.24 54.0 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.96 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -112.66 141.4 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.183 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.37 131.63 36.72 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.893 0.377 . . . . 0.0 111.292 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.26 148.61 19.41 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.617 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.0 mm -99.9 143.26 13.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 120.612 0.244 . . . . 0.0 111.183 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.574 HG23 ' CD1' ' A' ' 18' ' ' TYR . 1.0 OUTLIER -126.24 161.56 27.46 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.862 0.363 . . . . 0.0 111.053 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.6 m -46.45 151.95 0.49 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.668 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 81.67 -54.98 0.26 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.191 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.64 51.52 0.05 OUTLIER Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.426 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -118.54 151.81 37.15 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.633 0.254 . . . . 0.0 110.832 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -111.85 117.21 32.16 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.07 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.574 ' CD1' HG23 ' A' ' 12' ' ' THR . 20.1 p90 -110.94 151.39 27.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.617 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -124.13 149.58 46.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.741 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -131.23 147.37 52.58 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.197 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.471 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 34.3 t70 -114.75 122.38 46.21 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.739 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.649 HD21 ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -78.18 -29.75 48.67 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.19 179.731 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.587 HD11 ' HD3' ' A' ' 6' ' ' ARG . 4.5 mt -60.52 -60.16 3.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-O 120.684 0.278 . . . . 0.0 111.016 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.07 -30.81 25.74 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.484 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.22 45.82 7.31 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.18 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -132.63 151.41 51.96 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.916 0.389 . . . . 0.0 111.666 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.07 145.99 24.09 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.902 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -133.72 168.66 18.31 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.136 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -126.97 -40.97 1.83 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.044 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.88 137.56 33.61 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.59 0.233 . . . . 0.0 110.454 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.87 139.28 97.3 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.198 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo . . . . . 0 C--N 1.35 0.654 0 C-N-CA 122.765 2.31 . . . . 0.0 112.422 179.867 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 62.7 m95 . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.755 0.312 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 14.0 p -104.95 149.34 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.175 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -96.89 122.44 39.87 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.406 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.412 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.96 157.42 15.28 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.712 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.5 tp -106.25 130.42 54.11 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.905 0.383 . . . . 0.0 111.326 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.484 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 12.1 t -119.93 152.09 37.93 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.974 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.96 153.41 0.65 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.655 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 67.25 10.86 8.04 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.195 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.92 65.8 2.12 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.347 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 31.8 m-85 -131.13 106.61 8.47 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.717 0.294 . . . . 0.0 110.748 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.4 m -73.93 120.22 19.21 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.839 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.412 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 23.4 p90 -112.9 146.14 39.48 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.637 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 49.5 m-85 -120.04 141.97 49.26 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 110.777 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -129.51 147.16 51.29 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.438 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -113.11 128.34 56.46 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.974 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.7 p -79.13 -24.01 43.64 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.408 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -60.06 -64.7 0.86 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.294 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.2 t -90.06 -34.38 15.96 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.22 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.24 53.17 2.55 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.551 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -135.46 142.34 45.52 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.913 0.387 . . . . 0.0 111.308 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.52 144.71 27.77 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.762 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -133.49 157.83 44.64 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 82.7 m95 . . . . . 0 N--CA 1.465 0.294 0 CA-C-O 120.916 0.388 . . . . 0.0 110.913 179.841 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.656 ' HB3' HD21 ' A' ' 22' ' ' LEU . 6.6 mmt85 . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.984 0.421 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.513 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 94.6 m95 -120.46 137.47 54.33 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.101 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.7 p -113.03 130.95 65.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.028 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -90.55 129.64 36.68 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.891 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.24 148.67 19.68 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.678 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.1 mm -97.85 129.05 48.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.529 0.204 . . . . 0.0 111.011 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.546 HG23 ' CE1' ' A' ' 18' ' ' TYR . 7.6 p -131.66 154.04 49.36 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.714 0.292 . . . . 0.0 111.076 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.2 -150.14 0.42 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.758 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -81.29 3.49 23.88 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.48 68.91 0.01 OUTLIER Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.084 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -138.52 109.87 6.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.692 0.282 . . . . 0.0 110.596 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -78.12 116.72 18.79 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.963 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.546 ' CE1' HG23 ' A' ' 12' ' ' THR . 19.9 p90 -111.22 151.91 27.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.743 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -123.85 149.25 45.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.794 0.33 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -136.27 146.11 46.31 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.513 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 24.5 t70 -113.33 124.13 51.76 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.981 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.656 HD21 ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -81.43 -28.63 34.17 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.712 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.9 mt -60.46 -52.58 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.696 0.284 . . . . 0.0 110.998 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.9 m -93.07 -31.61 14.77 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.335 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.01 48.38 5.18 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.307 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -131.99 147.69 52.47 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.855 0.36 . . . . 0.0 111.735 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.76 131.07 41.0 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.731 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -121.53 168.86 11.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.914 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -127.0 -34.95 2.3 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.089 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -82.54 145.19 29.88 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.66 0.267 . . . . 0.0 110.643 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 7.3 ttmt -70.13 135.2 87.13 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.177 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 31' ' ' LYS . 36.1 Cg_exo . . . . . 0 C--N 1.353 0.801 0 C-N-CA 122.94 2.426 . . . . 0.0 112.769 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.442 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 71.0 m95 . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.693 0.282 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 2.1 t -104.12 155.69 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.725 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.414 ' HG2' HG22 ' A' ' 58' ' ' THR . 2.7 tm-20 -112.98 121.91 46.05 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.771 0.32 . . . . 0.0 111.307 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.445 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -119.33 158.27 15.08 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.86 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.82 127.96 55.97 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.756 0.313 . . . . 0.0 110.979 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.17 151.77 44.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.729 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.07 -158.67 0.31 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.809 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -57.31 -26.23 60.58 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.29 48.72 0.02 OUTLIER Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.121 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -98.37 123.87 42.72 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.414 HG22 ' HG2' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -90.99 120.52 32.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.32 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.445 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 25.1 p90 -112.73 145.68 40.09 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.455 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 13.9 m-85 -120.4 141.85 49.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.844 0.354 . . . . 0.0 111.044 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -124.81 146.53 49.2 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.627 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.442 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 35.4 t30 -113.6 122.74 48.13 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.543 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.3 p -74.98 -25.07 58.58 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.484 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -55.14 -61.79 2.09 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.381 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 t -97.27 -32.88 11.68 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.387 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.45 63.26 1.18 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.44 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -145.6 142.7 29.34 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.836 0.35 . . . . 0.0 111.617 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.88 141.24 28.92 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.91 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.27 156.67 48.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.781 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 45.0 m95 . . . . . 0 CA--C 1.532 0.253 0 CA-C-O 120.838 0.351 . . . . 0.0 110.652 179.525 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.424 ' HB2' HD11 ' A' ' 23' ' ' ILE . 14.6 mtp180 . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.887 0.375 . . . . 0.0 110.411 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.521 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 82.3 m95 -110.45 147.21 34.52 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.054 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 p -112.97 139.06 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.768 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.29 130.53 36.39 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.93 0.395 . . . . 0.0 110.909 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.3 147.91 19.37 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.779 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.3 mm -93.33 142.62 12.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.625 0.25 . . . . 0.0 111.107 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.39 161.97 24.85 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.673 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -50.0 151.18 2.01 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.383 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 80.73 -54.38 0.33 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.132 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.78 52.24 0.04 OUTLIER Glycine 0 C--N 1.336 0.563 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.357 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -118.67 146.18 44.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.599 0.238 . . . . 0.0 110.67 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -105.69 117.05 33.04 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.953 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -110.94 151.83 27.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.747 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -124.33 149.56 46.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.966 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -135.12 144.26 47.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.785 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.521 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 13.5 t70 -110.08 124.33 51.31 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.896 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.78 -32.08 35.57 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.936 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' A' ' 6' ' ' ARG . 3.5 mt -59.16 -54.73 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.757 0.313 . . . . 0.0 111.059 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.4 p -85.97 -35.7 20.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.167 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.39 54.11 3.07 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.28 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -140.73 147.03 38.53 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.879 0.371 . . . . 0.0 111.522 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.1 p -88.03 132.76 34.15 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.565 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -126.27 166.94 16.17 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.869 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -127.52 -43.99 1.56 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.031 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -70.11 150.93 46.03 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.783 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -99.08 102.54 15.88 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.94 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 C--N 1.349 0.585 0 C-N-CA 122.657 2.238 . . . . 0.0 112.605 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 90.1 m95 . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 120.806 0.336 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 2.2 t -106.3 133.77 49.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.65 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.1 122.26 33.6 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.825 0.345 . . . . 0.0 110.865 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.431 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.83 158.53 14.79 Favored Glycine 0 C--N 1.332 0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.581 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.8 tp -109.76 136.03 49.73 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.867 0.365 . . . . 0.0 111.236 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 3.9 t -123.88 151.81 43.07 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.641 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.42 155.18 0.78 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.481 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 69.91 7.4 6.21 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.278 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.83 63.04 2.15 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.911 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.419 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 28.4 m-85 -127.77 128.38 45.22 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.553 0.216 . . . . 0.0 110.544 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.68 120.44 39.12 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.829 0.347 . . . . 0.0 111.013 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.431 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 30.5 p90 -112.91 146.18 39.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.536 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.434 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 55.6 m-85 -119.8 141.88 49.1 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.852 0.358 . . . . 0.0 110.884 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -128.15 147.69 50.56 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.982 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -114.11 130.67 56.57 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.679 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.8 p -78.44 -29.06 46.81 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.862 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -59.98 -66.47 0.51 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.386 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.1 t -82.42 -39.13 23.05 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.475 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.3 40.61 6.04 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.929 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -125.46 133.95 52.25 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.813 0.34 . . . . 0.0 110.872 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.05 148.43 37.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.736 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -133.2 153.61 51.38 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.878 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 94.4 m95 . . . . . 0 N--CA 1.464 0.264 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.908 179.615 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.594 ' HB2' HD11 ' A' ' 23' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--O 1.234 0.262 0 CA-C-O 120.993 0.425 . . . . 0.0 110.627 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.495 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 97.0 m95 -116.18 151.49 35.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.142 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 2.8 t -124.7 131.51 72.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.613 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -90.69 130.05 36.73 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.939 0.399 . . . . 0.0 111.099 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.07 148.5 19.59 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.678 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.1 mm -97.86 144.25 11.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.639 0.257 . . . . 0.0 111.086 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.33 162.19 28.54 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.895 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.22 149.65 0.7 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.739 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 79.83 -55.98 0.38 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.295 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.57 52.44 0.04 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.336 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -116.48 134.66 54.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.617 0.246 . . . . 0.0 110.531 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -98.3 116.86 31.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.845 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.418 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 19.8 p90 -110.75 151.34 27.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.789 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 64.0 m-85 -124.2 149.52 46.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.131 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -125.99 147.34 49.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.035 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.495 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 32.9 t70 -118.92 122.09 41.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.704 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.44 -26.76 35.06 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.321 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.594 HD11 ' HB2' ' A' ' 6' ' ' ARG . 7.5 mt -58.69 -48.71 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.766 0.317 . . . . 0.0 110.984 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.2 m -100.83 -35.49 9.41 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.346 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.44 51.31 3.14 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.127 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -137.69 154.83 49.62 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.963 0.411 . . . . 0.0 111.78 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.95 143.57 26.35 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.853 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -134.18 168.63 18.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.037 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.418 ' CZ3' ' HB3' ' A' ' 18' ' ' TYR . 96.5 m95 -127.24 -47.9 1.46 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.582 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -73.47 125.23 27.43 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.346 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 9.8 ttmt -60.95 138.0 93.91 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.175 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 31' ' ' LYS . 36.0 Cg_exo . . . . . 0 C--N 1.353 0.771 0 C-N-CA 122.82 2.347 . . . . 0.0 112.59 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 33.0 m95 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.655 0.264 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 12.0 p -96.43 145.44 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -94.14 122.15 36.37 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.8 0.334 . . . . 0.0 111.105 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -119.0 153.02 17.08 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.53 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.4 tp -109.78 138.94 45.43 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.998 0.427 . . . . 0.0 111.687 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.03 152.38 38.67 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.685 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 0.4 OUTLIER -45.14 152.24 0.27 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.742 -179.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 25.6 m-20 81.04 -44.29 0.21 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.14 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.22 48.33 0.11 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.425 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -114.27 130.04 56.64 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.6 m -99.36 120.45 39.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.876 0.369 . . . . 0.0 111.213 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -112.56 145.59 40.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.567 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 93.4 m-85 -120.42 142.06 49.56 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.747 0.308 . . . . 0.0 111.068 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -120.93 150.6 40.84 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.061 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.463 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 48.8 t-20 -114.31 130.14 56.66 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.281 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.3 p -82.66 -26.11 32.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.452 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -56.77 -61.8 2.18 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.653 -0.248 . . . . 0.0 111.353 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.0 p -93.8 -46.92 7.0 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.136 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.16 55.27 0.87 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.65 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -134.59 132.06 38.61 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.715 0.293 . . . . 0.0 110.832 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 86.9 p -71.94 148.76 45.7 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.758 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.59 157.71 45.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.211 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.6 m95 . . . . . 0 CA--C 1.532 0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.611 179.517 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.486 ' HD2' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.21 0 CA-C-O 120.942 0.401 . . . . 0.0 110.135 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -121.52 135.93 54.99 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.812 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.6 p -119.24 143.02 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.134 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -96.66 133.48 41.14 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.827 0.346 . . . . 0.0 111.215 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.41 148.51 19.63 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.736 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.426 HD12 ' CD2' ' A' ' 17' ' ' HIS . 24.9 mm -102.52 123.2 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 120.63 0.252 . . . . 0.0 110.948 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.38 157.72 44.81 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.99 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.4 t 60.83 -148.29 0.43 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.69 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.99 -28.93 40.88 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 111.546 0.202 . . . . 0.0 111.546 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.45 46.72 0.03 OUTLIER Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.335 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -95.46 120.11 35.14 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.426 ' CD2' HD12 ' A' ' 11' ' ' ILE . 15.7 m170 -73.77 116.68 14.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.895 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -111.24 151.96 27.68 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.747 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -123.75 149.53 45.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.489 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -136.07 148.95 48.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.969 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -115.08 123.02 47.94 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.01 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.4 ' CG ' ' HB3' ' A' ' 6' ' ' ARG . 0.1 OUTLIER -83.53 -21.19 32.81 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.391 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.486 HG13 ' HD2' ' A' ' 6' ' ' ARG . 9.6 mt -51.95 -55.81 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 120.611 0.243 . . . . 0.0 111.038 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.29 -40.75 4.58 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.054 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.14 54.04 0.68 Allowed Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.48 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -127.74 110.27 12.47 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.717 0.294 . . . . 0.0 110.997 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.0 p -69.46 132.63 46.62 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.675 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.27 168.06 16.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.141 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -127.67 6.6 6.19 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.501 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -118.0 129.28 55.49 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -70.49 113.66 20.06 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.914 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 C--N 1.351 0.666 0 C-N-CA 122.672 2.248 . . . . 0.0 112.61 -179.939 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 87.3 m95 . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.9 t -110.7 139.25 35.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.624 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -91.06 122.07 33.4 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.82 0.343 . . . . 0.0 111.018 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.445 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.82 160.13 14.16 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.491 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.0 tp -113.1 135.46 53.78 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.847 0.356 . . . . 0.0 111.163 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.1 152.08 40.24 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.815 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -47.51 155.28 0.37 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.463 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 67.6 11.25 8.28 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.247 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.05 66.46 1.91 Allowed Glycine 0 C--N 1.338 0.667 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.061 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -131.95 120.12 22.05 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.655 0.264 . . . . 0.0 110.617 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.3 m -89.16 120.49 30.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.883 0.373 . . . . 0.0 111.062 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.445 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 33.4 p90 -112.75 146.06 39.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.392 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 80.1 m-85 -120.09 141.54 49.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.748 0.309 . . . . 0.0 111.063 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -127.75 149.08 50.4 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -119.44 129.33 54.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.932 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.8 p -74.94 -35.36 62.16 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.537 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -59.6 -60.19 4.24 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.694 0.283 . . . . 0.0 111.177 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.0 p -78.78 -34.43 45.53 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.204 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.49 44.66 20.77 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.25 -0.5 . . . . 0.0 112.591 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -136.74 134.4 37.08 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.886 0.374 . . . . 0.0 111.057 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.39 145.75 39.18 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.624 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -133.05 157.55 44.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.059 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 72.3 m95 . . . . . 0 C--O 1.234 0.241 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 179.658 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.461 ' HB2' HD11 ' A' ' 23' ' ' ILE . 22.4 mtt180 . . . . . 0 CA--C 1.531 0.216 0 CA-C-O 120.96 0.41 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.412 ' CZ3' ' HB2' ' A' ' 28' ' ' GLN . 86.8 m95 -114.54 140.48 48.73 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.954 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 11.8 p -110.7 133.25 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.594 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -90.44 130.15 36.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.003 0.43 . . . . 0.0 111.221 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.15 148.57 19.51 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.371 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.411 HD12 ' N ' ' A' ' 11' ' ' ILE . 1.5 mp -101.08 138.18 26.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.665 0.269 . . . . 0.0 110.937 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.68 161.76 20.15 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.167 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.8 m -41.87 148.64 0.16 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.739 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.452 ' HB3' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 82.16 -57.04 0.22 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.058 -179.528 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.79 58.39 0.03 OUTLIER Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.446 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.452 ' CE2' ' HB3' ' A' ' 14' ' ' GLU . 29.9 m-85 -124.78 138.78 54.26 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.718 0.295 . . . . 0.0 111.018 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -100.27 117.27 34.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.916 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.421 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 24.9 p90 -110.89 151.53 27.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.557 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 64.9 m-85 -124.39 149.54 46.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.911 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -131.84 145.81 51.77 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.175 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.406 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 2.6 t0 -110.64 123.13 49.41 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.098 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.82 -25.68 27.95 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.224 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.461 HD11 ' HB2' ' A' ' 6' ' ' ARG . 2.0 mp -57.3 -54.73 26.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.098 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.6 m -97.62 -38.55 9.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.099 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.07 53.24 1.52 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.265 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -135.75 129.33 32.42 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.797 0.332 . . . . 0.0 111.251 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.54 145.63 38.93 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.412 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -132.91 168.36 18.57 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.073 -179.672 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.421 ' CZ3' ' HB3' ' A' ' 18' ' ' TYR . 90.2 m95 -127.46 -47.13 1.44 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.847 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.7 134.09 37.13 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.664 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -68.16 133.91 91.54 Favored Pre-proline 0 N--CA 1.463 0.216 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.191 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo . . . . . 0 C--N 1.35 0.643 0 C-N-CA 122.659 2.239 . . . . 0.0 112.606 179.95 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.471 ' CH2' ' HB2' ' A' ' 62' ' ' ASN . 65.5 m95 . . . . . 0 C--O 1.233 0.231 0 CA-C-O 120.68 0.276 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 12.8 p -104.02 139.52 24.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.761 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -90.76 122.16 33.26 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.923 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.72 156.36 15.7 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.611 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.7 tp -108.99 137.85 46.26 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.76 0.314 . . . . 0.0 111.247 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.99 152.08 48.35 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.95 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -47.28 154.19 0.42 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.77 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 67.25 10.96 8.11 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.118 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.18 66.56 1.94 Allowed Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.171 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -130.67 108.05 9.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.742 0.306 . . . . 0.0 110.694 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.6 m -80.63 120.44 24.57 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.864 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.427 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 33.2 p90 -112.66 146.16 39.15 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.014 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 70.3 m-85 -119.99 141.92 49.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.804 0.335 . . . . 0.0 110.877 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -127.06 145.7 50.63 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.08 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.471 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 51.4 t-20 -114.02 126.23 54.89 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.162 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.0 p -75.92 -24.61 55.57 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.445 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -56.23 -62.43 1.72 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.287 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.0 p -91.37 -37.66 13.09 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.066 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.73 49.69 2.88 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.131 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -135.48 138.18 42.88 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.917 0.389 . . . . 0.0 111.231 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.35 140.45 38.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.805 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -133.57 157.85 44.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.774 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 69.1 m95 . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 120.879 0.371 . . . . 0.0 110.753 179.818 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.492 ' HB3' HD21 ' A' ' 22' ' ' LEU . 1.5 mmt180 . . . . . 0 C--O 1.233 0.216 0 CA-C-O 120.925 0.393 . . . . 0.0 110.542 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.57 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 80.1 m95 -108.29 132.11 54.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.905 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 1.6 t -103.46 132.14 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.469 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.66 129.65 36.75 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.965 0.412 . . . . 0.0 111.311 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.408 ' HA3' ' CE1' ' A' ' 18' ' ' TYR . . . -135.47 148.72 19.73 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.571 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.0 mm -95.43 125.82 48.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.481 0.182 . . . . 0.0 110.69 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.25 148.03 51.97 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.873 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.51 -150.54 0.39 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.549 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -56.62 -26.33 55.45 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.68 43.27 0.02 OUTLIER Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.635 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -93.24 111.95 23.74 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -73.35 116.69 14.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.408 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 17.9 p90 -110.86 151.72 27.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.203 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 55.3 m-85 -123.97 149.17 46.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.873 0.368 . . . . 0.0 110.975 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -133.99 139.46 46.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.798 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.57 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 16.6 t70 -110.14 126.38 54.0 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.551 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.492 HD21 ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -83.43 -31.19 26.75 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.742 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.3 mt -56.56 -45.53 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.78 0.324 . . . . 0.0 111.031 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.36 -35.2 9.67 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.166 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.92 41.52 6.29 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.171 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -128.88 153.62 47.3 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.895 0.379 . . . . 0.0 111.372 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.5 p -95.37 149.73 21.05 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.89 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.85 167.17 21.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.955 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -127.54 6.38 6.26 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.923 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -136.43 138.12 41.16 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.08 114.34 48.03 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.899 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo . . . . . 0 C--N 1.352 0.712 0 C-N-CA 122.805 2.337 . . . . 0.0 112.483 -179.87 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.471 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 44.9 m95 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.593 0.235 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 p -104.44 145.89 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.403 ' HG3' ' CG2' ' A' ' 58' ' ' THR . 41.1 tt0 -96.97 122.55 40.08 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.103 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.62 158.33 14.84 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.621 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.4 tp -106.59 141.7 37.44 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.862 0.363 . . . . 0.0 111.267 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.443 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 34.1 t -133.58 152.22 51.85 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.826 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.79 153.52 0.39 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.55 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.59 11.41 8.1 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.12 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.81 65.85 2.28 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.969 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.443 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 34.3 m-85 -128.19 103.89 7.44 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.756 0.312 . . . . 0.0 110.7 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.504 HG22 ' CE1' ' A' ' 60' ' ' TYR . 29.4 m -76.19 120.05 20.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.852 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -112.87 145.96 39.77 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.721 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.504 ' CE1' HG22 ' A' ' 58' ' ' THR . 11.0 m-85 -120.33 141.86 49.66 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.736 0.303 . . . . 0.0 110.79 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -124.57 152.36 43.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.471 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 18.3 t-20 -113.68 136.37 52.91 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.771 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.9 p -87.27 -30.84 20.59 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.814 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -60.58 -62.96 1.48 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.65 0.262 . . . . 0.0 111.045 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 75.1 p -84.02 -44.56 14.0 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.094 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.11 48.63 2.39 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.453 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -134.23 140.74 46.67 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.761 0.315 . . . . 0.0 110.855 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.2 p -80.71 148.99 29.9 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.0 tpt85 -134.02 155.67 49.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.732 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 87.8 m95 . . . . . 0 C--O 1.234 0.244 0 CA-C-O 120.788 0.327 . . . . 0.0 111.286 -179.98 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.501 ' HB2' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 120.853 0.358 . . . . 0.0 111.109 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.423 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 82.2 m95 -121.26 137.39 54.71 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.052 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.5 p -115.55 133.91 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.961 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -90.61 132.09 35.94 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.866 0.365 . . . . 0.0 111.174 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.73 147.73 18.76 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.549 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.3 mm -95.96 141.65 15.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.634 0.254 . . . . 0.0 110.914 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.09 162.08 25.37 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.805 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 m -46.66 152.7 0.45 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.528 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 77.48 -54.72 0.53 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.424 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.24 50.49 0.04 OUTLIER Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.578 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -115.85 141.2 48.41 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.506 0.193 . . . . 0.0 110.528 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -105.54 117.07 33.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.77 0.319 . . . . 0.0 110.825 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -110.74 151.27 27.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.721 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -124.84 149.23 47.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.751 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -127.48 144.64 51.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.076 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.423 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 29.1 t70 -117.34 123.23 45.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.679 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.409 HD11 ' HG2' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -84.35 -25.72 28.96 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.157 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 6' ' ' ARG . 6.5 mt -58.71 -46.7 90.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.576 0.227 . . . . 0.0 110.871 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -104.46 -32.24 9.09 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.526 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.56 45.39 5.24 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.265 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -132.77 132.45 42.26 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.815 0.34 . . . . 0.0 111.378 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.2 p -86.26 142.0 28.88 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.709 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.02 167.62 18.75 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.193 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -127.72 7.01 6.19 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.672 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.6 130.12 51.85 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.34 113.93 14.8 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.004 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo . . . . . 0 C--N 1.353 0.79 0 C-N-CA 122.996 2.464 . . . . 0.0 112.828 -179.518 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.523 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 72.0 m95 . . . . . 0 C--O 1.233 0.209 0 CA-C-O 120.711 0.291 . . . . 0.0 111.036 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.3 p -107.22 141.61 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.022 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -90.78 122.33 33.42 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.016 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.91 158.4 14.87 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.469 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.45 131.65 55.46 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.866 0.365 . . . . 0.0 111.424 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.08 151.94 27.5 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.794 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -44.56 148.54 0.48 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.327 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 82.6 -51.67 0.19 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.073 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 140.26 51.18 0.05 OUTLIER Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.451 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -117.51 118.68 32.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.608 0.242 . . . . 0.0 110.498 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.46 120.39 25.41 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.846 0.355 . . . . 0.0 111.117 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -112.75 146.11 39.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.436 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -119.75 141.93 49.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.843 0.354 . . . . 0.0 110.84 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -123.33 154.74 38.5 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.859 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.523 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 39.3 t30 -113.5 122.14 46.39 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.924 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.3 p -74.26 -30.74 62.26 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.716 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -64.58 -66.97 0.47 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.517 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.2 p -78.09 -48.95 14.87 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.517 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.82 42.25 2.7 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.599 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -129.67 133.24 46.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.763 0.316 . . . . 0.0 110.894 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.19 146.72 45.35 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.7 157.64 44.37 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.075 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 87.6 m95 . . . . . 0 CA--C 1.532 0.256 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.84 179.484 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.632 ' HB3' HD21 ' A' ' 22' ' ' LEU . 5.8 mmm180 . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.752 0.311 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.502 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 91.1 m95 -127.14 137.05 52.9 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.047 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 14.9 p -117.34 147.85 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.265 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.68 131.67 46.46 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.194 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.59 148.58 19.68 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.956 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.6 mm -94.35 144.17 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.72 0.295 . . . . 0.0 111.185 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.603 HG23 ' CD1' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -127.16 161.67 27.96 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.969 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 t -45.76 152.22 0.37 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.637 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 80.66 -55.82 0.33 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.187 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.16 51.9 0.05 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.484 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -118.32 151.65 37.3 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.57 0.224 . . . . 0.0 110.585 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -109.94 116.7 32.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.798 0.332 . . . . 0.0 110.871 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.603 ' CD1' HG23 ' A' ' 12' ' ' THR . 17.2 p90 -111.15 151.43 28.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.941 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 57.0 m-85 -124.41 149.29 46.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.783 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -125.86 149.53 48.59 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.232 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.672 ' OD1' HD12 ' A' ' 23' ' ' ILE . 23.5 t70 -119.11 122.02 41.12 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.022 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.632 HD21 ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -82.82 -26.46 31.69 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.672 HD12 ' OD1' ' A' ' 21' ' ' ASP . 3.5 mt -56.53 -46.8 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.759 0.314 . . . . 0.0 111.084 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m -103.83 -44.38 5.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.003 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.23 36.9 3.23 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.57 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -119.32 156.88 29.21 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.803 0.335 . . . . 0.0 111.297 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 p -100.09 131.14 46.22 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.033 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -122.2 168.4 12.05 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.832 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.433 ' CZ3' ' HB3' ' A' ' 18' ' ' TYR . 93.3 m95 -127.38 -45.34 1.52 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.078 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -73.41 119.6 17.87 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.578 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.02 125.27 91.25 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.748 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 C--N 1.349 0.582 0 C-N-CA 122.631 2.22 . . . . 0.0 112.236 179.826 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 94.2 m95 . . . . . 0 N--CA 1.464 0.231 0 CA-C-O 120.516 0.198 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.6 t -111.46 131.66 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.419 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.468 ' HG3' ' CD1' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -94.6 122.25 37.0 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.941 0.401 . . . . 0.0 111.521 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.446 ' HA3' ' CE2' ' A' ' 59' ' ' TYR . . . -118.86 158.0 15.02 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.265 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.43 121.59 45.26 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.753 0.277 . . . . 0.0 110.943 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.17 142.13 31.35 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.803 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 55.73 95.06 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.461 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 68.1 -63.29 0.33 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.052 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.37 40.21 0.05 OUTLIER Glycine 0 CA--C 1.518 0.272 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.696 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -85.31 121.28 27.81 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.11 120.03 23.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.998 0.427 . . . . 0.0 111.229 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.446 ' CE2' ' HA3' ' A' ' 51' ' ' GLY . 25.2 p90 -113.05 146.18 39.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.816 179.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.485 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 2.6 m-85 -119.59 141.74 49.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.935 0.398 . . . . 0.0 111.165 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -129.65 155.02 46.52 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.573 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -113.48 129.23 56.59 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.891 0.377 . . . . 0.0 111.265 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.6 p -93.39 22.27 5.41 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.757 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -95.7 -60.04 1.74 Allowed 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 120.666 0.269 . . . . 0.0 110.707 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.8 t -110.39 -36.2 5.85 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.14 73.58 0.71 Allowed Glycine 0 C--N 1.335 0.513 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.707 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -149.9 126.89 11.18 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.819 0.342 . . . . 0.0 111.007 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.49 150.69 25.84 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.697 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.6 ttt-85 -130.73 155.35 46.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.261 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.8 m95 . . . . . 0 CA--C 1.532 0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 179.602 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.419 ' CG ' HD11 ' A' ' 23' ' ' ILE . 31.3 mmt180 . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 121.08 0.467 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.433 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 80.9 m95 -105.75 140.17 39.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.754 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 p -116.17 133.57 62.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.085 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -90.7 131.51 36.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.272 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.25 148.58 19.65 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.66 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.8 mm -98.01 127.08 50.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.585 0.231 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.574 HG23 ' CE1' ' A' ' 18' ' ' TYR . 11.2 p -133.43 150.06 51.78 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.947 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.02 -149.78 0.41 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.622 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.28 -29.57 47.64 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.13 44.09 0.02 OUTLIER Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.56 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -92.81 112.75 24.82 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -74.54 116.8 15.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.949 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.574 ' CE1' HG23 ' A' ' 12' ' ' THR . 20.7 p90 -111.02 151.51 27.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.517 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -124.41 148.81 47.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.949 0.405 . . . . 0.0 110.93 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -136.56 147.88 47.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.132 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.433 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 4.7 t0 -112.09 122.05 46.68 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.653 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.39 -26.94 27.99 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.274 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.419 HD11 ' CG ' ' A' ' 6' ' ' ARG . 6.3 mt -60.72 -53.39 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.733 0.302 . . . . 0.0 110.871 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.06 -36.51 12.08 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.22 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.04 60.19 1.34 Allowed Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.293 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -142.64 129.24 20.27 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.844 0.354 . . . . 0.0 111.415 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.7 p -85.29 132.19 34.29 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.54 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -131.91 168.3 18.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.22 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.404 ' HH2' ' HG1' ' A' ' 12' ' ' THR . 73.3 m95 -127.81 7.37 6.18 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.705 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -120.44 139.89 52.18 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.662 0.268 . . . . 0.0 110.713 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -77.64 131.67 70.47 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.962 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 C--N 1.35 0.629 0 C-N-CA 122.679 2.253 . . . . 0.0 112.253 179.882 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.468 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 76.5 m95 . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.557 0.218 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.9 p -108.37 137.88 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.957 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -91.08 122.05 33.39 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.001 0.429 . . . . 0.0 110.952 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.75 151.38 17.75 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.349 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.81 133.4 54.83 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.911 0.386 . . . . 0.0 111.419 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.1 t -112.29 151.8 29.25 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.84 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -45.08 154.63 0.14 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.333 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 80.54 -55.58 0.34 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.061 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.16 55.06 0.03 OUTLIER Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.407 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -124.77 124.24 41.7 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.632 0.253 . . . . 0.0 110.538 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.3 m -93.56 120.95 34.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.85 0.357 . . . . 0.0 111.068 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -112.56 146.21 38.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.56 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -119.93 141.86 49.24 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.848 0.356 . . . . 0.0 110.942 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -125.91 147.19 49.55 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.926 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.468 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 53.3 t30 -113.33 122.76 48.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.668 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.1 p -77.75 -23.1 49.4 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.558 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -55.08 -60.94 2.69 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.405 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.7 t -102.27 -38.43 7.66 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.441 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.72 46.8 1.73 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.607 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -123.54 121.12 34.81 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.781 0.324 . . . . 0.0 110.674 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.2 p -71.32 150.14 45.41 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -133.82 157.79 45.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.088 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 94.1 m95 . . . . . 0 CA--C 1.533 0.32 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.049 179.695 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.445 ' CD ' HD11 ' A' ' 23' ' ' ILE . 1.5 mpt_? . . . . . 0 C--O 1.234 0.269 0 CA-C-O 120.999 0.428 . . . . 0.0 110.464 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.409 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 89.6 m95 -125.11 148.92 48.33 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.228 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 2.0 t -118.14 132.88 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.503 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -90.89 129.83 36.89 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.942 0.401 . . . . 0.0 111.53 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.52 148.69 19.72 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.653 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.6 mm -105.18 125.47 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.5 0.19 . . . . 0.0 110.809 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.89 153.76 51.53 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.34 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.1 -148.02 0.43 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.748 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -55.03 -29.24 57.0 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.56 44.43 0.02 OUTLIER Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.358 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -92.51 113.95 26.36 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -73.86 116.64 14.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.845 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -111.02 151.46 27.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.218 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 85.3 m-85 -124.05 149.39 46.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.844 0.354 . . . . 0.0 111.092 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -131.87 140.36 49.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.77 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.409 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 9.5 t70 -109.8 125.67 52.97 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.74 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.15 -29.67 28.45 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.714 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.445 HD11 ' CD ' ' A' ' 6' ' ' ARG . 4.1 mt -54.65 -49.34 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.804 0.335 . . . . 0.0 110.882 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m -101.92 -39.13 7.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.292 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.73 44.84 3.29 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.347 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -127.91 135.54 50.12 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 111.477 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.8 t -85.94 147.57 26.17 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.665 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -133.74 167.79 19.88 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.92 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -127.44 8.94 6.54 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.663 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -132.06 137.98 47.99 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.424 ' HE3' ' OH ' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -62.09 132.66 93.84 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.351 -179.49 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 C--N 1.35 0.641 0 C-N-CA 122.681 2.254 . . . . 0.0 112.268 179.768 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 78.3 m95 . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.592 0.234 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.2 p -106.33 132.29 53.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.462 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -90.59 122.0 33.01 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.915 0.388 . . . . 0.0 110.945 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.409 ' HA3' ' CE1' ' A' ' 59' ' ' TYR . . . -118.86 152.88 17.17 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.351 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.74 129.05 55.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.954 0.407 . . . . 0.0 111.296 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.422 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 40.2 t -109.39 151.94 25.98 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.648 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -45.64 151.98 0.37 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.368 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.405 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 0.3 OUTLIER 82.77 -53.68 0.19 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.9 -179.334 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.52 55.78 0.04 OUTLIER Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.445 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 22.0 m-85 -123.7 129.25 50.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.524 0.202 . . . . 0.0 110.749 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.3 m -98.1 120.85 39.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.854 0.359 . . . . 0.0 111.086 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.409 ' CE1' ' HA3' ' A' ' 51' ' ' GLY . 30.0 p90 -112.64 145.94 39.51 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.596 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -120.25 142.26 49.21 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.736 0.303 . . . . 0.0 110.86 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -124.2 152.25 43.12 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.851 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.61 122.51 47.89 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.911 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.3 p -78.74 -24.97 44.51 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.447 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -59.47 -63.41 1.31 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.432 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.0 t -91.24 -40.27 11.62 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.377 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.87 56.43 1.08 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.736 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -136.22 139.2 42.58 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.802 0.334 . . . . 0.0 110.865 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 p -80.58 146.35 31.28 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.789 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.48 149.29 49.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.07 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 63.5 m95 . . . . . 0 CA--C 1.531 0.239 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.013 179.75 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.0 mtt85 . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.752 0.311 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.44 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 58.2 m95 -126.15 141.21 52.03 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.117 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.8 p -114.72 134.48 57.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.826 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -90.64 130.87 36.61 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.913 0.387 . . . . 0.0 111.304 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.11 148.69 19.68 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.74 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.7 mm -98.09 125.74 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 120.452 0.168 . . . . 0.0 111.021 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.518 HG23 ' CE1' ' A' ' 18' ' ' TYR . 9.3 p -132.99 155.36 49.31 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.024 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.1 t 58.73 -148.09 0.48 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.67 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -62.0 -23.69 66.58 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.89 43.05 0.02 OUTLIER Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.577 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -94.0 112.24 24.05 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -75.0 116.45 15.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.002 0.429 . . . . 0.0 110.72 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.518 ' CE1' HG23 ' A' ' 12' ' ' THR . 14.2 p90 -111.03 151.71 27.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.388 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -124.05 149.35 46.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.819 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -134.42 147.98 50.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.679 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.44 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 10.2 t70 -109.93 122.1 46.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.679 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.67 -23.64 29.35 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.4 mt -57.85 -52.53 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.636 0.255 . . . . 0.0 110.953 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.67 -41.12 6.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.16 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.44 53.02 0.95 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.433 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -133.57 127.73 33.73 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.857 0.361 . . . . 0.0 111.281 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.7 t -76.11 145.75 39.78 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.762 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -132.66 168.19 18.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.121 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -127.57 -46.79 1.44 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.802 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.99 129.97 35.03 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.537 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -71.11 133.93 85.54 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.015 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo . . . . . 0 C--N 1.351 0.703 0 C-N-CA 122.61 2.207 . . . . 0.0 112.576 -179.938 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.453 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 85.4 m95 . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.715 0.293 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.5 p -105.64 136.8 38.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.855 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -91.54 122.0 33.73 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.817 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.422 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.75 153.38 16.98 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.431 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.23 141.5 45.86 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.113 0.482 . . . . 0.0 111.544 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.409 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 30.1 t -123.54 152.27 41.97 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.497 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 0.7 OUTLIER -44.7 156.23 0.09 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.849 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 22.2 m-20 76.88 -54.67 0.57 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.889 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.12 54.29 0.03 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.131 -0.556 . . . . 0.0 112.264 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 55' ' ' ASP . 18.3 m-85 -120.01 118.0 29.5 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.656 0.265 . . . . 0.0 110.811 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.47 120.67 29.0 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.01 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.432 ' HB3' ' CZ3' ' A' ' 70' ' ' TRP . 30.8 p90 -112.51 145.97 39.31 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.744 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -120.23 142.03 49.4 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.846 0.355 . . . . 0.0 110.95 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -130.27 150.55 51.46 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.341 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.461 HD22 HG22 ' A' ' 65' ' ' THR . 56.3 t30 -114.37 133.48 55.67 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.052 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.4 p -82.09 -26.26 33.79 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.617 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -62.58 -66.78 0.49 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.36 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.461 HG22 HD22 ' A' ' 62' ' ' ASN . 6.9 t -84.5 -34.77 23.27 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.307 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.21 49.88 3.83 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.601 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -129.52 137.07 50.59 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.801 0.334 . . . . 0.0 111.138 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.51 146.17 27.05 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.66 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.04 155.59 50.5 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.432 ' CZ3' ' HB3' ' A' ' 59' ' ' TYR . 94.1 m95 . . . . . 0 CA--C 1.532 0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.926 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.572 ' HB2' HD11 ' A' ' 23' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.235 0 CA-C-O 120.831 0.348 . . . . 0.0 111.409 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -127.98 148.42 50.52 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.892 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 2.2 t -119.3 129.06 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.758 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.76 131.98 36.11 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.95 0.405 . . . . 0.0 111.445 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.12 147.18 19.07 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.404 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.2 mm -100.39 123.9 53.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 120.465 0.174 . . . . 0.0 110.875 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.02 156.17 47.84 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.965 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 57.14 -148.32 0.5 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.523 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.43 -21.25 66.19 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.76 44.58 0.02 OUTLIER Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.411 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -92.83 105.46 17.59 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -73.36 116.67 14.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.929 0.395 . . . . 0.0 110.959 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.419 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 30.1 p90 -110.9 151.51 27.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.466 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 56.1 m-85 -124.32 149.47 46.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 111.21 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -131.81 142.26 49.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.964 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -109.54 124.35 50.95 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.528 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.66 -26.45 27.78 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.214 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.572 HD11 ' HB2' ' A' ' 6' ' ' ARG . 7.8 mt -62.65 -45.44 98.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.7 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 t -99.64 -35.83 9.7 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.301 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.9 62.52 1.3 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.335 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.19 157.19 33.93 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.94 0.4 . . . . 0.0 111.866 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.3 t -101.52 151.98 21.32 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.711 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.91 168.12 19.35 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.043 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.419 ' CZ3' ' HB3' ' A' ' 18' ' ' TYR . 98.3 m95 -127.57 7.49 6.32 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.706 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.12 131.97 47.3 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.544 0.211 . . . . 0.0 110.474 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -73.62 126.04 90.07 Favored Pre-proline 0 N--CA 1.462 0.17 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.875 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 31' ' ' LYS . 32.0 Cg_exo . . . . . 0 C--N 1.352 0.719 0 C-N-CA 122.941 2.427 . . . . 0.0 112.469 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.475 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 80.6 m95 . . . . . 0 C--O 1.233 0.219 0 CA-C-O 120.687 0.28 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.7 p -115.43 135.17 56.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.889 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.2 122.36 35.51 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.945 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.401 ' HA3' ' CE1' ' A' ' 59' ' ' TYR . . . -118.52 158.89 14.58 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.718 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.0 tp -107.71 136.8 46.85 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.954 0.407 . . . . 0.0 111.174 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.469 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 44.2 t -126.29 152.26 46.41 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.953 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -45.85 152.31 0.37 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.651 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 68.25 11.49 8.38 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.119 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.86 64.72 2.48 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.169 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.469 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 34.0 m-85 -128.03 106.55 9.15 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.731 0.3 . . . . 0.0 110.658 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.81 120.27 23.21 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.815 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.401 ' CE1' ' HA3' ' A' ' 51' ' ' GLY . 31.1 p90 -112.97 145.86 40.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.822 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -120.41 141.84 49.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.91 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -128.52 153.0 47.64 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.744 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.565 ' OD1' HG22 ' A' ' 65' ' ' THR . 20.8 t-20 -113.77 134.43 54.77 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.073 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.9 p -89.15 -29.8 19.06 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.51 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -59.1 -60.49 3.79 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.507 0.194 . . . . 0.0 111.178 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.565 HG22 ' OD1' ' A' ' 62' ' ' ASN . 4.1 t -91.09 -36.19 14.16 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.236 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.51 50.06 2.84 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.65 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -130.42 135.61 48.19 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.846 0.355 . . . . 0.0 111.198 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.93 145.1 26.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.784 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.23 143.96 46.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.856 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 55.4 m95 . . . . . 0 CA--C 1.535 0.397 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.226 179.901 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.487 ' HB2' HD11 ' A' ' 23' ' ' ILE . 5.1 mtt-85 . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.992 0.425 . . . . 0.0 110.624 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.533 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 91.6 m95 -109.17 141.6 41.17 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.75 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.5 p -114.64 135.4 54.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.978 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -90.41 130.42 36.49 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.881 0.372 . . . . 0.0 110.756 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.87 148.18 19.33 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.783 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.6 mm -97.16 142.12 14.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.723 0.296 . . . . 0.0 111.21 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.92 161.68 26.09 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.974 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -44.25 150.55 0.29 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.599 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.432 ' HB3' ' CE2' ' A' ' 16' ' ' TYR . 0.8 OUTLIER 81.1 -56.83 0.29 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.212 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.53 49.54 0.05 OUTLIER Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.585 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 14' ' ' GLU . 31.3 m-85 -113.44 148.55 35.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.538 0.209 . . . . 0.0 110.487 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -108.67 116.75 32.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.935 0.398 . . . . 0.0 110.824 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -111.35 151.79 28.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.122 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -124.17 149.69 46.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.709 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -135.55 147.74 48.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.224 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.533 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 5.9 t70 -113.66 122.28 46.67 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.858 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.4 -26.56 30.3 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.346 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.487 HD11 ' HB2' ' A' ' 6' ' ' ARG . 2.1 mt -59.33 -50.5 79.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-O 120.69 0.281 . . . . 0.0 111.023 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 m -98.74 -50.22 4.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.977 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.74 55.34 0.66 Allowed Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.456 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -137.68 142.5 41.09 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.808 0.337 . . . . 0.0 111.306 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.34 130.79 35.66 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.792 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -124.11 168.75 12.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.8 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -127.27 -45.95 1.51 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.788 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.03 136.46 46.69 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.361 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -65.32 119.36 58.73 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.818 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo . . . . . 0 C--N 1.352 0.72 0 C-N-CA 122.741 2.294 . . . . 0.0 112.614 -179.671 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.463 ' CH2' ' HB2' ' A' ' 62' ' ' ASN . 65.3 m95 . . . . . 0 C--O 1.234 0.255 0 CA-C-O 120.797 0.332 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 2.3 t -101.8 156.12 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.579 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -113.25 121.89 45.81 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.67 0.271 . . . . 0.0 111.267 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.484 ' HA3' ' CE2' ' A' ' 59' ' ' TYR . . . -119.13 154.94 16.25 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.826 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -113.16 121.95 46.04 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 57' ' ' PHE . 0.6 OUTLIER -142.76 142.09 31.85 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.444 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 56' ' ' GLY . 10.9 tt0 50.56 98.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.016 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 65.84 -63.54 0.22 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.35 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 176.14 40.27 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.733 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 53' ' ' SER . 20.9 m-85 -84.7 106.12 16.01 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.01 119.77 16.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.555 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.484 ' CE2' ' HA3' ' A' ' 51' ' ' GLY . 25.5 p90 -113.44 145.94 40.35 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.115 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 43.4 m-85 -120.08 141.77 49.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.787 0.327 . . . . 0.0 111.127 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -125.94 147.55 49.47 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.072 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.463 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 60.9 t30 -113.82 125.83 54.51 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.028 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.8 p -76.47 -26.58 55.52 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.332 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -58.46 -62.81 1.57 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.305 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.8 p -89.09 -44.27 10.46 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.131 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.47 52.78 1.52 Allowed Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.508 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -137.83 133.63 34.19 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.9 0.381 . . . . 0.0 111.025 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.4 p -75.34 145.57 41.62 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.919 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -132.82 158.13 43.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.807 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 65.6 m95 . . . . . 0 CA--C 1.534 0.332 0 CA-C-O 120.869 0.366 . . . . 0.0 111.039 -179.888 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.594 0.235 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.98 126.48 21.59 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.827 2.351 . . . . 0.0 112.701 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 t -170.31 -50.96 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.801 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.84 147.54 0.09 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.443 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.06 42.99 0.09 OUTLIER Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.713 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -94.41 76.56 3.88 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.148 0.499 . . . . 0.0 110.137 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.419 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 90.9 m95 -115.44 137.54 51.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.842 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 p -114.39 141.01 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.225 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.09 131.64 39.41 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.035 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.16 148.52 19.61 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.014 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.9 mm -91.49 142.62 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 120.676 0.274 . . . . 0.0 111.156 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.49 161.76 25.4 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.982 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.76 149.83 0.79 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.532 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 80.85 -55.76 0.32 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.217 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.1 55.84 0.03 OUTLIER Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.45 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -120.21 159.7 24.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.66 0.267 . . . . 0.0 110.755 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -115.83 117.04 29.1 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.06 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -111.12 151.84 27.67 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.96 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -124.19 149.26 46.56 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.82 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -135.24 145.4 47.57 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.929 0.395 . . . . 0.0 111.446 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.419 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 6.9 t70 -109.73 122.58 47.82 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.75 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.07 -24.82 32.55 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.589 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.8 mt -60.7 -59.88 3.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.754 0.311 . . . . 0.0 110.858 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.46 -34.7 20.0 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.083 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.25 56.53 1.91 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.351 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -142.92 141.6 31.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.799 0.333 . . . . 0.0 111.544 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -86.85 131.23 34.17 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.472 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -124.74 168.58 13.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.187 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -127.54 -46.55 1.45 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.25 126.55 29.99 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.64 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -67.59 122.26 82.6 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.984 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.34 179.14 5.78 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.735 2.29 . . . . 0.0 112.816 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.19 75.99 10.24 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.724 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 151.26 49.23 0.02 OUTLIER Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.578 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -124.81 170.94 10.55 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.558 0.218 . . . . 0.0 110.672 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.0 34.66 2.43 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.925 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.06 -139.05 31.93 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.605 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -78.87 178.28 8.08 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.671 0.272 . . . . 0.0 110.778 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.1 tt -146.61 96.97 2.85 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.136 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.7 tttm 64.0 171.75 0.18 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.025 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 62.54 100.26 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.084 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.6 m 63.36 24.3 14.14 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.986 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.23 177.3 7.78 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.0 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.66 90.71 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.13 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.74 118.74 11.87 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.824 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.6 p -73.3 176.95 5.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.231 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.566 HG13 ' CD1' ' A' ' 48' ' ' TRP . 14.9 p -77.88 -29.96 16.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.289 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.566 ' CD1' HG13 ' A' ' 47' ' ' VAL . 83.5 m95 -90.58 143.17 27.01 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.714 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.5 p -106.6 137.27 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.819 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.9 121.83 33.08 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.857 0.36 . . . . 0.0 111.151 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.416 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -119.42 160.34 14.39 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.862 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.422 HD11 ' HA2' ' A' ' 56' ' ' GLY . 3.3 tp -113.0 131.6 55.7 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.93 0.395 . . . . 0.0 110.745 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.46 151.77 42.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.576 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 66.58 -157.24 0.25 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.739 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.19 -26.37 60.53 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.422 ' HA2' HD11 ' A' ' 52' ' ' LEU . . . 163.7 46.53 0.02 OUTLIER Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.219 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -95.68 137.97 33.99 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.68 120.06 36.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.95 0.405 . . . . 0.0 111.328 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.416 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 19.6 p90 -113.2 146.24 39.63 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.526 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -119.9 141.96 49.12 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.784 0.326 . . . . 0.0 110.905 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -130.64 149.61 52.21 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.207 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.424 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 10.4 t-20 -113.45 128.36 56.42 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.243 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.4 p -81.32 -20.3 41.04 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.739 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -58.52 -62.87 1.53 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.548 0.213 . . . . 0.0 111.263 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.0 t -99.84 -41.56 7.19 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.183 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.13 61.28 0.71 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.722 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -137.67 126.92 24.59 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.788 0.328 . . . . 0.0 110.975 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.6 p -77.84 150.14 34.25 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.841 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.6 ttt85 -133.02 157.94 43.98 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.042 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -126.53 28.92 5.84 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.007 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -151.0 148.73 28.72 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.566 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.3 114.72 36.22 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.741 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.59 147.45 70.28 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.568 2.179 . . . . 0.0 112.838 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -98.74 160.81 14.02 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.462 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.1 p30 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.523 -0.751 . . . . 0.0 111.215 179.828 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.8 140.4 57.42 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.526 2.151 . . . . 0.0 112.813 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.663 ' CB ' HG21 ' A' ' 23' ' ' ILE . 1.9 t -116.43 175.54 5.51 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.242 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.64 131.16 27.07 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.93 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.23 -70.94 0.31 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.507 -0.854 . . . . 0.0 113.101 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.579 ' H ' HD11 ' A' ' 23' ' ' ILE . 11.5 mpt_? -71.99 88.94 1.08 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.931 0.396 . . . . 0.0 110.874 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -113.38 154.63 26.61 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.197 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 2.9 t -124.82 130.45 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.685 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -90.97 130.64 36.87 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.895 0.378 . . . . 0.0 111.025 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.29 148.75 19.59 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.603 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.9 mm -104.18 142.62 17.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.653 0.263 . . . . 0.0 111.092 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.87 161.53 27.22 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.931 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.53 150.77 0.63 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.792 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 82.4 -55.49 0.21 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.145 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.1 50.76 0.05 OUTLIER Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.533 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -113.98 147.6 38.32 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.504 0.192 . . . . 0.0 110.538 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -111.6 116.68 31.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.897 0.38 . . . . 0.0 110.923 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -111.35 151.68 28.14 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.84 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 59.9 m-85 -124.55 149.71 46.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.075 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -129.73 144.61 51.38 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.331 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.624 ' OD1' HD12 ' A' ' 23' ' ' ILE . 4.6 t0 -109.23 122.72 47.94 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.522 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.424 HD21 ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -85.75 -28.63 24.47 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.283 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.663 HG21 ' CB ' ' A' ' 3' ' ' SER . 3.8 mt -58.29 -49.8 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.167 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.01 -43.44 5.77 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.41 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.84 34.46 3.77 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.469 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -121.62 127.79 51.24 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.798 0.332 . . . . 0.0 111.068 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.91 152.68 33.14 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.969 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -133.36 167.56 20.18 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.106 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -127.64 7.99 6.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.72 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -136.03 129.56 32.18 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -66.92 133.28 93.9 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.09 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.44 178.06 5.4 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.655 2.236 . . . . 0.0 112.254 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -68.35 89.33 0.33 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.018 0.437 . . . . 0.0 110.591 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.22 -95.0 0.59 Allowed Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.649 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 87.3 t80 66.45 -73.9 0.07 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 122.661 0.384 . . . . 0.0 111.255 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.34 30.94 4.93 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.714 0.292 . . . . 0.0 110.854 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.09 153.38 7.37 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.427 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.44 31.19 2.87 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.66 0.267 . . . . 0.0 111.253 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 mt 51.5 56.31 8.09 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.064 0.459 . . . . 0.0 111.057 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.79 136.16 50.52 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.984 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -94.66 100.61 12.52 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.923 0.392 . . . . 0.0 111.281 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.25 150.12 26.6 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.026 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -96.37 103.81 15.73 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.031 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.4 p -104.42 131.31 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.046 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.542 ' O ' HG23 ' A' ' 47' ' ' VAL . 9.7 mttt -71.37 -179.8 2.61 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.063 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.2 p -61.84 105.26 0.54 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.181 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.552 ' O ' HG12 ' A' ' 47' ' ' VAL . 12.3 t -103.38 23.05 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.652 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -119.11 145.04 46.28 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.815 0.34 . . . . 0.0 111.388 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 2.9 t -112.07 139.08 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.811 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.77 122.51 44.63 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.638 0.256 . . . . 0.0 111.089 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.419 ' HA3' ' CE1' ' A' ' 59' ' ' TYR . . . -118.67 154.06 16.69 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.758 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.4 tp -109.67 126.51 53.75 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.853 0.359 . . . . 0.0 111.284 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.66 152.08 37.69 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.957 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -46.73 153.64 0.38 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.658 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 68.08 8.8 6.76 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.172 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.36 55.96 5.36 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.839 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -116.32 93.07 4.08 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.755 0.312 . . . . 0.0 110.543 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.3 m -72.6 120.58 18.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.989 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.419 ' CE1' ' HA3' ' A' ' 51' ' ' GLY . 32.9 p90 -112.61 145.88 39.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.504 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 24.0 m-85 -120.26 142.07 49.39 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.864 0.364 . . . . 0.0 111.331 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -125.88 156.1 40.18 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.654 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -113.53 126.75 55.65 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.221 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.5 p -93.85 29.51 2.06 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.869 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.522 ' HB2' HG11 ' A' ' 47' ' ' VAL . 10.1 tt0 -120.91 -55.47 1.99 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.877 0.37 . . . . 0.0 110.434 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.6 p -96.3 -33.1 12.09 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.016 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.25 64.45 1.23 Allowed Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.571 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -149.71 128.86 12.76 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.861 0.362 . . . . 0.0 111.022 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.94 149.93 29.19 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.584 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.58 156.6 48.4 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.274 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -126.73 24.57 6.54 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.09 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -145.05 132.14 20.39 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.522 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.1 ttpp -63.56 133.78 95.63 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.017 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.76 99.81 0.89 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.571 2.181 . . . . 0.0 112.182 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 67.9 177.8 0.24 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.227 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.893 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.558 0.218 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.78 74.76 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.875 2.383 . . . . 0.0 112.631 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.89 -49.49 2.98 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.172 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -150.26 49.63 0.9 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.312 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.79 -170.82 26.39 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.921 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -127.67 91.42 3.29 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.11 0.481 . . . . 0.0 110.823 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -106.55 141.66 37.47 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.564 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 p -115.76 138.78 45.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.935 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -90.45 132.77 35.46 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.875 0.369 . . . . 0.0 111.022 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.76 146.82 18.6 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.536 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.7 mm -102.56 141.72 18.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.557 0.218 . . . . 0.0 110.982 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.14 162.04 27.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.828 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.9 m -48.42 149.58 1.56 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.634 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 82.43 -55.89 0.21 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.086 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.93 52.21 0.04 OUTLIER Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.451 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -116.47 129.97 56.5 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.512 0.196 . . . . 0.0 110.577 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -95.58 117.14 29.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.768 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -110.69 151.28 27.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.737 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -124.42 149.38 46.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.872 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -136.45 147.71 47.35 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.483 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -111.98 122.23 47.18 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.612 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.81 -33.49 46.14 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.574 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.5 mt -60.88 -55.59 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.707 0.289 . . . . 0.0 110.994 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.9 t -84.22 -36.27 22.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.25 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.01 47.37 5.03 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.217 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -136.07 143.3 44.56 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.838 0.352 . . . . 0.0 111.539 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.01 143.01 27.55 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.572 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -134.39 167.03 21.49 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.188 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -127.38 7.25 6.4 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.671 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -123.54 127.83 48.89 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.41 110.94 3.55 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.757 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.19 149.94 71.12 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.393 2.062 . . . . 0.0 112.217 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.72 90.46 0.17 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.022 0.439 . . . . 0.0 110.611 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.97 47.72 0.07 OUTLIER Glycine 0 CA--C 1.52 0.396 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.479 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -117.38 -51.08 2.53 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.614 0.245 . . . . 0.0 110.784 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -124.71 176.96 6.23 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.267 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.9 64.78 4.17 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.985 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.26 91.52 1.69 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.827 0.346 . . . . 0.0 110.747 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.75 113.41 4.84 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.358 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -89.68 169.06 11.62 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.069 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.88 98.06 10.56 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.207 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.17 174.28 15.42 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -102.37 22.29 13.64 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.673 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -109.39 119.24 58.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.696 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.8 mttp -110.96 108.1 17.75 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.917 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.28 148.32 52.44 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.293 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.57 HG11 ' HG3' ' A' ' 64' ' ' GLU . 19.2 t -141.18 -53.59 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.628 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.51 ' CH2' ' HB2' ' A' ' 62' ' ' ASN . 78.9 m95 -72.47 142.67 48.59 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.264 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.5 p -115.45 144.73 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.005 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -95.57 122.21 38.07 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.781 0.324 . . . . 0.0 110.97 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.67 158.71 14.69 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.6 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.34 128.54 55.99 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.923 0.392 . . . . 0.0 111.234 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.6 m -107.46 151.96 24.85 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.861 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -44.15 148.9 0.38 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.918 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.404 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 7.7 t0 82.84 -52.82 0.18 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.173 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.22 54.13 0.03 OUTLIER Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.611 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.404 ' CE2' ' HB3' ' A' ' 55' ' ' ASP . 35.3 m-85 -122.14 132.1 54.29 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 110.48 -0.193 . . . . 0.0 110.48 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.05 120.69 35.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.805 0.336 . . . . 0.0 111.028 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -112.69 145.95 39.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.788 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -120.41 141.98 49.63 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.796 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -122.86 149.87 43.62 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.217 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.51 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 53.6 t30 -113.0 131.31 55.81 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.154 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.0 p -84.14 -28.68 27.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.56 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.57 ' HG3' HG11 ' A' ' 47' ' ' VAL . 10.1 mt-10 -60.07 -62.6 1.75 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.71 0.29 . . . . 0.0 111.018 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.1 p -86.21 -44.3 12.29 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.141 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.93 51.13 1.83 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.43 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -134.68 140.35 45.94 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 111.081 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.99 140.79 34.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.407 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.21 158.04 42.77 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.931 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -126.34 27.55 6.18 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.79 0.329 . . . . 0.0 111.016 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -143.22 130.84 21.26 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.015 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.5 mttp -55.77 109.19 1.48 Allowed Pre-proline 0 N--CA 1.467 0.377 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.176 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.95 167.19 16.41 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.785 2.324 . . . . 0.0 112.45 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 72.96 175.34 0.28 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.815 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.148 -0.929 . . . . 0.0 111.315 -179.778 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.3 t70 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 120.764 0.316 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.8 134.93 26.84 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.777 2.318 . . . . 0.0 112.607 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.94 88.33 0.96 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.811 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.49 96.41 9.11 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.008 0.432 . . . . 0.0 111.137 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.23 113.42 4.11 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.763 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -101.83 95.44 6.4 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.75 0.309 . . . . 0.0 110.841 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.559 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 58.8 m95 -123.8 144.77 49.51 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.329 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.2 p -112.71 138.01 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.725 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -90.25 131.02 36.3 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.827 0.346 . . . . 0.0 110.979 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.26 148.51 19.62 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.657 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.6 mm -95.32 144.5 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.712 0.291 . . . . 0.0 111.288 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.651 HG23 ' CD1' ' A' ' 18' ' ' TYR . 1.4 p -128.15 162.05 27.83 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.054 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.0 m -45.16 152.69 0.25 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.583 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 78.48 -55.99 0.47 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.132 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.8 51.99 0.04 OUTLIER Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.389 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -115.9 151.27 35.67 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.683 0.278 . . . . 0.0 110.86 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -108.59 117.07 33.23 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.922 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.651 ' CD1' HG23 ' A' ' 12' ' ' THR . 21.5 p90 -110.72 151.44 27.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.659 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -124.13 149.42 46.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.581 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -130.99 142.33 50.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.073 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.559 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 20.7 t70 -111.2 123.48 50.29 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.508 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.57 -30.34 33.06 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.393 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.1 mt -60.22 -45.27 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 120.685 0.279 . . . . 0.0 111.01 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.87 -35.6 10.05 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.277 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.05 60.89 1.71 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.311 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.6 155.58 37.63 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.989 0.423 . . . . 0.0 111.92 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 t -97.62 143.5 28.23 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.728 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -135.67 168.64 18.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.826 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.429 ' CZ3' ' HB3' ' A' ' 18' ' ' TYR . 95.3 m95 -127.0 -44.64 1.61 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.66 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -80.04 135.22 36.31 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.541 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.11 142.93 92.82 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.021 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -85.95 31.66 0.47 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.74 2.293 . . . . 0.0 113.229 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 52.12 28.71 5.67 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.685 0.279 . . . . 0.0 111.706 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.07 39.82 0.31 Allowed Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.769 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -120.74 -47.67 2.3 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.634 0.254 . . . . 0.0 110.933 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -105.6 128.04 53.39 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.84 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -158.41 146.31 13.03 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.683 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.25 113.28 25.66 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.734 0.302 . . . . 0.0 111.061 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.4 mt -94.58 175.7 6.57 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.107 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -99.25 34.84 2.06 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.82 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -137.88 153.47 49.55 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.891 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.42 127.69 33.52 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.93 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.81 141.39 29.33 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.239 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.9 p -89.31 145.27 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.339 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -98.14 36.06 1.64 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 m 59.77 85.76 0.1 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.009 0.433 . . . . 0.0 111.401 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 47' ' ' VAL . 9.2 t -98.09 40.34 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.921 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.471 ' CH2' ' HB2' ' A' ' 62' ' ' ASN . 80.1 m95 -126.14 144.2 50.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.93 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 4.2 t -100.85 153.83 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.675 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -106.34 122.27 45.91 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 111.128 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.9 157.91 15.07 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.607 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.2 tp -111.97 123.59 50.59 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.883 0.373 . . . . 0.0 111.149 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.53 152.24 30.49 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.87 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -46.79 154.98 0.28 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.683 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 67.81 9.6 7.22 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.227 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.38 58.72 3.52 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.003 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -123.53 110.52 15.16 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.63 0.253 . . . . 0.0 110.617 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.41 120.42 24.95 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.001 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.427 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 38.0 p90 -112.53 145.78 39.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.47 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 36.9 m-85 -120.11 142.12 49.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.834 0.349 . . . . 0.0 111.225 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -121.85 149.44 43.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.189 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.471 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 46.8 t-20 -117.47 131.77 56.67 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.191 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.2 p -78.82 -26.62 44.25 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.503 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -57.64 -63.34 1.27 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.307 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.4 p -88.12 -46.14 9.55 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.082 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.4 47.17 2.22 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.494 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -136.08 143.72 44.77 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.773 0.321 . . . . 0.0 110.973 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.4 p -74.52 148.78 40.62 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -133.66 155.26 50.01 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.076 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -126.41 32.23 5.23 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.765 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -139.86 120.04 13.77 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.596 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -72.66 116.34 48.84 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.833 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.92 105.66 1.19 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.681 2.254 . . . . 0.0 112.107 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -98.3 145.56 26.55 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.482 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.658 -0.687 . . . . 0.0 111.127 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.707 0.289 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.99 78.95 1.73 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.699 2.266 . . . . 0.0 112.429 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.87 146.71 30.27 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.019 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? 61.72 92.55 0.05 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.192 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.64 82.5 0.05 OUTLIER Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.706 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.496 ' HB2' HD11 ' A' ' 23' ' ' ILE . 3.3 mmp_? -99.53 78.81 2.21 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.962 0.411 . . . . 0.0 110.503 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.489 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 59.9 m95 -122.14 143.83 49.31 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.102 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 1.5 t -109.28 139.66 31.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.665 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -90.76 133.67 35.01 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.819 0.342 . . . . 0.0 111.202 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.89 148.47 19.56 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.695 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.0 mm -95.51 144.74 9.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.7 0.286 . . . . 0.0 111.257 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.539 HG21 ' HH2' ' A' ' 29' ' ' TRP . 0.2 OUTLIER -128.89 161.91 28.75 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.793 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -47.88 149.38 1.34 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.404 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 79.79 -56.8 0.38 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.926 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.18 48.72 0.03 OUTLIER Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.553 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -110.08 146.14 35.91 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.571 0.224 . . . . 0.0 110.516 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -108.73 116.98 33.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.811 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -110.64 151.14 28.03 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.514 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.7 m-85 -124.83 149.57 47.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.254 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -125.36 148.67 48.67 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.972 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.489 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 33.4 t70 -116.59 125.75 52.28 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.951 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.59 -31.78 24.13 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.478 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.496 HD11 ' HB2' ' A' ' 6' ' ' ARG . 3.5 mt -59.99 -57.61 10.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.637 0.256 . . . . 0.0 111.036 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.7 m -86.43 -41.43 14.44 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.978 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.07 48.46 2.86 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.298 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.3 144.92 48.6 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.823 0.344 . . . . 0.0 111.26 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.59 132.38 36.91 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.76 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.41 165.63 14.66 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.539 ' HH2' HG21 ' A' ' 12' ' ' THR . 89.8 m95 -127.52 6.28 6.26 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.747 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -132.14 128.15 37.47 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.38 112.34 6.3 Favored Pre-proline 0 C--O 1.233 0.205 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.744 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.53 169.56 3.08 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.766 2.311 . . . . 0.0 112.63 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.64 86.75 0.32 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.668 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.54 -68.71 0.54 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.661 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.0 t80 67.79 -70.84 0.11 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.696 0.398 . . . . 0.0 111.43 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -82.61 95.32 7.75 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.705 0.288 . . . . 0.0 110.638 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -122.16 38.7 2.51 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.774 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.69 -179.56 5.2 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.63 0.215 . . . . 0.0 111.066 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 68.47 101.8 0.05 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.725 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.0 tttt 71.5 119.03 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.896 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.14 131.22 55.27 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.499 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.8 m -128.27 -48.66 1.31 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.863 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.27 99.54 11.19 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.242 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.07 129.38 72.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.055 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.8 87.99 0.09 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.298 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.23 154.61 32.86 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.359 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.7 t -100.39 -29.0 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.456 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.489 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 84.5 m95 -78.53 144.32 35.76 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.776 0.322 . . . . 0.0 111.377 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 21.2 t -99.94 155.4 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.717 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -112.72 122.4 47.57 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.792 0.329 . . . . 0.0 111.116 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.414 ' HA3' ' CE1' ' A' ' 59' ' ' TYR . . . -118.83 156.69 15.57 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.812 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.4 tp -109.69 127.15 54.38 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.917 0.389 . . . . 0.0 111.233 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.442 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 17.0 t -119.97 152.05 38.03 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.702 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -45.39 155.39 0.14 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.564 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.19 6.71 5.81 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.137 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.04 51.42 5.8 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.635 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.442 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 32.6 m-85 -112.72 125.62 54.51 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.579 0.228 . . . . 0.0 110.412 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.5 m -100.43 120.6 40.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.834 0.35 . . . . 0.0 111.111 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.414 ' CE1' ' HA3' ' A' ' 51' ' ' GLY . 35.8 p90 -112.45 145.45 40.16 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.388 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.531 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 17.5 m-85 -120.73 141.92 50.0 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.84 0.352 . . . . 0.0 111.349 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -121.86 145.52 48.0 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.96 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.489 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 54.9 t-20 -113.17 126.15 55.12 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.0 p -78.61 -30.19 46.39 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.359 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -55.6 -54.83 39.28 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.284 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.8 p -93.82 -33.09 13.7 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.334 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.69 58.77 2.33 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.31 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -147.71 141.34 25.54 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.829 0.347 . . . . 0.0 111.204 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 99.1 p -76.35 143.5 40.72 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.627 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.449 ' HD3' ' CH2' ' A' ' 48' ' ' TRP . 14.3 ttt85 -133.72 158.2 43.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.411 ' CZ3' ' HB3' ' A' ' 59' ' ' TYR . 95.6 m95 -125.77 -47.33 1.68 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.532 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.82 134.18 48.24 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.412 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -72.24 134.56 82.65 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.901 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.71 161.09 44.82 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.598 2.199 . . . . 0.0 112.368 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.53 120.97 29.45 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.465 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.55 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.67 0.271 . . . . 0.0 111.411 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.84 112.43 2.68 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.754 2.303 . . . . 0.0 112.29 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.8 t -113.33 108.66 17.55 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -156.39 145.39 20.36 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.148 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.08 -174.87 21.71 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.987 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.46 ' HG3' HD11 ' A' ' 23' ' ' ILE . 16.8 mtt180 -114.46 99.74 7.78 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.437 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 80.0 m95 -116.29 149.91 38.47 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.09 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 3.0 t -113.69 150.73 15.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.974 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -102.46 130.18 49.18 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.829 0.347 . . . . 0.0 111.155 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.28 148.08 19.44 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.74 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.4 mm -106.68 146.68 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.693 0.282 . . . . 0.0 111.305 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.4 ' OG1' ' HB2' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -130.6 161.53 31.34 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.895 179.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 m -46.96 153.26 0.44 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.486 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 81.29 -56.33 0.28 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.03 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.72 51.05 0.05 OUTLIER Glycine 0 C--N 1.337 0.598 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.586 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.4 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 19.4 m-85 -114.82 140.96 48.51 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.66 0.267 . . . . 0.0 110.508 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -107.2 116.82 32.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.809 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -111.02 151.31 28.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.806 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 48.5 m-85 -124.56 149.82 46.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.834 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -128.75 148.25 50.84 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.329 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.437 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 10.7 t70 -113.93 127.89 56.16 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.795 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.29 -38.86 21.57 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.286 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.46 HD11 ' HG3' ' A' ' 6' ' ' ARG . 4.2 mt -61.13 -50.9 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.988 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.7 m -85.32 -40.83 16.1 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.173 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.7 37.27 8.75 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.391 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -127.6 148.02 50.36 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.82 0.343 . . . . 0.0 111.265 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 95.5 p -93.58 141.69 28.19 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.749 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.46 167.97 20.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.923 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -127.61 5.96 6.19 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.727 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -120.78 122.03 39.46 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 6.2 ttmt -64.15 119.51 56.36 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.85 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 31' ' ' LYS . 26.7 Cg_exo -61.89 177.53 0.99 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.724 2.282 . . . . 0.0 112.518 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.69 -35.33 78.62 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.028 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.53 91.46 0.65 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 121.165 -0.541 . . . . 0.0 112.399 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -139.8 162.76 34.37 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.524 0.202 . . . . 0.0 110.598 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 68.05 -154.93 0.19 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.398 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -132.39 -142.5 4.91 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.741 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.47 ' OD2' HD23 ' A' ' 39' ' ' LEU . 9.0 p-10 -165.25 173.56 11.14 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 122.014 0.125 . . . . 0.0 110.736 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.47 HD23 ' OD2' ' A' ' 38' ' ' ASP . 3.5 mm? 68.8 168.27 0.28 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.927 0.394 . . . . 0.0 111.142 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.62 171.92 7.29 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.709 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 73.08 128.9 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.75 122.02 9.6 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.252 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -146.5 95.42 2.6 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.321 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.86 135.77 38.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.936 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.6 tttt -75.92 104.73 6.59 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.792 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.4 p -105.79 177.84 4.74 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.41 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.532 ' O ' HG22 ' A' ' 47' ' ' VAL . 9.3 p -98.98 24.06 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.532 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 59.0 m95 -114.79 140.09 49.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.858 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 9.4 p -99.26 140.29 19.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.472 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.79 122.42 33.51 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.839 0.352 . . . . 0.0 111.032 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.406 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.75 158.93 14.61 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.459 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 tp -109.88 137.26 47.92 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 111.103 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.2 152.15 46.42 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.791 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.53 153.61 0.36 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.503 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 67.59 11.37 8.34 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.076 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.63 66.74 1.93 Allowed Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.869 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -131.33 111.7 12.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.723 0.297 . . . . 0.0 110.631 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 m -81.49 120.35 24.91 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.06 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.406 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 32.9 p90 -112.77 145.83 39.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.617 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 89.9 m-85 -120.38 141.87 49.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.771 0.319 . . . . 0.0 111.01 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -127.19 148.8 50.18 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.463 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 52.6 t-20 -115.55 132.31 56.67 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.182 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.1 p -80.71 -29.75 36.4 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.4 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.1 -64.66 0.86 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.179 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.1 t -82.74 -34.8 27.09 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.994 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.28 47.14 5.86 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.602 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -133.39 136.94 45.6 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.784 0.326 . . . . 0.0 110.899 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.6 p -80.81 143.54 32.74 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.966 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.44 157.7 44.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.925 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -126.45 39.84 3.85 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.865 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -146.95 138.12 24.02 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.786 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -73.17 116.52 51.59 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.524 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.84 100.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.866 2.378 . . . . 0.0 112.621 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.21 166.55 23.07 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.21 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.23 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.33 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.14 155.49 25.79 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.029 1.819 . . . . 0.0 112.325 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.4 t 59.39 46.13 12.89 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.253 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -172.26 76.6 0.05 OUTLIER 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.337 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -118.41 93.29 0.56 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.968 -0.635 . . . . 0.0 112.641 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.649 ' HB3' HD21 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -80.11 78.2 6.77 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.834 0.35 . . . . 0.0 110.915 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.471 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 87.4 m95 -112.35 134.24 54.0 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.96 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -112.66 141.4 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.183 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.37 131.63 36.72 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.893 0.377 . . . . 0.0 111.292 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.26 148.61 19.41 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.617 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.0 mm -99.9 143.26 13.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 120.612 0.244 . . . . 0.0 111.183 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.574 HG23 ' CD1' ' A' ' 18' ' ' TYR . 1.0 OUTLIER -126.24 161.56 27.46 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.862 0.363 . . . . 0.0 111.053 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.6 m -46.45 151.95 0.49 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.668 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 81.67 -54.98 0.26 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.191 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.64 51.52 0.05 OUTLIER Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.426 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -118.54 151.81 37.15 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.633 0.254 . . . . 0.0 110.832 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -111.85 117.21 32.16 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.07 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.574 ' CD1' HG23 ' A' ' 12' ' ' THR . 20.1 p90 -110.94 151.39 27.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.617 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -124.13 149.58 46.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.741 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -131.23 147.37 52.58 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.197 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.471 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 34.3 t70 -114.75 122.38 46.21 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.739 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.649 HD21 ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -78.18 -29.75 48.67 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.19 179.731 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.587 HD11 ' HD3' ' A' ' 6' ' ' ARG . 4.5 mt -60.52 -60.16 3.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-O 120.684 0.278 . . . . 0.0 111.016 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.07 -30.81 25.74 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.484 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.22 45.82 7.31 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.18 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -132.63 151.41 51.96 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.916 0.389 . . . . 0.0 111.666 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.07 145.99 24.09 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.902 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -133.72 168.66 18.31 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.136 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -126.97 -40.97 1.83 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.044 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.88 137.56 33.61 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.59 0.233 . . . . 0.0 110.454 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.87 139.28 97.3 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.198 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.448 ' HG2' ' HB2' ' A' ' 35' ' ' PHE . 42.1 Cg_endo -67.02 -177.3 0.97 Allowed 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.765 2.31 . . . . 0.0 112.422 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.6 87.25 2.13 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.872 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.79 -81.16 0.29 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.112 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.448 ' HB2' ' HG2' ' A' ' 32' ' ' PRO . 32.2 t80 69.42 148.03 0.07 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.533 0.333 . . . . 0.0 111.065 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 65.41 94.8 0.06 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.269 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.63 -82.96 0.05 OUTLIER Glycine 0 C--N 1.337 0.59 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.292 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -160.03 145.64 15.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.772 0.32 . . . . 0.0 111.121 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mt -131.87 115.7 16.25 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.217 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.1 ttpp -90.32 74.63 6.96 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.808 0.337 . . . . 0.0 111.236 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.78 150.68 5.88 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.143 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.28 161.41 39.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.951 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.56 107.92 9.83 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.201 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.549 ' O ' HG13 ' A' ' 44' ' ' VAL . 12.8 p -79.46 68.91 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 121.449 0.642 . . . . 0.0 110.66 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -129.81 163.07 27.06 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.063 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -116.6 38.0 3.58 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.068 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.489 ' O ' HG22 ' A' ' 47' ' ' VAL . 10.4 p -104.82 26.59 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.065 0.46 . . . . 0.0 111.054 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -110.08 142.49 41.46 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.99 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 14.0 p -104.95 149.34 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.175 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -96.89 122.44 39.87 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.406 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.412 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.96 157.42 15.28 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.712 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.5 tp -106.25 130.42 54.11 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.905 0.383 . . . . 0.0 111.326 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.484 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 12.1 t -119.93 152.09 37.93 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.974 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.96 153.41 0.65 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.655 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 67.25 10.86 8.04 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.195 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.92 65.8 2.12 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.347 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 31.8 m-85 -131.13 106.61 8.47 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.717 0.294 . . . . 0.0 110.748 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.4 m -73.93 120.22 19.21 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.839 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.412 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 23.4 p90 -112.9 146.14 39.48 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.637 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 49.5 m-85 -120.04 141.97 49.26 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 110.777 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -129.51 147.16 51.29 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.438 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -113.11 128.34 56.46 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.974 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.7 p -79.13 -24.01 43.64 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.408 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -60.06 -64.7 0.86 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.294 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.2 t -90.06 -34.38 15.96 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.22 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.24 53.17 2.55 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.551 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -135.46 142.34 45.52 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.913 0.387 . . . . 0.0 111.308 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.52 144.71 27.77 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.762 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -133.49 157.83 44.64 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -126.24 37.04 4.4 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.916 0.388 . . . . 0.0 110.913 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -153.03 133.4 13.59 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.334 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 112.94 6.97 Favored Pre-proline 0 N--CA 1.466 0.337 0 CA-C-O 120.661 0.267 . . . . 0.0 110.799 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.36 93.39 0.83 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.544 2.163 . . . . 0.0 112.548 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -161.57 90.35 0.79 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.736 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.941 -179.793 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 120.806 0.336 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.37 143.13 42.54 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.697 2.265 . . . . 0.0 112.534 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.6 150.74 47.67 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.137 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -129.55 158.03 40.41 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.791 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.13 46.76 4.34 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.323 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.656 ' HB3' HD21 ' A' ' 22' ' ' LEU . 6.6 mmt85 -75.64 81.62 2.63 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.984 0.421 . . . . 0.0 110.303 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.513 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 94.6 m95 -120.46 137.47 54.33 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.101 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.7 p -113.03 130.95 65.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.028 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -90.55 129.64 36.68 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.891 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.24 148.67 19.68 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.678 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.1 mm -97.85 129.05 48.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.529 0.204 . . . . 0.0 111.011 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.546 HG23 ' CE1' ' A' ' 18' ' ' TYR . 7.6 p -131.66 154.04 49.36 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.714 0.292 . . . . 0.0 111.076 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.2 -150.14 0.42 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.758 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -81.29 3.49 23.88 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.48 68.91 0.01 OUTLIER Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.084 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -138.52 109.87 6.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.692 0.282 . . . . 0.0 110.596 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -78.12 116.72 18.79 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.963 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.546 ' CE1' HG23 ' A' ' 12' ' ' THR . 19.9 p90 -111.22 151.91 27.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.743 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -123.85 149.25 45.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.794 0.33 . . . . 0.0 111.013 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -136.27 146.11 46.31 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.513 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 24.5 t70 -113.33 124.13 51.76 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.981 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.656 HD21 ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -81.43 -28.63 34.17 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.712 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.9 mt -60.46 -52.58 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.696 0.284 . . . . 0.0 110.998 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.9 m -93.07 -31.61 14.77 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.335 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.01 48.38 5.18 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.307 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -131.99 147.69 52.47 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.855 0.36 . . . . 0.0 111.735 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.76 131.07 41.0 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.731 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -121.53 168.86 11.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.914 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -127.0 -34.95 2.3 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.089 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -82.54 145.19 29.88 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.66 0.267 . . . . 0.0 110.643 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 7.3 ttmt -70.13 135.2 87.13 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.177 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 35' ' ' PHE . 36.1 Cg_exo -60.17 179.3 0.32 Allowed 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.94 2.426 . . . . 0.0 112.769 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -62.77 -36.44 83.09 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.5 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.19 81.82 0.2 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.977 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.457 ' HB2' ' HD2' ' A' ' 32' ' ' PRO . 85.5 t80 -99.85 -60.24 1.57 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.561 0.219 . . . . 0.0 110.801 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -117.44 -42.35 2.89 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.299 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.92 145.1 17.64 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.721 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -124.0 108.19 12.12 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.751 0.31 . . . . 0.0 111.118 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.78 81.83 1.5 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.728 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -96.38 117.64 31.28 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.874 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -144.31 161.48 38.85 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.453 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -81.63 -36.65 28.63 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.072 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.73 155.85 17.67 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.39 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.9 t -121.97 96.78 4.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.393 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.45 89.52 0.69 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.199 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.86 87.11 2.09 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.643 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.6 p -83.86 -24.71 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.215 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.442 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 71.0 m95 -78.35 142.6 37.57 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.011 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 2.1 t -104.12 155.69 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.725 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.414 ' HG2' HG22 ' A' ' 58' ' ' THR . 2.7 tm-20 -112.98 121.91 46.05 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.771 0.32 . . . . 0.0 111.307 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.445 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -119.33 158.27 15.08 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.86 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.82 127.96 55.97 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.756 0.313 . . . . 0.0 110.979 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.17 151.77 44.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.729 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.07 -158.67 0.31 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.809 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -57.31 -26.23 60.58 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.29 48.72 0.02 OUTLIER Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.121 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -98.37 123.87 42.72 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.414 HG22 ' HG2' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -90.99 120.52 32.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.32 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.445 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 25.1 p90 -112.73 145.68 40.09 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.455 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 13.9 m-85 -120.4 141.85 49.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.844 0.354 . . . . 0.0 111.044 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -124.81 146.53 49.2 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.627 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.442 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 35.4 t30 -113.6 122.74 48.13 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.543 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.3 p -74.98 -25.07 58.58 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.484 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -55.14 -61.79 2.09 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.381 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 t -97.27 -32.88 11.68 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.387 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.45 63.26 1.18 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.44 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -145.6 142.7 29.34 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.836 0.35 . . . . 0.0 111.617 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.88 141.24 28.92 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.91 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.27 156.67 48.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.781 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 45.0 m95 -126.42 31.78 5.31 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.838 0.351 . . . . 0.0 110.652 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -144.56 135.93 25.43 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.537 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -69.87 135.48 87.68 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.889 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 72' ' ' LYS . 40.5 Cg_exo -57.11 116.62 3.34 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.856 2.371 . . . . 0.0 112.857 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -136.56 118.13 14.87 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.029 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.021 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 15.4 t70 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.456 0.169 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.51 95.95 0.89 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.519 2.146 . . . . 0.0 112.261 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.09 -64.22 0.37 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.355 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -78.63 114.42 17.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.824 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.3 144.97 16.0 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.893 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.424 ' HB2' HD11 ' A' ' 23' ' ' ILE . 14.6 mtp180 -124.77 90.0 3.17 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.887 0.375 . . . . 0.0 110.411 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.521 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 82.3 m95 -110.45 147.21 34.52 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.054 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 p -112.97 139.06 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.768 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.29 130.53 36.39 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.93 0.395 . . . . 0.0 110.909 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.3 147.91 19.37 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.779 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.3 mm -93.33 142.62 12.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.625 0.25 . . . . 0.0 111.107 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.39 161.97 24.85 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.673 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -50.0 151.18 2.01 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.383 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 80.73 -54.38 0.33 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.132 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.78 52.24 0.04 OUTLIER Glycine 0 C--N 1.336 0.563 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.357 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -118.67 146.18 44.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.599 0.238 . . . . 0.0 110.67 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -105.69 117.05 33.04 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.953 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -110.94 151.83 27.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.747 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -124.33 149.56 46.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.966 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -135.12 144.26 47.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.785 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.521 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 13.5 t70 -110.08 124.33 51.31 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.896 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.78 -32.08 35.57 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.936 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' A' ' 6' ' ' ARG . 3.5 mt -59.16 -54.73 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.757 0.313 . . . . 0.0 111.059 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.4 p -85.97 -35.7 20.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.167 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.39 54.11 3.07 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.28 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -140.73 147.03 38.53 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.879 0.371 . . . . 0.0 111.522 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.1 p -88.03 132.76 34.15 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.565 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -126.27 166.94 16.17 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.869 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -127.52 -43.99 1.56 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.031 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -70.11 150.93 46.03 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.783 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -99.08 102.54 15.88 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.94 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.85 -176.15 1.68 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.657 2.238 . . . . 0.0 112.605 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -83.7 131.47 34.93 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.023 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.56 20.51 10.07 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.21 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -108.67 -51.75 2.85 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 117.03 0.415 . . . . 0.0 110.866 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.27 113.19 13.51 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.701 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.28 141.65 3.8 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.997 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -139.0 48.22 1.89 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.804 0.335 . . . . 0.0 111.785 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.408 ' O ' HD23 ' A' ' 39' ' ' LEU . 5.1 tt -162.51 77.61 0.48 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.578 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 tttt 64.03 168.02 0.16 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.43 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.73 178.72 6.15 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 26.7 m -87.44 -60.88 1.85 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.2 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 61.38 102.25 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.82 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.493 HG21 ' O ' ' A' ' 74' ' ' ASP . 14.6 t -112.06 135.8 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.516 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -100.45 35.31 2.15 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.807 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.1 p 42.31 84.27 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.101 -0.499 . . . . 0.0 112.274 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.495 ' O ' HG12 ' A' ' 47' ' ' VAL . 11.4 t -121.95 38.82 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.397 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -123.51 143.83 49.93 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.806 0.336 . . . . 0.0 111.078 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 2.2 t -106.3 133.77 49.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.65 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.1 122.26 33.6 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.825 0.345 . . . . 0.0 110.865 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.431 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.83 158.53 14.79 Favored Glycine 0 C--N 1.332 0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.581 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.8 tp -109.76 136.03 49.73 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.867 0.365 . . . . 0.0 111.236 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 3.9 t -123.88 151.81 43.07 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.641 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.42 155.18 0.78 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.481 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 69.91 7.4 6.21 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.278 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.83 63.04 2.15 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.911 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.419 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 28.4 m-85 -127.77 128.38 45.22 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.553 0.216 . . . . 0.0 110.544 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.68 120.44 39.12 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.829 0.347 . . . . 0.0 111.013 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.431 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 30.5 p90 -112.91 146.18 39.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.536 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.434 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 55.6 m-85 -119.8 141.88 49.1 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.852 0.358 . . . . 0.0 110.884 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -128.15 147.69 50.56 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.982 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -114.11 130.67 56.57 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.679 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.8 p -78.44 -29.06 46.81 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.862 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -59.98 -66.47 0.51 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.386 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.1 t -82.42 -39.13 23.05 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.475 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.3 40.61 6.04 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.929 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -125.46 133.95 52.25 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.813 0.34 . . . . 0.0 110.872 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.05 148.43 37.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.736 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -133.2 153.61 51.38 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.878 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -126.26 29.82 5.73 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.908 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -141.91 135.76 29.78 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.127 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.61 111.39 4.68 Favored Pre-proline 0 C--O 1.234 0.28 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.642 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -70.03 169.36 19.44 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.406 2.071 . . . . 0.0 112.638 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.493 ' O ' HG21 ' A' ' 44' ' ' VAL . 1.9 m-20 -89.77 101.11 13.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.624 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.163 -179.995 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 120.503 0.192 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.54 101.84 0.92 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.729 2.286 . . . . 0.0 112.667 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 p -98.11 -57.7 2.15 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.257 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -143.89 -171.64 3.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.849 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 138.77 -31.0 2.43 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.825 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.594 ' HB2' HD11 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -78.42 72.91 4.98 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.993 0.425 . . . . 0.0 110.627 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.495 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 97.0 m95 -116.18 151.49 35.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.142 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 2.8 t -124.7 131.51 72.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.613 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -90.69 130.05 36.73 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.939 0.399 . . . . 0.0 111.099 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.07 148.5 19.59 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.678 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.1 mm -97.86 144.25 11.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.639 0.257 . . . . 0.0 111.086 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.33 162.19 28.54 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.895 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.22 149.65 0.7 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.739 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 79.83 -55.98 0.38 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.295 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.57 52.44 0.04 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.336 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -116.48 134.66 54.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.617 0.246 . . . . 0.0 110.531 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -98.3 116.86 31.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.845 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.418 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 19.8 p90 -110.75 151.34 27.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.789 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 64.0 m-85 -124.2 149.52 46.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.131 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -125.99 147.34 49.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.035 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.495 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 32.9 t70 -118.92 122.09 41.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.704 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.44 -26.76 35.06 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.321 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.594 HD11 ' HB2' ' A' ' 6' ' ' ARG . 7.5 mt -58.69 -48.71 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.766 0.317 . . . . 0.0 110.984 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.2 m -100.83 -35.49 9.41 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.346 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.44 51.31 3.14 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.127 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -137.69 154.83 49.62 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.963 0.411 . . . . 0.0 111.78 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.95 143.57 26.35 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.853 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -134.18 168.63 18.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.037 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.418 ' CZ3' ' HB3' ' A' ' 18' ' ' TYR . 96.5 m95 -127.24 -47.9 1.46 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.582 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -73.47 125.23 27.43 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.346 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 9.8 ttmt -60.95 138.0 93.91 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.175 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 31' ' ' LYS . 36.0 Cg_exo -60.15 -178.79 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.82 2.347 . . . . 0.0 112.59 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -93.69 41.07 1.08 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.093 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.38 -42.83 0.23 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.032 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 72.99 -68.45 0.23 Allowed 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.176 0.19 . . . . 0.0 111.063 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -124.86 127.12 46.64 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.623 0.249 . . . . 0.0 110.687 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -174.81 75.11 0.08 OUTLIER Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.682 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -98.19 122.88 41.89 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.796 0.331 . . . . 0.0 110.784 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 35.9 mt -76.53 88.3 3.26 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.882 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -98.24 34.03 2.06 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.04 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.63 31.89 5.42 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.235 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.8 m -84.44 -38.89 19.63 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.178 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.78 126.05 10.75 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.302 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -87.41 64.3 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 120.982 0.42 . . . . 0.0 110.501 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.36 159.45 17.14 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.919 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.9 m -87.97 87.3 7.3 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.096 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.522 ' O ' HG22 ' A' ' 47' ' ' VAL . 10.7 p -97.62 23.73 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.274 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 33.0 m95 -115.87 140.07 49.59 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.799 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 12.0 p -96.43 145.44 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -94.14 122.15 36.37 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.8 0.334 . . . . 0.0 111.105 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -119.0 153.02 17.08 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.53 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.4 tp -109.78 138.94 45.43 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.998 0.427 . . . . 0.0 111.687 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.03 152.38 38.67 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.685 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 0.4 OUTLIER -45.14 152.24 0.27 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.742 -179.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 25.6 m-20 81.04 -44.29 0.21 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.14 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.22 48.33 0.11 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.425 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -114.27 130.04 56.64 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.6 m -99.36 120.45 39.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.876 0.369 . . . . 0.0 111.213 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -112.56 145.59 40.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.567 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 93.4 m-85 -120.42 142.06 49.56 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.747 0.308 . . . . 0.0 111.068 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -120.93 150.6 40.84 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.061 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.463 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 48.8 t-20 -114.31 130.14 56.66 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.281 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.3 p -82.66 -26.11 32.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.452 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -56.77 -61.8 2.18 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.653 -0.248 . . . . 0.0 111.353 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.0 p -93.8 -46.92 7.0 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.136 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.16 55.27 0.87 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.65 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -134.59 132.06 38.61 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.715 0.293 . . . . 0.0 110.832 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 86.9 p -71.94 148.76 45.7 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.758 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.59 157.71 45.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.211 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -126.25 29.61 5.78 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.611 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.433 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 4.3 mt-10 -146.14 162.42 38.01 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.239 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -99.02 99.25 7.59 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-O 120.578 0.228 . . . . 0.0 110.975 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 71' ' ' GLU . 72.4 Cg_endo -76.02 125.59 8.74 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.686 2.257 . . . . 0.0 112.841 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -171.61 118.25 0.43 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.931 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.4 t70 . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.373 -0.822 . . . . 0.0 111.125 -179.715 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 120.605 0.241 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.17 132.64 48.94 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.735 2.29 . . . . 0.0 112.471 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.05 -170.32 0.72 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.969 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.3 tttm 65.02 45.26 3.15 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.128 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.79 35.87 0.85 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.85 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.486 ' HD2' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -137.36 70.96 1.4 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.942 0.401 . . . . 0.0 110.135 179.618 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -121.52 135.93 54.99 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.812 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.6 p -119.24 143.02 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.134 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -96.66 133.48 41.14 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.827 0.346 . . . . 0.0 111.215 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.41 148.51 19.63 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.736 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.426 HD12 ' CD2' ' A' ' 17' ' ' HIS . 24.9 mm -102.52 123.2 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 120.63 0.252 . . . . 0.0 110.948 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.38 157.72 44.81 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.99 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.4 t 60.83 -148.29 0.43 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.69 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.99 -28.93 40.88 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 111.546 0.202 . . . . 0.0 111.546 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.45 46.72 0.03 OUTLIER Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.335 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -95.46 120.11 35.14 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.426 ' CD2' HD12 ' A' ' 11' ' ' ILE . 15.7 m170 -73.77 116.68 14.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.895 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -111.24 151.96 27.68 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.747 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -123.75 149.53 45.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.489 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -136.07 148.95 48.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.969 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -115.08 123.02 47.94 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.01 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.4 ' CG ' ' HB3' ' A' ' 6' ' ' ARG . 0.1 OUTLIER -83.53 -21.19 32.81 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.391 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.486 HG13 ' HD2' ' A' ' 6' ' ' ARG . 9.6 mt -51.95 -55.81 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 120.611 0.243 . . . . 0.0 111.038 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.29 -40.75 4.58 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.054 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.14 54.04 0.68 Allowed Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.48 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -127.74 110.27 12.47 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.717 0.294 . . . . 0.0 110.997 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.0 p -69.46 132.63 46.62 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.675 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.27 168.06 16.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.141 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -127.67 6.6 6.19 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.501 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -118.0 129.28 55.49 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -70.49 113.66 20.06 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.914 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.57 -173.04 0.74 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.672 2.248 . . . . 0.0 112.61 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.2 pm0 -89.28 30.24 1.0 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.806 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.17 32.3 1.78 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.777 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -111.46 -59.48 1.97 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.703 0.251 . . . . 0.0 110.664 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -136.97 87.06 2.25 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.876 0.369 . . . . 0.0 110.604 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.09 130.54 16.63 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.716 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.52 114.16 26.46 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.815 0.34 . . . . 0.0 111.176 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.13 62.98 0.68 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.481 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.4 tttp 57.78 36.95 26.98 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.02 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.55 169.63 15.22 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.032 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.17 -30.61 65.16 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.362 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.78 144.07 55.31 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.73 0.3 . . . . 0.0 111.247 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.763 HG12 HG22 ' A' ' 46' ' ' THR . 20.5 t -129.97 140.2 49.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.099 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -108.62 67.6 0.67 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.346 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.763 HG22 HG12 ' A' ' 44' ' ' VAL . 9.0 t -168.83 106.67 0.44 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.947 0.403 . . . . 0.0 111.313 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.65 HG11 ' HG3' ' A' ' 64' ' ' GLU . 19.7 t -109.24 -24.46 4.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.566 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -70.87 143.66 50.94 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 111.141 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.9 t -110.7 139.25 35.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.624 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -91.06 122.07 33.4 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.82 0.343 . . . . 0.0 111.018 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.445 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.82 160.13 14.16 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.491 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.0 tp -113.1 135.46 53.78 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.847 0.356 . . . . 0.0 111.163 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.1 152.08 40.24 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.815 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -47.51 155.28 0.37 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.463 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 67.6 11.25 8.28 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.247 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.05 66.46 1.91 Allowed Glycine 0 C--N 1.338 0.667 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.061 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -131.95 120.12 22.05 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.655 0.264 . . . . 0.0 110.617 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.3 m -89.16 120.49 30.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.883 0.373 . . . . 0.0 111.062 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.445 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 33.4 p90 -112.75 146.06 39.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.392 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 80.1 m-85 -120.09 141.54 49.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.748 0.309 . . . . 0.0 111.063 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -127.75 149.08 50.4 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -119.44 129.33 54.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.932 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.8 p -74.94 -35.36 62.16 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.537 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.65 ' HG3' HG11 ' A' ' 47' ' ' VAL . 13.5 mt-10 -59.6 -60.19 4.24 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.694 0.283 . . . . 0.0 111.177 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.0 p -78.78 -34.43 45.53 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.204 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.49 44.66 20.77 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.25 -0.5 . . . . 0.0 112.591 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -136.74 134.4 37.08 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.886 0.374 . . . . 0.0 111.057 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.39 145.75 39.18 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.624 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -133.05 157.55 44.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.059 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -126.64 31.51 5.32 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.31 135.21 15.57 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.797 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.1 pttm -60.01 146.19 83.02 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.718 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.86 94.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.934 2.422 . . . . 0.0 112.753 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.05 95.13 0.19 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.794 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.6 t0 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.064 -0.97 . . . . 0.0 111.297 -179.508 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 120.725 0.298 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.37 133.71 26.98 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.717 2.278 . . . . 0.0 112.529 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.91 97.96 11.23 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.999 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.19 177.58 5.81 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.085 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.74 147.58 19.09 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.278 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.461 ' HB2' HD11 ' A' ' 23' ' ' ILE . 22.4 mtt180 -71.51 80.86 0.8 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.96 0.41 . . . . 0.0 110.246 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.412 ' CZ3' ' HB2' ' A' ' 28' ' ' GLN . 86.8 m95 -114.54 140.48 48.73 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.954 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 11.8 p -110.7 133.25 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.594 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -90.44 130.15 36.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.003 0.43 . . . . 0.0 111.221 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.15 148.57 19.51 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.371 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.411 HD12 ' N ' ' A' ' 11' ' ' ILE . 1.5 mp -101.08 138.18 26.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.665 0.269 . . . . 0.0 110.937 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.68 161.76 20.15 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.167 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.8 m -41.87 148.64 0.16 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.739 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.452 ' HB3' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 82.16 -57.04 0.22 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.058 -179.528 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.79 58.39 0.03 OUTLIER Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.446 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.452 ' CE2' ' HB3' ' A' ' 14' ' ' GLU . 29.9 m-85 -124.78 138.78 54.26 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.718 0.295 . . . . 0.0 111.018 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -100.27 117.27 34.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.916 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.421 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 24.9 p90 -110.89 151.53 27.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.557 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 64.9 m-85 -124.39 149.54 46.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.911 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -131.84 145.81 51.77 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.175 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.406 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 2.6 t0 -110.64 123.13 49.41 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.098 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.82 -25.68 27.95 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.224 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.461 HD11 ' HB2' ' A' ' 6' ' ' ARG . 2.0 mp -57.3 -54.73 26.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.098 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.6 m -97.62 -38.55 9.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.099 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.07 53.24 1.52 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.265 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -135.75 129.33 32.42 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.797 0.332 . . . . 0.0 111.251 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.54 145.63 38.93 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.412 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -132.91 168.36 18.57 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.073 -179.672 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.421 ' CZ3' ' HB3' ' A' ' 18' ' ' TYR . 90.2 m95 -127.46 -47.13 1.44 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.847 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.7 134.09 37.13 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.664 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -68.16 133.91 91.54 Favored Pre-proline 0 N--CA 1.463 0.216 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.191 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.87 -176.36 2.04 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.659 2.239 . . . . 0.0 112.606 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -97.83 41.24 1.13 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.19 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.27 41.98 0.12 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.854 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -114.24 -59.43 2.02 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.588 0.232 . . . . 0.0 110.708 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.73 93.23 3.87 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.609 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -114.87 140.79 16.61 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.615 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -143.43 98.24 3.22 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.974 0.416 . . . . 0.0 111.212 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.11 78.35 1.67 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.787 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.05 156.01 1.24 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.985 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 59.68 -163.11 0.24 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.127 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 81.1 p -57.28 139.76 51.89 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.84 0.353 . . . . 0.0 110.967 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.76 161.28 10.39 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.874 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.62 146.12 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.755 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.572 ' O ' HG22 ' A' ' 46' ' ' THR . 0.0 OUTLIER -117.23 150.55 38.58 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.713 179.638 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 45' ' ' LYS . 10.3 t 50.1 -175.65 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.063 0.545 . . . . 0.0 112.155 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.486 ' O ' HG12 ' A' ' 47' ' ' VAL . 8.2 t -144.76 31.64 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.12 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.471 ' CH2' ' HB2' ' A' ' 62' ' ' ASN . 65.5 m95 -118.65 143.59 46.72 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.983 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 12.8 p -104.02 139.52 24.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.761 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -90.76 122.16 33.26 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.923 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.72 156.36 15.7 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.611 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.7 tp -108.99 137.85 46.26 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.76 0.314 . . . . 0.0 111.247 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.99 152.08 48.35 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.95 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -47.28 154.19 0.42 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.77 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 67.25 10.96 8.11 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.118 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.18 66.56 1.94 Allowed Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.171 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -130.67 108.05 9.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.742 0.306 . . . . 0.0 110.694 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.6 m -80.63 120.44 24.57 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.864 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.427 ' CZ ' ' HA3' ' A' ' 51' ' ' GLY . 33.2 p90 -112.66 146.16 39.15 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.014 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 70.3 m-85 -119.99 141.92 49.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.804 0.335 . . . . 0.0 110.877 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -127.06 145.7 50.63 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.08 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.471 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 51.4 t-20 -114.02 126.23 54.89 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.162 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.0 p -75.92 -24.61 55.57 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.445 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -56.23 -62.43 1.72 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.287 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.0 p -91.37 -37.66 13.09 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.066 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.73 49.69 2.88 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.131 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -135.48 138.18 42.88 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.917 0.389 . . . . 0.0 111.231 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.35 140.45 38.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.805 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -133.57 157.85 44.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.774 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -126.2 33.67 4.99 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.879 0.371 . . . . 0.0 110.753 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -145.74 123.95 12.22 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.442 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.98 113.78 8.15 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.975 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.87 -177.48 0.25 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.787 2.325 . . . . 0.0 112.796 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.87 163.96 21.79 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.731 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 t0 . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.549 -0.738 . . . . 0.0 110.84 179.701 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 120.681 0.277 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.66 128.06 15.57 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.867 2.378 . . . . 0.0 112.491 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 m -74.68 -36.49 62.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.15 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -109.53 164.78 12.2 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.789 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.74 130.47 3.53 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.664 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.492 ' HB3' HD21 ' A' ' 22' ' ' LEU . 1.5 mmt180 -92.55 85.76 5.4 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.925 0.393 . . . . 0.0 110.542 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.57 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 80.1 m95 -108.29 132.11 54.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.905 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 1.6 t -103.46 132.14 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.469 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.66 129.65 36.75 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.965 0.412 . . . . 0.0 111.311 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.408 ' HA3' ' CE1' ' A' ' 18' ' ' TYR . . . -135.47 148.72 19.73 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.571 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.0 mm -95.43 125.82 48.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.481 0.182 . . . . 0.0 110.69 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.25 148.03 51.97 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.873 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.51 -150.54 0.39 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.549 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -56.62 -26.33 55.45 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.68 43.27 0.02 OUTLIER Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.635 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -93.24 111.95 23.74 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -73.35 116.69 14.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.408 ' CE1' ' HA3' ' A' ' 10' ' ' GLY . 17.9 p90 -110.86 151.72 27.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.203 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 55.3 m-85 -123.97 149.17 46.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.873 0.368 . . . . 0.0 110.975 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -133.99 139.46 46.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.798 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.57 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 16.6 t70 -110.14 126.38 54.0 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.551 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.492 HD21 ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -83.43 -31.19 26.75 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.742 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.3 mt -56.56 -45.53 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.78 0.324 . . . . 0.0 111.031 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.36 -35.2 9.67 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.166 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.92 41.52 6.29 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.171 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -128.88 153.62 47.3 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.895 0.379 . . . . 0.0 111.372 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.5 p -95.37 149.73 21.05 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.89 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.85 167.17 21.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.955 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -127.54 6.38 6.26 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.923 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -136.43 138.12 41.16 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.08 114.34 48.03 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.899 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.16 -179.98 0.98 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.805 2.337 . . . . 0.0 112.483 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -73.2 106.85 5.21 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.929 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.03 -59.13 0.45 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.744 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 25.1 t80 66.97 -75.23 0.06 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.545 0.338 . . . . 0.0 111.1 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -93.04 -33.18 14.21 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.569 0.223 . . . . 0.0 110.892 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.95 -110.75 3.58 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.286 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.4 54.13 2.24 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.98 0.419 . . . . 0.0 110.787 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.4 mt -143.89 108.72 4.93 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.727 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 61.97 93.49 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.537 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.6 mttt -107.94 94.05 4.87 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.048 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.3 p -84.12 168.03 16.22 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.018 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.32 172.92 15.14 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.881 0.372 . . . . 0.0 111.717 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.464 ' O ' HG22 ' A' ' 44' ' ' VAL . 12.2 p -93.91 42.99 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.216 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.429 ' O ' HG23 ' A' ' 46' ' ' THR . 0.4 OUTLIER -128.28 28.17 5.52 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.99 179.649 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -161.28 130.17 4.55 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.882 179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.634 HG11 ' CG ' ' A' ' 64' ' ' GLU . 12.5 t -97.77 37.82 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.01 0.434 . . . . 0.0 110.911 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.471 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 44.9 m95 -136.96 140.87 42.53 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 p -104.44 145.89 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.403 ' HG3' ' CG2' ' A' ' 58' ' ' THR . 41.1 tt0 -96.97 122.55 40.08 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.103 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.62 158.33 14.84 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.621 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.4 tp -106.59 141.7 37.44 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.862 0.363 . . . . 0.0 111.267 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.443 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 34.1 t -133.58 152.22 51.85 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.826 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.79 153.52 0.39 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.55 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.59 11.41 8.1 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.12 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.81 65.85 2.28 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.969 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.443 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 34.3 m-85 -128.19 103.89 7.44 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.756 0.312 . . . . 0.0 110.7 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.504 HG22 ' CE1' ' A' ' 60' ' ' TYR . 29.4 m -76.19 120.05 20.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.852 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -112.87 145.96 39.77 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.721 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.504 ' CE1' HG22 ' A' ' 58' ' ' THR . 11.0 m-85 -120.33 141.86 49.66 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.736 0.303 . . . . 0.0 110.79 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -124.57 152.36 43.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.471 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 18.3 t-20 -113.68 136.37 52.91 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.771 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.9 p -87.27 -30.84 20.59 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.814 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.634 ' CG ' HG11 ' A' ' 47' ' ' VAL . 11.3 mt-10 -60.58 -62.96 1.48 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.65 0.262 . . . . 0.0 111.045 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 75.1 p -84.02 -44.56 14.0 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.094 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.11 48.63 2.39 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.453 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -134.23 140.74 46.67 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.761 0.315 . . . . 0.0 110.855 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.2 p -80.71 148.99 29.9 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.0 tpt85 -134.02 155.67 49.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.732 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -126.5 25.12 6.57 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.788 0.327 . . . . 0.0 111.286 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -146.4 133.5 20.4 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.135 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -59.86 111.85 4.5 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.642 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -56.96 101.9 0.1 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.843 2.362 . . . . 0.0 112.576 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -90.0 126.85 35.9 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.874 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.0 t70 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.617 -179.925 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.71 0.29 . . . . 0.0 111.523 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.35 155.82 59.66 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.841 2.361 . . . . 0.0 112.458 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 t -145.98 104.74 3.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.87 0.367 . . . . 0.0 111.076 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -134.09 33.14 3.4 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.758 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.75 81.84 1.6 Allowed Glycine 0 C--N 1.337 0.591 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.616 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.501 ' HB2' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -79.33 75.66 5.9 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.853 0.358 . . . . 0.0 111.109 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.423 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 82.2 m95 -121.26 137.39 54.71 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.052 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.5 p -115.55 133.91 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.961 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 35' ' ' PHE . 44.0 tt0 -90.61 132.09 35.94 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.866 0.365 . . . . 0.0 111.174 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.73 147.73 18.76 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.549 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.3 mm -95.96 141.65 15.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.634 0.254 . . . . 0.0 110.914 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.09 162.08 25.37 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.805 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 m -46.66 152.7 0.45 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.528 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 77.48 -54.72 0.53 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.424 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.24 50.49 0.04 OUTLIER Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.578 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -115.85 141.2 48.41 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.506 0.193 . . . . 0.0 110.528 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -105.54 117.07 33.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.77 0.319 . . . . 0.0 110.825 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -110.74 151.27 27.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.721 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -124.84 149.23 47.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.751 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -127.48 144.64 51.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.076 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.423 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 29.1 t70 -117.34 123.23 45.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.679 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.409 HD11 ' HG2' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -84.35 -25.72 28.96 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.157 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 6' ' ' ARG . 6.5 mt -58.71 -46.7 90.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.576 0.227 . . . . 0.0 110.871 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -104.46 -32.24 9.09 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.526 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.56 45.39 5.24 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.265 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -132.77 132.45 42.26 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.815 0.34 . . . . 0.0 111.378 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.2 p -86.26 142.0 28.88 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.709 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.02 167.62 18.75 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.193 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -127.72 7.01 6.19 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.672 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.6 130.12 51.85 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.474 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 0.4 OUTLIER -66.34 113.93 14.8 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.004 -179.291 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.46 -175.12 0.4 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.996 2.464 . . . . 0.0 112.828 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.51 29.35 1.74 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.612 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -132.9 -46.43 0.11 Allowed Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.82 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 9' ' ' GLU . 52.8 t80 -54.01 -64.12 0.93 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.645 0.222 . . . . 0.0 111.105 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.474 ' HB2' ' HE2' ' A' ' 31' ' ' LYS . 20.6 mt-30 -153.36 81.67 1.18 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.732 0.301 . . . . 0.0 110.723 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.33 172.82 23.34 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.882 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -72.21 174.95 6.51 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.811 0.338 . . . . 0.0 111.246 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.34 157.83 18.86 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.436 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -78.15 157.78 29.3 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.246 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.15 169.18 21.3 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.369 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.97 -37.09 62.01 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.169 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.93 99.22 12.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.01 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.4 t -128.84 130.18 68.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.291 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.48 161.1 29.48 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.96 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.7 p 47.08 52.89 11.34 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.665 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.51 ' O ' HG22 ' A' ' 47' ' ' VAL . 11.7 p -102.1 9.58 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.917 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.523 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 72.0 m95 -117.31 141.98 47.64 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.711 0.291 . . . . 0.0 111.036 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.3 p -107.22 141.61 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.022 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -90.78 122.33 33.42 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.016 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.91 158.4 14.87 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.469 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.45 131.65 55.46 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.866 0.365 . . . . 0.0 111.424 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.08 151.94 27.5 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.794 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -44.56 148.54 0.48 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.327 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 82.6 -51.67 0.19 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.073 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 140.26 51.18 0.05 OUTLIER Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.451 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -117.51 118.68 32.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.608 0.242 . . . . 0.0 110.498 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.46 120.39 25.41 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.846 0.355 . . . . 0.0 111.117 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -112.75 146.11 39.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.436 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -119.75 141.93 49.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.843 0.354 . . . . 0.0 110.84 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -123.33 154.74 38.5 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.859 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.523 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 39.3 t30 -113.5 122.14 46.39 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.924 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.3 p -74.26 -30.74 62.26 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.716 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -64.58 -66.97 0.47 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.517 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.2 p -78.09 -48.95 14.87 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.517 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.82 42.25 2.7 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.599 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -129.67 133.24 46.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.763 0.316 . . . . 0.0 110.894 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.19 146.72 45.35 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.7 157.64 44.37 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.075 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -126.47 30.79 5.49 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.84 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -148.48 122.47 9.43 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.609 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -65.42 123.75 85.23 Favored Pre-proline 0 CA--C 1.529 0.173 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.665 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 72' ' ' LYS . 33.4 Cg_exo -61.62 85.25 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.617 2.212 . . . . 0.0 111.841 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.98 119.59 39.12 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.877 -179.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.32 -0.848 . . . . 0.0 111.076 179.682 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.743 0.306 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.54 151.53 64.69 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.869 2.38 . . . . 0.0 112.963 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.4 t -102.68 -35.25 8.75 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.447 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.59 178.99 9.24 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.718 0.294 . . . . 0.0 111.298 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -123.07 139.76 12.57 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.543 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.73 ' H ' HD11 ' A' ' 23' ' ' ILE . 5.8 mmm180 -78.99 92.83 5.0 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.752 0.311 . . . . 0.0 110.722 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.502 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 91.1 m95 -127.14 137.05 52.9 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.047 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 14.9 p -117.34 147.85 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.265 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.68 131.67 46.46 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.194 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.59 148.58 19.68 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.956 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.6 mm -94.35 144.17 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.72 0.295 . . . . 0.0 111.185 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.603 HG23 ' CD1' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -127.16 161.67 27.96 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.969 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 t -45.76 152.22 0.37 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.637 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 80.66 -55.82 0.33 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.187 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.16 51.9 0.05 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.484 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -118.32 151.65 37.3 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.57 0.224 . . . . 0.0 110.585 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -109.94 116.7 32.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.798 0.332 . . . . 0.0 110.871 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.603 ' CD1' HG23 ' A' ' 12' ' ' THR . 17.2 p90 -111.15 151.43 28.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.941 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 57.0 m-85 -124.41 149.29 46.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.783 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -125.86 149.53 48.59 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.232 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.672 ' OD1' HD12 ' A' ' 23' ' ' ILE . 23.5 t70 -119.11 122.02 41.12 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.022 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.632 HD21 ' HB3' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -82.82 -26.46 31.69 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.73 HD11 ' H ' ' A' ' 6' ' ' ARG . 3.5 mt -56.53 -46.8 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.759 0.314 . . . . 0.0 111.084 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m -103.83 -44.38 5.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.003 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.23 36.9 3.23 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.57 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -119.32 156.88 29.21 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.803 0.335 . . . . 0.0 111.297 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 p -100.09 131.14 46.22 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.033 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -122.2 168.4 12.05 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.832 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.433 ' CZ3' ' HB3' ' A' ' 18' ' ' TYR . 93.3 m95 -127.38 -45.34 1.52 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.078 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -73.41 119.6 17.87 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.578 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.02 125.27 91.25 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.748 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.39 167.05 28.01 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.631 2.22 . . . . 0.0 112.236 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -66.76 120.06 12.87 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.519 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.58 -97.1 0.87 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.444 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 25.7 t80 66.97 160.12 0.15 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.521 0.2 . . . . 0.0 110.975 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -60.78 101.15 0.13 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.828 0.347 . . . . 0.0 110.671 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.68 -123.34 6.09 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.109 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.7 t70 61.43 100.27 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.996 0.427 . . . . 0.0 111.569 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 mp -105.94 38.06 2.1 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.143 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.0 mtpp -140.89 136.42 32.28 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.566 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -81.78 56.68 3.13 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.672 0.272 . . . . 0.0 111.305 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.1 m 65.12 166.78 0.18 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.16 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.06 143.83 47.31 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.557 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.492 ' O ' HG12 ' A' ' 44' ' ' VAL . 11.0 t -137.6 37.65 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.362 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -144.22 80.89 1.66 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.692 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.06 105.46 8.4 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.259 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.726 HG13 ' CD1' ' A' ' 48' ' ' TRP . 11.9 p -104.04 -18.12 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.775 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.726 ' CD1' HG13 ' A' ' 47' ' ' VAL . 94.2 m95 -113.7 145.15 41.78 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.516 0.198 . . . . 0.0 110.913 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.6 t -111.46 131.66 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.419 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.468 ' HG3' ' CD1' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -94.6 122.25 37.0 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.941 0.401 . . . . 0.0 111.521 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.446 ' HA3' ' CE2' ' A' ' 59' ' ' TYR . . . -118.86 158.0 15.02 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.265 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.43 121.59 45.26 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.753 0.277 . . . . 0.0 110.943 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.17 142.13 31.35 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.803 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 55.73 95.06 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.461 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 68.1 -63.29 0.33 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.052 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.37 40.21 0.05 OUTLIER Glycine 0 CA--C 1.518 0.272 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.696 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -85.31 121.28 27.81 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.11 120.03 23.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.998 0.427 . . . . 0.0 111.229 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.446 ' CE2' ' HA3' ' A' ' 51' ' ' GLY . 25.2 p90 -113.05 146.18 39.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.816 179.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.485 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 2.6 m-85 -119.59 141.74 49.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.935 0.398 . . . . 0.0 111.165 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -129.65 155.02 46.52 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.573 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -113.48 129.23 56.59 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.891 0.377 . . . . 0.0 111.265 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.6 p -93.39 22.27 5.41 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.757 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -95.7 -60.04 1.74 Allowed 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 120.666 0.269 . . . . 0.0 110.707 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.8 t -110.39 -36.2 5.85 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.14 73.58 0.71 Allowed Glycine 0 C--N 1.335 0.513 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.707 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -149.9 126.89 11.18 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.819 0.342 . . . . 0.0 111.007 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.49 150.69 25.84 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.697 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.6 ttt-85 -130.73 155.35 46.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.261 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -126.59 27.1 6.17 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.11 162.27 40.3 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.724 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -86.3 107.68 14.38 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.993 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.95 143.39 49.77 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.71 2.273 . . . . 0.0 112.694 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -168.06 111.12 0.61 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.947 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.6 t70 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.438 -0.791 . . . . 0.0 111.386 -179.84 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.689 0.28 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.04 143.72 36.68 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.847 2.364 . . . . 0.0 112.391 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 t -124.42 141.11 52.33 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.044 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.2 124.02 35.72 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.75 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.17 79.49 0.04 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.75 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.419 ' CG ' HD11 ' A' ' 23' ' ' ILE . 31.3 mmt180 -87.16 68.53 9.95 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.08 0.467 . . . . 0.0 110.516 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.433 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 80.9 m95 -105.75 140.17 39.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.754 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 p -116.17 133.57 62.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.085 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -90.7 131.51 36.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.272 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.25 148.58 19.65 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.66 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.8 mm -98.01 127.08 50.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.585 0.231 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.574 HG23 ' CE1' ' A' ' 18' ' ' TYR . 11.2 p -133.43 150.06 51.78 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.947 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.02 -149.78 0.41 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.622 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.28 -29.57 47.64 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.13 44.09 0.02 OUTLIER Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.56 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -92.81 112.75 24.82 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -74.54 116.8 15.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.949 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.574 ' CE1' HG23 ' A' ' 12' ' ' THR . 20.7 p90 -111.02 151.51 27.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.517 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -124.41 148.81 47.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.949 0.405 . . . . 0.0 110.93 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -136.56 147.88 47.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.132 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.433 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 4.7 t0 -112.09 122.05 46.68 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.653 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.39 -26.94 27.99 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.274 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.419 HD11 ' CG ' ' A' ' 6' ' ' ARG . 6.3 mt -60.72 -53.39 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.733 0.302 . . . . 0.0 110.871 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.06 -36.51 12.08 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.22 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.04 60.19 1.34 Allowed Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.293 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -142.64 129.24 20.27 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.844 0.354 . . . . 0.0 111.415 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.7 p -85.29 132.19 34.29 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.54 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -131.91 168.3 18.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.22 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.404 ' HH2' ' HG1' ' A' ' 12' ' ' THR . 73.3 m95 -127.81 7.37 6.18 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.705 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -120.44 139.89 52.18 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.662 0.268 . . . . 0.0 110.713 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -77.64 131.67 70.47 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.962 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.56 -171.08 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.679 2.253 . . . . 0.0 112.253 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.62 89.9 0.11 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.907 0.384 . . . . 0.0 110.732 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.97 -90.95 0.68 Allowed Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.652 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 67.7 t80 66.16 -77.45 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 122.431 0.293 . . . . 0.0 110.883 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -142.87 31.78 1.42 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.87 0.367 . . . . 0.0 110.791 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -124.26 114.42 2.27 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.151 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -63.43 123.77 19.61 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.669 0.271 . . . . 0.0 111.154 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 tp -103.63 108.19 19.36 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 1.9 mmtp -65.9 135.63 55.04 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.554 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 52.15 -171.23 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.35 0.406 . . . . 0.0 111.386 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.3 m 57.16 26.11 11.75 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.798 0.332 . . . . 0.0 111.073 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -165.11 -177.11 4.43 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.19 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.5 p -59.34 140.8 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 120.891 0.377 . . . . 0.0 111.446 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -108.56 127.28 53.8 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.104 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 48' ' ' TRP . 11.9 t -95.53 -177.51 4.1 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.097 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.421 HG12 ' OD1' ' A' ' 62' ' ' ASN . 19.5 t -78.81 -31.27 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.404 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.468 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 76.5 m95 -93.87 143.38 26.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.82 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.9 p -108.37 137.88 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.957 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -91.08 122.05 33.39 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.001 0.429 . . . . 0.0 110.952 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.75 151.38 17.75 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.349 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.81 133.4 54.83 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.911 0.386 . . . . 0.0 111.419 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.1 t -112.29 151.8 29.25 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.84 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -45.08 154.63 0.14 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.333 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 80.54 -55.58 0.34 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.061 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.16 55.06 0.03 OUTLIER Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.407 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -124.77 124.24 41.7 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.632 0.253 . . . . 0.0 110.538 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.3 m -93.56 120.95 34.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.85 0.357 . . . . 0.0 111.068 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -112.56 146.21 38.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.56 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.403 ' CE2' ' HG3' ' A' ' 72' ' ' LYS . 85.7 m-85 -119.93 141.86 49.24 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.848 0.356 . . . . 0.0 110.942 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -125.91 147.19 49.55 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.926 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.468 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 53.3 t30 -113.33 122.76 48.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.668 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.1 p -77.75 -23.1 49.4 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.558 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -55.08 -60.94 2.69 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.405 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.7 t -102.27 -38.43 7.66 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.441 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.72 46.8 1.73 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.607 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -123.54 121.12 34.81 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.781 0.324 . . . . 0.0 110.674 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.2 p -71.32 150.14 45.41 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -133.82 157.79 45.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.088 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -126.5 28.4 5.95 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.049 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -151.68 134.61 15.72 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.296 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.403 ' HG3' ' CE2' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -56.91 109.65 1.86 Allowed Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.827 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.4 105.17 1.94 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.604 2.202 . . . . 0.0 112.658 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.1 t70 68.01 158.62 0.15 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.357 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.7 t70 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.104 -0.951 . . . . 0.0 111.347 -179.65 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 120.334 0.111 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.79 94.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.759 2.306 . . . . 0.0 112.558 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.8 46.37 2.34 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.771 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -157.32 109.03 2.36 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.293 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.05 147.67 19.35 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.586 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.445 ' CD ' HD11 ' A' ' 23' ' ' ILE . 1.5 mpt_? -75.68 85.05 2.7 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.999 0.428 . . . . 0.0 110.464 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.409 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 89.6 m95 -125.11 148.92 48.33 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.228 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 2.0 t -118.14 132.88 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.503 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -90.89 129.83 36.89 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.942 0.401 . . . . 0.0 111.53 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.52 148.69 19.72 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.653 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.6 mm -105.18 125.47 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.5 0.19 . . . . 0.0 110.809 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.89 153.76 51.53 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.34 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.1 -148.02 0.43 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.748 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -55.03 -29.24 57.0 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.56 44.43 0.02 OUTLIER Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.358 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -92.51 113.95 26.36 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -73.86 116.64 14.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.845 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -111.02 151.46 27.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.218 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 85.3 m-85 -124.05 149.39 46.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.844 0.354 . . . . 0.0 111.092 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -131.87 140.36 49.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.77 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.409 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 9.5 t70 -109.8 125.67 52.97 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.74 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.15 -29.67 28.45 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.714 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.445 HD11 ' CD ' ' A' ' 6' ' ' ARG . 4.1 mt -54.65 -49.34 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.804 0.335 . . . . 0.0 110.882 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m -101.92 -39.13 7.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.292 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.73 44.84 3.29 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.347 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -127.91 135.54 50.12 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 111.477 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.8 t -85.94 147.57 26.17 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.665 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -133.74 167.79 19.88 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.92 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -127.44 8.94 6.54 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.663 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -132.06 137.98 47.99 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.424 ' HE3' ' OH ' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -62.09 132.66 93.84 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.351 -179.49 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.38 -177.21 2.88 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.681 2.254 . . . . 0.0 112.268 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.96 107.72 7.21 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.341 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 35' ' ' PHE . . . 94.25 -84.21 1.0 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.908 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 34' ' ' GLY . 24.2 t80 69.87 161.43 0.22 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.605 0.203 . . . . 0.0 110.738 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -66.66 88.14 0.14 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.912 0.387 . . . . 0.0 110.932 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.1 122.09 0.73 Allowed Glycine 0 CA--C 1.517 0.21 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.084 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -78.33 95.85 5.15 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.909 0.385 . . . . 0.0 111.26 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.3 mt -72.2 174.14 7.61 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.63 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -107.22 172.67 6.7 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.24 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 69.25 92.92 0.08 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.037 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.9 m -62.21 -34.32 76.25 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.323 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.47 127.29 35.83 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.97 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 p -100.55 144.08 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.302 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -83.95 151.53 25.0 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.307 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.9 t -162.78 97.22 0.95 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.393 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 47' ' ' VAL . 3.5 t -119.82 31.96 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.935 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -133.87 143.99 48.63 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.69 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.2 p -106.33 132.29 53.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.462 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -90.59 122.0 33.01 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.915 0.388 . . . . 0.0 110.945 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.409 ' HA3' ' CE1' ' A' ' 59' ' ' TYR . . . -118.86 152.88 17.17 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.351 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.74 129.05 55.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.954 0.407 . . . . 0.0 111.296 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.422 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 40.2 t -109.39 151.94 25.98 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.648 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -45.64 151.98 0.37 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.368 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.405 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 0.3 OUTLIER 82.77 -53.68 0.19 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.9 -179.334 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.52 55.78 0.04 OUTLIER Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.445 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 22.0 m-85 -123.7 129.25 50.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.524 0.202 . . . . 0.0 110.749 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.3 m -98.1 120.85 39.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.854 0.359 . . . . 0.0 111.086 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.409 ' CE1' ' HA3' ' A' ' 51' ' ' GLY . 30.0 p90 -112.64 145.94 39.51 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.596 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -120.25 142.26 49.21 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.736 0.303 . . . . 0.0 110.86 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -124.2 152.25 43.12 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.851 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.61 122.51 47.89 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.911 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.3 p -78.74 -24.97 44.51 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.447 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -59.47 -63.41 1.31 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.432 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.0 t -91.24 -40.27 11.62 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.377 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.87 56.43 1.08 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.736 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -136.22 139.2 42.58 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.802 0.334 . . . . 0.0 110.865 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 p -80.58 146.35 31.28 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.789 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.48 149.29 49.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.07 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -126.97 29.0 5.7 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.013 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -145.06 123.86 12.63 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.534 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -63.9 121.77 73.15 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.729 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.07 106.61 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.716 2.278 . . . . 0.0 112.591 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.17 110.54 11.66 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.627 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 t70 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.887 -179.64 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -76.26 -177.63 3.83 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.428 2.085 . . . . 0.0 112.71 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.4 t -138.88 113.87 9.34 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.156 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.5 tttp -145.79 94.84 2.55 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.782 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -175.79 169.38 42.07 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.689 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.0 mtt85 -135.71 99.94 4.33 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.752 0.311 . . . . 0.0 110.489 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.44 ' CZ3' ' HB2' ' A' ' 21' ' ' ASP . 58.2 m95 -126.15 141.21 52.03 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.117 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.8 p -114.72 134.48 57.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.826 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -90.64 130.87 36.61 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.913 0.387 . . . . 0.0 111.304 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.11 148.69 19.68 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.74 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.7 mm -98.09 125.74 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 120.452 0.168 . . . . 0.0 111.021 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.518 HG23 ' CE1' ' A' ' 18' ' ' TYR . 9.3 p -132.99 155.36 49.31 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.024 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.1 t 58.73 -148.09 0.48 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.67 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -62.0 -23.69 66.58 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.89 43.05 0.02 OUTLIER Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.577 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -94.0 112.24 24.05 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -75.0 116.45 15.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.002 0.429 . . . . 0.0 110.72 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.518 ' CE1' HG23 ' A' ' 12' ' ' THR . 14.2 p90 -111.03 151.71 27.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.388 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -124.05 149.35 46.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.819 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -134.42 147.98 50.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.679 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.44 ' HB2' ' CZ3' ' A' ' 7' ' ' TRP . 10.2 t70 -109.93 122.1 46.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.679 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.67 -23.64 29.35 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.4 mt -57.85 -52.53 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.636 0.255 . . . . 0.0 110.953 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.67 -41.12 6.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.16 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.44 53.02 0.95 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.433 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -133.57 127.73 33.73 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.857 0.361 . . . . 0.0 111.281 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.7 t -76.11 145.75 39.78 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.762 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -132.66 168.19 18.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.121 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -127.57 -46.79 1.44 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.802 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.99 129.97 35.03 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.537 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -71.11 133.93 85.54 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.015 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -73.06 -176.81 2.58 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.61 2.207 . . . . 0.0 112.576 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.84 31.57 1.59 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.496 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.18 33.45 0.38 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.009 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -111.33 -47.98 3.14 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.7 0.286 . . . . 0.0 110.629 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.84 -179.87 6.08 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.926 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.41 154.3 6.7 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.084 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -164.15 134.06 4.05 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.629 0.252 . . . . 0.0 111.355 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 pp -124.58 161.49 26.1 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.085 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.689 ' HG2' HG23 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -118.28 143.26 46.72 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.055 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -84.28 80.09 9.32 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.189 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.5 m 66.45 -76.9 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.289 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.21 122.29 30.0 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.632 0.253 . . . . 0.0 110.901 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.689 HG23 ' HG2' ' A' ' 40' ' ' LYS . 13.0 p -77.58 126.46 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.379 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -104.82 113.32 26.83 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.9 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.5 p -88.94 121.92 31.79 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.191 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.494 ' O ' HG22 ' A' ' 47' ' ' VAL . 8.2 p -113.93 21.72 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.615 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.453 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 85.4 m95 -119.02 143.68 46.95 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.715 0.293 . . . . 0.0 110.962 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.5 p -105.64 136.8 38.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.855 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -91.54 122.0 33.73 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.817 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.422 ' HA3' ' CZ ' ' A' ' 59' ' ' TYR . . . -118.75 153.38 16.98 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.431 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.23 141.5 45.86 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.113 0.482 . . . . 0.0 111.544 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.409 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 30.1 t -123.54 152.27 41.97 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.497 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 0.7 OUTLIER -44.7 156.23 0.09 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.849 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 22.2 m-20 76.88 -54.67 0.57 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.889 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.12 54.29 0.03 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.131 -0.556 . . . . 0.0 112.264 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 55' ' ' ASP . 18.3 m-85 -120.01 118.0 29.5 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.656 0.265 . . . . 0.0 110.811 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.47 120.67 29.0 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.01 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.432 ' HB3' ' CZ3' ' A' ' 70' ' ' TRP . 30.8 p90 -112.51 145.97 39.31 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.744 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -120.23 142.03 49.4 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.846 0.355 . . . . 0.0 110.95 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -130.27 150.55 51.46 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.341 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.461 HD22 HG22 ' A' ' 65' ' ' THR . 56.3 t30 -114.37 133.48 55.67 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.052 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.4 p -82.09 -26.26 33.79 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.617 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -62.58 -66.78 0.49 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.36 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.461 HG22 HD22 ' A' ' 62' ' ' ASN . 6.9 t -84.5 -34.77 23.27 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.307 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.21 49.88 3.83 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.601 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -129.52 137.07 50.59 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.801 0.334 . . . . 0.0 111.138 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.51 146.17 27.05 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.66 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.04 155.59 50.5 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.432 ' CZ3' ' HB3' ' A' ' 59' ' ' TYR . 94.1 m95 -126.32 29.95 5.69 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.926 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -148.12 127.93 13.46 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.558 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 125.82 90.33 Favored Pre-proline 0 N--CA 1.465 0.31 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.103 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.37 -178.45 2.58 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.685 2.257 . . . . 0.0 112.269 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.7 t70 75.9 158.8 0.21 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.712 0.292 . . . . 0.0 110.997 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.231 -179.617 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.656 0.265 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.29 125.7 19.27 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.911 2.408 . . . . 0.0 112.737 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.2 t -103.89 175.84 5.35 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.386 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -144.18 76.1 1.49 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.311 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.67 -88.54 0.07 OUTLIER Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.994 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.572 ' HB2' HD11 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -67.78 92.19 0.34 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.831 0.348 . . . . 0.0 111.409 -179.536 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -127.98 148.42 50.52 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.892 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 19' ' ' TYR . 2.2 t -119.3 129.06 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.758 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -90.76 131.98 36.11 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.95 0.405 . . . . 0.0 111.445 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.12 147.18 19.07 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.404 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.2 mm -100.39 123.9 53.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 120.465 0.174 . . . . 0.0 110.875 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.02 156.17 47.84 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.965 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 57.14 -148.32 0.5 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.523 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.43 -21.25 66.19 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.76 44.58 0.02 OUTLIER Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.411 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -92.83 105.46 17.59 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -73.36 116.67 14.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.929 0.395 . . . . 0.0 110.959 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.419 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 30.1 p90 -110.9 151.51 27.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.466 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 56.1 m-85 -124.32 149.47 46.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 111.21 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -131.81 142.26 49.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.964 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -109.54 124.35 50.95 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.528 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.66 -26.45 27.78 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.214 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.572 HD11 ' HB2' ' A' ' 6' ' ' ARG . 7.8 mt -62.65 -45.44 98.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.7 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 t -99.64 -35.83 9.7 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.301 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.9 62.52 1.3 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.335 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.19 157.19 33.93 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.94 0.4 . . . . 0.0 111.866 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.3 t -101.52 151.98 21.32 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.711 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.91 168.12 19.35 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.043 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.419 ' CZ3' ' HB3' ' A' ' 18' ' ' TYR . 98.3 m95 -127.57 7.49 6.32 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.706 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.12 131.97 47.3 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.544 0.211 . . . . 0.0 110.474 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -73.62 126.04 90.07 Favored Pre-proline 0 N--CA 1.462 0.17 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.875 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 31' ' ' LYS . 32.0 Cg_exo -61.64 -174.83 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.941 2.427 . . . . 0.0 112.469 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.89 35.98 0.75 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.624 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 160.22 71.95 0.02 OUTLIER Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.835 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 9' ' ' GLU . 23.0 t80 -88.85 -72.09 0.56 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.612 0.206 . . . . 0.0 110.684 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -149.15 39.15 0.82 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.826 0.346 . . . . 0.0 110.922 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.87 92.36 1.68 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.248 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -83.32 83.84 7.72 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.862 0.363 . . . . 0.0 110.983 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.9 mt -153.28 64.07 0.76 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.948 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.7 89.59 0.06 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.439 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.64 97.23 3.16 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.363 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.5 m -103.85 23.66 12.48 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.953 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.75 139.84 30.36 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.067 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.5 p -96.5 146.1 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.383 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.85 36.66 1.38 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.395 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 64.4 p -137.7 85.44 2.11 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.966 0.412 . . . . 0.0 110.812 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.5 p -80.15 -31.41 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.431 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.475 ' CZ3' ' HB2' ' A' ' 62' ' ' ASN . 80.6 m95 -82.01 139.17 34.67 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.83 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.7 p -115.43 135.17 56.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.889 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.2 122.36 35.51 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.945 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.401 ' HA3' ' CE1' ' A' ' 59' ' ' TYR . . . -118.52 158.89 14.58 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.718 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.0 tp -107.71 136.8 46.85 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.954 0.407 . . . . 0.0 111.174 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.469 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 44.2 t -126.29 152.26 46.41 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.953 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -45.85 152.31 0.37 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.651 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 68.25 11.49 8.38 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.119 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.86 64.72 2.48 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.169 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.469 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 34.0 m-85 -128.03 106.55 9.15 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.731 0.3 . . . . 0.0 110.658 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.81 120.27 23.21 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.815 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.401 ' CE1' ' HA3' ' A' ' 51' ' ' GLY . 31.1 p90 -112.97 145.86 40.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.822 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -120.41 141.84 49.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.91 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -128.52 153.0 47.64 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.744 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.565 ' OD1' HG22 ' A' ' 65' ' ' THR . 20.8 t-20 -113.77 134.43 54.77 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.073 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.9 p -89.15 -29.8 19.06 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.51 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -59.1 -60.49 3.79 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.507 0.194 . . . . 0.0 111.178 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.565 HG22 ' OD1' ' A' ' 62' ' ' ASN . 4.1 t -91.09 -36.19 14.16 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.236 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.51 50.06 2.84 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.65 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -130.42 135.61 48.19 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.846 0.355 . . . . 0.0 111.198 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.93 145.1 26.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.784 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.23 143.96 46.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.856 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -126.23 19.84 7.53 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.226 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -137.87 16.38 2.86 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp 71.14 137.07 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.13 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.14 151.06 66.76 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.591 2.194 . . . . 0.0 112.704 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -127.07 167.31 16.13 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.349 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.1 t70 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.421 -0.799 . . . . 0.0 110.961 179.824 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.1 t0 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 120.633 0.254 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.55 118.71 5.18 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.89 2.393 . . . . 0.0 112.58 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 t -82.55 81.22 8.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.633 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 ptpm? -117.33 114.01 22.96 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.795 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.11 165.93 54.69 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.885 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.487 ' HB2' HD11 ' A' ' 23' ' ' ILE . 5.1 mtt-85 -104.16 78.35 1.5 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.992 0.425 . . . . 0.0 110.624 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.533 ' CH2' ' HB2' ' A' ' 21' ' ' ASP . 91.6 m95 -109.17 141.6 41.17 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.75 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.5 p -114.64 135.4 54.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.978 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -90.41 130.42 36.49 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.881 0.372 . . . . 0.0 110.756 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.87 148.18 19.33 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.783 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.6 mm -97.16 142.12 14.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.723 0.296 . . . . 0.0 111.21 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.92 161.68 26.09 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.974 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -44.25 150.55 0.29 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.599 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.432 ' HB3' ' CE2' ' A' ' 16' ' ' TYR . 0.8 OUTLIER 81.1 -56.83 0.29 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.212 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.53 49.54 0.05 OUTLIER Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.585 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 14' ' ' GLU . 31.3 m-85 -113.44 148.55 35.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.538 0.209 . . . . 0.0 110.487 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -108.67 116.75 32.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.935 0.398 . . . . 0.0 110.824 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -111.35 151.79 28.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.122 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -124.17 149.69 46.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.709 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -135.55 147.74 48.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.224 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.533 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 5.9 t70 -113.66 122.28 46.67 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.858 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.4 -26.56 30.3 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.346 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.487 HD11 ' HB2' ' A' ' 6' ' ' ARG . 2.1 mt -59.33 -50.5 79.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-O 120.69 0.281 . . . . 0.0 111.023 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 m -98.74 -50.22 4.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.977 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.74 55.34 0.66 Allowed Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.456 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -137.68 142.5 41.09 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.808 0.337 . . . . 0.0 111.306 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.34 130.79 35.66 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.792 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -124.11 168.75 12.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.8 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -127.27 -45.95 1.51 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.788 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.03 136.46 46.69 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.361 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -65.32 119.36 58.73 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.818 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.97 171.34 0.8 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.741 2.294 . . . . 0.0 112.614 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -68.12 84.42 0.24 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.609 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.89 -78.77 0.34 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.772 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.1 t80 67.33 -75.32 0.06 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.34 0.256 . . . . 0.0 110.986 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -154.48 100.61 2.28 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.64 0.257 . . . . 0.0 110.748 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -139.46 -159.53 8.02 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.847 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.79 171.33 8.15 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.776 0.322 . . . . 0.0 111.122 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tp -96.77 32.91 1.96 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.992 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -92.02 144.09 25.8 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.075 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.38 34.55 3.73 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.17 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.3 m -111.82 134.3 53.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.687 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 62.71 -174.57 0.15 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.597 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.8 t -112.09 155.79 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.098 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.79 110.93 0.72 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.424 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.43 -178.27 6.86 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.117 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.515 ' O ' HG12 ' A' ' 47' ' ' VAL . 13.2 t -95.8 37.08 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.23 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.463 ' CH2' ' HB2' ' A' ' 62' ' ' ASN . 65.3 m95 -130.12 144.28 51.26 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.204 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 2.3 t -101.8 156.12 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.579 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -113.25 121.89 45.81 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.67 0.271 . . . . 0.0 111.267 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.484 ' HA3' ' CE2' ' A' ' 59' ' ' TYR . . . -119.13 154.94 16.25 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.826 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -113.16 121.95 46.04 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 57' ' ' PHE . 0.6 OUTLIER -142.76 142.09 31.85 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.444 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 56' ' ' GLY . 10.9 tt0 50.56 98.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.016 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 65.84 -63.54 0.22 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.35 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 176.14 40.27 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.733 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 53' ' ' SER . 20.9 m-85 -84.7 106.12 16.01 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.01 119.77 16.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.555 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.484 ' CE2' ' HA3' ' A' ' 51' ' ' GLY . 25.5 p90 -113.44 145.94 40.35 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.115 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 43.4 m-85 -120.08 141.77 49.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.787 0.327 . . . . 0.0 111.127 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -125.94 147.55 49.47 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.072 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.463 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 60.9 t30 -113.82 125.83 54.51 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.028 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.8 p -76.47 -26.58 55.52 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.332 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -58.46 -62.81 1.57 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.305 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.8 p -89.09 -44.27 10.46 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.131 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.47 52.78 1.52 Allowed Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.508 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -137.83 133.63 34.19 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.9 0.381 . . . . 0.0 111.025 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.4 p -75.34 145.57 41.62 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.919 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -132.82 158.13 43.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.807 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -125.97 28.17 6.18 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.869 0.366 . . . . 0.0 111.039 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -152.18 127.91 10.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.45 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -63.86 122.04 74.61 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.881 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -73.43 150.95 47.24 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.614 2.209 . . . . 0.0 112.689 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.11 -165.96 0.23 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.295 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.834 -179.917 . . . . . . . . 0 0 . 1 stop_ save_